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Abstract 
Advances in drug development and screening protocols have lead to a dramatic increase 
in the number of candidate drugs for clinical application. Many of these drugs show 
strong in vitro effects, however in vivo they suffer from off-site toxicity, reduced 
bioavailability, and poor water solubility. Drug delivery systems have been developed 
to encapsulate these drugs, only releasing them at target sites. This has led to a greater 
bioavailability at the target site, reducing the total drug dosage required for delivery, 
whilst increasing the concentration and potency of these drugs where they are required. 
However, one of the growing challenges for drug delivery systems is drug 
hydrophobicity. 
Microbubbles (MBs) have been used in medicine for over 30 years as ultrasound 
contrast enhancing agents. More recently, they have been shown to enhance drug 
delivery through co-delivery and ultrasound exposure. For improved delivery, a number 
of MB-drug composites have been developed, with many showing a high degree of 
success for hydrophilic drugs. The effective delivery of primarily hydrophobic drugs 
remains a challenge. A number of research groups have looked into forming MBs with 
the inclusion of an oil layer for drug encapsulation into the MB shell, giving an Oil 
Layer Inside MB (OLI-MB). Problems arose in each study ranging from; polydispersity, 
low stability, clinically unviable size distributions, ultrasound requirements for drug 
release outside of clinical application, and a general lack of control over the formation 
and the oil layer thickness per OLI-MB. 
This project aimed to develop a reliable and simple route for the formation of OLI-MBs 
with thin oil layers, at clinically relevant sizes and concentrations. Three formation 
routes were tested; oil nanodroplet self-assembly and spreading at MB surfaces, three-
phase flow through a single microfluidic flow focused nozzle, and activation of liquid 
perfluorocarbon-oil droplets into OLI-MBs. With the use of microfluidics, the first 
formation route was found to produce OLI-MBs of 2.4 μm at 106 OLI-MBs/ml, with oil 
layers 10s of nanometres thick, which showed ultrasound response. As such, this 
formation route is of further clinical interest. 
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1. Introduction 
 
Cancer is one of the leading health concerns worldwide. Globally it accounted for the 
deaths of 8.8 million people in 2015, and in Europe alone it causes the deaths of 1.9 
million people per year (20% of all deaths in Europe).1 In the UK, it is currently 
estimated that 1 in 2 people will get cancer in their lifetime.2 While research into the 
large field of cancer treatment has in general improved survival rates of at least 10 years, 
from 25% in the early 1970s to 50% in 2014, the treatment of certain types of cancer 
and patient have remained poor. For example, people diagnosed with pancreatic or lung 
cancer still suffer survival rates of 1% and 5% respectively.2 Progress has been made, 
but clearly improvements to diagnosis and treatment are still crucial. Treatment of 
cancer is commonly undertaken through a combination of surgery, radiation therapy, 
and chemotherapy. The latter of which forms the primary basis for treatment of 
advanced and metastatic tumours.3,4 All three of these methods have varying degrees of 
invasiveness, patient recovery time, and efficacy challenges. For the development of 
effective chemotherapy agents, the pharmaceutical industry faces a number of obstacles. 
Drugs can show high levels of toxicity towards healthy non-target tissue, a problem that 
is made worse when coupled with non-selective in vivo distribution. Many drugs also 
present poor aqueous solubility and stability issues.5–7 These can lead to irritant 
properties and damage to healthy, rapidly dividing tissue (e.g. bone marrow).3,5 In 
addition, these obstacles lead to a lower concentration of the drug at the target site, 
which decreases the desired effect from the drug whilst limiting the total dose the 
patient can receive. These problems often limit therapy and can lead to a higher chance 
for treatment failure. As such, recently there has been a wealth of study into the 
formation and use of drug delivery systems.4,5,8,9 The primary goals of these systems are 
to contain the drug safely until it is released and to enhance the selectivity of its 
distribution in vivo. This is to allow for a wider range of drugs to be administered to the 
patient, with a higher bioavailability of the drug at the target site, whilst reducing the 
negative side effects of off-site toxicity, enhancing patient treatment, recovery, and 
overall quality of life. Drug delivery systems are by no means limited only to 
chemotherapeutic drugs, but cancer treatment is often given as one of, if not the primary, 
driving forces for research into these systems. 
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	Fig.	1.1.	Schematic	of	a	liposome	encapsulating	(teardrop	shape)	hydrophilic	and	(trapezoid	shape)	hydrophobic	drug	payloads.	Formed	with	pegylated	lipid	and	targeting	agent,	for	‘stealth’	from	the	immune	 system	 and	 targeted	 delivery	 respectively.	 (Figure	 is	 not	 to	 scale.	 For	 example	 the	 PEG	chains	(pink)	would	realistically	be	far	longer	than	the	lipid	tails	(black)).		
Many drug delivery systems have now been developed including, porous 
nanoparticles,10–12 micelles,9,13 lipid emulsions,9 and polymer microcapsules,8,14 but 
perhaps the most prevalent system is currently that of liposomes.5 Figure 1.1 shows a 
schematic of a liposome loaded with hydrophilic and hydrophobic drugs. Liposomes 
consist of a lipid bilayer surrounding an aqueous core. Since the carrier is formed 
primarily from lipid, the structure is biodegradable after it has delivered its payload. 
Further, they can be functionalised, for example with pegylated lipid for ‘stealth’ 
against the immune system,4 and target-specific surface molecules to aid delivery (for 
example antibodies).15 The first liposomal anti-cancer drug to reach clinical approval 
was Doxorubicin, with the successful encapsulation of almost all traditional anti-cancer 
drugs following after that.5 This has led to the clinical approval of a number of 
commercial liposomal anti-cancer drug agents including Myocet, Doxil, DepoCyte, and 
DaunoXome, with many clinical trials occurring for other agents and their drugs.5 
Liposomal delivery has reduced the toxic effect of drugs in almost all studies, however 
there are drawbacks to liposomes as a drug delivery system. Liposome-specific side 
effects have been noted, for example, to cause skin reactions, most commonly hand-foot 
syndrome,16 and hypersensitivity, which can lead to cardiopulmonary distress.17 
Meanwhile, whilst liposomal delivery has reduced off-site toxicity, no significant 
improvement has been shown to overall patient survival. Whilst the aqueous core can be 
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loaded with a high concentration of hydrophilic drug, the space for hydrophobic and 
amphiphilic drugs, within the bilayer shell, is far more limited. Due to combinatorial 
chemistry and high-throughput screening, the number of drug candidates that present 
hydrophobicity or poor aqueous solubility has risen in recent years. Estimates vary that 
this accounts for 30-70% of all drugs currently being developed.18–22 If these drugs are 
delivered as free-drug in the blood stream they tend to agglomerate, reducing their 
efficacy and potentially causing toxic effects.20 As such there is a requirement for a 
system capable of safely transporting higher concentrations of these drugs into the body, 
and then delivering them efficiently to the target site.  
There are three primary solutions to aiding the delivery of poorly aqueous soluble 
drugs; making physical or chemical modifications to the drug, delivering the free drug 
in a co-solvent, or loading the drug into particles with hydrophobic cores and 
hydrophilic exteriors.21,23 Each of these routes has associated problems. One of the most 
typical ways to modify hydrophobic drugs for better aqueous solubilisation is to form 
them into a salt.22,24 However, salts can undergo common-ion self-association, 
becoming supersaturated and precipitate out of solution. These can become the acidic or 
basic forms, becoming toxic, leading to epigastric distress.22,24 A co-solvent is made 
when a water- and fat-miscible solvent is mixed with water. This solution is able to 
solubilise hydrophobic drugs more effectively, with some examples seeing a 500-fold 
increase in solubility of the drugs, due to reducing the concentration of water in the 
solution and breaking up the water’s hydrogen bonds.25,26 This can also allow poorly 
water stable drugs, which can rapidly degrade or transition through reactive states, to be 
placed in an environment to which they have increased stability.26 However, drugs have 
been shown to distribute inhomogenously throughout co-solvents.27 The co-solvent 
itself must also be non-toxic, blood compatible, non-sensitising, non-irritating, and 
physically and chemically inert. However, most candidate co-solvents that show a 
clinically relevant increase to drug solubility do not follow all of the aforementioned 
requirements.26,27 The third possible solution given was that of loading drugs into or 
onto hydrophobic drug delivery structures. 
This thesis deals with the prospect of forming hydrophobic structures for the loading 
and then delivery of drug payloads (more specifically oil coated microbubbles - this will 
be covered in greater detail in section 1.2). In recent years hydrophobic drug delivery 
systems have been the focus of a large amount of research. Oil emulsions, stabilised by 
a shell presenting a hydrophilic outside, remain one of the most simple and effective 
ways to transport hydrophobic drug into the body.6,28 Since these are typically similar in 
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structure to the liposomes described earlier, but with an oil core and a lipid monolayer 
shell as apposed to a liposome’s water core and bilayer, oil emulsions typically have the 
same benefits of having a biodegradable, functionalisable shell. 
The release mechanisms of most available drug delivery systems, which are covered by 
the above descriptions, can be either passive, e.g. due to drug leakage from the carrier, 
or active, due to environmental triggered release, e.g. in response to local temperature or 
pH.29,30 However, such mechanisms often lead to unpredictable drug release profiles 
when applied in vivo.31 Therefore, a hydrophobic drug delivery system with a controlled, 
externally activated, triggered release mechanism could offer a considerable advantage 
over existing technologies. Microbubbles (MBs) offer a promising solution to this 
problem. 
 
1.1. Microbubbles – Combining theranostic properties with 
controlled, externally activated release of payloads 
Over the past 35-45 years, MBs have become well established as the most powerful 
particulate for enhancing contrast in ultrasound (US) radiography.32 Fist generation 
MBs incorporated air cores, stabilised by human albumin shells.33 Second generation 
MBs are often stabilised by lipid, protein, or polymer, and changed the gas cores to be 
high molecular weight, with low aqueous-solubility and diffusion rates, in order to 
extend lifetime and vasculature perfusion (most commonly perfluorocarbon gases are 
used).33,34 Wider research has formed MBs incorporating a number of other materials, 
including gas cores of nitrogen, oxygen, and carbon dioxide and shells formed from 
sugars and solid particles (often referred to as armoured MBs), and has seen their wider 
use in fields such as particle propulsion and the recovery of oil from wastewater.33,35–40 
The compressibility of a MB’s gas core, combined with its high acoustic impedance 
mismatch against surrounding blood plasma, leads to a large scattering cross-section, 
which gives MBs a high acoustic response.41 This response can be as high as the 
response from bone or air in lung, but the response is higher from MBs compared to 
tissue when imaging non-linear, or sub- or super-harmonic response, providing a higher 
contrast-to-tissue ratio.42,43 These properties make MBs a powerful tool in diagnostic 
US imaging of the cardiovascular system and organs. As an example, contrast-
enhancement of US by MBs was recently evaluated to be a potential powerful tool for 
monitoring the success of liver cancer radio frequency ablation.44 Since they are used in 
the bloodstream, an important limitation has been that MBs are at maximum 8 µm in 
diameter in order to prevent issues with blood flow such as arterial embolisms.45  
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	Fig.	1.2.	Schematic	showing	MBs	in	the	vasculature,	and	how	US	can	drive	MBs	to	(a)	oscillate	under	stable	 cavitation	 ((aii)	 compressing	 and	 (aiii)	 expanding	 from	 their	 (ai)	 at	 rest	 size),	 (b)	 stream	fluid,	 and	 (c)	 jet	 towards	 the	 vasculature,	 injecting	 surrounding	 contents	 into	 cells.	 The	 Figure	presents	how	these	effects	can	aid	the	penetration	of	drugs	(green)	into	cells.	
 
More recently, MBs have also been shown to be capable of enhancing the therapeutic 
delivery of drugs.46 Figure 1.2 shows how MBs can interact with vasculature walls 
when undergoing exposure to an ultrasound wave, and how this can affect neighbouring 
drugs during MB-drug co-delivery. When a MB is exposed to an US wave, it oscillates 
with the wave, expanding and contracting.47,48 This oscillates any fluid in the 
surrounding area. As shown in Figure 1.2a, if this occurs near the boundary of a cell, the 
oscillations of the MB provide stresses on the cell wall, which induces holes to appear 
in the membrane. This effect is known as sonoporation.49–51 Stable cavitation of a MB 
can also lead to streaming of surrounding fluids (Figure 1.2b). Streaming increases the 
mobility of any drug-carrying fluid (for example in MB and drug co-delivery) and can 
contributes further to sonoporation, enhancing the chance for drug to cell 
uptake.32,48,50,52 Sonoporation has been shown to allow drugs easier access to cross the 
cell membrane through the short-lived pores it creates. After sonoporation stops the 
pores can be transient, where cell is able to rapidly repair the pores, or the pores can 
remain open and lead to cell death.49 One factor that determines if pores become 
transient or lethal is MB mobility. Van Rooij et al (2016) found that limited 
Streaming	
Cavita-on	
Microjet	
(ai)	 (aii)	 (aiii)	
(b)	
(c)	
Drug	loaded	
nanostructure	
Ultrasound	wave	
 6 
displacement of MBs during sonoporation led to the greatest enhancement of drug 
perfusion into cells whilst inhibiting cell death that would have occurred from static 
MBs.53 For the method of sonoporation, pre-formed MBs can be injected into a 
patient’s vasculature. However in the absence of pre-formed MBs, US can still induce 
sonoporation by firstly generating MBs through cavitation directly from the gasses 
dissolved in the liquid media (blood plasma in vivo).46,54 If a MB is driven to collapse 
near a wall, this can lead to the formation of a “microjet” (Figure 1.2c), which can 
provide momentum to surrounding fluid and drugs.50,55,56 The direction of the microjet 
depends upon the mechanical properties of the wall. Whilst microjets have been found 
to face towards cells mounted on a rigid substrate, microjets formed in ex vivo tissue 
were found to be directed away from the nearest vessel wall.55,57 Saleki-Haselghoubi 
and Dadvand (2018) gained a deeper understanding of bubble jet dynamics by 
simulating a bubble oscillating near a circular aperture made in a curved rigid plate. 
They found that dependant on the aperture’s diameter and proximity to the bubble, a jet 
may not form, may form and face towards or away from the aperture, or jets towards 
and away may form simultaneously.58 This could suggest that for drug delivery, where 
it is likely difficult to control individual MB proximity to defined vasculature on a large 
MB population, MB jet direction could be difficult to control and in multiple directions 
for clinically relevant MB populations. Due to the above, MBs have become very 
promising “theranostic” agents, with both ‘diagnostic’ and ‘therapeutic’ capabilities. 
However, since MBs can be site-specifically driven to destruction, they have also 
presented a promising solution to solve the issue that many drug delivery systems lack a 
controlled, externally activated, triggered release mechanism. As well as the co-delivery 
of drugs with MBs, MB composites can be made that act as a vehicle for drugs, 
encapsulating them into or adsorbing them onto their shells. US destruction pulses can 
then be used to trigger the release of the encapsulated or attached drug payload by 
destroying the MB vehicle at the target site. This would allow the drug to be safely 
transported around the body, targeted to problem sites via functionalisation of the 
commonly lipid MB shell, located in real-time via US, and then released controllably by 
a change in the US exposure. 
 
1.2. Microbubble-drug composites 
Figure 1.3 shows a number of different drug-MB composite designs that have been 
developed, which roughly fall into the following six categories:45,47,50,59–62 
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Composite 1. Surface loaded MBs (Figure 1.3b) 
Composite 2. Shell loaded MBs (Figure 1.3c) 
Composite 3. MBs decorated with hydrophilic core nanoparticle (Figure 1.3d) 
Composite 4. MBs decorated with hydrophobic core nanoparticle (Figure 1.3e) 
Composite 5. Echogenic liposomes (Figure 1.3f) 
Composite 6. Echogenic oil droplets (Figure 1.3g) - this is the structure focal to this 
thesis. This structure contains three keys parts; a gas core, surrounded by an oil 
layer, surrounded by a shell. The materials of those key parts has been different for 
different groups, but the layout of the structure has remained the same. This 
composite has been given a number of different names including: 
• Oil layer inside MBs (OLI-MBs) - the term used in this thesis 
• Acoustically active lipospheres (AALs) 
• Oil-filled polymer-shelled microcapsules 
 
The odd numbered MB composites (1, 3, and 5) are able to hold both hydrophilic and 
hydrophobic drugs. However, they have a far greater capacity for hydrophilic drugs, 
which can be held in their large aqueous volumes, but a limited capacity for 
hydrophobic drugs, which can be held only in their shells. For each odd numbered MB, 
the following even numbered MB is better suited to the delivery of hydrophobic drugs. 
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 Fig.	 1.3.	 Schematics	 of	MB	 drug	 delivery	 systems.	 (a)	 Co-delivery	 of	 a	 drug-free	MB	with	 (green	teardrop)	 hydrophilic	 drug	 loaded	 liposomes	 and	 (green	 trapezoid)	 hydrophobic	 drug	 loaded	(orange)	oil	droplets	is	shown,	followed	by	MB	composites	for	loading	with	(b,	d,	and	f)	hydrophilic	or	(b,	e,	and	g)	hydrophobic	drugs,	and	(h)	a	key	to	identify	each	structure.	
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1.2.1. Hydrophilic drug-MB composites 
Surface loaded MBs (Figure 1.3b, composite 1) usually consist of a charged payload 
and a MB with an opposingly charged shell. Electrostatic attraction then holds the two 
components together. This structure has been a focus for the delivery of nucleic acids, 
though it has also been used for a wider range of drugs. Vannan et al. (2002) and 
Christiansen et al. (2003) formed this composite from MBs containing cationic lipids, 
loaded with plasmid DNA, and Taylor et al. (2007) formed a similar composite by 
loading MBs with envelope[protein]-deficient retrovirus.63–65 For the latter, it was 
found that roughly only 30 viral particles were loaded per MB, however this was 
enough to lead to a 100-fold higher gene expression than compared to co-delivery of the 
retrovirus with bare MBs. In order to load more payload onto a MB, the number of 
charged molecules in the shell needs to be increased. However, the percentage of 
charged lipid molecules in a MB’s shell is restricted since higher amount lead to 
increases in the surface tension of the MB, which results in a lower MB stability and 
lifetime.66 MBs decorated with hydrophilic nanoparticles (Figure 1.3d, composite 3) 
were first reported by Lum et al. (2006) where they attached polystyrene beads to MBs 
by the use of DSPE-PEG-biotin lipid and biotin-avidin attachment.67 The same group 
then used this technique to form MB-liposome composites.68 Typically, this leads to 105 
liposomes per MB, which can be filled with high volumes of hydrophilic drug due to 
their large aqueous core. These composites have also been used for the delivery of 
sRNA and genes. However, injections of biotin-avidin links have been shown to cause 
immune system responses.45,66 Other groups have looked into coupling the liposomes 
and MBs directly. For example Geers et al. (2011) and Luan et al. (2012) used covalent 
thiol-maleimide links.69,70 It has been reported that whilst MBs with attached liposomes 
showed no significant difference in shell elasticity, the shell viscosity and the US 
pressure threshold (required for the onset of MB oscillations) were both increased over 
MBs without liposomes. Expansion-only behaviour, where MBs expand with little to no 
compression during US cycles, was found to occur at lower frequencies for MBs with 
attached liposomes over non-liposome attached MBs. This behaviour was attributed to 
the liposomes close packing during compression, inhibiting further compression.70 
Echogenic liposomes (Figure 1.3f, composite 5) are a liposomal structure with at least 
one bubble (regularly nanoscale) located within either the lipid bilayer or the aqueous 
core. As such, they have the drug delivery benefits of liposomes with the added 
capabilities of MBs as theranostic agents and a route for activated payload release. 
Echogenic liposomes have been formed at diameters comparable to typical MBs and the 
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other MB composites presented in this section (typically formed at 1-5 µm), with 
Raymond et al. (2016) and Shekhar (2017) forming them at 0.8-3 µm.71,72 However in 
addition, Huang et al. (2004) formed echogenic liposomes of ~800 nm, and Klegerman 
et al. (2016) formed monodisperse echogenic liposomes of ~100 nm.73,74 This potential 
for smaller size allows echogenic liposomes to extravasate in the body more efficiently. 
 
1.2.2. Hydrophobic drug-MB composites 
Shell loaded MBs (Figure 1.3c, composite 2) consist of a MB stabilised by an 
amphiphilic surfactant (lipid, polymer, or protein) shell, where drugs are loaded into the 
shell. Hydrophobic drugs and amphiphilic drugs can be loaded into the shell. However, 
adding payload molecules into the shell is likely to result in less stable MBs. Added to 
this, at least for lipid MBs, the hydrophobic regions available for drug loading are small, 
so it can be expected that shell loading is limited. Work using this construct has seen 
Teupe et al. (2002) load DNA into BSA MBs, Zhao et al. (2005) load therapeutic 
protein and hirudin into lipid MBs, Howard et al. (2006) form adenoviral MBs, and 
Phillips et al. (2011) load rapamycin into lipid MBs.75–78 Mico (2017) presented (Figure 
1.3e, composite 4) MBs decorated with hydrophobic oil nanoparticles, termed lipid oil 
nanodroplets (LONDs), forming MB-LONDs.79 The purpose of this work was to form 
the same biotin-avidin bound structure as seen for composite 3, but with the attached 
nanoparticles containing a core of oil rather than aqueous, to allow for a high volume of 
hydrophobic payload to be loaded inside. MB-LONDs were successfully formed from 
squalane and tripropionin oils, which are able to solubilise non-polar payloads, such as 
dodecanethiol-coated quantum dots, and partially-polar, hydrophobic payloads, such as 
combretastatin A4 and Calcein AM, respectively.79 
 
The main issues with the approaches described above are the low loading capacity in 
MB shells, and the immune response to the biotin-avidin bonds in the MB-LONDs. 
OLI-MBs (Figure 1.3g, composite 6), which can be thought of as echogenic oil droplets 
(in comparison to echogenic liposomes, Figure 1.3f, composite 5), and which have been 
referred to before as AALs, consist of a central gas core, surrounded by a layer of oil, 
with the oil-aqueous continuous phase interface stabilised by a lipid, protein, or polymer 
shell. Compared to the shell loaded MBs, the oil layer allows for a high volume of drug 
loading and foregoes the need to squeeze payload into the stabilising shell. Compared to 
the MB-LONDs, the outer shell is expected to give the same limited immune response 
as that of non-echogenic oil droplets. Unger et al. (1998) were the first to incorporate an 
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oil layer into MBs, giving them the name AALs.80 Since then AALs have been 
reproduced and further characterised by other groups. AALs are produced through the 
mechanical agitation of lipid solution, oil (primarily soybean or triacetin), and a gas 
such a perfluorobutane (C4F10), resulting in MBs of 2.9 µm average diameter with a 
thick oil shell capable of high drug loading per MB.80 However, large MB to MB 
variability has been observed, with sizes ranging from 1-10 µm and drug-loading being 
inconsistent between vehicles.81,82 Oil layers can range from 500-1000 nm and 300-700 
nm for triacetin and soybean oil respectively, with some vehicles containing no gas at 
all.82,83 It is thought that this large MB to MB variability is due to the chaotic nature of 
the production method, and lack of control over gas encapsulation. In terms of their US 
capabilities, AALs’ thick oil layer is thought to lead to viscous damping.83 Compared to 
non-oil-MBs, AALs fragmentation by US is significantly more difficult, with a high 
mechanical index of 0.67-2.0, and a five-fold higher pulse length being required for MB 
destruction.81,83 During tests of AALs on cells, 30% of the cells were found to die from 
the US alone.47 In 2007 Fang et al. claimed to be capable of forming AALs with further 
control over their average oil layer thickness by varying the relative concentrations of 
perfluorocarbon to oil. These AALs were repeatedly referred to as MBs. However their 
diameters ranged from 200 to 600 nm, their cores were perfluoropentane or 
perfluorohexane (bulk boiling points of 29 and 59 °C respectively, which increases with 
decreasing droplet size - see Theory Chapter, Figure 3.14), and thermal (37 °C) lifetime 
experiments showed that only 10% of AAL weight was lost over 12 h. It is far more 
likely that these AALs were fully liquid filled, with no gas core, so were double 
emulsion droplets, rather than MBs.84 In 2009 Lentacker et al. concluded that it 
remained difficult to efficiently release drugs from any of these AALs using medically 
relevant US.47 Clearly there was a need to be able to form OLI-MB like structures with 
a thinner and more consistent oil layer. During 2008-2009 Kooiman et al. formed 
polymer shelled OLI-MB like structures that showed an improved clinical application 
over that of AALs.81,85,86 They formed hexadecane OLI-MBs with fluorinated end-
capped poly(L-lactic acid) polymer shells. These OLI-MBs showed a tighter size 
distribution than AALs, with a mean diameter of 1.3 µm, and US response at clinically 
relevant MI.47,81 When exposed to US of a higher MI to release of their payload, these 
MBs were found to crack, rather than collapse as would be expected for lipid shelled 
MBs. This was likely due to a stiffer shell supplied by the polymer. The differences 
between lipid and polymer shelled non-oil-MBs collapsing and cracking respectively 
has been presented before.45 This may indicate that stable oscillations and the formation 
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of a shock wave on MB destruction could be smaller for these OLI-MBs. This would 
lead to a less efficient sonoporation effect for enhancing drug transport into target cells 
during release. During these studies Kooiman et al. were limited to forming OLI-MBs 
filled with ~90 vol% or 35 vol% oil, or MBs filled with no oil, meaning there was room 
for better control over the structure’s gas to oil ratio.81 For gas-only MBs, resonant 
frequency is known to be inversely proportional to the MB size. Since the polymer OLI-
MBs remained at a constant total diameter regardless of the oil loading, the more oil 
filled capsules contained smaller gas cores. However, the non-oil-MBs and both oil 
filled MBs were found to have resonance frequencies around 20 and 13 MHz 
respectively, meaning that the MBs with smaller gas cores had a lower resonance. 
Kooiman et al. attributed this to the higher shell volume (due to the added oil thickness) 
relative to the gas core for the oil filled capsules, leading to increased damping of the 
MB oscillations, which would lower the resonance, and the MBs being encapsulated by 
a polymer-hexadecane shell (rather than just polymer) where the presence of the oil 
would contribute to a less ridged shell. In the case of the latter, hexadecane-water has a 
lower interfacial tension (52 mN/m) than that of air-water (72.8 mN/m).87 This would 
provide less of a driving force for the polymer to stabilise the MB-oil capsule, which 
could give a lower polymer concentration across the capsule surface, leading to a less 
rigid shell. To the best of this author’s knowledge, to date, no further progress has been 
seen with these polymer-shelled OLI-MB like structures. 
 
In order to overcome the lack of control presented in the above research, a number of 
groups have looked into forming OLI-MB like structures through the use of 
microfluidics. Microfluidic flow focusing (FF) geometries have been widely shown to 
form lipid MBs with high levels of size control. Typically, these MBs are formed at 1-5 
µm with polydispersity indices as low as 2-5%.88–90 This control also extends to foams 
(architectures of highly close-packed MBs), where Andrieux et al. (2018) gained fine 
tuning over a foams’ polydispersity and spatial organisation through FF formation.91 
Ahmad et al. (2008) demonstrated the production of ~50 µm multi-layered OLI-MBs 
through the use of coaxially arranged needles, providing a high degree of 
monodispersity.92 However this method is in part limited by the needles’ inner and outer 
diameters, often leading to MBs that are larger than that required for medical 
applications. Zhang et al. (2013) were able to form multi-layered MBs, of air-in-tween 
80/water-in-paraffin, by using a system of two subsequent two-phase FF nozzles 
respectively.93 However off-chip imaging showed their MBs to be ~50 µm, far above 
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the clinical size limit of 8 µm. Hettiarachchi et al. (2009), Kendall et al. (2012), and 
Shih et al. (2013) presented three linked publications that demonstrated methods for 
OLI-MB formation by using a three-phase FF nozzle system.31,94,95 Successful on-chip 
formation of OLI-MBs was presented, but off-chip imaging of the MBs was minimal, 
and it was claimed that collection of sufficient samples for post-production imaging and 
further use was not possible, providing evidence that the structures were unstable. 
Meanwhile, sizing data showed that the OLI-MBs formed were too large to be used 
clinically, at ~15 µm, 18.6–22.3 µm, and controlled down to a minimum diameter of 8 
µm respectively. It was also assumed in all three papers that all of the oil flow was 
incorporated into the OLI-MBs. No work was done to assess the efficiency of oil 
loading, even though triacetin oil was used which is highly soluble in water (70 g/l),96 
and could have solubilised away during or after OLI-MB formation. There was strong 
reason to suspect that, with a few further steps of progress, microfluidic FF formation 
would have been capable of forming OLI-MBs at clinically relevant sizes, but that the 
OLI-MBs formed needed to be assessed more thoroughly for oil loading and off-chip 
stability. 
 
1.3. Aims of this project and outline of the thesis 
The main aim of this project was to develop an effective, simply, and reliable technique 
for the formation of OLI-MBs with a thin oil layer, clinically relevant size (1-5 µm, < 8 
µm), and a concentration that would allow for further study of the OLI-MBs’ ultrasound 
and drug loading characteristics and be of clinical interest, all with the intent to enhance 
the delivery potential for therapeutic, hydrophobic drugs. 
 
This work aimed to: 
(1) Improve upon and fill the gaps in the work already published on OLI-MB formation. 
Specifically by forming; 
• OLI-MBs with a thin oil layer, in order to decrease oscillation damping, leading 
to a higher ultrasound response within clinical ranges. 
• OLI-MBs that were stable enough for imaging, potentially through the 
transition from on-chip formation to off-chip collection. 
(2) After that was achieved; 
• Gain further control over the oil layer thickness in respect to the OLI-MB 
diameter. 
• Reliably assess the OLI-MBs for their oil content. 
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• Evaluate how the oil layer thickness affected the OLI-MBs’ ultrasound and drug 
loading capabilities.  
 
Control of three different phases on-chip is inherently difficult and often leads to poor 
MB yields. Therefore two objectives became apparent as different routes for OLI-MB 
formation, which were explored separately throughout this project: 
(1) In a two-phase FF system, evaluate the potential for an oil-in-water emulsion 
(LONDs) to be used as the continuous stabilising phase and as a precursor to oil 
layer formation at fresh MB surfaces (Figure 1.4a). 
(2) In a three-phase FF system, introduce the oil and aqueous phases upstream from the 
gas phase and nozzle, allowing the two phases to controllably co-flow, then allow 
them to be presented at the gas phase as an effective single liquid phase (Figure 
1.4b). 
Literature surrounding the clinical application of liquid perfluorocarbon droplets that 
can be activated into MBs led to a third possible route for the formation of OLI-MBs. 
Here, the objectives were to; 
(3) Controllably form double emulsion liquid perfluorocarbon-in-oil-in-aqueous 
droplets that after activation to OLI-MBs would be of a clinically appropriate size, 
and assess how the geometry changed during activation (Figure 1.4c). 
In the chapter immediately following this one, the literature behind each of these three 
OLI-MB formation routes is described in greater depth.  
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	Fig.	 1.4.	 Schematic	 of	 the	 three	 OLI-MB	 formation	 routes	 that	 were	 examined	 during	 this	 thesis	project.	(a)	Oil	nanodroplet	self-assembly	and	spreading	to	form	an	oil	layer	at	the	MB	surface.	(b)	Three-phase	FF	microfluidic	pinch-off.	(c)	Liquid	perfluorocarbon-in-oil	double	emulsion	activation	into	gas	perfluorocarbon-in-oil	MBs.	
 
This thesis is structured as follows: 
• Chapter 2 presents the literature background to the three OLI-MB formation 
techniques that were explored within this project. This covers; (1) Destabilising oil 
droplets to produce thin oil layer films. (2) Three-phase microfluidic FF formation 
of MBs. (3) Activation of single and double emulsion liquid perfluorocarbon 
droplets into gas MBs. 
 
• Chapter 3 describes the theory that underpins the techniques used and that were 
important to form and characterise the structures and surfaces formed in this project. 
 
• Chapter 4 provides the experimental methods that were used for the formation and 
characterisation of MBs and includes those used to help understand their formation. 
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• Chapter 5 is concerned with studying the energetic favourability of potential 
configurations of gas, oil, and lipid/water phases. This was carried out to determine 
if the OLI-MB structure was expected to be formed either spontaneously or under 
controlled introduction of the three phases, and to give insight on the expected 
stability of the OLI-MB structure after formation. 
 
• Chapter 6 is concerned with forming OLI-MBs through destabilising LONDs to 
form a thin oil layer at the MB surface. The work details the average OLI-MB 
diameter, estimations of the oil layer thickness, studies the lifetime and 
preliminarily ultrasound response, and evaluates the formation route for a number of 
oils towards extending the drug delivery potential. 
 
• Chapter 7 is concerned with three-phase FF formation of OLI-MBs controlled by 
upstream introduction and co-flow of the aqueous and oil phases.  
 
• Chapter 8 is concerned with forming double emulsion liquid perfluorocarbon 
droplets capable of activation into OLI-MBs. The work details formation of the lipid 
droplets from a number of oils, and then looks at the activation of the droplet both 
as a bulk sample and how the geometry changes during actions. 
 
• Chapter 9 summaries the main findings presented and discussed during this thesis, 
gives a final conclusion of the work as a whole, and provides an outlook to future 
studies in this field. This includes a discussion on which of the three formation 
techniques showed the most success and which should be taken forward in future 
work, including suggestions for how to move forward. 
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2. Context and background to the three OLI-MB 
formation techniques 
 
The primary goal during this thesis was to develop a method that would allow for the 
formation of the OLI-MB structure within clinical size limits (<8 µm) and 
concentrations. Three formation routes were studied; (1) the spreading of oil 
nanodroplets at the MB gas-water interface, (2) three-phase microfluidic FF pinch-off, 
and (3) the activation of double emulsion liquid core droplets into gas core OLI-MBs. 
This chapter serves as a literature review of studies that have previously been published 
that were integral to these three approaches. 
 
2.1. Destabilising oil droplets to produce thin oil layer films 
The first OLI-MB formation route studied the potential for oil nanodroplets to be used 
as precursors to the formation of an oil layer at MB surfaces. The literature of this 
section therefore focuses on oil-in-water emulsion formation and coalescence times at 
water-gas or –oil interfaces, and anti-foaming and stabilisation of foams and bubbles by 
oil droplet self-assembly. 
 
Formation of oil droplet nanoemulsions is typically performed by ultrasonification or 
high-pressure homogenisation, both of which commonly lead to droplets under 300 nm 
in diameter.6,97–101 A wealth of studies have been undertaken on the use of 
nanoemulsions in the food industry, typically focusing on the conditions that affect 
droplet formation size.102,103 However, interest in their use as drug delivery systems in 
the pharmaceutical industry is growing, partially driven by their ability to penetrate 
through small capillaries and the high uptake seen across biological tissue barriers.104 
Nanoemulsions capable of therapeutic drug delivery have been developed from a 
number of biocompatible surfactants including Tween,105 polyethylene glycol (PEG),106 
and a range of lipids.100,107–110 Lipid based emulsions are of particular promise to 
therapeutics due to being cheap, easy to handle, and their ability to be functionalised for 
targeted delivery.6 Droplet formation size has been found to be primarily dependant on 
the surfactant shell type, oil viscosity, and formation pressure. The effect from the 
surfactant shell stems from its ability to lower surface tension, change the shell stiffness, 
and geometrically control the shell curvature due to its packing parameter (ratio of head 
to tail size). For example, Hak et al. (2012) found that droplets stabilised by PEG were 
smaller with a higher PEG concentration.111 The long PEG chain likely increased the 
 18 
packing parameter, increasing shell curvature, giving smaller droplets. Lower viscosity 
oils have been found to result in smaller droplets due to a high deformability. A 
comparison by Wooster et al. (2008) of droplets formed from hexadecane and higher 
viscosity peanut oil found a 33% diameter difference between the two.112 Lastly, Mico 
et al. (2017) found that higher pressures for homogenisation formation led to smaller 
droplets.6 This last study is of particular interest to this project as the formation protocol 
presented in that paper was used for emulsion formation during this project with some 
adaptations (for more information see Experimental Chapter 4.9.1). The work by Mico 
et al. (2017) evaluated high-pressure homogenisation formation of Lipid based Oil 
Nanodroplets (LONDs) towards medical application. They examined formation using a 
range of biocompatible oils; squalane, squalene, olive oil, triacetin, tripropionin, 
isoamyl acetate, and eicosapentaenoic acid, eventually choosing squalane and 
tripropionin as their successful model oils. Lipid shells consisted of POPC + 5 mol% 
DSPE-PEG(2000)-Biotin and DSPC + 20 mol% cholesterol + 5 mol% DSPE-
PEG(2000)-Biotin for squalane and tripropionin respectively. Optimal formation was 
found to occur at 175 MPa, forming LONDs of average diameter 165 and 100 nm for 
squalane and tripropionin respectively, with polydispersity index of 0.1-0.3. Figure 2.1 
shows example transmission electron microscopy images of these LONDs. The droplets 
were found to be stable (less than a 10% change to diameter) over 6 weeks at both 4 °C 
and 37 °C, with the latter result being of particular interest to clinical application. 
Tripropionin LONDs were loaded with Combretastatin A4 at 76% efficiency. SVR 
mouse endothelial cells were treated with these LONDs, resulting in microtubule 
disruption. This provided evidence for successful drug release and uptake into the cells. 
 
	Fig	 2.1.	 Transmission	 electron	 microscopy	 images	 of	 high	 pressure	 (175	 kPa)	 homogenisation	LONDs.	(a)	Squalane	LONDs	stabilised	with	POPC	+	5	mol%	DSPE-PEG2000-biotin.	(b)	Tripropionin	LONDs	stabilised	with	DSPC	+	20%	Cholesterol	+	5%	DSPE-PEG2000-biotin.	This	Figure	has	been	taken	from	reference	[6].	
size variation of around 16% for squalane LONDs, and around 15%
for tripropionin LONDs. This small variation of the LONDs diameter
over time suggests good stability of the LONDs against agglomer-
ation and coalescence. Fig. 5b shows the size variation for squalane
and tripropionin LONDs duri g 2 h, and incubated 37 !C more
consistent with conditions in vitro. The sizes of both LOND types
did not change, showing good stability under these conditions. This
suggests that LONDs are suitable vehicles for the delivery of
hydrophobic compounds in vivo and have an excellent potential to
enhance the delivery of poor water soluble drugs.
3.4. TEM imaging of LONDs
TEM was used to image LOND samples. Fig. 6 shows the TEM
images of squalane and tripropionin LONDs. Squalane LONDs
appeared as globular structures ranging 100–300 nm, with an
average size of 111 nm (n = 187, with a standard deviatio  of the
sample s = 85 nm). In contrast, tripropionin LONDs appeared to
lose their structure under va um conditions in TEM, and
exhibited a shell appearance. These LONDs were found to have
an average size 89 nm (n = 71, with a standard deviation of the
sample s = 23 nm). A small discrepancy was observed between the
TEM and DLS sizing of both squalane and tripropionin LONDs. This
was expected and it is attrib te   the different conditions under
which the samples are studied in one and another techniques (i.e.
the sample is dried for TEM imaging, whereas the hydrodynamic
radius of the colloids are measured by DLS).
3.5. Encapsulation of CA4 in LONDs
Drug delivery using nanoemulsions, and LONDs in particular,
rely on drug encapsulation within their structure. It is generally
accepted that the drug is encapsulated within the oil core of the
nanoemulsions, and that its lipophilicity directly affects its release
from the nanodroplets and therefore its biodistribution (Takino
et al., 1994). It is also known that the polarity of a therapeutic
compounds deﬁnes its solubility in oils (Ganta et al., 2008; Bunjes,
2010). CA4 is a largely polar molecule with poor water solubility.
However, its polarity made it difﬁcult to dissolve in squalane, as it
s a saturated, non-p lar oil. Triacetin  tripropionin were
proﬁled as more suitable oils for the preparation of LONDs
encapsulating CA4, as the polarity of the oil enhanced the solubility
of CA4. Tripropionin was chosen over triacetin, in light of its
reduced water solubility. The concentration of the drug encapsu-
lated in LONDs was deter ined by measuring its absorption in the
UV-VIS. The calibration curve produced for the CA4 in tripropionin
is pres nted in the supplementary. The encapsulation efﬁciency of
CA4 in tripropionin LONDs was approximately 76%, with 1270 mg/
ml in the ﬁnal LOND sample.
3.6. CA4 tripropionin LONDs cause microtubule disruption
To qualitatively and quantitatively assess LOND-based drug
delivery, CA4 tripropionin LONDs were used to treat SVR
endothelial cells. The cells were treated with escalating concen-
trations of CA4 tripropionin LONDs from 2 to 100 nM for 2 h at
37 !C. Fig. 7 is a representative panel of images showing the effect
caused by CA4 tripropionin LOND exposure. CA4 tripropionin
LONDs caused complete microtubule disruption evident in all SVR
Fig. 5. (a) Size change of squalane and triacetin LONDs over a six week period, stor d at 4 !C, and measured using DLS. (b) Size change of squalane and triacetin LONDs at 37!
over 2 h, as measured by DLS. Experimental points in both graphs were produced averaging three size measurements on the same sample.
Fig. 6. TEM images of LONDs. (a) Squalane LONDs stabilised with POPC + 5% biotin-PEG2000-DSPE. (b) Tripropionin LONDs stabilised with DSPC + 20% Cholesterol + 5% biotin-
PEG2000-DSPE. Both samples were prepared under at 175 kPa.
552 V. Mico et al. / International Journal of Pharmaceutics 526 (2017) 547–555
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Once a lipid coated oil nanoemulsion is formed it is typically stable against droplet-to-
droplet coalescence for hours, days, or months. However, the coalescence time of these 
droplets with a partially stable water-oil or water-gas surface can differ greatly. In terms 
of this project, the surface for droplet coalescence (later in this thesis referred to as 
adsorption, rupture, spreading, and merging) was that of a fully or only partially lipid 
stabilised MB. Dickinson, et al. (1988) looked at how protein surfactants extend the 
coalescence time of microscale oil-in-protein/water droplets to a water/protein-oil 
film.113 They studied n-hexadecane oil droplets with three different proteins β-casein, κ-
casein and lysozyme. Figure 2.2 shows how the droplet size affected the coalescence 
time and shows an extension of the relationship into the nanoscale. These results 
showed that the average droplet coalescence time increased from 5 to 30 s with 
decreasing droplet size from 10 to 2 µm, and that a protein shell with a greater surface 
viscoelasticity led to further inhibition against coalescence. Oil nanodroplets used in 
this thesis project were on an order of magnitude smaller than those studied by 
Dickinson, et al. (1988), and so would be expected to take longer to coalesce. Extending 
the exponential relationship of Dickinson, et al. (1988) predicts that nanodroplets of 170 
nm would take 80 ± 17 s for coalescence to occur. Since the oil and surfactant shells 
used in this thesis project were different, this cannot be used as a direct estimate for the 
coalescence time, however this information did give an indication that coalescence 
would be expected on the order of seconds to minutes rather than milli to microseconds 
or hours to days. 
 
	Fig	 2.2.	 Average	 coalescence	 time	 of	 n-hexadecane	 lysozyme	 droplets,	 as	 a	 function	 of	 droplet	diameter,	 against	 a	 20	 min	 old	 water/lysozyme-air	 surface.	 This	 Figure	 has	 been	 adapted	 from	reference	[113].	
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The stabilisation and destabilisation of single bubbles and bubble foams have both been 
reported by the introduction of oil emulsion droplets to the air-water interface.114–116 
Most commonly, stabilisation is caused by droplets accumulating and adsorbing at the 
foam plateau borders or bubble surfaces.114,117 Koczo et al. (1992) claimed that the 
accumulation of a higher oil fraction of stable droplets between foam bubbles leads to a 
more stable overall foam.114 On the other hand, destabilisation usually occurs if droplets 
spread at the air-water surface, leading to an anti- or de-foaming effect by reducing 
surface elasticity.115,116 During de-foaming, oil locally penetrates a foam’s film structure 
as a defect, displacing the stabilising surfactant. This lowers the surface tension at that 
point, presenting a ‘weak’ point. The pulling forces from the surface tension of 
neighbouring MBs then pull this weak film apart destroying the MBs in that area.116 
However, stabilisation and destabilisation is not always as strict as defined above, with 
one of the primary and most extensively studied examples being the stabilisation 
process of whipped cream. When air is incorporated into an oil emulsion this often leads 
to an adsorption of the oil droplets at the fresh air-aqueous surfaces in order to minimise 
the total surface free energy of the system. Once droplets begin to adsorb, it is expected 
that flocculation and further coalescence will occur.117 Heller and Peters (1970) 
presented how flocculation of insoluble droplets at air-water interfaces occurs at a far 
higher rate than flocculation in the bulk aqueous phase.118 For the case of whipped 
cream, the process of whipping the cream introduces air bubbles into the emulsion of 
part solid, part liquid fat droplet stabilised by the proteins found in milk. Mulder and 
Walstra (1974) described the process that eventually leads to the formation of a stable 
emulsion of air encapsulated by fat in aqueous as such;119 Fat droplets penetrate the 
bubbles’ surface and partially spread, displacing any stabilising layer, inhibited from 
full spreading by their solid fat content. Many of the larger bubbles then immediately 
coalesce with the surface due to the unstable coating layer. Over time, as the insoluble 
aqueous, gas, and oil phases become vigorously mixed, the effective viscosity of the 
solution increases, allowing time for larger bubbles to become fragmented before they 
can coalesce. These smaller bubbles are then coated and stabilised by a close-packed, 
semi-spread, particle network layer. The network then adds to the firmness of the 
overall whipped cream solution. Figure 2.3 shows electron microscopy images of the 
whipped cream gas domains, presenting how the gas, fat, and protein/aqueous phases 
are organised. Schmidt and van Hooydonk (1980) used a cryo-scanning electron 
microscopy technique to show the build-up of fat droplets around the air bubbles 
(Figure 2.3a).120 Using an osmium staining technique followed by transmission electron 
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microscopy of thin sections of whipped cream Graf and Müller (1965) were able to 
show that no membrane exists between the stable air and fat phases (Figure 2.3b).121 
Since the emulsion is stable, it is therefore most likely that a stabilising protein layer 
exists between the fat and aqueous phases. These findings were important to this thesis 
as they showed that incorporation of oil droplets can hinder bubble formation, by 
increasing coalescence, and can destabilise an already stable emulsion of bubbles, but 
that the controlled introduction of droplets during the formation of bubbles can lead to 
bubbles stabilised by a spread oil film as long as the oil layer is allowed time to spread 
and stabilise fully before contact with another bubble. 
 
	Fig.	2.3.	 	 (a)	Scanning	electron	microscopy	 image	of	 fat	droplets	adsorbed	at	 the	surface	of	an	air	bubble	in	whipped	cream.	(b)	Thin	section	transmission	electron	microscopy	of	a	fat	encapsulated	air	cell	in	whipped	cream.	(White)	Air,	(grey)	stained	fat,	and	(black)	protein/aqueous	phase.	Bars	represent	(a)	1	and	(b)	5	μm	respectively.	These	Figures	have	been	taken	from	references	[117,121].	
 
2.2. Three phase microfluidic production of microbubbles 
The second OLI-MB formation route discussed in this thesis aimed to improve on the 
work that had been presented by Hettiarachchi et al. (2009), Kendall et al. (2012), and 
Shih et al. (2013).31,82,94,95 Here, they had presented a three-phase microfluidic 
technique for the formation of oil coated MBs using a single FF nozzle, with the two 
latter publications improving on the formation rate and MB stability. 
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Fig. 3. Scanning electron micrograph of emulsion droplets adsorbed at the surface of an air bubble
in whipped cream. Bar represents 1 /tm.
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Fig. 4. Thin section transmission electron micrograph of a fat encapsulated air cell in whipped cream.
White region, air; grey, stained fat; black, protein/aqueous phase. Bar represents 5/<m.
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	Fig.	 2.4.	 Geometry	 of	 Hettiarachchi	 et	al.	 (2009)	 device	 for	 the	 production	 of	 oil	 coated	MBs.	 All	channels	had	a	rectangular	cross	section	and	a	height	of	25	μm.	The	main	functional	area	is	shown	with	a	25	μm	orifice	and	filtering	channels.	The	arrows	indicate	direction	of	flow.	This	Figure	has	been	taken	from	reference	[31].	
 
Figure 2.4 shows an image of the region of interest of the PDMS device that 
Hettiarachchi et al. (2009) presented for the formation of oil coated MBs (termed multi-
layer gas lipospheres).31 An inner C4F8 gas phase, an outer lipid solution phase, and a 
triacetin oil phase located in-between the gas and lipid solution, were introduced to each 
other at close proximity at a microfluidic nozzle. The oil phase was loaded with 0.01 
mg/ml Oil Blue N dye or 1 mmol/l Doxorubicin for fluorescence and drug 
encapsulation respectively. The lipid solution consisted of 0.5 mg/ml lipid (89.1 mol% 
DSPC + 9.9 mol% DSPE-PEG2000-biotin + 1 mol% DiI-C18 molecular probe) in a 10 
w% glycerol/propylene glycol solution. They were able to show the successful 
formation of MBs on-chip at a maximum of 1 x 103 MB/s, with a degree of control over 
the MB size. Keeping the oil flow rate constant at 0.016 µl/s, varying the lipid solution 
flow rate and gas pressure was found to give a minimum MB size of 7.5 ± 0.2 µm at a 
lipid solution flow rate of 0.33 µl/s with a gas pressure of 1 psi. At higher flow 
conditions, larger MBs were formed due to on-chip coalescence. Coalescence occurred 
because of the small distances between MBs and the low shell resistance on MB contact 
due to the MBs only being given time to partially stabilise. Figure 2.5 shows off-chip 
imaging of larger 15-30 µm MBs. These MBs showed a blue hue and a thin fluorescent 
exterior, attributed to the fluorophore and Doxorubicin. The major problem for this 
work was that, while it claimed to show clinically relevant MB formation, the stability 
of a sample of MBs less than 8 µm, with a confirmed oil layer, was not shown off-chip. 
On-chip the MBs were claimed to have a polydispersity index under 5%. However, 
transferring the MBs off-chip may have easily changed this due to coalescence or 
Ostwald ripening, giving a portion of MBs too large to use clinically. Added to this, 
those MBs that were shown off-chip showed a very thin layer of fluorescence. Knowing 
Figure 2.
Geometry of device for gas liposphere production. (a) Schematic view of the microfluidic
flow-focusing device. All channels have a rectangular cross section and a height of 25 μm.
(b) Main functional area with a 25 μm orifice and filtering channels. The arrows indicate
direction of fl w. (c) 3D view of sembled PDMS device on an inverted microscope.
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that triacetin is highly soluble in water (70 g/l),96 and with the aqueous phase not being 
saturated with triacetin before use, this means that there was a high likelihood that the 
oil layer could have solubilised into the surrounding solution after MB stabilisation, 
leaving behind the hydrophobic payload but not the oil phase. This could be a route to 
give a far higher drug shell-loaded MB composition than seen previously (see Figure 
1.3 for the composition of shell-loaded MBs), but the work did not confirm the 
formation of MBs with a stable oil layer. 
 
	Fig.	2.5.	Multi-layer	gas	lipospheres	showing	(ai)	a	close-up,	where	the	inner	blue	hue	can	be	seen,	(aii)	and	a	 larger	population	in	bright	 field.	(bi)	Bright	 field	and	(bii)	 fluorescence	of	Doxorubicin	loaded	lipospheres.	Scale	bar	is	15	μm.	This	Figure	has	been	taken	from	reference	[31].		
A study by Kendall et al. (2012) aimed to improve the low formation rate found in 
Hettiarachchi et al. (2009).94 Figure 2.6 shows how, using a very similar microfluidic 
design to Hettiarachchi et al. (2009), the working region was multiplexed into a 4- and 
8-channel multiarray, where all outlets met in a single MB collection point. Again, 
triacetin with 0.01 mg/ml Oil Blue N dye was used, however this MB formation used 
nitrogen gas, and after initial formation of the lipid solution (as in Hettiarachchi et al. 
(2009)) Pluronic F-68 was added at 1 vol%. Pluronic is a non-ionic, triblock copolymer 
used to control shear forces and reduce foaming and cell attachment to glass, effective 
down to 0.1 vol%.122 Using 280 µl/min and 12 psi for lipid solution and gas, formation 
rates were pushed up to 1 x 105 MB/s in the 8-channel multiarray. However, this work 
found the MBs to be limited to formation at 18.6-22.4 µm with polydispersity index of 
9%. While the MB concentration was improved for clinical application, this study 
actually reduced clinical relevance in terms of the MB size. 
Figure 3.
Flow rate vs. size relationships. (a) The optimum flow rate regime (highlighted) to produce
<15 μm multi-layer lipospheres, with five different flow condition points (filled diamonds)
that produce mean liposphere sizes of {11, 7, 17, 22, 30 ± 0.2 μm} respectively. (b) High-
speed images showing changes in gas liposphere size upon application of a low lipid/water
flow rate of 0.33 μL s−1 (left) and a high lipid/w ter flow rate of 0.5 μL s−1 (right). The
widths of the liquid, oil, and gas inlet channels are 30 μm, 25 μm, and 20 μm respectively,
and the orifice size is 25 μm. (c) Images showing close-up of two multi-layer lipospheres
clearly showing the inner blue oil layer (top) and monodisperse multi-layer gas lipospheres
visible in brightfield (bottom).
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Figure 4.
Microscopy images of multi-layer gas lipospheres containing Doxorubicin. (a) Brightfield
image of lipospheres. Scale bar is 15 μm. (b) Fluorescence image of lipospheres showing
Dox fluorescence within the lipid-oil complex. Scale bar is 15 μm.
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 Fig.	 2.6.	 Geometry	 of	 Kendall	 et	al.	 (2012)	 device	 for	 high	 production	 rate	 of	 oil	 coated	MBs.	 (a)	Schematic	 view	 and	 (b)	 image	 of	 the	 hydrodynamic	 flow-focusing	 region.	 All	 channels	 were	rectangular	with	a	height	of	25	μm.	Lipid	solution,	oil,	and	gas	inlet	channels	measure	50μm,	35	μm,	and	35	μm	in	width	and	directed	flow	to	orifices	9	μm	in	width.	This	Figure	has	been	taken	from	reference	[94].		
	Fig.	2.7.	Geometry	of	Shih	et	al.	(2013)	device	for	production	of	oil	coated	MBs.	Microscope	view	of	empty	device,	with	arrows	denoting	how	gas	(pink),	oil	 (blue),	and	 lipid	solution	(yellow)	phases	were	flowed	in.	This	Figure	has	been	taken	from	reference	[95].		
Shih et al. (2013) tackled the same problem of low MB formation rate found in 
Hettiarachchi et al. (2009), but instead of multiplexing the microfluidics, they focused 
on extending the use of Pluronic F-68 in order to reduce coalescence, allowing higher 
flow velocities to be used.95 Figure 2.7 shows the PDMS microfluidic design that was 
used. In the device outlet, expansion was significantly reduced from the Hettiarachchi et 
al. (2009) design. This was designed to keep the distance between MBs high, reducing 
the chance for coalescence to occur. The lipid solution consisted of 0.5 mg/ml 90 mol% 
DSPC + 10 mol% DSPE-PEG2000 made up with ultra-pure water. The oil phase was 
triacetin with 0.01 mg/ml Oil Blue N dye or Fluorol Yellow 088 for fluorescent imaging. 
Pluronic F-68 was added to either the lipid or oil phase, or both, at a concentration of 2 
Figure 1.
Geometry of the top level of the 4- and the 8-channel multi-array microflu dic module for
the generation of dual-layer microbubbles. (a) Schematic view. All channels are rectangular
with a height of 25 μm. (b) Image of the hydrodynamic flow-focusing region. Lipid
solution, oil, and gas distribution channels measure 50μm, 35 μm, and 35 μm in width and
direct flows to orifices 9 μm in width.
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payloads for release by ultrasonic destruction.7,10–17 Fortu-
itously, the acoustic excitation and destruction of micro-
bubbles also enhances local uptake of therapeutic agents by
generating microjets that temporarily perforate cell mem-
branes, i.e. sonoporation.7,11,16–18 Kang et al.,15 for instance,
found that a combination of Docetaxil-loaded microbubbles
and ultrasound (DOC+MB/US) was more effective against
rabbit liver tumors than treatments that omitted one element
or the other (i.e. DOC, DOC+MB, DOC+US, MB+US). Similar
results have been observed in gene delivery experiments
in vitro16,17,19 and in vivo;18,20–22 used as such, sonoporation
presents an alternative to immunogenic viral vectors for
gene transfection.
Conventionally, microbubbles are produced using
mechanical agitation or sonication of a solution under a
headspace gas. However, these techniques are not ideal for
either contrast enhancement or drug delivery, due to the pro-
duced bubbles' polydispersity. Talu et al.8 found that about
half of the bubbles in a conventional population resonated
outside the bandwidth of a typical ultrasound transducer,
reducing the efficiency of contrast-enhancement. Addition-
ally, stray large bubbles (e.g. 2% of Definity contrast agents
exceeding 10 μm in diameter) can cause capillary embolisms,
which give rise to such side effects as inflammation and
clotting.23 Further, drug loading in conventional production
methods is inconsistent, with typical loading efficiencies
of 50–60%.15,24
Microfluidic flow-focusing is an alternative method to
produce microbubbles, in which fluids are forced through a
narrow orifice where high shear and capillary instability break
bubbles off the tip of a gas bulb (Fig. 1).25,26 The technique
results in uniform bubble sizes and payloads, tunable by
adjusting gas pressure and liquid flow rates.14,27,28 One
challenge it has faced, however, is generating clinically use-
ful amounts in a practical timeframe, due to production
being serial rather than bulk. For reference, a whole-body
human dose requires tens of millions of monodisperse
bubbles,5 and mechanical shaking produces 12 billion
Definity contrast agents in 45 seconds. By comparison,
although Hettiarachchi et al.28 experimented with produc-
tion rates up to 1 MHz sans drug-loading, the close bubble
spacing and high shear resulted in bubble coalescence and
polydispersity in excess of 50%. More recently, Seo et al.29
achieved monodisperse production at up to 1 MHz with a
narrower orifice, Castro-Hernández et al.30 reached hun-
dreds of kHz with a wider orifice in a jetting regime, and
Peyman et al.31 demonstrated 1 MHz with a more-
polydisperse spraying regime. These rates are sufficient to
produce a human dose of contrast agent within minutes,
but have not incorporated therapeutic payloads. When
adding an oil phase for drug loading, Hettiarachchi et al.14
reduced their design's generation rate to a more modest
1 kHz, which would take 5–6 hours to reach 20 million.
Kendall et al.32 advanced this work by developing a multi-
layer parallelized design, demonstrating eight simultaneous
production streams of oil-carrying bubbles. However, since
parallelization progressively increases design size and com-
plexity, improving the per-channel production rate remains
of great interest as a complementary approach.
Anna et al.33 observed that flow-focusing droplet forma-
tion transitions through at least three regimes as the
continuous-phase velocity is increased: geometry-controlled,
Fig. 1 Flow-focusing microfluidic design, adapted from Hettiarachchi et al.14 for high-speed production. a) Photo of microfluidic device, with penny for scale. b) Top-view
schematic of microfluidic design. The lipid inlet was augmented with parallel debris-filter arrays since its flow rate is highest. c) Microscope view of empty flow-focusing inter-
section, with arrows denoting how phases were flowed in. d) Magnified view of three flow-focusing regimes; from top to bottom: geometry-controlled, dripping, and jetting.
e) Diagram of dual-layer, oil-carrying bubble. A condensed lipid monolayer self-assembles at the oil/aqueous interface.
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vol%. The gas phase was C4F8. Figure 2.8a shows the resultant formation of MBs with 
and without pluronic in the liquid phases. It was claimed that the addition of pluronic to 
either phase showed reduced coalescence. This was most likely due to the size 
distribution of MBs formed. However, addition of pluronic to the oil phase also led to 
the formation of debris. As such, further study only added pluronic to the lipid solution. 
Formation of MBs down to 7-8 µm could be achieved on-chip, of which reached 3 x 105 
MB/s. However, closer inspection showed that for the MBs formed at this size range the 
oil phase may not have pinched off successfully, bridging the MBs, which would have 
led to significant coalescence further down stream of the device. In the concluding 
remarks it is explained that collection of MB solutions for observation off-chip 
encountered problems with dissolution and size variation. This was likely due to 
coalescence and potentially the oil-MB constructs being unstable. Figure 2.8b shows 
off-chip imaging of a number of MBs above 10 µm that could be collected as a small 
sample volume. These MBs showed fluorescent exteriors, including a bead of 
concentrated fluorescence, which was claimed as excess oil. Since again the oil used 
here was triacetin, the oil layer could have solubilised into the surrounding aqueous 
phase, as explained with the Hettiarachchi et al. (2009) results. However, due to the 
presence of the fluorescent beads, it is believed by this author that this was an indication 
of ‘pseudo-partial’ wetting as was seen later for the successful OLI-MB formation 
results of this thesis (see Chapter 6, Figures 6.23, 6.39). From the Shih et al. (2013) 
publication, this thesis project took information on developing the microfluidic design, 
such as decreasing the width of the outlet, and using high concentrations of pluronic in 
the liquid phases. 
 
	Fig.	2.8.	(a)	MBs	imaged	on	exiting	the	microfluidic	device	where	pluronic	was	in	neither	phase,	the	lipid	solution,	the	oil,	or	both	phases.	(b)	Fluorescence	from	Fluorol	Yellow	088	contained	in	the	MB	shell.	This	Figure	has	been	taken	from	reference	[95].		
Fluorescence imaging
To visualize the oil in dual-layer bubbles, an excess of Fluorol
Yellow 088 (Sigma-Aldrich) was added to the triacetin oil in
place of Oil Blue N. Bubbles were transferred to a glass slide
for viewing as described above. Fluorescence imaging was
done on an Olympus IX51 inverted microscope with a FITC
filter and mercury lamp (Olympus U-LH100HG). Two cameras
were used: a black-and-white Hamamatsu C4742-80-12AG,
and a Canon EOS 5D Mark II.
Results and discussion
Coalescence prevention
Adding Pluronic F68 surfactant to the lipid and/or oil phases
greatly reduce bubble coalescence, particularly when added
to the lipid solution (Fig. 2). Notably, the addition of Pluronic
F68 to the oil phase also reduced the size of bubbles pro-
duced, all else being equal. However, mixtures of oil and
Pluronic F68 tended to develop congealed debris after a few
days on the shelf. Due to this, and the oil's primary purpose
as a drug carrier, Pluronic was only used in the lipid for sub-
sequent production characterization.
Bubble formation regime transitions
The transition from the geometry-controlled regime to dripping
was observed to be smooth and continuous with increasing
lipid flow rate (Table 1). Due to the narrow sub-10 μm orifice,
much of the production range was geometry-controlled,
even as production rates exceeded 100 kHz. But with
increasing lipid flow, bubble diameter decreased until the
gas phase definitively avoided contact with the orifice walls,
and formation could be classified as dripping. This continu-
ity was also evident in plots of size-scaling and production
rate (Fig. 3–5): in both cases, the two formation regimes fell
along a unified curve when parameters aside from lipid flow
rate were held constant. By contrast, a more abrupt transi-
tion is observed in droplet production,36 with Anna et al.33
clearly demarcating the two regimes in their graphs of flow
ratio vs. capillary number.
As gas flow rate decreased relativ to oil, production could
exhibit jetting of the oil phase while the gas phase remained in
Fig. 2 Reduction of bubble coalescence while exiting microdevice, by premixing of
Pluronic F68 surfactant into oil or lipi s lution at a concentration of 20 mg mL
−1
.
Dramatic benefits were evident when adding to either phase, but more so with lipid.
Table 1 Production regime transition from geometry-controlled to dripping
was smooth and continuous
Lipid flow
(μL min−1)
Bubble
diameter
(μm)
Bubble
rate (kHz)
Production
(9 psi, oil 0.5 μL min−1)
44 15.6 158.4
48 13.9 187.2
52 12.7 220.8
56 12.1 235.2
60 9.4 273.6
64 8.9 268.8
Fig. 3 Effect of gas pressure on size scaling. Orifice width measured ~5.7 μm. Oil
was not used. Lipid flow-rate sweeps were performed at nine gas pressures (9–15,
18, and 22 psi), with arrows denoting the sequence of increasing lipid flow. Produc-
tion transitioned gradually from geometry-controlled to dripping, becoming the
latter definitively below y = 2. At each pressure, scaling roughly followed a power
trend of y = ax5/12 (a = 4 shown), similar to observations by Castro-Hernández et al.30
Here, however, a was found to vary with gas pressure.
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Neither oil flow rate nor gas press re exhibited correlation with
PDI. However, polydispersity was inversely related to bubble
size, due partly to measurement precision limits: with each
pixel in an image corresponding to ~1 μm, one pixel represents
12.5% of an 8 μm bubble's diameter, versus 5% for a 20 μm
bubble. Despite this, the PDI for 8 μm bubbles remained ~6%,
just slightly higher than the 5% threshold reported by
Hettiarachchi et al.14
In experiments where fiv recordings were taken per setting
at ~20-second intervals, data was analyzed as follows: For each
recording, the average diameter and standard deviatio were
calculated (Fig. 6d), as well as the polydispersity index. Then
for each setting (five videos), he five average diameters and
five PDIs were used to calculate another level of averages and
standard deviations (Fig 6c). It was found that average diame-
ters had a standard deviation of 0.19 μm per setting, on aver-
age. PDI averaged 3.21% overall (max 6.43%), with a standard
deviation of 0.28% per setting, on average.
Stability
Microbubble samples were observed for Ostwald ripening, a
degradation of size uniformity due to gas exchange through
the solution (Fig. 7). Polydispersity for both types grew line-
arly at ~3.75% per minute, with the dual-layer bubbles
starting at 10% rather than 5% due to greater coalescence
tendency during collection. Despite the widening size range,
average diameter remained relatively stable for single-layer
bubbles (down ~1 μm in 10 minutes). By contrast, dual-layer
bubbles dipped ~3 μm in 4 minutes, implying s rinkage
outweighed expansion in the population. Subsequently the
dual-layer average regrew, possibly due to the smallest bub-
bles disappearing; this would also account for the dip in
polydispersity after 8 minutes, which coincided with a slight
jump in average size. Notably, whereas shrinking dual-layer
bubbles were observed to dissolve out of existence, shrinking
single-layer bubbles tended to reach a stable size below
5 μm, stopping short of disappearance. This result suggests
that oil interfered with the formation of a stable, condensed
lipid membrane.
Fluorescence imaging
The presence of an oil phase in the bubbles was confirmed
by fluorescence im ging (Fig. 8), in ke ping with the results
of Hettiarachchi et al.14 In some cases, a brighter drop was
visibl on the bubble surface, suggesting a bead of excess oil.
Drug capacity
Oil volume per bubble, calculated from oil flow rate divided
by bubble production rate, was ~0.031 pL per 7.6 μm bubble
Fig. 7 Stability of C4F8 bubble samples (200–300 count) with and without oil,
observed floating in C4F8-saturated lipid solution under a raised cover glass.
a) Average bubble diameter remained relatively constant for single-layer bubbles
(down ~1 μm in 10 minutes), but dipped ~3 μm for dual-layer bubbles before
recovering. b) Polydispersity (std dev/avg diam) grew linearly at ~3.75% per minute
for both single- and dual-layer bubbles.
Fig. 8 Fluorescent images of microbubbles with Fluorol Yellow 088 in oil phase.
a) Black-and-white contrast-enhanced photo. Excess oil seemed to bead up on one
side of bubble. b) Color photos of fluorescent and brightfield view.
Lab on a Chip Paper
Lab ChipThis journal is © The Royal Society of Chemistry 2013
Pu
bli
sh
ed
 on
 25
 O
cto
be
r 2
01
3. 
Do
wn
loa
de
d b
y U
niv
ers
ity
 of
 L
ee
ds
 on
 07
/11
/20
13
 10
:13
:20
. 
View Article Online
Oﬀ-chip	imaging	
(b)	(a)	
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The main issue with these publications was that they formed OLI-MBs that were too 
large to be used in-vivo, did not confirm the presence of the oil layer, and were not 
stable when transferred off-chip. The work in this thesis aimed to address these issues, 
forming OLI-MBs at smaller, more clinically relevant, sizes, with a higher stability off-
chip. It also looked into the use of a wider range of less water-soluble oils for less 
chance of oil layer solubilisation. 
 
2.3. Activation of liquid perfluorocarbon droplets to gas bubbles 
The third OLI-MB formation route discussed in this thesis studied the potential for 
double emulsion, liquid perfluorocarbon (PFC)-in-oil-in-aqueous nanodroplets to be 
used as precursors for activation into MBs of gas PFC-in-oil-in-aqueous, OLI-MBs. 
This section therefore gives a brief overview of the large background into the formation 
and activation of single emulsion PFC-in-aqueous droplets, and then details the limited 
publications on formation and activation of double emulsion PFC-in-oil-in-aqueous 
droplets. 
 
The previous chapter explained why MBs offer a promising tool for drug delivery (see 
Introduction Chapter 1.1-1.2, p 4-13). However, due to the typical size of clinically 
relevant MBs, 1-5 µm, they are often too large for complete circulation, having varied 
access across the chaotic vasculature of tumour sites. Compared to healthy tissue, 
tumour vasculature typically has larger inter-endothelial gaps and poor lymphatic 
drainage.123–126 If nanoparticles are introduced to a tumour site, these can pass into the 
tumour, but due to the poor drainage, they have trouble leaving. This leads to a retention 
effect, where the number of nanoparticles entering the tumour site outweigh those 
leaving.124 A method known as acoustic droplet vapourisation (ADV) takes advantage 
of these findings. ADV involves forming a nanoemulsion of liquid PFC droplets that are 
later phase converted into gas PFC MBs using ultrasound (US). The liquid PFC droplets 
can enter a tumour site more effectively that pre-formed MBs, be activated into MBs by 
US exposure, and then deliver drug payload by the same mechanisms of MB enhanced 
drug delivery as regular MBs, but over a wider target area. During clinical US imaging, 
PFC droplets show a strong echogenic response due to their high acoustic impedance 
mismatch with aqueous phases, though the response is not as strong as PFC MBs of the 
same size (the reason for this is explained in the Theory Chapter 3.2.2, p 39-41).127 
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	Fig	 2.9.	 Pressure	 threshold	 to	 activate	 C5F12	 droplets	 of	 given	 diameters	 from	 a	 number	 of	publications.	All	droplets	were	BSA	shelled,	with	US	exposure	at	duty	cycles		<1%	and	occurring	at	37	°C	(black	diamond,	red	circle)	or	~25	°C	(blue	and	pink	triangles,	green	square).	The	data	in	this	Figure	has	been	acquired	from	references	[127–129].	
 
Activation of PFC droplets into MBs was first presented by Apfel et al. (1998).130 Since 
then ADV of PFC droplets has been proposed for use in tissue occlusion, gene transfer 
enhancement, phase aberration correction, drug delivery, and as a cavitation nucleation 
agent for non-thermal US therapy.131–134 Bovine serum albumin (BSA) coated C5F12 
droplets have seen the most publication.127,129,131,132,134–141 Bulk C5F12 has a boiling point 
of 29 °C. This offers a volatile liquid state at room temperature, which is simple to 
handle when care is taken, yet offers the lowest energy requirement for activation into 
gas compared to other PFCs that are bulk liquid at room temperature. ADV of C5F12 
micro-nanodroplets has been regularly found to require US negative peak pressures of 1 
to 3 MPa,138 with micrometre sized droplets being capable of activation into 20-80 µm 
MBs with short tone bursts of US in the diagnostic range (1.5-8 MHz).127 The pressure 
threshold for activation is primarily dependant on the US frequency, exposure time, the 
introduction of bubbles to the solution (including pre-formed bubbles and ones 
activated from droplets), and droplet size, with the threshold decreasing on an increase 
to any of these factors.127,129,137,142 Figure 2.9 shows the recorded ADV pressure 
threshold, based on C5F12 droplet sizes, for a number of publications. However, contrary 
to the frequency relationship, Rapoport et al. (2009) claimed that lower frequencies can 
allow for more efficient activation due to the longer rarefaction (low pressure) period of 
the wave, though they also stated that this can increase the chance for coalescence and 
gas diffusion.143 Theory states that on activation the droplets should increase to five 
Fabiilli et al. Fabiilli et al. 
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times their initial diameter (see Theory Chapter 3.5.1, p 54).127,144,145 However, 
publications from many groups have seen that the post-activation MB size is often 
much larger than this.127,137,143,146–148 Where 500 nm droplets should give 2.5 µm MBs, 
MBs of 10s – 100s of micrometres are often observed. It has been proposed that this 
observation was due to a three-step process of droplet activation, MB coalescence, and 
diffusion of dissolved air and PFC into the newly formed MBs.123 Fabiilli et al. (2009) 
studied the relationship been the thresholds for C5F12 droplet ADV and inertial 
cavitation (IC).135 Where ADV identifies the point of PFC droplet activation into a gas 
MB, IC identifies the onset of US driven oscillations that would lead a MB to collapse. 
Figure 2.10a shows how ADV and IC changed with droplet size. They found that for all 
cases the threshold for ADV was below IC. Schad and Hynynen (2010) also studied the 
thresholds of ADV to IC for C5F12 droplets of 1-6 µm, at ~25 and 37 °C, using US 
within the therapeutic range (0.6-2.9 MHz).142 They found that while the ADV 
threshold decreased with an increase in either droplet size or frequency, IC threshold 
increased with an increase in frequency and was independent of droplet size. Figure 
2.10b shows how the ADV and IC thresholds changed with US frequency for two 
different publications on similar droplet emulsions. While the US duty cycle (DC - the 
time an US wave is active within an entire exposure duration) of the two publications 
differed greatly, these results, with the findings of Schad and Hynynen (2010) based on 
the size dependence, offer the hypothesis that at a certain limit to droplet size and US 
frequency, IC could occur at a lower threshold than ADV. Rapoport (2009) presented 
activation of C5F12 PEG-PLLA and PEG-PCL droplets, where 70% of the population 
was 590 nm.143 They showed that droplet activation occurred at 1.3-1.7 MPa when 
using DC 100% US of 1-3 MHz, which was dropped to 0.7 MPa when using 90 kHz in 
the presence of pre-existing MBs. For the latter case, the droplets were held in a gel 
where the semi-flexible solid would have likely dampened the potential for activation. It 
was claimed the “explosive” 90 kHz activation was due to presence of pre-existing MBs, 
which was most probably due to their ability to act as concentration sources for the US. 
They also explained that activation of PFC droplets by thermal routes is an ineffective 
way to activate droplets, and that physiological temperatures would not be expected to 
result in any activation.  
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	Fig	2.10.	ADV	and	IC	thresholds	dependant	on	(a)	droplet	size	and	(b)	US	frequency.	C5F12	BSA	or	DPPC-DPPA	 (*)	 droplets.	 All	 droplets	 in	 degassed	 water	 at	 37	 °C.	 DC	 of	 (a)	 0.03%	 and	 (b)	 <1	(diamond)	 or	 100%	 (red	 circle).	 For	 Figure	 a,	 the	 frequency	 is	 constant	 at	 3.5	 MHz,	 for	 b,	 the	droplet	size	is	constant	at	~1.5	μm.	Figure	a	has	been	taken	from	reference	[135].	
 
The above text described the formation and activation of single emulsion PFC droplets. 
The following text describes the same but for double emulsion oil-PFC droplets. 
 
	Fig	2.11.	C5F12-in-soybean	oil-in-BSA	double	emulsion	droplets,	 showing	 fluorescence	 loaded	 into	the	oil	phase.	Although	 large	droplets	appear	 in	this	Figure,	droplets	≤10	μm	diameter	accounted	for	only	4.9%	(by	number)	of	total	droplets.	This	Figure	has	been	taken	from	reference	[138].		
Fabiilli et al. (2010) presented a mechanical agitation route for the formation of C5F12-
in-soybean oil-in-BSA double emulsion droplets.138 45 s mechanical agitation of 12 
vol% C5F12 and 12 vol% oil in 4 mg/ml BSA PBS solution formed droplets of 3.1 ± 0.2 
µm, with ~1.2 ± 0.4 µm PFC cores, and a wide size distribution up to ~30 µm. 25 mg/ml 
chlorambucil was loaded into the oil before droplet formation. Figure 2.11 shows 
imaging of these double emulsion droplets. Figure 2.12 shows how these droplets were 
then introduced to a 37 °C OptiCell with Chinese hamster ovary cells adhered to the top 
almost 16-fold increase in the droplet surface area, the IC 
threshold does not decrease as the average droplet diame-
ter increases. This suggests that the IC nucleation process 
involved in ADV is dissimilar to the nucleation process of 
IC of polystyrene spheres. It is speculated that IC nuclei 
are generated from the presence of gas pockets on the 
surface of the spheres, caused by the hydrophobicity and 
surface roughness on the sphere. Considering the favorable 
wettability properties of albumin and lipid shells in the 
bulk fluid, as well as the high fluidity of the PFC in the 
dispersed phase, it may be likely that the presence of gas 
pockets, compared with polystyrene spheres, is minimal.
Based on an approximate 5-fold expansion of a droplet 
as it is vaporized into a gas bubble [7], a 1 µm and 10 µm 
droplet would yield a 5 µm and 50 µm bubble, respec-
tively. Using an analytical model [28] the minimum acous-
tic rarefactional pressures required to produce IC in the 
aforementioned bubbles sizes, using a 3.5 MHz insonation 
frequency, are 3.77 MPa and 39.2 MPa, respectively. This 
is based on a collapse temperature of 5000 K and the 
surface tension, viscosity, and density of water as input 
parameters to the model; additionally, the heat capacity 
ratio of PFP at 37°C was determined to be 1.044 using 
the Universal Functional Activity Coeﬃcient (UNIFAC) 
method in Aspen Plus software (Aspen Technology Inc., 
Cambridge, MA). For a micron-sized or larger bubble, the 
viscous and inertial eﬀects of the surrounding fluid cause 
the IC threshold to increase as the diameter of the bubble 
(IC nucleus) increases. This range of computed values 
supports the hypothesis that gas bubbles generated by 
ADV can undergo IC due the application of US from the 
single-element transducer.
Fig. 7 also displays the eﬀect of the shell material—
albumin versus lipid—that is seemingly negligible relative 
to the mean diameter. For gaseous contrast agents, lipid 
shells, which are on average 1 to 2 nm thick, are more 
stable and inhibit diﬀusion be ause of their greater flex-
ibility than albumin shells, which are on average 10 to 
15 nm thick and more rigid [32]. If this is the case, then 
the smaller diﬀusion coeﬃcients of liquid PFCs relative 
to gaseous PFCs coupled with the mechanistic diﬀerences 
between ADV and contrast agent destruction may render 
the eﬀects of the shell negligible except for Ostwald ripen-
ing. This further indicates that the nucleation mechanism 
does not occur at the shell of the droplet.
C. Acoustic Parameters
The eﬀects of the pulse repetition frequency (PRF) on 
the ADV and IC thresholds are shown in Fig. 8. In all cas-
es, the ADV threshold is lower than the IC threshold (p < 
0.001). Additionally, an inverse trend is observed for both 
thresholds below 25 Hz while the thresholds are statistical-
ly constant above 25 Hz (95% CI of the slopes of ADV and 
IC data are [−6.3 × 10−5, 3.0 × 10−4] and [−6.7 × 10−4, 
4.8 × 10−4], respectively). The ADV and IC data above 
and below 25 Hz form 2 distinct populations, with respec-
tive p-values of <0.03 and <0.02. The decrease in both 
thresholds, clearly seen from 10 to 100 Hz PRF, relates to 
the number of times a fluid volume passing the single-ele-
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Fig. 6. Mean (n = 5) ADV and IC thresholds, plotted with standard 
deviations, for PFP and PFH droplets as function of degree of superheat. 
The points denoted with asterisks (*) are cases where IC was measured 
11°C or 19°C below the boiling point of PFP or PFH, respectively—
though no corresponding increase in MEP was recorded. The follow-
ing conditions were used: degassed water with albumin-coated droplets, 
83 Hz PRF, and 13 cycles.
Fig. 7. Mean (n = 3) ADV thresholds and IC thresholds, plotted with 
standard deviations, for albumin-coated PFP droplets of various mean 
diameters. The points denoted with an asterisk (*) are lipid-coated drop-
lets, whereas the other points are albumin-coated droplets. The follow-
ing conditions were used: degassed water at 37°C, 83 Hz PRF, and 13 
cycles.
(b)	(a)	
DMSO or emulsified CHL. Analysis of variance
(ANOVA) was used to establish the significance between
the different experimental groups. The Tukey-Kramer
method was applied to differentiate significant differences
between the groups.
ADV efficiency
The ADV efficiency in the OptiCell, using the exper-
imental setup and acoustic parameters from the previous
section, was determined using chambers without cells.
The e ulsion was intr duced into the chamber, exposed
to US, and the droplets remaining post-exposure were
counted with the Coulter counter. The droplet sample
was briefly over-pressurized in a syringe and then diluted
before counting, thereby decreasing the likelihood that
bubbles were still present in solution. The ADV efficiency
was defined as the ratio of the droplet concentration re-
maining in the chamber post–US exposure to the initial
droplet conce tration (i.e., before US exposure). The
experiment was repeated using one, two, and five pass s
of the US array across the chamber surface.
RESULTS
Emulsion characterization
Figure 2 displays the visible and fluorescent images
of the droplets, where two distinct phases are clearly
seen within the droplets. The dye is contained within the
oil phase because of the lipophilicity of the dye and the
lipophobicity, and also hydrophobicity, of the PFP phase
(Riess 2001). The oil phase surrounds the PFP core as
a result of the relative hydrophobicites of the two phases;
fluorocarbons are significantly more hydrophobic than
hydrocarbons (Riess 2001). A similarly structured emul-
sion, with a fluorocarbon surrounded by oil, was observed
when silicone was emulsified with a perfluoropolyether
and water (Lee et al. 2002).
Based on the micrographs, Fig. 3 displays the ratio of
the inner droplet diameter (PFP) to the outer droplet diam-
eter (PFP plus soybean oil) for the emulsion. Microscopy
magnification limitations prevented the optical sizing of
droplets with outer diameters ,1.5 mm. Although these
smaller droplets could not be sized, it is evident that as
the outer droplet diameter increases, the ratio of the inner
to outer diameter also increases. Therefore, larger droplets
tend to have a larger volume percentage of PFP relative to
smaller droplets and a tighter distribution of the ratio. It
also appears that there is a cutoff for each droplet diameter
that limits how small the ratio may be for a given size. The
ratio distribution has a slight positive skew with a mean
ratio of 0.45. The actual outer diameter size distribution,
as obtained by the Coulter counter, is displayed in Fig. 4.
Characterizing the ratio of the inner and outer droplet
diameters may enable a clearer interpretation of the ADV
threshold for the dual-phase emulsion, which is seen in
Fig. 5. Previous findings using PFP droplets (Fabiilli
Table 1. Groups used in the OptiCell experiments
Group Droplets CHL US
1 2 2 2
2 1 2 2
3 2 1 2
4 2 2 1
5 1 1 2
6 1 2 1
7 2 1 1
8 1 1 1
For each group, the positive (1) and negative (2) symbols indicate the
presence or absence, respectively, of each parameter. In the case of groups
5 or 8, the CHL is present within the dispersed phase of the emulsion.
Fig. 2. A visible image (left) and its correspondi g fluorescent image (right) of the dual-phase emulsion containing PFP
and soybean oil stai ed with a fluorescent dye. The spacing between the two horizontal lines on the hemacytometer is 200
mm and a 20 m sc le is included in each image. Although large droplets appear in this figure, droplets.10 mm in diameter
account for only 4.9% (by number) of total droplets. Refer to Fig. 4 for a size distribution, obtained via Coulter counter, for
the emulsion.
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surface, before US exposure at 6.3 MHz, 1.57 MPa peak negative pressure, DC 1%. 
After US the droplets were seen to float to the top of the cell, indicating activation into 
MBs. Activation required less than 20 s. Growth inhibition studies showed that 
activated drug loaded droplets showed the same inhibition effect as free drug, indicating 
effective drug release. However, it was shown that only a small fraction of the droplets 
were successfully phase converted. 10 µm droplets activated at an efficiency of 90%, 
dropping to 5% for 2 µm droplets. In terms of the oil released, 6-30 µm droplets 
released 50%, dropping to 2% for the more clinically relevant 1-6 µm droplets. In this 
work they showed a significant lack of efficient droplet to MB conversion where the 
final MB was of clinically relevant size, < 8 µm. Dayton et al. (2006) presented work 
using C6F14:C5F12 (90:10 or 100:0 vol%) droplets with a triacetin oil shell (≤ 50 vol% of 
the total droplet volume), stabilised by a DPPC:DPPA:DPPE-PEG(5000) (82:8:10 
mol%) shell, purchased from ImaRx Therapeutics.149 These droplets were 270 ± 90 nm. 
US of 10 MHz, 3 MPa, 10 cycles, lead to expansion of the droplets by less than 5% 
diameter, indicating that the PFC cores did not phase convert into gas. Presumably this 
was due to the high C6F14 content and small droplet diameter. Fang et al. (2009) showed 
a high-shear homogenization formation route for PFC-in-coconut oil-in-lipid 
droplets.150 C5F12 and C6F14 droplets were encapsulated in coconut oil with a lipid shell 
of 3.5 w/v% HSPC or HSPE, 1.5% cholesterol, 1% Pluronic F-68, and 0.05% 
camptothecin. Formation with 2 w/v% oil in the solution (PFC at 20 w/v%) led to 
average 250 nm droplets, which increased to 425 nm when using 20 w/v% oil. 
 
	Fig	2.12.	Experimental	(a)	setup	and	(b)	method	used	to	perform	double	emulsion	oil-PFC	droplet	ADV	experiments	with	adherent	CHO	cells	in	an	OptiCell.	This	Figure	has	been	taken	from	reference	[138].		
cells in the control group and Nexp,tf is the final number of
cells in the experimental group. The %GI data, as a func-
tion of CHL concentration in DMSO, was fit using
a sigmoidal curve:
y 5 m1 1
m22m1
11
!
x
m3
"m4 (2)
where m1 is the maximum y-value, m2 is the minimum y-
value, m3 is the x-value at the midpoint of y and m4 is the
slope at the y-midpoint.
Ultrasound triggering of CHL-loaded emulsion
OptiCell (Thermo Fisher Scientific, Rochester, NY,
USA) chambers were coated with 20 mg/cm2 collagen
(type I, BD Biosciences, Bedford, MA, USA) 24 h before
plating approximately 4.03 104 CHO cells/mL within the
chambers. The cells, seeded 24 h before treatment, were
grown using the same conditions as previously described
for the six-well plate experiments. Figure 1 displays the
experimental setup and exposure conditions. For experi-
ment l groups treated with drople s, the emulsion was
diluted with DPBS and introduced into the OptiCell,
yielding a concentration of 7.0 3 07 droplets/mL within
the chamber. The chamber was gently and repeatedly in-
verted to homogenously mix the droplets, then inverted
to allow the droplets to settle onto the bottom window;
the chamber was then placed into the OptiCell holder,
which was located within a tank (40 3 60 3 27 cm)
that contained degassed, deionized water heated to 37!C
(Ex 7; ThermoNESLAB, Newington, NH, USA). The
surface of the tank water, located 5 cm above the
OptiCell, was covered with air-filled plastic balls
(Cole-Parmer Inc., Vernon Hills, IL, USA) to minimize
regassing and heat loss and reduce the planar reflection
of the US at the air/water surface. A linear array (10L
probe, Logiq 9, GE Healthcare, Milwaukee, WI, USA)
operating at the following conditions - 6.3 MHz, contrast
mode, single focus at 2.5 cm, 1.57 MPa peak rarefactional
focal pressure, 0.8 ms pulse duration per scan line, 12 kHz
scan line pulse rep tition frequency, 10 Hz frame rate -
was positioned below the chamber such that the 2.5 cm
focus was at the bottomwindow of the chamber. The array
was rastered in a minimally-overlapping manner via a
computer-controlled positioning system at 2 mm/s across
the chamber surface to vaporize the emulsion. Only two
rasters of the linear array were required to insonify the
entire chamber (approximately 75 s to scan the entire
chamber). After the exposure, the chamber was removed
from the tank, inverted so that the cells were once again
on the bottom window, and incubated for 60 min. During
the incubation, any droplets that did not vaporize re-
mained in contact with the cells; bubbles and, hence,
PFP gas generated as a result of ADV were not i contact
with the cells because of their buoyancy and size. The
chamber was then washed using similar ethods as for
the six-well plate experiments, and the cells were grown
for another 48 h post-washing. The cells were counted
as previously described and the %GI was calculated for
all experimental groups listed in Table 1. Because of the
fluid movement into and out of the OptiCell during
washing, a relatively large shear force was exerted on
the cells adjacent to the OptiCell injection port, resulting
in their deplating. The %GI for each chamber was
normalized by the deplated area to account for this loss.
All control groups received the same handling during
the exposure and washing processes. The same CHL
concentration was used for groups receiving CHL in
Fig. 1. Left: Experimental setup used to perform ADV experiments with OptiCells. Right: Exposure conditions used
during experiments. The emulsion was added to the chamber containing adherent CHO cells and subsequently exposed
to US to cause ADV of the introduced droplets.
Delivery of chlorambucil using perfluoropentane emulsion d M. L. FABIILLI et al. 1367
(a)	 (b)	
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These three publications showed effective means of forming PFC-oil double emulsion 
droplets from a variety of oils and shells. The latter two could be of more clinical 
interest due to their smaller formation sizes, which (according to theory) would lead to 
MBs within clinically relevant size limits, and their lipid shell that could potentially be 
functionalised with more precision than BSA shells. However, as previously stated, for 
activation, C5F12 cores would be required. These publications lacked observations of the 
droplets’ changes during activation or an understanding of how the droplets grew and 
how the oil layer was displaced. The work in this thesis looked to address these issues 
and to study further the optimisation of droplet size and oil layer thickness. 
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3. Theory and Background 
 
This chapter contains the underpinning theory relevant to this thesis. The following 
pages were considered for both design of experiments and analysis of experimental data. 
This covers; the microfluidic theory of MB formation, the relationships that govern the 
ultrasound properties and life-time of MBs, the conditions under which a liquid can be 
activated into a gas through control of temperature and pressure, and Fluorescence, in 
particular reference to Fluorescence Resonance Energy Transfer (FRET). 
 
3.1. Microfluidics 
There are a number of equations that govern microfluidics that have to be considered 
when developing a microfluidic device. On top of this, microfluidics that concern 
multiphase flow, specifically with pinch-off of a discontinuous phase in a continuous 
phase, have relationships that help predict how the phases will interact. When 
considering two phases where one is encapsulated in another, the phase that is or has 
been broken up (pinched-off) into discrete objects is referred to as the discontinuous 
phase, and the phase that pinches-off the discontinuous phase but remains as one 
complete phase is referred to as the continuous phase. However it should be noted that, 
throughout this thesis, if the intent was for pinch-off to occur, then these phases are still 
referred to as the discontinuous and continuous phases before pinch-off and even if 
pinch-off did not occur (for example, if pinch-off of one phase in another did not occur 
at a microfluidic nozzle, the central phase which was intended to be pinched-off is still 
referred to as the discontinuous phase). 
 
3.1.1. Fluid flow in micrometre scale channels 
Reynolds Number 
One of the key quantities for describing flow of liquids is the dimensionless parameter 
known as the Reynolds number (Re). Re is used to indicate whether flow will be under 
laminar or turbulent conditions, where viscous or inertial forces dominate 
respectively.151 Re is a measure of the ratio of the inertial to viscous forces acting in a 
fluid and is given by: 
 
 𝑅𝑒 = !"#$%!&' !"!"#$!"#$%&# !"#$%& = !"!!!   (3.1) 
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Where ρ is the density, v is the flow velocity, DH is the hydraulic diameter (𝐷! = !!! , for 
a channel of cross-sectional area A and wetted perimeter P), µ is the fluid viscosity.152 
Re < 2300 predicts laminar flow. Re > 2300 predicts turbulent flow. Re in microfluidic 
devices is typical found to be < 1, so well within predicting laminar flow.153 
Microfluidics often deals with volumetric flow rates (Q) [m3/s] rather v [m/s], as a phase 
will typically be introduced at one end of a microchip design with a specified Q that 
remains constant. On the other hand v is dependent on the variable width of the channel, 
so may change. Therefore, it is important to consider Re with respect to the Q. Since v = 
Q/A: 
 
 𝑅𝑒 = !!"!"   (3.2) 
As a channel's cross sectional area changes in a microfluidic system, the only variable 
that changes is P. Therefore, a decrease in dimensions at constant Q will increase Re 
back towards predicting turbulent flow. Most often however, Q is too low to reintroduce 
turbulence to the system. When one dimension of a channel's cross sectional area 
becomes significantly smaller than the other (for example in a microfluidic nozzle), the 
fluid flow will be constrained by the smaller dimension (x) far more than the larger 
dimension (y). In this case, to make Re represent the flow conditions better, DH ~ 2x.152 
Since A = x.y: 
 
 𝑅𝑒!≪! ≈ !!"!"   (3.3) 
Figure 3.1 shows how Re is approximated in this case, when considering flow down a 
thin channel. Under these conditions, Re unintuitively becomes independent of x as it is 
always balanced by an opposing change in v. Only a further change to y would cause a 
change to Re. This last consideration was crucial to this project as microfluidic nozzles 
and flow channels were used where one dimension (width) was around an order of 
magnitude smaller than the other (height) (~7 x 25 µm for a nozzle and 25 x 300 µm for 
a flow channel). 	
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	Fig.	 3.1.	 Schematic	 showing	how	Re	 is	 approximated	when	 considering	 volumetric	 flow	 rate	 in	 a	thin	channel	(x	<<	y).		
During this project, typically the highest possible on-chip Re value was ~20, occurring 
at nozzles. A high Q of ~3.5 ml/min (which was experimentally unusable, due to the 
high pressure that would be required to flow fluid through the small microfluidic 
dimensions of this project, as explained in the flowing section “Flow resistance”) 
would be required to make Re = 2300 and introduce the conditions for prediction of 
turbulence. This indicated that laminar flow was expected throughout all of the devices 
used in this project, aiding co-flow of species and preventing turbulent mixing. 
 
Flow resistance 
It is important to consider the resistance to flow (Rϕ) within microfluidic channels in 
order to determine how multiple fluid components interact throughout a microfluidic 
network. 
 
 𝑅! = !!!"!"!(!!)!   (3.4) 
 ∆𝑃 = 𝑄𝑅!  (3.5) 
Where f Re is the coefficient of friction (f Re = 24 for a filled rectangular channel), l is the 
channel length, and ΔP is the pressure difference across the channel.154 
It should be noted that Rϕ is dependent on the viscosity of the fluid in the channel. 
During this project, microfluidic experiments often dealt with two or three phase flow. 
This meant that it was often necessary to consider the resistance of a number of fluids 
relative to each other through the same channel to avoid backflow of one phase due to 
the force supplied by another. Practically, Rϕ must be considered as a limiting factor to 
microfluidic systems. If the resistance increases too high, the pressure required to flow a 
!! ≈ 2!"!"  
x	 x	
y	 y	
x	≈	y	 x	<<	y	
!! = 4!"!"  
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fluid down the channel may not be experimentally attainable with the equipment 
available. 
 
3.1.2. Microfluidic droplet and bubble pinch-off formation 
Capillary number 
Capillary number (Ca) defines the relative importance of the viscous forces (local shear 
stress) against the interfacial tension/capillary forces acting across the interface between 
two immiscible fluids. Ca is used to predict the regime under which a discontinuous 
phase pinches-off in a continuous phase. 
 
 𝐶𝑎 = !"#$%&# !"#$%&!"#$%&'(!') !"#$%& = !"! = !"!"    (3.6) 
Where γ is the interfacial tension.155,156 
A Ca value is often obtained for both of the fluid phases. However it has been 
recognised that the continuous phase plays a greater role in defining the pinch-off 
regime.157 Ca studies have typically considered three microfluidic pinch-off geometries; 
(1) coaxial, where the discontinuous phase inlet ends inside of a wider parallel 
continuous inlet, such as a tube within a tube, (2) flow focusing (FF), where the 
continuous phases forces the discontinuous phase through a small nozzle from both 
sides, and (3) T-junction, where the discontinuous phase inlet joins onto the continuous 
phase inlet (typically at 90°), giving a ‘T’ shape. As shown in Figure 3.2, a very low Ca 
predicts a squeezing regime, also known as “geometry controlled”, where the 
discontinuous phase repeatedly plugs up the nozzle before the continuous phase builds 
up enough pressure to push a packet of the discontinuous phase through the pinch-off 
region. A low to medium Ca predicts a dripping regime, where the discontinuous phase 
is held at the nozzle and packets of the discontinuous phase rapidly shear off the tip. A 
high Ca predicts a jetting regime, where the continuous phase travels through the 
nozzle and destabilises into packets a small distance downstream of the nozzle.156 It is 
suggested that a far greater Ca predicts laminar co-flow, or rather a non-pinch-off 
regime.158 For a FF geometry a Ca<<10-1, <10-1, >10-1, and >>10-1, would predict a 
squeezing, dripping, jetting and co-flow regime respectively, with a rough transition 
zone at 10-2 – 100 between the characteristic regimes, where it would be difficult to 
predict which fluid flow rates would give what regimes.156 
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	Fig.	3.2.	Schematic	showing	(rows)	the	three	most	common	pinch-off	geometries,	coaxial,	FF,	and	T-junction,	with	(columns)	the	four	pinch	off	regimes,	squeezing,	dripping,	jetting	and	co-flow	(non-pinching).	 This	 project	 was	 most	 concerned	 with	 the	 FF/dripping	 and	 T-junction/co-flow	regimes.156		
Typical flow rates used in this project for aqueous and oil phases centred around 30 
µl/min and 1 µl/min respectively. These flow rates gave Ca ≤ 10-1. Therefore, pinch-off 
was typically expected in the dripping regime. 
 
Weber number 
Weber number (We) defines the relative importance of the inertial forces against the 
interfacial tension/capillary forces acting across the interface between two immiscible 
fluids. 
 
 𝑊𝑒 = !!!!!! = !"#$%!&'!"#$%&'(!') = !!!!!!!!    (3.7) 
Where d0 is the diameter of the discontinuous phase bubble/droplet during pinch-off in 
the continuous phase. We is typically calculated in reference to the discontinuous 
phase.156,159–161 
We becomes an important characteristic of pinch-off and aids predictions for 
microfluidic geometry design when inertial forces are no longer negligible (when We ≥ 
1). However, typical flow rates used in a planar FF geometry, including the higher end 
of the flow rates used in this project (~ 100 µl/min), usually lead to We << 1, so for 
most cases We can be neglected in favour of concentrating on Ca which defines the 
pinch-off characteristics in more detail.159,160 
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Pinch-off scaling law 
During microfluidic pinch-off of one phase in another, it is expected that for every 
distinct discontinuous phase flow rate, Qd, there will be a range of continuous phase 
flow rates, Qc, that facilitate pinch-off. For example, when using a FF geometry, if the 
continuous phase flow rate is set too low the discontinuous phase will flow through the 
nozzle without pinching off, if it is set too high the discontinuous phase will be held at 
the nozzle or be pushed back up its own inlet. Within this pinch-off region, the lowest 
Qc is expected to produce the largest discontinuous phase bubble/droplet and the highest 
Qc is expected to produce the smallest bubble/droplet. Between these two points, the 
bubble/droplet diameter is described by the following scaling law; 
 𝑑/𝐷 ∝ (𝑄!/𝑄!)!  (3.8) 
Where d is the apparent diameter of the bubble/droplet (if the outlet channel is thinner 
than the bubble/droplet’s diameter, so that it is squeezed, this is the diameter observed 
from the top/bottom interface), D is the characteristic diameter of the nozzle, and n is a 
value dependant on the geometry of the microfluidic chip.43 The value of n varies 
between different chip geometries. For example, n = 0.17, 0.37 and 0.4 for 
axisymmetric geometries, FF designs with elongated nozzles, and planer FF short 
nozzle designs respectively.43,159,162–164 
 
3.2. Microbubbles and ultrasound 
The following theory covers how MBs respond to ultrasound and how their size and 
concentration changes over time. 
 
3.2.1. Echogenicity 
When an ultrasound wave is incident to an interface between two substances, a portion 
of that wave is reflected/scattered and a portion of that wave is refracted. The higher the 
acoustic impedance mismatch between the two substances, the greater the reflected 
portion.41 The scattered portion is what is typically collected during ultrasound imaging. 
Medical ultrasound images of the body have a relative higher contrast when imaging 
bone against soft tissue and a lower contrast when imaging organs against soft tissue, 
where the acoustic impedances are on the orders of 106-7, 106, and 104-5 kg.m-2.s-1 for 
bone, soft tissue, and organs respectively.51,165,166 One of the greatest acoustic 
impedance differences in the human body are between lung tissue and teeth enamel, at 
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1.80 x 105 and 1.60 x 107 kg.m-2.s-1 respectivley.165,166 Air and blood have acoustic 
impedances of 4 x 102 and 1.66 x 106 kg.m-2.s-1 respectively.51,165,166 This two orders of 
magnitude greater mismatch allows MBs in the blood stream to be capable of scattering 
far greater ultrasound intensities per unit area of interface, compared to any human 
tissue components. However, the compressibility of MBs pushes their echogenetic 
properties even higher. 
 𝐼! = !!!!!!!  (3.9) 𝜎 ∝ 𝑟!𝑓![𝑓 Z ]  (3.10) 
Where Is is the intensity of scattered ultrasound, Ii is the intensity of incident ultrasound, σ is the scattering-cross section, R is the distance the wave has travelled after scattering, 
r is the radius of the scattering particle, f is the frequency of incident ultrasound wave, 
f(Z) is a variable which takes into account acoustic impedance mismatch between the 
phases inside and outside of the scattering interface. 
A large acoustic mismatch leads to an increase of f(Z). This leads to a high σ, resulting 
in a high Is. As the MB r increases so does Is. However, MBs for medical use have an 
upper diameter limit of <8 µm to allow them to transit the microcirculation, cross the 
lung capillary bed and to prevent health issues such as atrial embolisms.43,167,168  
 
  	Fig.	3.3.	A	sketch	to	show	how	the	scattering	cross-section	of	a	MB,	proportional	to	the	scattering	intensity,	changes	with	the	frequency	of	an	incident	ultrasound	wave.	The	resonant	frequency,	f0,	is	indicated.	Adapted	from	reference	[41].		
Equations 3.9 and 3.10 apply to any particle. However, due to a MB’s gas core being 
compressible, MBs can additionally respond to exposure of ultrasound waves by 
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oscillating.167 Here, the MBs contract and expand with the ultrasound wave’s frequency 
as it presents the MBs with an environment that oscillates between a relative high and 
low pressure. This process is called stable cavitation.47 When the f of the ultrasound 
wave is equal to the MB’s fundamental/resonant f, f0, the oscillation of the MB become 
resonant, where the amplitude of the oscillation becomes greater. At these large 
oscillation amplitudes, the compression against the encapsulated gas is smaller than the 
expansion. On average, this leads to the MB being larger over time.167 Since σ increases 
to the sixth power with r, only a small increase in size leads to a very large increase in σ 
and Is, giving a many orders of magnitude higher echogenic particle.41,169 Whilst the 
high acoustic impedance mismatch is enough to give MBs a large Is, the property of 
oscillation gives them a vastly superior scattering yield.41 Additionally, due to the non-
symmetrical oscillation, this gives the MB a non-linear response. The non-linear 
response can be especially useful for distinguishing MBs from surrounding tissue, 
which will typically oscillate in a strongly linear manner. MBs also oscillate with peak 
amplitudes in response to US waves at subharmonic and harmonic frequencies of the 
MB’s resonant frequency (fsubharmonic = f0/n and fharmonic = f0.n, where n is a positive 
integer). In general, the scatter of a MB at f0 provides the most intense signal, with 
subharmonic and harmonic signals being progressively less intense. However, the 
second harmonic can be two or three times more intense than that at f0. On the other 
hand, human tissue gives off a far lower signal at these harmonic frequencies. This 
means that if the harmonic signals are used for imaging it is possible to achieve a higher 
signal-to-noise raio.41,167 
If a MB is exposed to a high acoustic pressure ultrasound wave, then the expansion and 
compression of the MB can become large enough to destabilise it, causing the MB to be 
destroyed in a catastrophic nature.167 This type of mechanism is called inertial 
cavitation and generally leads to the fragmentation of the original MB, forming smaller 
MBs.47 Figure 3.4 represents the differences between stable and inertial cavitation, 
whilst Figure 3.5 shows how the latter technique can be used to release encapsulated 
drugs. 
The increased intensity of the scattered ultrasound due to the MB’s oscillations is also 
dependent on effective energy and momentum transfer to the MB, which in turn is 
controlled by the mechanical properties of the shell, with a more rigid shell requiring a 
higher acoustic power to drive the same scale of oscillations and rupture.167,170 
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	Fig.	3.4.	Schematic	of	the	link	between	(a)	the	rarefaction	(expansion)	and	compression	sections	of	a	pressure	wave	created	from	an	ultrasound	wave,	(b)	the	displacement	of	particles	in	the	solution	the	 wave	 is	 exposed	 to,	 and	 (c)	 stable	 and	 (d)	 inertial	 cavitation	 of	 a	 bubble	 under	 the	 applied	pressure	wave.47	
 
	Fig.	3.5.	Schematic	of	a	bubble	being	destroyed	by	an	ultrasound	signal	and	releasing	a	loaded	drugs	in	a	patient’s	vasculature.	Adapted	from	Bekeredjian	et	al.	2005.171	
 
The oscillations of the gas core can be modelled by the Rayleigh-Plesset equation 
 !!!!!!!! = 𝑟 !!!!!! + !! !"!" ! + !!!! !"!" + !!!!!  (3.11) 
Where PB is the pressure inside the MB, PL∞ is the pressure of the liquid at infinite 
distance from the MB (when at rest PL∞ = Pa), ρL is the density of the liquid, t is the 
time, vk is the kinematic viscosity,  
For the case of an external pressure source, like a moving ultrasound wave, PB is 
assumed to be uniform across the MB. 
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3.2.2. Resonant frequency, f0 
The resonant frequency of a MB, considering the shell stiffness, can be given by the 
following model, which was introduced by Marmottant et al. (2005) and later linearised 
by van der Meer et al. (2007).172,173 This equation assumes that the acoustic pressure of 
the US wave being used to oscillate the MB is not high enough to cause buckling of the 
shell or MB rupture: 
 𝑓! = !!! !!!!! 3𝜔𝑃! + !!!! 3𝜔 − 1 + !!!!   (3.12) 
Where ρ is the density of the surrounding continuous phase, r0 is the radius of the MB at 
rest, ω is the polytropic gas index (1.07 for C4F10), P0 is the hydrostatic pressure (which 
for most cases considered in this work is equal to atmospheric pressure, Pa), and χ is the 
elastic modulus of the shell. 
 
	Fig.	 3.6.	 Schematic	 showing	 how	 the	 parameters	 of	 density,	 viscosity	 (μ),	 shell	 thickness	 (ε),	interfacial	tension,	and	elastic	modulus	apply	to	an	OLI-MB,	given	the	addition	of	the	oil	layer.		
 
Figure 3.6 shows how the MB parameters for determining resonant frequency are 
applied to an OLI-MB due to the addition of the oil layer. For the case of an OLI-MB, 
the ρ could be equal to the oil layer (ρO), the surrounding aqueous phase (ρA), or more 
realistically a coupling of the two. This is due to the gas core oscillations being 
constrained by displacement of the surrounding solution. Here, it can be assumed that 
an infinitely thin oil layer would not impart much of a damping force on the oscillations, 
with damping instead being supplied by the aqueous phase, compared to an OLI-MB 
with an effectively infinitely thick oil layer, where almost all (if not all) of the damping 
would be supplied by the oil. For simplification, we assume that the higher ρ fluid 
εO	
ρA,	μA	
ρO,	μO	
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would be dominant here. χ can be assumed to be equivalent to that of a lipid shelled MB 
as the elastic modulus of the oil layer would be negligible compared to the lipid 
monolayer. Calculations using equation 3.12 (Figure 3.7) considered MBs and OLI-
MBs with POPC shells. For an uncoated MB, χ = 0 N/m. For a DPPC and DSPC lipid 
shelled MB, χ = 0.06 and 0.26 N/m respectively.174 Apart from one C=C bond, POPC’s 
two tails are identical to one tail from DPPC and one from DSPC. We can therefore 
estimate POPC’s χ ≈ 0.16 N/m. An OLI-MB would have two interfaces, both of which 
would contribute to the pressure inside the structure. Therefore: 
 Δ𝑃 = 2 !!!!!! + !!!!/! !!  = 𝛼  (3.13) 𝑟! = 𝑟! + 𝜀!  (3.14) 
Where γG-O and γO-L/A are the surface tensions at the gas-oil and oil-lipid/aqueous 
interfaces respectively, rG is the radius of the gas core at rest, and εO is the thickness of 
the oil shell. 
Factoring Equation 3.13 into Equation 3.12 gives: 
 𝑓! = !!! !!"# !!,!!  !!! 3𝜔𝑃! + 𝛼 3𝜔 − 1 + !!!!   (3.15) 
	Fig.	3.7.	Graph	showing	the	dependence	of	a	MB’s	resonant	frequency	on	its	size,	 for	an	uncoated	(black)	and	 lipid	 shelled	 (green)	MB,	and	OLI-MBs	with	a	20	nm	shell	of	 squalane	 (orange	 solid)	and	 tripropionin	 (blue),	 and	 a	 500	 nm	 squalane	 shell	 (orange	 dotted).	 Diameter	 given	 is	 for	 the	whole	MB	including	any	oil	 layer.	All	 lipid	shells	are	POPC,	ρA	=	998.2	kg/m3,	P0	=	101	kPa,	μA	=	1	mPa.s,	γG-L/A	=	26.3	mN/m.	All	oil	parameters,	 including	surface	 tensions,	are	detailed	 later	 in	 the	thesis	methods	and	results.	Relationships	use	Equations	3.12	and	3.15.	
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Parameters that the above resonance theory neglects are the thickness of the surfactant 
shell (εL), and the viscosities of the oil and aqueous phases. As equation 3.12 has been 
used before to adequately model lipid shelled MBs such as DPPC and DSPC, and 
DPPC MBs with long chained DPPC-PEG-SPDP molecules, it can be assumed that the 
εL parameter is negligible for all similarly structured lipid shelled MBs, including 
POPC.70,174 Marmottant et al. (2005) discussed that a MB with a higher modulus of 
compression (the ratio between the force applied per unit area to an object and that 
object’s change in volume per unit volume) will have a higher resonant frequency.172 
On oscillation, the gas core of a MB or OLI-MB must displace the surrounding fluid, 
which provides resistance against the oscillations, effectively increasing the MB’s 
modulus of compression. For an OLI-MB, the thicker the oil layer, the more the oil’s 
viscosity will contribute to this resistance. Since squalane and tripropionin have 
viscosities of ~31 and ~8 times that of water, it can therefore be assumed that Figure 3.7 
underestimates the resonant frequency for the OLI-MBs, where a thicker oil layer 
should give higher resonant frequencies. Unfortunately the degree of underestimation is 
unknown. It should also be noted that Figure 3.7 is in terms of the full MB size, not the 
gas core, so for OLI-MBs the gas core will be smaller. This leads to an increase in the 
resonant frequency, but not as significantly as for a single interface MB due to the total 
volume, and so the outer interface, remaining the same. This effect is almost negligible 
for the 20 nm oil layer thickness OLI-MBs. The effect can be seen on the 500 nm OLI-
MBs, but it only becomes significant when the oil layer makes up two thirds of the OLI-
MB diameter, and asymptotic approaching the loss of all gas to a 1 µm oil droplet.  
Morgan et al. (2000) and McLaughlan et al. (2017) have previously presented an 
alternate model for calculating the resonance frequency of MBs, the Herring 
equation.175,176 This equation does include the above parameters that equation 3.12 lacks. 
When compared to equation 3.15, the Herring equation gives the same results for 
uncoated MBs and squalane OLI-MBs without a lipid monolayer (where χ is assumed 
to be 0 N/m). However, when considering the more realistic case where stabilising lipid 
monolayers are present, the resonances of both MB types are reduced. This does not 
agree with experimental findings from non-oil MBs, where a lipid monolayer is found 
to increase resonance (see Luan et al. (2012) and van Rooij et al. (2015)).70,174 
Therefore, the Herring equation was not used to estimate the OLI-MB resonance. The 
parameter that appears to contribute most to the significant difference between equation 
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3.15 and the Herring equation is the surface/interfacial tension, which, on addition of a 
lipid monolayer to a MB, typically reduces by half to approaching zero. 
 
3.2.3. MB life-time 
Single MB lifetime 
MB lifetime is limited by two mechanisms. An external force can disrupt them or cause 
them to collapse, or the gas can leak out of the MBs over time, leading to a passive 
dissolution. The following details how a MB dies passively. 
When at rest, PB, which is equal to the MB’s gas pressure (PG) plus the vapour pressure 
(PV), must be equal to the pressure of the liquid directly outside of the MB (PL) plus the 
pressure acting inwards on the bubble due to surface tension (Pσ).177 
 𝑃! = 𝑃! + 𝑃! = 𝑃! + 𝑃!   (3.16) 𝑃! − 𝑃! = 𝑃! = 𝛥𝑃 =  2𝛾/𝑟  (3.17) 
Where ∆P is pressure difference across the MB interface. 
This means that for a MB at rest the internal pressure will always be above the pressure 
outside, with the excess pressure being equal to Pσ, described by the Laplace pressure, 
ΔP (Equation 3.17). Since the bubble has a higher pressure inside compared to the 
outside environment, there is a driving force for dissolution of the gas to occur into the 
surrounding environment in order to lower the pressure difference (there are other 
driving forces such as the concentration gradient of the gas molecules inside to outside 
of the MB). Over time the gas dissolves into the surroundings, reducing the MB radius. 
By giving the MBs a surfactant shell (such as a phospholipid), γ is reduced at the gas-
liquid interface. This reduces ΔP, inhibiting gas dissolution and prolonging bubble 
lifetime.178 Theory dictates that the bubbles should dissolve completely. However 
evidence from scattering experiments has suggested that nanobubbles of ~100 nm could 
last for several days if allowed to sit at a hydrophobic interface.179 Other groups have 
found that during dissolution the MB shell can compact, leading to a relative rapid MB 
shrinkage rate until the shell molecules are fully close-packed, followed by a distinct, 
far lower shrinkage rate.180 The rate of decay for a MB with constant γ is described by 
the Epstein-Plesset equation (advanced by Borden and Longo (2002) to take into 
account the resistance towards mass transfer across the MB shell, Rshell): 
 − !"!" = !(! !!)!!!!!"" !!!!"!(!! !!!)!!(!! !!!!)   (3.18) 
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Where r is the radius, H is the Ostwald coefficient (the concentration ratio of dissolved 
gas in the surrounding aqueous phase to that of the gas inside the MB core), Dw is the 
diffusivity of the gas in the surrounding aqueous phase, Pxy is the ratio of the partial 
pressure of the diffusing gas in the surrounding medium to that at saturation.177,181 
To increase the bubbles lifetime, dr/dt needs to be reduced towards 0. This can be 
achieved by pre-saturating the solution with gas, decreasing H, using a low Dw gas, and 
using a surfactant shell that provides a high Rshell and reduces γ. The MB shell can be 
defined as being soft (also known as thin or flexible) or hard (also known as stiff). A 
soft shell, such as a lipid monolayer, will be ~2-3 nm thick, allowing large oscillations 
and acoustic signal, but typically provides a small Rshell. A hard shell, such as denatured 
albumin, will be ~10-200 nm thick, proving a large Rshell, producing a very stable MB, 
but reduces the ability to oscillate, giving rise to lower acoustic signals.182 Extreme 
temperatures and high pressures aid diffusion of the gas and may make the shell more 
fluid, reducing its rigidity and resistance, thereby decreasing life-time. However, 
practically this is only a user controllable concern when storing MBs since the 
temperature and pressure of blood during medical MB use is fixed to the patient.167 
Many MB designs include a polyethylene glycol (PEG) brush to the MB shell. This 
further increases Rshell. However, as well as giving a MB stability, a PEG brush coat is 
also important for use of MBs within the body as it provides stealth against the immune 
system, increasing in vivo lifetime.183 The PEG layer acts as an antifouling layer, 
inhibiting the build up of biological material, primarily the adsorption of plasma 
proteins,184 on the MB’s exterior, preventing immune system antibodies from binding to 
the MB and the body's immune system from destroying the bubble. PEG is a 
hydrophilic, flexible, long chain, which sticks out from the MB.  Each chain forms 
hydrogen bonds with surrounding water molecules, occupying the space adjacent to the 
MB’s surface. This blocks access to the large majority of the MB’s surface from any 
blood proteins that would activate the immune system to it.185 
 
For the lifetime of the proposed OLI-MB structure, there are a number of elements to 
consider about the above descriptions of lifetime due to the addition of the oil layer with 
considerable thickness. Similar to the Borden and Longo (2002) approach, the mass 
transfer resistance of water (Rwater) can be approximated through the nondimensional 
Sherwood number (NSh), Rwater = r/(NSh.Dw),181 the resistance due to the oil-gas interface 
(Roil) could be estimated as, Roil = d/(NSh.Do), where Do is the diffusivity of the gas in 
the oil. Equation 3.18 can be modified with the assumption that Rshell = Rlipid + Roil, 
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where Rlipid is the resistance due to the lipid monolayer (typically ~ 1-103 s/cm 181). 
However Roil has proven difficult to calculate since NSh cannot be approximated to 1 (as 
it is for Rwater) due to the oil layer not being long enough to provide a fully developed 
concentration profile of dissolved gas. Since gas diffusing out of the core would need to 
first pass through an oil layer before reaching the outer fluid, the effective Dw could 
only be decreased. If Do was low, the gas would take an increased length of time to 
reach the outer fluid, making the effective Dw dependent on the oil. The thinner the oil 
layer, the less effect this would have, however as the rG shrinks due to dissolution, the 
εO would increase as the oil volume would remain constant. Therefore Do would 
become more dominant as the MB decreased in diameter. If Do was high, then the gas 
would take little time to reach the interface to the outer fluid, but would still take as 
long to diffuse into the fluid as if the oil was not there, making the effective Dw almost 
completely dependent on the outer fluid. A primary consideration would be the change 
to the Laplace pressure as an OLI-MB would have two interfaces, requiring the use of 
Equation 3.13. As the gas-oil interface is a hydrophobic-hydrophobic interface, the 
surface tension would be difficult to lower, so would be a limiting factor in reducing the 
internal pressure. This could result in the OLI-MB having a lower lifetime due to the oil 
layer. 
Factoring the above, including Equation 3.13, into Equation 3.18 gives: 
 − !"!" = !!!!(!! /!)!"# (!!,!!)!(!!"#"$!!!"#) !!!!"!(! !!)!!(!! !!!)   (3.19) 
As stated above, there are a number of unknowns for estimating OLI-MB lifetime. 
However, if NSh is set to 1, and Do is made equal to Dw, an estimate can be made which 
shows that the addition of an oil layer can prolong MB lifetime (Figure 3.8). Due to the 
second interface increasing the internal pressure, the lifetime is reduced for OLI-MBs 
with thin oil layers (< 200 nm), but increases for thick oil layers as Roil becomes 
dominant. 
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	Fig.	 3.8.	 Estimated	 results	 for	 the	 passive	 dissolution	 time	 of	 C4F10	OLI-MBs,	with	 given	 oil	 layer	thickness	and	a	POPC	lipid	monolayer,	in	water,	at	room	temperature.	Bubble	radius	refers	to	the	gas	core	only.	Initial	bubble	diameter	=	2.4	μm,	H	=	2.02	x	10-4,	Pxy	=	5/6,	Pa	=	101	mPa,	γG-L/A,	γG-L/A,	and	 γG-L/A	 =	 26.5,	 28.0,	 and	 1.9	mN/m	 respectively,	Do	 =	Dw	 =	 6.9	 x	 10-6	 cm2/s,	Rlipid	=	 100	 s/cm.	Values	acquired	and	estimated	from	Borden	and	Longo	181	and	Sarkar	186.		
Ostwald ripening 
In the above section, the lifetime of a MB was described by the Epstein-Plesset equation. 
However, practically this only describes a single MB in solution. A population of MBs 
will generally follow this trend statistically, however another phenomenon termed 
‘Ostwald ripening’ also takes place at the same time. Ostwald ripening is a 
thermodynamically driven process whereby smaller particles of gas, liquid or solid in a 
liquid medium shrink whilst contributing material to larger particles of the same 
material. More specifically, over time, the particles shed their surface molecules 
through diffusion into the solution, in order to reduce the concentration gradient from 
inside to outside of the particles. Meanwhile, there is a redeposition of a portion of the 
dissolved material onto the surface of the larger particles since surface molecules are 
less energetically favourable than interior ones (this is what leads to surface tension) 
and the larger a particle becomes the smaller the ratio between surface molecules to 
interior molecules becomes. Ostwald ripening is a balance between these two 
energetically driven mechanisms. If the redeposition mechanism dominates, the end 
result is fewer particles (eventually one), each of a greater diameter than the particles of 
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the starting solution. Ostwald ripening is quantified by the Lifshitz– Slesov–Wagner 
equation: 
 
  𝑟! = !!"!!!!!!!"# 𝑡   (3.20) 
Where r is the average particle radius, S and DC are the solubility and diffusion 
coefficient of the particle material in the surrounding solution respectively, Vm the molar 
volume, ρ is the particle material density, R is the gas constant, and T is the temperature, 
t is the time.187,188 
 
3.3. Wettability 
Wetting is a term used to describe the degree to which one material spreads at the 
interface between two other materials. The result is that the material might spread fully, 
‘wetting’, not spread at all, ‘dewetting’, or form an intermediate lens at the interface, 
‘partial wetting’. To understand wetting, the concepts of cohesion, adhesion and 
spreading must firstly be understood. 
 
	Fig.	3.9.	Schematic	of	the	adhesion	of	two	immisible	materials	(A	and	B),	showing	the	interaces	that	are	formed.	Materials	are	in	a	vacuum.	
 
The amount of energy, per unit area, it takes for two immiscible materials to go from 
being separate to touching is known as the work of adhesion, WAB. Figure 3.9 shows a 
schematic of two materials going through adhesion, noting the interfaces present before 
and after adhesion. This work can be defined using the Dupré equation: 
 
vacuum		
A	
B	
A	
B	
γAB	
γA	
γB	
γA	
γB	
 49 
𝑊!" = 𝛾! + 𝛾! − 𝛾!"   (3.21) 
Where γA, γB, and γAB, are the surface tensions (or energies) of materials A and B in a 
vacuum, and the interfacial tension between materials A and B respectively.189 
The lower the value of WAB the more energetically favourable it is for materials A and B 
to contact over a larger surface area, leading to a greater spreading. Alternatively for 
two volumes of the same material this is known as the work of cohesion, WAA, where 
Equation 3.21 simplifies to: 
 !!𝑊!! = 𝛾!  (3.22) 
 
This allows Equation 3.21 to be written as: 
 𝛾!" = !!𝑊!! + !!𝑊!! −𝑊!" = !!𝑊!"! = !!𝑊!"!   (3.23) 
Where WABA and WBAB are the work cleavage of material B between A, and material A 
between B respectively. 
When three phases are considered, where work is given in terms of the cleavage of 
material C between materials A and B, WACB, Equation 3.23 is factored into Equation 
3.21 (where the vacuum is now considered as material C) to give: 
 𝑊!"# = 𝛾!" + 𝛾!" − 𝛾!" =𝑊!! +𝑊!" −𝑊!" −𝑊!"   (3.24) 
When WACB < 0, γAB > γAC + γCB, leading material C to fully displace material B from 
material A, wetting the interface. Under these circumstances, W is often then referred to 
as the spreading coefficient, S, where WACB = -SACB.189 
The Young’s equation considers a three-phase system between a flat solid, a liquid 
droplet and surrounding gas/vapour: 
 𝛾!!! = 𝛾!!! + 𝛾!"𝑐𝑜𝑠𝜃!   (3.25) 
Where So, L, and G, denote if the surface tension is between the solid, liquid or 
gas/vapour interfaces respectively, and θL is the angle the liquid droplet makes at the 
solid-liquid-gas triple point. 
 
If the gas/vapour is considered a vacuum and materials So = B and L = A, the Young’s 
equation factors into the Dupré equation, to give the Young-Dupré equation: 
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 𝛾! 1 + cos 𝜃! =𝑊!"  (3.26) 
 
Figure 3.10 shows how an emulsion of material C in B can result in spreading, a partial 
spreading lens, or no spreading, dependant on the cleavage of materials A-C with 
respect to one another. As stated above, when WACB < 0, C will displace B from A. 
However this does not mean that when WACB > 0, C will not spread at A. (For the case 
where material C originates from material B) Instead, partial wetting may occur where 
both materials B and C are in contact with A, here WBAC < 0, giving rise to lenses of C, 
or dewetting of C may occur where C does not spread at the interface. For dewetting of 
C to occur, WABC < 0.189 
	Fig.	3.10.	Schematics	of	interaction	between	materials	A,	B	and	C	in	respect	of	the	work	of	adhesion.	Starting	with	(a)	material	C	dispersed	in	B,	where	B	is	in	contact	with	A,	C	either	(b)	fully	wets	the	
A-B	interface,	(c)	partially	wets	the	interface,	or	(d)	begins	to	coalesce	without	wetting	the	interface,	based	on	the	work	of	adhesion	between	the	martials	being	positive	or	negative	as	indicated	below	each	image.	(Adapted	from	Israelachvili,	2011)189	
 
3.3.1. Droplets entering a stabilised interface 
The above theory describes what is observed for bulk materials, or where material C is 
solubilised in B and precipitates out. However, when finite particles/droplets of C are in 
the system, the ‘entering’ or ‘rupture’ coefficient, ER, must be considered.115,190 For a 
system where droplets of liquid C, dispersed in immiscible liquid B, are introduced to 
an interface between B and fluid A (A can be a third immiscible liquid, but for most 
cases, including what we consider from this point on, A is a gas) there is almost always 
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some surfactant dispersed in B which keeps C stabilised in B, preventing coalescence of 
C, and that surfactant can also stabilise the B-A interface. In this case, even though 
energetically it may be preferable for the phases to have a conformational interface of 
A-C-surfactant-B, the surfactants at C-B and B-A can produce a thin water film which 
separates C from A with a kinetic energy barrier. The primary factor that inhibits the 
droplets of C from entering the B-A interface is if the surfactants sufficiently decrease 
the interfacial tension of B-A without C. Sirks (1938), Schokker et al (2002), and King 
(1955) have all reported on this phenomenon experimentally, with the latter finding that 
fat globules resting below a milk-air surface would not enter the surface until it was 
disturbed by contact with a platinum loop.191–193 Here it was theorised that the contact 
disturbed the milk proteins at the surface that were acting as the surfactants to give the 
energy barrier.115 
 𝐸! = 𝛾!" + 𝛾!" − 𝛾!" =𝑊!"# + 2(𝛾!" − 𝛾!")  (3.27) 
If ER < 0, then the droplet of C remains submerged in B. However if ER > 0 then the 
droplet of C enters B-A, resulting in a lens of C if S < 0, or a thin film of C if S > 0.  
An important thing to note is that the surfactants will usually pack at the B-A interface 
at their equilibrium spreading pressure (ESP), before the droplets of C come into 
contact. If C is calculated to become a thin film; as it enters B-A and then begins to 
spread from a lens into a thin film, the surfactants at B-A can become compressed at a 
greater rate than they move to the increasing C-B interfacial area. If this happens then 
the γ of B-A will decrease. This will continue until S = 0, at which point the rate of 
spreading will be limited by the surfactant diffusion, or an equilibrium will have been 
reached (the ESP and collapse pressure concentrations at A-B will likely be different 
than that at C-B) and spreading will stop entirely. 
 
3.4. Fluorescence and Förster/Fluorescence Resonance Energy 
Transfer (FRET) 
Figure 3.11 shows a Jablonski diagram that illustrates the excitation and emission 
mechanisms that occur during standard fluorescence and Förster/Fluorescence 
Resonance Energy Transfer (FRET). During typical fluorescence, an excitation source 
(most commonly a photon) comes into contact with a fluorescent molecule. In Figure 
3.11 this molecule is the ‘donor’ (though for typical fluorescence this name can be 
ignored). An electron in this molecule takes in part or all of the energy of the excitation 
source, and is excited into a higher energy band, relating exactly to the amount of 
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energy it acquired. After this, the electron may lose energy, whilst remaining within the 
same energy band, by moving down vibrational energy states, but eventually the 
electron will relax down to the initial energy band by releasing a photon with the same 
amount of energy as the difference between the two energy bands. Since the energy of a 
photon is inversely proportional to its wavelength, the energy difference between the 
molecule’s energy bands, which the excited electron was excited up and down, directly 
defines the wavelength of the emitted photon. On the other hand, FRET is an interaction 
that occurs between two molecules (at least one fluorescent) whereby one molecule, the 
donor, is excited and then passes its energy over to a second molecule, the acceptor, 
allowing the second molecule to release that energy (typically) as fluorescence. This is 
different from the first molecule being excited and fluorescing radially and then a 
second molecule being excited by that fluorescence and fluorescing radially. Instead, a 
long-range, non-radiative, dipole-dipole coupling transfer takes place between the donor 
and acceptor molecules. Here, the donor electrons relax back to the ground state without 
releasing fluorescence.194 A different way to think about this would be to consider the 
excited donor as having an oscillating dipole, where the energy of the oscillation is 
passed to the acceptor dipole, which has a similar resonant frequency.195 Figure 3.12 
shows an example schematic of the excitation and emission spectra for FRET 
fluorophores, where the important aspect is that FRET will only occur if there is a 
significant spectral overlap of the donor emission with the acceptor excitation (their 
wavelength bands must overlap). Typically, FRET only occurs when donor and 
acceptor molecules are within 1-10 nm as the efficiency of transfer, ET, decreases 
rapidly with the sixth power of inverse distance, d: 
 𝐸! = !!! !/!! !  (3.28) 
Where dE is the distance when ET is at 50% of its maximum.196 
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	Fig.	3.11.	 Jablonski	diagram	showing	 the	 interactions	 that	 lead	 to	 (1	and	2a)	 typical	 fluorescence	emission,	and	(1,	2b,	and	3)	FRET	emission	between	a	donor	and	acceptor.		
	Fig.	3.12.	Sketches	to	show	(a)	how	donor	emission	and	acceptor	absorption	spectra	must	overlap	for	FRET	to	occur	and	the	expected	emission	observed	from	a	sample	where	(b)	donor	and	acceptor	molecules	are	too	distant	and	(c)	close	enough	for	FRET	to	occur.	
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3.5. Activation of perfluorocarbon liquid droplets to gas bubbles 
One route to forming MBs, which has been extensively studied in recent years, is the 
vapourisation of liquid (typically PFC) nanodroplets into gas MBs. The following 
details the equations to determine the ratio of liquid to gas expansion and the conditions 
under which droplets would be expected to phase convert. 
As a droplet of liquid decreases in size the thermal energy/temperature required to boil 
it into a gas, the vaporisation temperature, increases above the bulk boiling point. This 
increase is due to the Laplace pressure increasing the internal pressure of the droplet as 
its radius is reduced. If the droplets are brought above the bulk boiling point in literature 
they are often termed as being superheated, without regarding the vaporisation 
temperature change.34,35 If the droplets are heated enough (past the point of being 
superheated) or the pressure of the surrounding solution dropped enough (which can be 
supplied by an ultrasound wave), or through a combination of both, the droplets will 
phase convert into bubbles.36,37 After activation, the MBs are larger than the droplets 
they were formed from, and the interfacial tension is expected to be different between 
liquid PFC- and gas PFC-water. Hence, the Laplace pressure differs, resulting in the 
boiling/condensation points not being the same for a single PFC particle in liquid or gas 
phase. 
 
3.5.1. Droplet to MB size expansion 
The droplet radius that will result in any given MB radius, due to a phase change of the 
material, can be gained by combining the ideal gas law (Equation 3.29) and the Laplace 
equation: 
 𝑃!𝑉! = 𝑛!𝑅𝑇  (3.29) 𝑟! = (!!!!!!!)!!!!!!"!!!   (3.30) 
Where subscripts refer to the type of cavity, for the post-activation MB, B, or the pre-
activation droplet, D. n is the number of moles of material in the cavity, MW is the 
molecular weight. 
 
Evans et al. (2006) described how Equation 3.30 gives an overestimate of the expansion 
found practically, as it works on the assumption that the number of droplet molecules, 
nD, is equal to the number of post-activation MB molecules, nB.197 Equation 3.30 
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neglects that the solubility of the material, when confined in a droplet or a MB, is 
different. Taking solubility into account: 
 𝑛! = 𝑛! + 𝑉!(𝑆! − 𝑆!)  (3.31) 𝑆! = 𝑆! exp !!!!!!!!!" , where t = D or B 
Where subscript t refers to the type of cavity the calculation is made on, either the post-
activation MB (t = B) or the pre-activation droplet (t = D), Vs is the volume of fluid 
around the MB which has the volatile material solubilised into it as a shell, S(D or B) is the 
enhanced solubility of the material in the surrounding fluid due to confinement, and S0 
is the bulk solubility of the material in the surrounding fluid. 197 
Factoring this into Equation 3.30 gives: 
 𝑟! = (!!!!!!!)!!!!!!"!! − !!!!!(!!!!!) !!!!!   (3.32) 
For use inside the body, MBs have an upper practical limit to their size. Meanwhile, 
droplets require more energy to active the smaller they are. Therefore, it is important to 
form droplets as large as possible whilst keeping their maximum activated MB size 
under the upper limit. The maximum activated MB size occurs at the moment of 
activation, when Vs = 0, when no additional solubilisation has yet occurred due to phase 
change. Equation 3.32 collapses back to Equation 3.30, and so this is the equation that 
we use for estimating droplet to MB expansion, keeping in mind that experimentally 
this would be an overestimate. 
Conversely to this, it was found by Kripfgans et al. (2000) that experimentally PFC 
droplet activation forms MBs far larger than expected from Equation 3.30. This is 
because even though Evans et al. (2006) took into account the solubility of the 
droplet/MB material in the surrounding solution, they neglected diffusion of the 
dissolved gasses from the surrounding solution into the MB.127 	
Figure 3.13 shows the resulting bubble size after single droplet activation, as a function 
of initial droplet size, considering cases for; interfacial tension, 0 mN/m (fully 
stabilised by surfactant) to 72 mN/m (bare air-water interface), temperature, below the 
water freezing point to the water boiling point, PFC cores, where all PFC molecules 
follow a CnF2n+2 formula, for n = 3-6, and the pressure of the system after activation 
into a MB. The first three variables indicate that to produce a 3 µm PFC MB, a PFC 
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droplet of ~600-700 nm would be required. Due to the Laplace pressure, an exponential 
growth in the diameter expansion ratio is seen for droplets up to ~200 nm in diameter, 
after this the relationship becomes linear, with a diameter expansion ratio of ~4-5 times. 
Pressure was indicated to cause a far larger size variation due to the compressible nature 
of the MB gas core. However, just considering atmospheric and body pressure (1.00 and 
1.13 atm respectively), which are the primary ways that the droplets would be stored 
and delivered, leads to a negligible size change. 
 
	Fig.	3.13.	Diameter	expansion	of	PFC	droplets	 to	bubbles,	outlining	how	different	variables	affect	the	 expansion,	 and	 indicating	 what	 size	 droplets	 would	 be	 needed	 to	 produce	 a	 3	 μm	 bubble	(dotted	black	line	and	grey	box),	as	desired.	Variables	are;	(a)	surface	tension,	(b)	temperature,	(c)	PFC	 type,	 and	 (d)	 constant	 pressure	 after	 activation.	 Unless	 varied	 as	 indicated,	 droplets	 were	calculated	to	have	a	surface	tension	of	33	mN/m,	at	25	°C,	to	have	a	PFC5	(C5F14)	core,	and	were	at	1	atm.		
(a)	 (b)	
(c)	 (d)	
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3.5.2. Vapourisation temperature as a function of droplet size  
How the vapourisation temperature increases due to a decrease in droplet size can be 
gained by combining the Antoine equation (Equation 3.33), a correlation which 
describes the relationship between a bulk material’s vapour pressure (PV0) and the 
temperature, the Kelvin equation (Equation 3.34), which describes how the vapour 
pressure (PV) increases for a curved interface, and the Laplace pressure equation, with 
the assumption that droplet to MB expansion occurs when the resultant droplet pressure 
(PD) = PV. 
 𝑙𝑜𝑔!"𝑃!! = 𝐴 − !!!!  (3.33) 𝑃! = 𝑃!! + exp !!!!!!!"   (3.34) !!!! + 𝑃! = 10!! !!!! + exp !!!!!!!"   (3.35) 
Where A, B and C are model parameters specific to a material (acquired from the 
National Institute of Standards and Technology (NIST) Chemistry WebBook (Linstrom 
and Mallard 2010) for temperatures between -50.98 and 149.75 °C).198 
Due to how Equation 3.35 has variables T and rD arranged, it is laborious to rearrange it 
in terms of either variable. However, we can simplify Equation 3.35 knowing that the 
Kelvin equation is negligible below a certain droplet diameter; for C5F12, the primary 
PFC liquid used in these studies that dealt with this section of theory, PV is only affected 
significantly (defined as when PV = 1.1 x PV0) below droplet diameters of 85 nm, which 
would result in a 240 nm MB after activation (calculated in the previous section). This 
allows us to approximate Pv ≈ PV0 when rD > 85 nm. This leads to the simplified 
equation of: !!!! + 𝑃! = 𝑃!! = 10!! !!!!  𝑟! = !!!"!! !!!!!!! , when rD > 85 nm (3.36) 	
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	Fig.	 3.14.	 C5F12	 droplet	 vapourisation	 temperature,	 given	 three	 values	 for	 the	 droplet	 shell	interfacial	 tension,	 as	 a	 function	of	 initial	 droplet	 diameter.	Dotted	 lines	 give	 the	30	mN/m	shell	droplet	activation	point	at	body	temperature,	37	°C	(black),	and	for	droplets	of	650	nm	(white).		
As shown in Figure 3.14, as a C5F12 liquid droplet decreases in size the temperature 
required to vapourise the liquid into a gas increases from the bulk vapourisation 
temperature of 29 °C. A 650 nm droplet, defined as the desirable in the previous section, 
with an interfacial tension of 30 mN/m, would vapourise at ~62 °C, whilst any droplet 
of 4.5 µm or larger would activate at in vivo temperatures of ~37 °C.  
 
3.5.3. Vapourisation pressure as a function of droplet size  
In the previous section an assumption was made that a liquid droplet will activate into a 
MB when PD = PV. It follows that as well as increasing the temperature of the droplet, 
the pressure of the system/surrounding solution, P0, can be reduced until the resultant 
PD would be equal to PV at a given temperature. Rearranging Equation 3.35 in terms of 
P0 gives: 
 𝑃! = 10!! !!!! + exp !!!!!!!" − !!!!   (3.37) 
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	Fig.	 3.15.	 Pressure	 properties	 of	 a	 C5F12	 MB,	 with	 a	 shell	 interfacial	 tension	 of	 50	 mN/m,	 as	 a	function	of	 the	C5F12	droplet	diameter	before	activation	 into	a	MB.	Vapour	pressure	(orange),	MB	internal	 pressure	 at	 atmospheric	 conditions	 (pink),	 and	 the	 maximum	 surrounding	 solution	pressure	 required	 to	 cause	PD	 =	PV,	 at	which	point	 phase	 conversion	 from	a	C5F12	 droplet	 to	MB	would	occur	(black).	Temperature	at	25	°C.			
Figure 3.15 shows the degree to which the pressure of a C5F12 emulsion needs to be 
reduced in order to cause phase change to occur, and how the required pressure drop 
increases due to a decrease in the initial droplet diameter. The required pressure drop 
increases because as the droplet decreases in size its internal pressure increases (due to 
Laplace pressure) at a faster rate than the vapour pressure. For droplets of 650 nm, a 
pressure drop of 57 kPa (from atmospheric conditions) would be required for phase 
conversion at 25 °C. 
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4. Experimental 
 
In this chapter the chemicals, instrumentation, and procedures used throughout the work 
presented in this thesis are described. 
During this thesis, results are presented in the following format; a ± b (SD or FWHM c). 
Where a is the calculated mean or the peak of a typically Gaussian distribution, b is the 
standard error, and c is the population spread given either in terms of a standard 
deviation (SD) or the full width half maximum (FWHM) of a Gaussian distribution. 
 
4.1. Chemicals, solutions, and microscopy 
Table 4.1 lists the chemicals commonly used in this study (other than the oils) and their 
suppliers. Table 4.2 lists the oils used in this study, their suppliers and their physical 
properties that impacted this work. 
 Tab.	4.1.	List	of	chemicals	(apart	from	oils)	used	throughout	this	project,	with	suppliers.	
	
Abbreviation	
in	this	thesis	
/	Chemical	
formula
Long	name Supplier
Atto488 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine	labeled	with	Atto	488 Avanti	Polar	Lipids,	USA
Atto590 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine	labeled	with	Atto	590 Avanti	Polar	Lipids,	USA
BSA Bovine	serum	albumin	 Sigma-Aldrich,	UK
C4F10 Perfluorobutane	 F2	Chemicals,	UK
C5F12 Perfluoropentane F2	Chemicals,	UK
C6F14 Perfluorohexane Sigma-Aldrich,	UK
DiI 1,1ʹ-Dioctadecyl-3,3,3ʹ,3ʹ-tetramethylindocarbocyanine	perchlorate Sigma-Aldrich,	UK
DiO 3,3ʹ-Dioctadecyloxacarbocyanine	perchlorate Sigma-Aldrich,	UK
Dotap 1,2-dioleoyl-3-trimethylammonium-propane	(chloride	salt) Avanti	Polar	Lipids,	USA
DPPA 1,2-dihexadecanoyl-sn-glycero-3-phosphate	(sodium	salt) Avanti	Polar	Lipids,	USA
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine	 Avanti	Polar	Lipids,	USA
Nile	red 9-diethylamino-5-benzo[α]phenoxazinone Sigma-Aldrich,	UK
ODT Octadecanethiol	 Sigma-Aldrich,	UK
Oregon	green 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine	labeled	with	Oregon	Green	488	 Life	technologies,	USA
PBS Phosphate	Buffered	Saline	 Life	technologies,	USA
PDMS Polydimethylsiloxane	 Dowcorning,	USA
DSPE-PEG 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene	glycol)-2000]	(ammonium	salt) Avanti	Polar	Lipids,	USA
Pluronic Pluronic	F-68	/	Poloxamer	188 Life	technologies,	USA
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	 Avanti	Polar	Lipids,	USA
Span	80 Sorbitan	monooleate Sigma-Aldrich,	UK
Stearic	acid Octadecanoic	acid Sigma-Aldrich,	UK
SU-8 SU-8	photoresist	 Microchem,	USA
Triton Triton	X-100 Fisher	Scientific,	USA
CHCl3 Chloroform Sigma-Aldrich,	UK
C5H10O3 Ethyl	lactate	solvent	 Microposit	EC	solvent,	Microchem,	USA
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			Tab.	4.2.	List	of	oils	used	throughout	this	project,	and	their	physical	properties	that	were	critical	to	the	work.	All	oils	were	purchased	from	Sigma-Aldrich	(UK).96,199–206	
	
 
Phosphate Buffered Saline solution 
PBS was prepared by dissolving one 5 g tablet of PBS powder in 500 ml of MilliQ 
water (pH 7.45, 140 mM NaCl, 10 mM PO4, 2.68 mM KCl). PBS was filtered through 
a 200 nm cellulose membrane syringe filter (Minisart RC4, Sartorius Stedim, UK) prior 
to use. 
 
Bovine Serum Albumin solution 
BSA protein is commonly used in biochemical procedures as a blocking reagent. 
Blocking agents are introduced to surfaces and biological molecules before studies 
begin to reduce non-specific binding of biological entities of interest, such as proteins 
and antibodies, which are introduced afterwards. The entities of interest are then forced 
to compete for binding/adherence with the blocking agent, which they will not achieve 
at non-specific binding sites.153 BSA solutions were prepared by dissolving 250 mg of 
lyophilised BSA crystals in 50 ml of MilliQ or PBS solution. These solutions were 
stored for up to two weeks at 4 °C and diluted further if required. For most work 
involving glass surfaces, the surface was incubated at ~25 °C in BSA at a concentration 
of 1-5 mg/ml for 10-30 min, followed by a MilliQ rinse and N2 dry if required. 
 
Bubble buffer solution 
A 100 ml solution, termed bubble buffer (BB), was made from 4 mg/ml NaCl dissolved 
in MilliQ and 1 vol% glycerol (unless stated as otherwise). BB was used for preparing 
Oil Other	names
Molecular	
formular
Density	
[g/cm3]
Viscosity	
@	20	oC		
[mPa.s]
Solubility	in	
water											
@	20	oC	[g/L]	
	Excitation	
[nm]
	Emission	
[nm]
Suface	
tension	
[mN/m]
Water H2O 0.9982 1 72.8
Isoamyl	
Acetate
Banana C7H14O2 0.88 0.88 2 25.6
Squalane C30H62 0.81 ~31 Immiscible 300 334 28	±	3
Squalene C30H50 0.858 12 Immiscible 350 463 29	±	3
Triacetin C9H14O6 1.1562 23 70 275 330 36.5
Tripropionin C12H20O6 1.1	±	0.1 7.63 3.07	@	37	°C 35.9	±	3.0	
Dodecane CH3(CH2)10CH3 0.7808 1.34 1 25.3
12%	w/w	α-Linolenic	acid C18H30O2
48%	w/w	Linolenic	acid C18H32O2
16%	w/w	Oleic	acid C18H34O2
5%	w/w	Steric	acid C18H36O2
17%	w/w	Palmitic	acid C16H32O2
31.3Soybean 0.917
40.5								
@	30	°C Immiscible
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standard lipid solutions used throughout the work presented in this thesis, such as in 
typical on-chip microbubble (MB) production. BB was stored for up to two months at 
4 °C and filtered through a 200 nm cellulose membrane syringe filter prior to use. 
 
Standard lipid solution 
Dried lipid stocks of DPPC, DSPE-PEG, and POPC were dissolved in 
chloroform:methanol (1:1). The lipid solutions were pipetted into a glass vial at 
100 mol% DPPC or 100 mol% POPC, or at 5 mol% DSPE-PEG with 95 mol% DPPC 
or POPC (to give a DPPC-PEG or POPC-PEG lipid solution respectively) and dried 
under nitrogen gas for 30 minutes. BB was then added to the lipid to give a final 
concentration of 1 mg/ml lipid. When stated, Pluronic was added, from a stock of 10 
vol% in deionized, distilled water, to the dried lipids, to give a final concentration of 0.1 
or 2 vol% pluronic. The final volume was 1 ml. The solution was vortexed for 1 min 
and further sonicated in an ultrasonic bath for at least 1 hour to facilitate lipid re-
suspension, then filtered through a 200 nm PTFE membrane syringe filter (Minisart 
SRP4, Sartorius Stedim, UK) to remove non-suspended lipid. 
 
Fluorescence, including hydrophobic fluorescence resonance energy transfer (FRET) 
For labelling lipid shells of MBs or droplets, Atto590, or Atto488 was added to the lipid 
solution at 0.1 mol% during the lipid-drying step. 
For labelling the oil phase, the fluorescent label Nile red was dissolved into oil at 3.20 
µg/ml, 2.29 µg/ml and 24.0 µg/ml (unless otherwise stated) for triacetin, isoamyl acetate 
and squalane/squalene oils respectively. Nile red was also added to soybean oil at a non-
optimised concentration as a few flakes in 10 ml of oil. For fluorescence resonance 
energy transfer (FRET), powdered DiO or DiI was solubilised into the oils at 1 mg/ml 
(unless otherwise stated). For solubilisation, the oil with fluorophore was vortexed for 
30 s, followed by bath sonication for 30 min. Excitation and emission recordings for 
DiO and DiI in bulk oil and oil nanodroplets are described in section 4.9.7 (p 94-95).  
Excitation/absorbance and emission was recorded from nile red in triacetin, isoamyl 
acetate and squalane oil. Nile red was dissolved at ~1 mg/ml, then dilutions were made 
down to 0.76 µg/ml. Quartz cuvettes were used to hold samples during these studies, 
which were cleaned with chloroform:methanol (1:1) before, during and after use. 
Absorbance measurements were performed on a Lambda 35 Ultraviolet-Visible 
spectrometer (UV-Vis) (Perkin Elmer, USA). Here, a 300-800 nm sweeping excitation 
laser light source was emitted through a fluorophore + oil sample contained in a 1 ml 
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cuvette. Transmission of the light source was recorded at 480 nm/min across excitation 
light wavelengths with a 1 nm slit width window, in reference to a control sample in an 
identical cuvette, which contained only oil. As in Equation 4.1, the recorded 
transmission was converted into an absorbance measurement. 	
  𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 = log (1 𝑇𝑟𝑎𝑛𝑠𝑚𝑖𝑡𝑡𝑎𝑛𝑐𝑒)   (4.1) 
 
Emission measurements were performed on a LS 55 Fluorescence Spectrometer (Perkin 
Elmer, USA). Here, a constant wavelength excitation laser source was used to excite the 
fluorophore (in oil) in a 1 ml cuvette. Excitation light of 530, 520, or 505 nm was used 
for triacetin, isoamyl acetate and squalane oil respectively, based on the peak 
absorbance measurements. Emission intensity was recorded with a detector positioned 
at 90° to the excitation laser source. The detector performed a 500–900 nm sweep with 
a 4 nm window at 5 nm steps. 
 
Microscopy 
The most commonly used microscope during these studies was an inverted fluorescence 
microscope (Eclipse Ti-U, Nikon, Japan) with FITC and TexRed filters, 10x and 40x 
magnification lenses, and an optional 1.5x internal magnification. Unless otherwise 
stated, videos were collected at 100 fps, or at 50 kfps with the use of a high frame rate 
camera (FASTCAM SA-X, Photron, USA). Within this report this microscope will be 
referred to as the inverted microscope. An upright fluorescence microscope (Eclipse 
E600, Nikon, Japan) with FITC and TexRed filters, and a 60x magnification lens was 
also used. Within this report this microscope will be referred to as the upright 
microscope. A second inverted microscope (Eclipse Ti-S, Nikon, Japan) was used, 
though with an attached dark field condenser, and 100x oil immersion lens. Within this 
report this microscope will be referred to as the dark field microscope. Lastly, a dual 
function Confocal-Raman system (Confocal Laser Scanning Platform, Leica TCS SP8 
on a DMi8 microscope, Leica Microsystems, UK) (inVia Raman, Renishaw, UK) was 
used, primarily for the Confocal functionality, with 10x, 40x, and 100x oil immersion 
lenses. Within this report this microscope will be referred to as the confocal microscope.  
 
4.2. Microfluidic microchips 
This section describes how microfluidic devices were fabricated, the designs that they 
were formed into, and how fluid phases were flown into them.  
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4.2.1. Microchip fabrication 
PMMA-SU8-PMMA microchips were fabricated by Epigem Ltd (Redcar, UK) utilising 
photolithography to a depth of 25 µm. These chips were used for on-chip MB 
production and imaging during ultrasound (US) exposure. All other fluidic devices, for 
use as described in the design section below, were formed from PDMS on glass. 
  
	Fig.	4.1.	Schematic	of	fabrication	of	(a-e)	a	SU-8-silicon	master	and	its	use	in	the	fabrication	of	(g-m)	a	 PDMS	 device	 on	 glass.	 (Green	 and	 pink	 arrows)	 Direction	 of	 production	 steps	 indicated,	 with	associated	 text	 describing	 actions	 not	 shown.	 (fi-iii,	 pink	 arrows)	 Preparation	 of	 PMDS	 before	introduction	to	master	shown	as	a	separate	group	of	steps.	(eii)	A	real	complete	SU-8-silicon	master	is	shown	besides	 its	(ei)	schematic	version.	(h)	PDMS	under	vacuum	is	shown	mid-process.	 (k)	A	cleaned	glass	slide	(preparation	not	shown)	is	introduced	in	the	plasma	treatment	step.	(li)	Contact	of	 the	 plasma	 treated	 PDMS	 and	 glass	 is	 shown	 with	 (lii)	 a	 zoomed	 in	 section,	 to	 indicate	 the	covalent	bonding	that	occurs.	
 
Two types of PDMS design were formed on glass; ones with large open chambers (on 
the order of millimetres in scale (see section 4.2.2, ‘Microfluidic flow cells’, p71), and 
one with microfluidic channels (with micrometre scale design). The initial step to form 
either designs was to form the master. 
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For the large open chambers: Either a thin silicon wafer (0.55 mm thick) or glass slide 
(~1.0 – 1.2 mm thick) (Smith Scientific, UK) was cut into the shape of a master.  
For microfluidic designs: A microfluidic master (Figure 4.1eii) was formed from 
negative photolithography of SU-8 photoresist onto a silicon wafer that had been 
cleaned by submersion in acetone, IPA, rinsing with water and baking. To form the SU-
8-silicon master; (Figure 4.1a-b) the SU-8 was spun on the wafer accelerating at 100 
rpm/s up to 500 rpm, where it was kept for 10 s, then accelerated at 300 rpm/s up to 
2800 rpm, where it was kept for 60 s. This gave a 25 µm thick layer. The SU-8-wafer 
was then soft baked with a slow ramp up to 55 °C, kept at 55 °C for 30 min, then a slow 
ramp down to room temperature. (Figure 4.1c) The SU-8-wafer was then exposed to a 
raster scanning 375 nm laser, at 400 mJ/cm2, following the microfluidic design 
specified, in order to harden the exposed areas against development. The SU-8-wafer 
was baked again as before, (Figure 4.1d) then developed, whereby unexposed SU-8 was 
removed by placing it in ethyl lactate solvent for 4 min with a following IPA rise and 
dry. A final hard bake was performed, at 210 °C for 30 min, annealing any surface 
cracks that had formed, (Figure 4.1ei) completing the microfluidic master. 
At this stage, either a millimetre scale or micrometre scale master had been formed. 
From this point on, both masters were used with PDMS in an identical manner. 
(Figure 4.1f) PDMS (9 w% crosslinker) was centrifuged (Megafuge 16R, Thermo 
Scientific, USA) at 1 krpm for 1 min to remove bubbles, after which it was (Figure 
4.1g) poured over the master in a small petri dish and (Figure 4.1h) put under vacuum 
for 1 h to remove any remaining gasses that were solubilised in the PDMS. The PDMS 
was allowed to cure at 75 °C until set. Curing could take 30 min – 2 h, based on the 
thickness and total volume of the PDMS layer. Excess PDMS was cut from the cured 
disk and the remaining PDMS (Figure 4.1i) was carefully peeled away from the master. 
Circular inlets and outlets were punctured through the PMDS with a 1 mm diameter 
biopsy punch. A glass coverslip, or slide, was cleaned through a four-step sonication 
with Decon, acetone, isopropanol, MilliQ and N2 dried. Meanwhile the PDMS was 
cleaned of any dust that had settled using Scotch tape. (Figure 4.1k) Both the PDMS 
and glass were placed inside a plasma-cleaning chamber (Zepto, Diener electronics, 
Germany) face up, and were plasma treated for 2 min, at 0.8-1 mbar of O2. The surfaces 
of both PDMS and glass are made of –Si-CH3. After reaction with the reactive gas, 
these were both replaced by a –Si-O-H surface. (Figure 4.1li) The PDMS and glass 
surfaces were then brought into contact for bonding by pressing down on the contact 
areas while making sure not to collapse the engraved chip design. (Figure 4.1lii) This 
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formed a –Si-O-Si- covalent bond between the PDMS and glass.207 (Figure 4.1m) 
Finally the completed chip was baked at 75 °C for 30 min. The strength of the –Si-O-Si- 
bonds can withstand pressures of 75 psi.208 
 
4.2.2.  Microchip designs 
The different microfluidic designs that were used throughout this project are outlined 
below. 	
Two-phase flow focus / monodisperse MB microchip 
	Fig.	4.2.	Two-phase	FF	microchip	design	used	primarily	for	the	production	of	monodisperse	MBs.	
 
Flow focus (FF) microchips are commonly used in the production of monodisperse 
droplets and MBs.43 (Figure 4.2) A simple two-phase FF system was used in this project, 
primarily for the production of monodisperse MBs and droplets. This design was 
fabricated from PMMA-SU8-PMMA to a constant depth of 25 um, and included one 
gas inlet feeding to a 30 µm channel and one aqueous inlet branching to two 50 µm 
channels, one either side of the gas channel. Up stream, on chip filters prevented larger 
agglomerates from reaching the nozzle. The three channels converged, 46.34° aqueous 
to gas, at a 7 µm nozzle and further progressed as only one outlet channel. Here, two 
outlet designs were used. Figure 4.2 shows the first outlet design when the outlet was 
expanded to 270 µm, which remained constant until off-chip. The second outlet design 
expanded to 260 µm over 320 µm, before shrinking back down to 100 µm over 200 µm, 
finally continuing as a 100 µm outlet. The shrinkage and following expansion of the 
channel at the nozzle gave a pressure drop across this area, which draws the gas phase 
through the nozzle. The pressure drop, inertia, surface tension, and high shear around 
the nozzle area, then facilitated pinch-off of the central gas phase in the surrounding 
aqueous phase.88,90,159 
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Micro-spray MB microchip 
	Fig.	4.3.	Two-phase	microchip	design	used	primarily	for	the	production	of	microspray	MBs.	Depth	change	from	25	μm	to	50	μm	is	indicated.		
(Figure 4.3) The microspray microchip was a development from the two-phase FF chip, 
which aims to increase MB production rate and concentration. In this project, this 
design was fabricated from PMMA-SU8-PMMA. Here, aqueous and gas inlets were 
brought together at 90° with a constant depth of 25 µm, the exit channel expanded to 
270 µm over 140 µm, then an additional 25 µm depth was added as a step increase, after 
which the design then continued as a 270 µm wide, 50 µm deep exit channel. This extra 
depth produced a greater pressure drop across the nozzle, causing an atomisation 
process on the gas phase.43,209 The micro-spray production regime has been shown to 
bring MB solutions up to clinically relevant concentrations 108-109 MBs/ml.43 
Single-module and multiplexed four-module chips were used during this project. For 
multiplexing, single aqueous and gas inlets were used, both which branched off into 
four channels, one for each module. The outlets for all four modules were brought to 
one outlet for collection. 
 
Three-phase flow focus microchip 
Three-phase FF microchips were modifications to the two-phase flow focus microchips, 
designed to add an extra immiscible oil phase inlet in between the gas phase inlet and 
the aqueous phase inlet. Four three-phase microfluidic microchip designs were used in 
this project. These design were all fabricated from PMMA-SU8-PMMA. Two separate 
deigns were originally used (Figure 4.4a-b, 5C1 and 3C1) with a further two 
generations of one of these designs being formed (Figure 4.4c-d, 3C2 and 3C3). 
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	Fig.	 4.4.	 Schematics	 of	 three-phase	 microchip	 designs	 used	 for	 OLI-MB	 production.	 Evolution	 of	design	is	shown	from	5C1	to	3C3,	zoomed	to	show	the	progressive	changes	in	microfluidic	design.	Channel	wall	and	measurements	are	shown	in	white	and	red	respectively.		
One of the original designs focused all three phases at the nozzle (Figure 4.4a), leading 
to a five-channel FF chip (5C1). Other groups have studied this and similar geometries 
before for multilayer MB and droplet formation.31,82,94,95 The aqueous, oil and gas 
phases were introduced at the nozzle through inlets of 50 µm, 27 µm and 32 µm wide 
respectively. The oil and aqueous inlets were angled at 24° and 90° to the gas inlet 
respectively. The three phases were then focused through a 7 µm wide nozzle, after 
which the outlet then expanded to 270 µm over 140 µm, at which point it continued on 
unchanged. 
The second original design (Figure 4.4b) introduced the oil and aqueous phases 
upstream of the gas phase, and then focused the resulting liquid channels and gas phase 
at the nozzle, giving a final three-channel FF chip (3C1). Here, on either side of the gas 
inlet channel, a 300 µm wide oil inlet channel shrank to 150 µm over 160 µm, and then 
after 1150 µm contacted the 300 µm wide aqueous channel at 45°. After this, the 
combined oil-aqueous channel reduced to 50 µm wide and continued straight, towards 
the gas inlet, at 45°, and the nozzle. The three channels were then focused through the 7 
µm wide nozzle and continued as in the 5C1 design. 
The first 5C1 and 3C1 chips to be used had hydrophilic surfaces (only when specified), 
after which these and all following designs were treated to have a hydrophobic coat 
(treatment performed by Epigem). 
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(Figure 4.4c) The second generation of the 3C1 microchip design (3C2) changed the 
outlet. Here, the outlet expanded from the nozzle at 22.5° for 320 µm until it was 260 
µm wide. The outlet then retracted at 22° for 200 µm until it was only 100 µm wide, at 
which point it continued on unchanged. 
(Figure 4.4d) The third generation of the 3C1 microchip design (3C3) changed the oil 
inlet. When thinning to 150 µm, the oil inlet was angled to the aqueous phase at 24°. 
The last section of the oil inlet was further thinned to 15 µm for 150 µm prior to 
introduction to the aqueous inlet to increase flow resistance in that channel. 
 
Microfluidic particle trap device 
	Fig.	4.5.	Schematics	of	(a)	the	main	microfluidic	particle	trap	design	used	in	the	project,	and	(b)	the	total	 trap	 array	 that	 was	 used.	 Channel	 wall	 and	 measurements	 are	 shown	 in	 white	 and	 red	respectively.		
Microfluidic particle traps were formed from PDMS on glass aiming to catch 5-30 µm 
MBs. A few updates were made to the design, where the main device used is shown in 
Figure 4.5. The trapping channel had a constant depth of 25 µm. Each individual trap 
was essentially a rounded solid square, width and length of 33 µm, with a semi-circular 
opening at the trap’s forward edge with a radius of 8 µm. From this semicircle a thin 
channel, 2 µm wide, led to the trap’s rear edge. There were 40 columns of traps with the 
next column being staggered up the channel width by half of the trap-to-trap distance 
from the previous. Figure 4.6 shows an optimised trap design, which was developed 
with a geometry that aimed to trap 2-5 µm particles (this device was introduced near the 
end of the project, so is specified when used). This geometry balanced the flow 
resistance throughout the device to make it more preferable for particles to fall into 
empty traps, and zigzag around full traps, whilst keeping traps distant enough to prevent 
clogging. An algorithm to calculate this optimal geometry was developed by J. Gala De 
Pablo, based on the work by Xu (2013).210 
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	Fig.	4.6.	Schematics	of	the	optimized	trap	design	and	array	that	was	made	with	the	aim	to	capture	2-5	μm	particles.	Channel	wall	and	measurements	are	shown	in	white	and	red	respectively.		
	Fig.	4.7.	Schematic	of	apparatus	for	PDMS	particle	trapping	devices	using	the	confocal	microscope.	
 
Figure 4.7 shows how trap devices were set-up for use with the confocal microscope. 
All traps devices were flowed through with 1 ml 70% isopropanol or ethanol at 50–100 
µl/min prior to use. This was followed by 500 µl MilliQ at 50–100 µl/min, then 1 ml of 
1 mg/ml BSA or 1 mg/ml POPC at 50–100 µl/min to coat the chip walls to reduce non-
specific binding of the following sample. MBs were flown into the trap device at 10 
µl/min for at least 30 min or until traps stopped being filled (up to 80 min), and washed 
by further flowing PBS into the chamber at 10 µl/min for 30 min. All flow into the 
chamber was delivered via a syringe pump connected to a switch valve. When changing 
the fluid type, the valve was closed to prevent all flow between the valve and the trap 
device outlet, allowing the syringe to be removed from the system and replaced without 
disturbing the trapped sample. For the flow of all fluids apart from the sample to be 
trapped, a 200 nm PTFE filter was placed between the syringe and the valve. After the 
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initial isopropanol/ethanol wash, it was imperative that no air be re-introduced to the 
system. This was prevented by allowing all relevant components to be filled with the 
next fluid before connections were made.  
Polystyrene, 15 µm diameter, red fluorescent (580 nm excitation, 605 nm emission) 
coated beads (FluoSphere, Life Technologies, USA) were flown into these traps at 50 
µl/min. This was done to assess their trapping capabilities, and so that it could be 
identified how known spheres would be observed by confocal imaging (552 nm 
excitation laser, at 1 % power, with a 570 – 781 nm emission window, 364 V gain), 
with priority on z-stack imaging from top to bottom of the spheres. 
During confocal fluorescent imaging with microfluidic trap devices, the walls of the 
PDMS regularly gave off a fluorescent signal. This occurred as long as the trap device 
was filled with a liquid, including MilliQ, even if the device was fresh and fluorophore 
was not present and had not come into contact with the device. This was thought to be 
due to reflections off of the PDMS walls. Non-fluorescent MBs did not give off a 
fluorescent signal when used with these devices, including whilst trapped, meaning that 
reflection off of MBs from the PDMS walls did not need to be considered. 
 
Microfluidic flow cells 
Three microfluidic flow cell designs were used for imaging static MB and droplets. One 
design was fabricated from PMMA-SU8-PMMA. Here four 0.5 mm wide inlets 
spanned one short edge of a 4 mm wide, 19 mm long rectangular chamber, followed by 
four 0.5 mm wide outlets spanning the chamber’s other short edge. Inlets and outlets 
were spaced out equally along their edge. Two alternative designs were also fabricated 
from PDMS. For the first, a one ~3 mm wide, ~0.5 mm tall inlet led to a ~1 cm x ~2 cm 
wide viewing chamber, ~5 mm tall, with a following outlet mirroring the inlet. The 
ceiling of this flow cell was a glass coverslip, which allowed it to be used for US studies 
(PDMS has a high US attenuation and was difficult to produce with a defined ceiling 
thickness). The second design, as shown in Figure 4.8, had a ~1 cm x ~2 cm wide 
viewing chamber, was ~1 mm tall, and had a ceiling of PDMS. 
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	Fig.	 4.8.	 Photograph	of	 a	~1	mm	 tall	 PDMS	 flow	cells,	 indicating	 a	 ‘slice’	 into	 the	PDMS	 that	was	used	for	measuring	temperature	during	studies	where	the	flow	cell	was	heated.	
 
4.2.3. Interfacing fluid phases to the microfluidic chips 
	Fig.	 4.9.	 Photo-schematic	 of	 the	 microfluidic	 apparatus	 for	 PMMA-SU8-PMMA	 microchips.	Specifically,	 the	 image	 shows	 the	 set-up	 for	 two-phase	FF.	 For	 three	phase	 experiments	 an	 extra	syringe	pump	system	was	added	between	the	two	inlets	seen	here,	and	for	some	experiments	the	syringe	pump	seen	here	was	changed	to	the	P-Pump	system.		
PMMA-SU8-PMMA microchip interfacing 
As shown in Figure 4.9, PMMA-SU8-PMMA microfluidic chips were mounted into the 
recess of a custom-built holder on the moveable stage of an inverted microscope. PTFE 
tubing ferrules (Supelco Analytical, USA) were used to connect the microchip inlets 
and outlet to an in-house made PTFE manifold, which was brought into firm contact 
with the microchip by level clamping arms, forming a gas tight seal at least up to 40 psi. 
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Further PTFE tubing, 0.3 mm I.D. 1.58 mm O.D., was used for inlet and outlet lines 
protruding out from the manifold. 
 
PDMS microchip interfacing 
PTFE tubing (Smith Medical, UK) lines, 0.36 mm I.D. 1.09 mm O.D., were placed 
directly into punctured PDMS inlets and outlets, which gave a water/air tight seal. 
 
Gas and liquid controllers 
Flow of liquids into microchips was controlled by a 1 ml glass lure lock Hamilton 
syringe mounted into a syringe pump (Aladdin, World Precision Instruments, USA). If 
the liquid was standard lipid solution, it was controlled by a Mitos P-Pump (Dolomite) 
using Mitos Flow Control software. The P-Pump could only deliver at flow rates down 
to 6 µl/min, below which a syringe pump was used, even for aqueous samples. Gas flow 
of C4F10 into microchips was delivered from a compressed gas cylinder using a digital 
gas flow controller (Alicat Scientific, USA). When using the PDMS flow cell to image 
static samples, the sample was injected directly by hand using a 1 ml glass Hamilton 
syringe and a square cut 0.84 mm I.D., 1.27 mm O.D. needle at ~2 ml/min. When using 
the PMMA-SU8-PMMA flow cell to image static samples, the chip was placed in a 
tight fitting plastic collar with PTFE tubing 0.3 mm I.D. inlet lines located to match up 
with the microchip inlets and outlets. One of these PTFE inlets was used to inject liquid 
sample by hand into the flow cell via a glass Hamilton syringe at ~2 ml/min. 
 
4.3. Non-microfluidic imaging chambers 
Two imaging chambers were used through the work described in this thesis; a 50 µm 
deep glass chamber and a non-microfluidic flow cell. When using these chambers to 
image MBs, the MBs were allowed to float to the top surface, and concentration was 
taken as a measurement in regards to the chamber depth. The 50 µm deep chamber was 
the standard cell used for imaging MBs. The flow cell had a greater chamber depth 
allowing for concentration measurements from samples of low concentration. A third 
method of sample observation (used on low concentration samples) was to place a 
droplet of solution directly onto a glass slide. 
 
50 µm deep chamber and a droplet of solution on glass 
This chamber was made from a glass slide, a glass coverslip, and 50 µm thick plastic 
(polyethylene terephthalate film) spacers (Goodfellow, UK) (Figure 4.10a). Both glass 
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surfaces were cleaned with an acetone, isopropanol, MilliQ wash and N2 dry before use. 
Capillary action was used to insert sample into the chamber. If this chamber had to be 
turned upside down for following imaging or was imaged over time, the chamber was 
sealed on all four sides with wax (1:1:1, Vaseline:Paraffin wax:Lanolin, made in-house, 
recipe from Institut Curie, Paris) to prevent the chamber from displacing and to avoid 
sample evaporation. 
If the sample to be imaged was of too lower concentration for the 50 µm chamber to 
give accurate particle size and concentration measurements, a droplet of the sample 
solution could be placed directly onto a glass slide, uncovered (Figure 4.10b). The 
meniscus would then lead any buoyant particles to concentrate at the highest point. The 
problems with this sample preparation method were that the sample concentration was 
not possible to measure reliably, and the particles were not static (due to solution 
convection and air currents) leading to inconsistencies between subsequent images, for 
example brightfield followed by fluorescence. 
 
 Fig.	4.10.	Sample	preparation	methods	for	microscope	imaging.	(a)	50	μm	deep	chamber,	where	the	number	of	particles	imaged	per	sample	solution	volume	can	be	known,	and	(b)	a	droplet	of	sample	solution	on	a	 glass	 slide,	where	 the	meniscus	 leads	buoyant	particles	 to	 concentrate.	The	 former	and	 latter	 methods	 allowed	 for	 a	 measurement	 of	 particle	 concentration	 and	 imaging	 of	 a	 low	concentration	sample	respectively	
 
Non-microfluidic flow cell for imaging of low concentration samples 
(Figure 4.11) This flow cell was made from a plastic base, a circular O-ring wall and a 
cleaned glass coverslip ceiling. This flow cell had a circular diameter of 12.5 mm, and a 
height of ~500 µm. Inlets and outlets were located on the plastic base, close to the wall 
edge. Sample was flowed into the flow cell through a needle in the side of the flow cell 
wall. The inlet had an I.D. of 1 mm at smallest. 
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	Fig.	 4.11.	 Non-microfluidic	 flow	 cell,	 showing	 (yellow	 dotted	 line)	 the	 flow	 pattern	 of	 sample	through	the	device.	
 
4.4. Non-oil MB production 
Non-oil MBs were produced via three methods, namely by mechanical agitation, 
monodisperse microfluidic, or spray microfluidic production. 
 
Mechanical agitation 
The most common method used for the preparation of MB samples is mechanical 
agitation.211–216 This is because it is a robust approach, which gives a clinically relevant 
concentration of MBs, orders of magnitude higher than most microfluidic methods can 
achieve, with minimal effort or time. Generally, the method includes the rapid shaking 
of a vial semi-filled with free lipid solution, topped up the desired MB core gas.94 The 
forces provided by the rapid agitation are sufficient enough to introduce gas from the 
headspace into the aqueous environment. Agitation protocols for leading medical MB 
solutions commonly use ~4500 oscillations per minute.88 However, since the stresses 
used to break up the gas into MBs are non-uniform, monodisperse MB populations can 
be difficult to form.160,212 This reduces their bulk sensitivity to US, since their resonant 
frequency is different, and MBs are often found > 8 µm, which could pose health 
risks.89,95 During this project, a 1.75 ml vial filled with 1 ml standard lipid solution, had 
C4F10 gas bubbled through it, filling the vial head space. This vial was then tightly 
sealed with parafilm before undergoing mechanical agitation (3M ESPE CapMix, 3M 
UK PLC, Bracknell, UK) for 45 s. Due to the high concentration produced, these MBs 
were often diluted 1:1000 in PBS buffer before counting and sizing or further use. 
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To produce MBs under a monodisperse microfluidic production, the two-phase FF 
microchip was used. Gas pressure was set to 3-4 psi and standard lipid solution was 
flown into the microchip at 20-30 µl/min. 
 
Spray MBs 
The spray MB microchip was used to produce MBs under a spray regime at a high 
concentration and fast rate. Gas pressure was set to 20 psi, for the single-module and 
four-module designs standard lipid solution was flown into the microchip at 20 µl/min 
and 80 µl/min respectively. 
 
For both monodisperse and spray production, samples were allowed to pass from the 
PTFE tubing outlet into a 1.75 ml glass vial or a 2 ml eppendorf, in which 10 µl of 
liquid C6F14 had been pre-injected. The liquid C6F14 was there to saturate the MB 
solution bolus with perfluorocarbon (PFC) molecules, reducing/removing the positive 
concentration gradient of PFC from the MB interior to exterior. It has also been shown 
that adding C6F14 to a lipid MB solution bolus causes C6F14 molecules to intercalate into 
the lipid shell, reducing the surface tension, decreasing Laplace pressure inside the MBs, 
and increasing shell resistance. These effects act to slow the leakage of the PFC gas into 
the surrounding solution, increasing MB lifetime.217 
 
4.5. Surface pressure measurement of air-aqueous interfaces by a 
Langmuir-Blodgett trough 
	Fig.	4.12.	Set-up	and	basic	output	for	a	LB	trough,	showing	(a)	how	droplets	of	surfactant	solution	were	deposited	on	 to	 the	surface,	and	 then	 the	barriers	moved	to	change	 the	active	surface	area,	whilst	a	Wilhelmy	plate	(b)	recorded	the	change	 in	surface	pressure.	The	pressure-area	 isotherm	relationship	shown	is	typical	of	DPPC	lipid.		
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Much of the work described in this thesis is underpinned by the self-assembly of 
surfactant molecules (primarily lipids) at hydrophilic-hydrophobic interfaces, lowering 
the interfacial tension to give a more energetically favourable state, often leading to the 
stabilising of one phase in another as an emulsion. More specifically, MBs are stabilised 
by these surfactants self-assembling at their gas-liquid interface, which reduces the 
surface tension (see Theory Chapter, Equation 2.17). A Langmuir-Blodgett trough, as 
shown in Figure 4.12, was used to model a MB surface for measures of how the surface 
tension of air-aqueous surfaces changed due to the concentration of surfactant 
molecules. 
 
A KSV NIMA Langmuir-Blodgett (LB) trough (Biolin Scientific, Sweden), placed 
inside an air-flow inhibiting, transparent box, was used to measure surface pressure 
change of an air-MilliQ interface during a change of lipid concentration at the interface. 
Surface pressure, π, relates to surface tension by the following equation: 
 
  𝜋 = 𝛾! − 𝛾   (4.2) 
Where γ0 = native surface tension of subphase liquid, and γ = surface tension of 
subphase with surfactant. 
 
The LB trough was prepared for use by a typical cleaning method. The Teflon trough 
was filled with MilliQ from a sterile, thoroughly cleaned, glass container to form a 
meniscuses in-between and either side of two movable Teflon barriers. The MilliQ was 
fully aspirated, always removing from the surface, and the trough was refilled 
afterwards. This process was repeated at least twice. After this just the top few 
millimetres of surface was aspirated to remove surface contaminants by eye, refilling 
the trough as needed. Compressions of the barriers were performed on the semi-clean 
central meniscus with further cleaning and filling, making sure to keep the menisci from 
falling below the barriers, until the π (measured via a Wilhelmy plate) did not rise above 
0.3 mN/m at full compression. The central meniscus was now considered free of 
contaminants. A 1 mg/ml steric acid, POPC, DPPC, or DPPC-PEG lipid in chloroform, 
hexane, or hexadecane solution was prepared fresh in a glass vial, sealed with parafilm 
and stored at 4 °C until use. 
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4.5.1. Pressure-area isotherms 
With the trough area set to maximum (324 mm x 75 mm), a ~ 30 µl droplet of the lipid 
solution was deposited directly onto the central meniscus from a cleaned glass syringe, 
allowing the droplets to spread directly from the needle tip. The solution was allowed 
10 min for the volatile solvent to evaporate, leaving a gaseous phase (low 
concentration) lipid monolayer. The barriers were then compressed up to a set π (~30 
mN/m) and expanded back to 0 mN/m at 5 mm/min three times each. This transitioned 
the lipid through gaseous to liquid to solid phases. Changes in π were measured against 
changes in area per lipid molecule, AS, at the subphase surface. 
 
  𝐴! =  !!.!!!.!.!!    (4.3) 
Where AT is the current trough area, Mw is the molecular weight, V is the volume, C is 
the lipid solution concentration, and Av is Avogadro's constant. 
 
As shown in Figure 4.12b, by tracing the linear solid phase relationship back to the area 
per molecule where π = 0, it was possible to measure the native molecular area of the 
lipid. When surfactant molecules in a monolayer are fully close-packed and under their 
maximum compression possible, any more compression will require some of the 
surfactant to leave the monolayer. If single molecules leave the monolayer a significant 
decrease in the gradient of the π over area per molecule will be observed. Often 
however this occurs as a small section ‘flake’ of the monolayer delaminating from the 
rest, which can lead to the formation of a small section of bilayer or the surfactant flake 
can enter the subphase. Either way, at this point the π will significantly decrease, due to 
the bare section of surface. If surfactant molecules are forced out of the monolayer 
under any of these mechanisms the monolayer is being said to collapse, with the π at 
this point being termed the collapse pressure. To measure the collapse pressure, the LB 
trough barriers were allowed to compress slowly at 5 mm/min after a typical isotherm, 
only being stopped after the lipid was observed to collapse. 
 
4.5.2. Equilibrium spreading pressure: Spreading of lipid from a 
volatile solvent 
When a structure is formed by the self-assembly of surfactant molecules between two 
phases, without an external stimulus, they will accumulate up to an equilibrium 
interfacial tension/pressure, termed the equilibrium spreading pressure (ESP). 
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The trough surface area was set to be static (at 138 cm2). Known volume (~5 µl) 
droplets of the lipid solution were deposited directly onto the central meniscus from a 
cleaned glass syringe, allowing the droplet to spread directly from the needle tip. 
Equation 4.3 was used to calculate AS against changes to π. It was expected that the 
lipid solution would spread at the subphase surface until ESP was reached. At this point, 
additional lipid solution would remain as a droplet/lens on the surface, becoming a 
concentrated crystal/flake as the volatile solvent evaporated. Here, an equilibrium 
would be reached between lipid molecule spreading to the surface from the crystal 
lattice structure and reversibly re-joining the lipid crystal lattice from the surface. 
However, as is detailed later (see Results Chapter 5.1, p121), all results using this 
method followed each lipid’s pressure-area isotherm. This method of lipid solution 
addition did not identify the ESP. 
 
4.5.3. Equilibrium spreading pressure: Spreading of lipid from a 
deposit on glass 
This section describes an alternative method for determining the ESP, adapted from the 
method introduced by Bois (1989),218 who found that measuring the ESP of DPPC from 
deposits on the surface was insufficient.  
The trough surface area was set static at 138 cm2. ~ 10 µl of the lipid in chloroform 
solution was pipetted onto the end of a cleaned glass plate and allowed to dry. Further 
10 µl lipid solution volumes were added on top, up to ~ 50 µl, allowing the solution to 
dry each time. The plate was then slowly drawn through the gas-subphase interface and 
pulled back out. This allowed the top surface of lipids on the lipid coated plate to 
migrate to the gas-subphase interface in order to stabilise it, observed as an increase of π. 
The above process was repeated with new lipid coated plates until the surface pressure 
was found to remain constant. This indicated that the lipid was in equilibrium between 
spreading at the gas-subphase surface and adhering to the remaining lipid at the glass 
plate. This was assumed to be the ESP. 
Subsequently, a pressure-area isotherm was performed on the monolayer in order to 
compare the total trough surface area when the lipids were in a solid phase to the area 
when ESP. As the native molecular area of the lipids was known from previous typical 
pressure area isotherms, the number of lipids present could be calculated, allowing the 
lipid concentration at ESP to be calculated. 
This method was used to measure the ESP for monolayers of steric acid, DPPC, and 
DPPC-PEG. Due to the order that experiments were carried out, later contamination of 
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the equipment, and time constraints of this thesis project, it was not possible to reliably 
measure the ESP for a lipid monolayer of POPC using this technique. 
 
4.6. Contact angle measurements and total surface energy 
calculations 
During the work outlined in this thesis a number of solid surfaces needed to be 
measured for water contact angle in order to measure their 
hydrophobicity/hydrophilicity. 
A FTA4000 contact angle system (First Ten Angstroms, USA) was enclosed in a box to 
restrict airflow and reduce dust settling on any surfaces to be measured. (Figure 4.13a) 
A 30 psi vacuum water pump system (The Lee Company, USA) ending in a 30 gauge 
needle, I.D. 0.159 mm, pointing vertically down was used to delivery and contact a 
MilliQ droplet to the solid surface underneath to be measured. A 12x magnification lens 
camera (Navitar, USA), with internal 0.58-7x modifier, observing horizontally across 
the solid surface was used to acquire images of the MilliQ droplet and ImageJ was used 
to measure both the left and right contact angles, which were averaged. Contact angles 
were measured for the water droplet both advancing, θA, and then receding, θR, at least 
six times, each time in different places across the surface, aiming to be as spaced out as 
possible. 
The following equations were used to acquire the equilibrium Young contact angle, θ0: 
219 
 
  𝜃! = arccos !!!"#$!!!!!"#$!!!!!!    (4.4) 
where 
  Γ! = !"#! !!!!!!"#!!!!"#! !! !!  (4.5) 
and 
  Γ! = !"#! !!!!!!"#!!!!"#! !! !!  (4.6) 
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	Fig.	 4.13.	 Apparatus	 used	 for	 the	 contact	 angle	measurement	 of	 (a)	water	 on	 a	 solid	 flat	 surface	(here	glass),	and	(b)	oil	on	a	water	surface.		
	Fig.	4.14.	A	schematic	showing	the	arrangement	of	air,	oil,	and	water	phases,	and	the	position	of	the	lipid	monolayer	from	the	Figure	4.13bii	images.	The	surface	tensions,	γ,	and	contact	angles,	θ,	of	the	three-phase	geometry	are	indicated.		
As shown in Figure 4.13b, contact angle measurements were also taken of droplets of 
squalane and tripropionin oil against a water-lipid-air interface to determine the 
interfacial tension of water-lipid-oil interfaces.  
A 6 cm diameter, circular Teflon dish was filled with MilliQ to allow a meniscus to 
form above the top of the dish walls. This meniscus was aspirated before the dish was 
refilled. This was repeated at least five times to remove surface contaminants. POPC, 
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DPPC, or DPPC-PEG lipid, solvated in chloroform at 1 mg/ml, was added directly to 
the water surface as droplets to give concentrations of; (1) no lipid, (2) the equilibrium 
spreading pressure (ESP) (see section 1.8.1 for LB trough experiment to acquire ESP 
for DPPC), or (3) enough lipid until additional lipid-chloroform solution no longer 
spread, at which point the monolayer was assumed to be at the collapse pressure. The 
sessile drop technique was used for contact angle measurement, where a droplet of oil 
was added directly to the air-lipid interface via an oil filled syringe needle. The contact 
angle was measured on both the left and right sides of 6-9 droplets for each lipid 
monolayer type. 
Figure 4.14 shows how the air, oil, and water phases, and the lipid monolayer were 
thought to have arranged from observation of the Figure 4.13bii images. Using Young's 
relation altered for a two liquid with one gas phase system (Equation 4.7), the oil-lipid-
water interfacial tension was calculated. It was assumed that no lipid migrated to the oil-
air interface, keeping the surface tension at constant 28 mN/m for squalane and 36.5 
mN/m for tripropionin oil. Due to a limitation in the experiment (that only the oil-air 
surface could be observed, and therefore measured for its contact angle), it had to be 
assumed that the oil-air and oil-lipid/water contact angles were equivalent. This means 
that any calculations made using the results from these experiment should be considered 
as estimates. The surface tension of the water-lipid-air interface was known from LB 
trough experiments (see sections 4.5 and 4.5.1, p76-78). Using the calculated interfacial 
tension, the total surface energy was calculated for one 2 µm OLI-MB with a range of 
oil layer thicknesses (Equation 4.8). Using the same oil and gas volumes, the equivalent 
total surface energies were calculated for a separate MB and oil droplet, and an oil-in-
air-in-water structure. 
 
  𝛾!"# = !!"#!!"#!!"!!"!"#!!"#   (4.7) 
  𝐸 = 𝛾!"𝐴!" + 𝛾!"#𝐴!"#   (4.8) 
Where γ is the surface/interfacial tension, θ is the contact angle (θolw was assumed equal 
to θoa), E is the total surface energy, and A is the surface area. 
 
4.7. Particle sizing and concentration measurements 
Nanoparticle size measurement 
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Particle sizing and concentration measurements were made using Zetasizer Nano ZSP 
system (Dynamic Light Scattering, DLS) and by a NanoSight NS300 system (Malvern 
Instruments, Malvern, UK).  
 
To calculate particle size, DLS uses an autocorrelation function (ACF) (Equation 4.9), 
and both DLS and NanoSight use the Stokes-Einstein relationship (Equation 4.12). 
 
  𝐴𝐶𝐹 = 𝑒!!!"   (4.9) 
  𝑞 = !!"! sin !!      (4.10) 
  𝐷! = !!!    (4.11) 
  𝐷! = !!!!!"!!    (4.12) 
Where Γ is the decay constant, τ is the delay time, q is the scattering vector, n is the 
refractive index of the continuous liquid, λ is the laser wavelength, θ is the scattering 
angle, Dt is the diffusion coefficient, Dh is the hydrodynamic diameter, kB is the 
Boltzmann’s constant, T is the temperature, and η is the dynamic viscosity. 
 
For DLS, the process of particle sizing is limited in that it cannot measure samples of 
polydisperse size, particles are assumed to be spherical, and it cannot determine 
concentration. DLS is also more sensitive to larger particles, so a near monodisperse 
sample, or a sample with a few larger contaminants, relative to the sample particles, will 
be measured as larger than reality. 
For a DLS experiment, 1 ml of sample, diluted to ~108-1010 particles/ml, was placed in a 
plastic cuvette and measured immediately, to prevent particles from precipitating 
before/during measurement. Three measurements were taken of the same sample, one 
after the other, for averaging and error calculation. 
 
The NanoSight used a ~50 µm wide laser to illuminate particles in solution. These 
particles scatter the light, which is collected by a long working distance x20 lens. 
Particles appear as bright point sources moving under Brownian motion, which is 
recorded as a video. Nanoparticle tracking analysis software then analyses the random 
walk pattern of the particles to give a Dt value, and thus, using the Stokes-Einstein 
relationship (Equation 4.12), give a Dh value for each particle. This process of particle 
sizing excels at giving high resolution sizing analysis of 10 – 2000 nm particles, due to 
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direct observation and measurement of diffusion events from single particles. This 
allows for polydisperse samples to be analysed for size and allows for concentration 
calculation due to knowing how many particles are measured per given imaging 
volume.220 
For a NanoSight experiment, the sample was diluted with an aim at ~108 particles/ml 
(concentrations were estimated from similarly formed, previous samples, or multiple 
trial and error dilutions were run for samples of entirely unknown concentration). The 
sample was then injected from a sterile 1 ml syringe into the NanoSight’s ~100 µl 
viewing flow cell. Measurements were taken, and then fresh sample was then flown into 
the flow cell and the process repeated for a total of five times. The flow cell system was 
thoroughly cleaned between samples, and before and after use, using MilliQ, 70 vol% 
ethanol and polyester cellulose wipes (Integrity cleanroom, UK). 
 
At early stages in the project a qNano (Izon Science, UK) device was used for both 
sizing and concentration measurements. The qNano works on the basis of measuring 
changes in current flowing through nanopores of defined diameter causing blockade 
events where the current is momentarily decreased. During a qNano experiment, a 
voltage is applied across the pore, with the ionic current being recorded in real time. As 
a particle crosses this pore it leads to an increase in electrical resistance, seen as a 
resistive pulse, where the magnitude of the pulse is proportional to the particle’s volume. 
The rate of these resistive pulses, defined by the pressure applied, is proportional to the 
particle concentration.221 
 
	Fig.	 4.15.	 Schematic	 of	 (a)	 nanoparticles	 passing	 through	 a	 qNano	 pore,	 with	 (b)	 the	 observed	resistive	pulses	shown	over	time.	Orange	and	purple	particles	shown	to	represent	difference	in	size	seen	as	a	difference	in	resistive	pulse	magnitude.	
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Nanoparticles to be measured, and calibration particles, were diluted to 108 particles/ml 
in PBS, vortexing the calibration particles for 30 s before dilution. The apparatus was 
set up so that the horizontal pore connected two PBS filled chambers, with the pore 
stretched to a known value, which was factored into the software. The PBS in the upper 
chamber was then replaced with either the calibration or sample solution. A given 
pressure was applied to the top chamber, forcing particles in the solution to cross the 
pore. This allowed for measurement of the sample particle’s size distribution and 
concentration in reference to the calibration particles. 
 
Microscale particle sizing 
Many experiments detailed in this thesis either used or formed droplets and/or MBs 
which required information to be collected on both their size and concentration. To do 
this, a sample was taken directly from the droplet or MB stock after gentle agitation to 
prevent pre-concentration. This sample was then either injected into a 50 or 120 µm 
deep viewing chamber, or flown into the non-microfluidic flow-cell. The chambers or 
flow-cell were then imaged either at the top or bottom of the internal volume based on 
the oil/gas buoyancy with an assumption that all particles had risen or fallen to one of 
the faces. For the chambers, an inverted fluorescence microscope, upright fluorescence 
microscope, or inverted darkfield microscope were used for imaging, where as the flow-
cell only used the upright fluorescence microscope. At least 10 images were taken to 
ensure wide sampling. (Figure 4.16) Measurements on all imaged particles were 
undertaken using ImageJ (National Institutes of Health, USA) with a graticule for pixel 
to real length calibration. These were averaged with a standard deviation and error. For 
concentration measurements, all particles counted in each image were compared to the 
known area of the image and the internal volume’s depth. This gave each image a 
concentration, all of which were averaged with a standard deviation and error. 
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	Fig.	4.16.	Method	used	to	measure	microscale	particles	(here	MBs)	for	diameter	and	concentration	information.		
Figure 4.16 shows the step-by-step method for measuring mean average microscale 
particle size and concentration, as well as plotting of a sizing histogram with a Gaussian 
(often LogNormal) fit. 
Steps taken were; (1) Image loaded into ImageJ and calibrated for size against graticule 
measurement (graticule image not shown). (2) Image background corrected to remove 
illumination gradient. (3) Image made binary, where grey scale values above 50% of the 
maximum grey scale value across the image (ignoring single pixel noise) were set to 
white, ‘empty’, and values below 50% were set to black, ‘full’. (4) Black shapes filled. 
(5) Black shapes watershed, where shapes determined as two merged circles are cut to 
two shapes. (6,7) Black shapes identified and measured for area, noting the image that 
the particles are measured from. The next image was loaded and steps 1-7 were repeated 
until all images were measured. (8a) Areas converted into diameters, mean averaged 
with SD and error calculated. Number of particles observed calculated into a 
concentration, knowing imaged area and chamber depth, per image, then averaged with 
SD and error calculated between the images. (8b) All diameters measured were plotted 
as a histogram, with a Gaussian or log-normal fitting, for determining singular or 
multimodal distribution. If a multimodal distribution was found, then mean averaging 
was not accepted as indicative of the distribution and peak analysis would be used for 
size distribution. 
 
(1)	 (2)	
(3)	 (4)	
(5)	 (6)	
(7)	
(8a)	
(8b)	
Diameter	average 2.57 µm
SD 0.85 µm
Count 159 Bub	total
Diameter	error 0.07 µm
Concentration 3.57E+07 Bub	per	mL	
SD 8.20E+06 Bub	per	mL	
Concentration	error 3.35E+06 Bub	per	mL	
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4.8. US equipment calibration – transducer drive voltage to 
pressure at the target 
Three US transducers were used in this project, a high intensity focused US 1.1 MHz 
transducer (H102, Sonic Concepts, USA), a focused 3.5 MHz transducer (V380, 
Olympus Industrial, UK), and an unfocused broadband transducer, centred on 3.5 MHz 
(V384, Olympus Industrial, UK). The first two transducers were used for activating 
liquid PFC droplets (section 4.11.3.3, p 109), whilst the third transducer was used for 
MB scatter measurements (section 4.12, p 111-112). All transducers were tested for 
their pressure output at the focal point in the same manner, as described below for the 
first 3.5 MHz transducer. The pressures delivered by the remaining two transducers had 
previously been calibrated by Dr J. Mclaughlan (Electronic and Electrical Engineering, 
University of Leeds). 
A waveform generator (33250A, Agilent Technologies, UK) was connected to an 
amplifier (Broadband Power Amplifier A150, Electronics & Innovation, USA), which 
was then connected to the transducer to be calibrated. This transducer was directed at a 
0.2 mm needle hydrophone (Precision Acoustics, UK), with both being submerged in a 
degassed distilled water tank, roughly separated by the manufacturer’s quoted focal 
length of the transducer. The hydrophone was then connected up to an oscilloscope 
(WaveSurfer 104Xs, Teledyne LeCroy, UK). Additionally, separated from the main 
apparatus above, the waveform generator and amplifier were both connected to the 
oscilloscope. The entire system had a resistance of 50 Ω. When a mVpp (peak-to-peak) 
voltage was output from the waveform generator this signal was amplified by the 
amplifier x123 ± 2 (SD 7), causing the transducer to output a pressure wave. 
Attenuation occurred on this wave until it reached the hydrophone, where the remaining 
pressure would be recorded as a voltage, with a sensitivity of 338 mV/MPa for a 3.5 
MHz wave. The voltage profiles as a function of time at the waveform generator, 
amplifier, and hydrophone were observed on the oscilloscope. Before any 
measurements were taken, the hydrophone was positioned into the transducer’s focal 
spot using xyz roller translation stages. 
Measurements of peak negative hydrophone voltages, which were converted into 
negative peak wave pressures, were then taken at waveform generator voltages from 0 – 
450 mVpp, with 50 mVpp steps. 
The waveform generator to transducer set up (without the oscilloscope) were used in 
this way during experiments to supply US waves with calibrated peak negative 
pressures to samples.  
 88 
 
4.9. Monitoring the mechanics of Lipid Oil Nanodroplet (LOND) 
rupture into an oil layer and the production of OLI-MBs 
from LOND precursors 
Emulsions of oil in lipid solution, termed lipid oil nanodroplets (LONDs) were 
examined, through the methods described in this section, as a precursor tool for the 
production of an oil layer at the gas-aqueous interface of MBs.  	
4.9.1. LOND formation 
LONDs were formed via two methods, as shown in Figure 4.17, either by tip sonication 
or homogenisation. Fluorophores were used both as drug mimics and for analytical 
purposes. 
 
	Fig.	 4.17.	 Schematics	 of	 LOND	 production	 via	 (pink	 arrows)	 tip	 sonication	 and	 (green	 arrows)	polytron	 and	 emulsiflex.	 (Yellow)	Oil	with	 (red)	 lipid	 is	 shown	 to	 homogenise	 into	 nanodroplets	through	a	step-by-step	process.	 (Dotted	purple)	An	 inset	of	 the	polytron	head	 is	 shown,	with	 the	(green	arrow)	motion	of	the	oil	by	centrifuge	shown.		
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Tip sonication 
10 mg POPC lipid, with or without 5 mol% DSPE-PEG, suspended in 1:1 chloroform-
methanol, was dried under nitrogen in a glass vial for 30 min, then redispersed in 930 µl 
of PBS. 70 µl of squalane, squalene or tripropionin oil was added. To form an emulsion, 
the solution was vortexed for 30 s, then tip sonicated (Sonifier S-250A, Branson 
Ultrasonics, UK) at 200 W, 20% power, 100% duty cycle, for 15 min in a 4 °C cooled 
jacketed glass vessel. The emulsion was dialysed utilising a 100 kDa pore size 
membrane for over 12 hr in PBS to remove non-encapsulated oil and fluorophore, and 
to remove any excess lipid in solution down to equilibrium with the LONDs. 
To confirm that tip sonication was suitably emulsifying the oil into monodisperse 
LONDs, a post-vortex sample was sized by DLS during 30 min of tip sonication. 50 µl 
was removed from the centre of the sample every 5 min during emulsification for 
investigation. 
 
Homogenisation 
100 mg dried lipid was redispersed in 3.3 ml of PBS. 700 µl of the oil was added. To 
form an emulsion, the solution was vortexed, coarsely homogenised with a Polytron 
PT1300 D (Kinematica AG, Luzern, Switzerland) at 12.5 krpm, 40 °C and atmospheric 
pressure for 10 min. The emulsion was made up to 10 ml with PBS buffer and, to form 
a LOND emulsion, finely homogenised under high-pressure in an Avestin EmulsiFlex-
C5 (Avestin Europe GmbH, Germany) at ~175 MPa, 4 °C for 20 min. The emulsion 
was then filtered using a KrosFlow Research IIi Tangential Flow Filtration System 
(Spectrumlabs Europe, The Netherlands) at 100 kDa, 45 ml/min for at least 2 hours for 
the same reason as dialysis above.  
 
Sizing and concentration of LONDs was performed by DLS and NanoSight. LONDs 
were diluted 1:100000 before measurement in both systems. Typically, LONDs were 
produced at 1013 LONDs/ml with 170 nm diameter for both preparation techniques. 
 
4.9.2. Hydrophilic/hydrophobic treatment of surfaces 
To observe and monitor how LONDs interacted with both hydrophobic and hydrophilic 
interfaces, from their aqueous continuous phase, glass slides and quartz crystal 
microbalance with dissipation monitoring (QCM-D) crystals were treated to have either 
a hydrophobic or hydrophilic surface. These solid surfaces then acted as a model for 
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LOND interaction with the surface of an unstabilised MB's hydrophobic gas core in 
aqueous solution. 
Glass slides were treated through a range of methods, giving a range of 
hydrophobicities/hydrophilicities. (1) Glass slides were cleaned through a decon, 
acetone, isopropanol, MilliQ sonication bath process for 15 min each step, dried with N2, 
then stored in N2 (unless otherwise stated, this was the typical cleaning procedure for all 
glass slides and coverslips used in this entire work) or (2) 1 mg/ml BSA solution. (3) 
Fresh glass slides were etched with sand paper to produce a ‘rough’ surface, then 
cleaned as above. (4) Cleaned glass slides were further cleaned with piranha solution 
and stored in MilliQ. (5) Glass slides coated with 200 nm of evaporated Au (cleaved 
from a silicon wafer), were exposed to UV ozone for 20 min, washed with the above 
sonication process, dried with N2, re-exposed to UV ozone for 20 min, then submerged 
in 1 mg/ml ODT in ethanol for ≥ 12 hrs. This allowed the thiol to covalently bond to the 
Au surface, forming a self-assembled monolayer. The slides were rinsed in ethanol, then 
MilliQ, and dried and stored under N2. All glass surfaces prepared as above were used 
within three days and as soon as possible. 
QCM-D crystals (Q-Sense AB, Sweden) (explained further in section 4.9.4, p 87-89) 
were purchased either with a quartz or Au surface for treatment as a hydrophilic or 
hydrophobic surface respectively. To give a hydrophilic surface, the quartz surface 
QCM-D crystals were thoroughly cleaned by UV-ozone cleaning for 20 min, followed 
by immersion in Decon 90 and then MilliQ whilst in a sonication bath, and finally 
vigorous agitation in isopropanol. The crystals were kept in each solution for about 10 
min. The crystals were dried in N2, then re-exposed to UV ozone for 20 min and stored 
under N2. To give a hydrophobic surface, the Au surface QCM-D crystals were 
prepared in the same way as the quartz surface QCM-D crystals, and then hydrophobic 
self-assembled monolayers were formed on the Au coated crystals by immersion in 
ODT in ethanol (1 mg/ml) for ≥ 12 h, after which they were rinsed with ethanol, to 
remove excess ODT, and MilliQ. These were then dried and stored under N2. All QCM-
D surfaces prepared as above were used immediately. 
When surfaces were treated in any of the above processes, the θ0 of one reference 
treated surface was measured (as explain in section 4.6, p 76-78) to assess 
hydrophobicity/hydrophilicity. 
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4.9.3. LOND interaction with hydrophobic/hydrophilic treated 
glass surfaces 
LOND solution was added to slides treated to be hydrophilic, hydrophobic, and 
roughened. Whilst the LONDs were nanoscale, macro and microscale observations 
were made here. 
Glass slides were treated as above in section 4.9.2 and dried under N2 if stored in 
solution.  30 µl of nile red squalane POPC LOND solution was pipetted directly onto 
each glass slide. Camera phone (D626, HTC, UK) videos were recorded from a ‘birds-
eye’ view to record any millimetre-scale solution displacement. If displacement of 
solution occurred, the top surface of the glass, where displacement had occurred, was 
observed on an inverted microscope under both bright field and TexRed fluorescence. 
After the introduction of nile red squalane POPC LOND solution to 50 µm deep 
chambers, where all glass surfaces had been treated as in section 4.9.2, the glass-
solution interfaces were observed under confocal microscopy, using a 552 nm excitation 
laser, 5 % power, and 570 – 781 nm emission window, 750 V gain. 
  
4.9.4. Quartz crystal microbalance with dissipation monitoring 
	Fig.	4.18.	(a)	Apparatus	used	for	QCM-D	experiments	with	a	(b)	schematic	of	the	internal	workings	around	the	QCM-D	crystal.			
Quartz	
ODT	
Flow	
Au	contact	
Au	
Inlet	 Outlet	
LOND	
Oil	layer	
Sample	
QCM-D	holders	
Q-Sense	E4	
Flow	
PeristalDc	
pump	
Waste	
Time	
(a)	
(b)	
 92 
Quartz crystal microbalance with dissipation monitoring (QCM-D) was used to study 
LOND interactions with hydrophilic and hydrophobic solid surfaces in an aqueous 
environment, with the latter being used as a mimic to the gas-aqueous MB interface. 
QCM-D utilises the piezoelectric properties of quartz to measure the damping in 
resonant frequency of the oscillations as a response to mass addition to the surface of 
the crystal. The technique (without dissipation monitoring) was originally introduced by 
Sauerbrey (1959), with an added mass resolution of 4 ng/cm-2.222 
As shown in Figure 4.18, a Q-Sense E4 (Q-Sense AB, Sweden) was used to monitor the 
interaction between LONDs and QCM-D crystals treated to be hydrophilic or 
hydrophobic. Crystals were allowed to equilibrate for at least 1 h in degassed PBS, 
flowing at 14 µl/min. The 5th, 7th, 9th and 11th overtones were recorded and used in the 
analysis. The LONDs were introduced in to the flow chambers at a dilution of 1012 
LONDs/ml in PBS, at 140 µl/min. The flow was then stopped for ~2 h until no further 
frequency or dissipation changes were observed. PBS was used to rinse the system, in 
order to remove any unattached material (140 µl/min), followed by a MilliQ rinse, and 
another rinse in PBS to monitor any change in attached material due to buffer change. 
The Sauerbrey and the viscous models were fitted to the above harmonics to calculate 
the mass adhered to the crystal during the experiment and estimate the thickness of any 
oil-lipid layer formed. 
The Sauerbrey equation presents a proportional relationship between the change in 
frequency (Δf) of a resonating flat quartz crystal and the change of mass (Δm) to the 
crystal’s surface. 
 
  ∆𝑓 = − !!"!!! !!!! Δ𝑚   (4.13) 
Where n is the overtone being measured, f0 is the native resonant frequency of the 
crystal, A is the active area of the crystal, and ρq and Gq are the density and shear 
modulus of the crystal.223–225 
As more mass is added to the crystal it acts to slow down the vibrations of the crystal, 
lowering the resonant frequency. Strictly, the Sauerbrey equation is only true for the 
crystal and added mass resonating in a vacuum. This is because interactions occur 
between the crystal/mass’s top surface and the fluid the mass is being deposited from. 
However, the Sauerbrey equation only needs to be corrected for this when the deposited 
mass is from a soft viscoelastic material. When the material is an elastic film, and for 
many practical cases, the correction would be negligible, and so the Sauerbrey equation 
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remains valid.226 This model assumes that the mass being deposited onto the crystal acts 
as an extension of that crystal, notably that it moves with the same elastic properties (is 
ridged) and is flat. If the material is too viscoelastic, then it causes energy dissipation 
during oscillation, further changing the frequency measured. For a film of thickness 
below 40 nm, the Sauerbrey equation is sufficient to model the change in mass as any 
viscoelasticity is negligible.223 
The Kelvin-Voigt viscoelastic model addresses the limitations of the Sauerbrey 
equation, allowing measurement of a viscoelastic film by modelling it as a spring and 
dashpot in parallel, measuring the Δf and change in dissipation (ΔD).227 The equation 
takes into account the shear modulus and viscosity of the added mass and properties of 
the fluid the mass has come from. It assumes that the added mass is applied as a discrete 
number (i) of flat material layers.  
 
  ∆𝑓 ≈ − !!!!!!! !!!! + ℎ!𝜌!𝜔 − 2ℎ! !!!! ! !!!!!!!!!!!!!!    (4.14) 
  ∆𝐷 ≈ − !!!"!!!! !!!! + 2ℎ! !!!! ! !!!!!!!!!!!!     (4.15) 
Where hq is the thickness of the quartz, ηw and δw are the viscosity of the surrounding 
fluid and the penetration depth of the shear wave into the fluid respectively, hi, ρi, ηi, 
and µi are the height, density, viscosity and shear modulus of the material layer i, and ω 
is the angular frequency of oscillation.224,227,228 
In the analysis throughout this project, i was set to 1, being a single layer of mixed oil 
and lipid, where the oil was assumed to be the dominant material. The model was used 
to calculate µi and hi from ranges given in the relevant results sections. The fluid was set 
to water, ηw = 1000 kg/m3 and δw = 1 mPa.s.. 
 
4.9.5. Changes to surface pressure due to interactions between 
LONDs and an air-lipid/aqueous surface 
Using the LB trough previously described in section 4.5 (p 72), changes to the π of an 
air-lipid/aqueous surface were monitored during the introduction of LONDs into the 
aqueous subphase and their floating and further interaction with the surface. This 
worked as a model to the surface of a MB, with LOND interaction occurring from the 
surrounding solution. In this work, the LB trough was washed and subphase prepared as 
in section 4.5 (p 73), but with a PBS subphase in order to more closely represent the 
LOND solution aqueous phase. 
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	Fig.	4.19.	Schematic	of	experimental	set-up	used	for	measuring	surface	pressure	changes	due	to	the	introduction	 of	 LONDs	 to	 a	 monolayer	 pre-set	 to	 a	 defined	 surface	 pressure.	 Here,	 whilst	 the	moveable	barriers	are	shown	with	green	and	red	moving	arrows	to	mirror	Figure	4.12,	they	were	static.	
 
LOND addition to static monolayers set to defined surface pressures 
DPPC lipid, representing a typical MB shell, was spread onto the subphase surface so 
that after barrier compression to a target π of 15, 8, 4, or 0 mN/m (just prior to any 
increases in surface pressure) the LB trough area would be between 50 and 200 cm2. 
The subphase was also prepared without a lipid monolayer and compressed to 60 cm2. 
The surface was monitored for 30 min to confirm π stability. As shown in Figure 4.19, 
squalane POPC or POPC-PEG LONDs were injected into the sub-phase via a syringe 
and tubing that travelled from one of the two subphase volumes outside of the barriers, 
under one barrier, into the main subphase volume. The outlet of the tubing was gently 
moved around the bottom of the main subphase to avoid surface fluctuations whilst 
promoting uniform LOND distribution across this subphase. The tubing was then 
slowly and fully removed from the system. Enough LONDs were added so that, after 
floating to the surface, they would close-pack. From the Hadamard-Rybczynski 
equation, each LOND would individually take 14 days to rise the trough depth (0.5 
cm).229 However, by eye, the bulk of the LOND emulsion was observed to rise to the 
surface seconds after injection. Therefore, the change to π was recorded over an hour 
following an initial rise in π, where it was assumed that the majority of the LONDs 
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were either at or approaching the monolayer. These experiments were conducted at 21.3 
± 0.2 °C. 
 
LOND addition to fully compressed monolayers with following expansion 
POPC lipid was spread onto the subphase surface with a following pressure-area 
isotherm being performed to confirm the monolayer’s validity. The monolayer was 
compressed to a π of 35-40 mN/m, close to POPC’s collapse pressure, aiming for a 
trough area of 10 – 20 cm2, and allowed 30 min to relax to a constant π. POPC squalane 
LONDs were introduced to the subphase as in the previous section and 30 min was 
allowed for the LONDs to rise, equilibrate under the surface monolayer, and for any 
change in π to plateau. The trough area was rapidly expanded by moving the barriers 
outwards at 27 mm/min, either (1) constantly until the π decreased to 0 mN/m or (2) 
sequentially decreasing by ≤ 10 mN/m steps, allowing the π 10 min to relax and plateau 
before the next decrease. After this step, and potentially a recording of how the π 
relaxed from a stretch to 0 mN/m, a new pressure-area isotherm was taken and the 
surface was compressed to the same area as the initial compression to be compared with 
the recordings before LOND addition. It was proposed that on decreasing the π of the 
initially compressed monolayer, the LONDs would enter and spread at the surface, 
increasing the number of lipids and adding a volume of oil at the surface. This would 
allow observations to be made of the critical surface pressure under which LOND 
entering and spreading would occur, and then how the addition of the oil component 
would alter the surface pressure of a monolayer at different compressions in respect to 
the number of lipid molecules in the system at each time. 
 
4.9.6. Production of OLI-MBs from LOND solution 
Two-phase FF devices (section 4.2.2, p 63) were used for on-chip production of OLI-
MBs from LOND solution. POPC squalane, squalene or tripropionin LOND solution 
was diluted to 1012 LONDs/ml in 10 vol% glycerol, 4 mg/ml NaCl. If the LONDs were 
tripropionin, then the solution the LONDs were diluted into was firstly saturated with 
tripropionin by heating to ~50 °C and stirring for ~ 30 min. LOND solution flow rates 
of 15-50 µl/min were delivered via a syringe pump, passing first through a 200 nm 
PTFE filter to remove any oil that was not successfully homogenised or from LONDs 
that had destabilised over time. C4F10 gas pressures of 20-34.5 kPa were regulated by a 
digital gas flow controller. At the nozzle the gas was pinched off and stabilised as a MB 
by the LOND solution. The MB solution contained 10 µl of liquid C6F14 per 1 ml of 
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precursor MB solution to extend MB lifetime by intercalation of the C6F14 into the MB 
shell.217 High frame rate imaging (FASTCAM SA-X, Photron, USA) between 10 – 50 
kfps, performed on an inverted light microscope (Eclipse Ti-U, Nikon, Japan), was used 
to observe single MB pinch off and flow immediately after the nozzle during production. 
For size and concentration measurements squalane and squalene OLI-MBs were imaged 
in 120 or 50 µm deep chambers by darkfield (Eclipse Ti-U, Nikon, Japan), whereas 
tripropionin OLI-MBs were imaged in a flow-cell (as detailed in section 4.7, p 70-71). 
Squalane and tripropionin OLI-MBs were also imaged over 4 h for lifetime 
measurements. Here, three wax sealed 50 µm MB loaded glass chambers, or a single 
MB loaded flow cell were observed over time at ambient conditions. 
 
OLI-MBs were also produced via a mechanical agitation method. This gave a high 
proportion of >8 µm diameter MBs, allowing for higher resolution imaging of the MB 
surface fluorescence from 10-30 µm MBs, in comparison to ~2-3 µm MBs produced 
microfluidically. The LOND stock solution was first diluted to 1012 LONDs/ml in PBS. 
The mechanical agitation method was then continued as in section 4.4 (p 71), with the 
dilute LOND solution replacing the standard lipid solution. Size and concentration 
measurements were taken using 50 µm deep chambers and the inverted microscope 
detailed previously. These measurements were performed over 4 h, at ambient 
conditions, using three wax sealed chambers for lifetime measurements.  
 
OLI-MBs made from LONDs loaded DiO/DiI were washed in microfluidic particle 
traps, whilst imaged by confocal microscopy to confirm the fluorescence and stability of 
the oil component (excitation 488 nm at 10 % power, and emission windows 500-520 
nm and 561-582 nm, 600 V gain). OLI-MB samples were flown into a microfluidic 
particle trap device (prepared as in Chapter 4.2.2) at 10 µl/min for 30 – 60 min. A 
following PBS wash was performed at 10 µl/min for ~ 60 min. Single slice and z-stack 
images were taken of the trapped MBs both before and after washing occurred. The 
resulting images’ grey scale values located at and off the MBs’ shells were compared to 
assess the MB fluorescence retention, indicating the stability of the oil portion, and 
confirm fluorescence removal from the surrounding solution, indicating the successful 
washing/removal of the LOND solution. 
 
To further understand the production of OLI-MBs, mechanically agitated non-oil-MBs 
stabilized by a POPC or DPPC-PEG shell were trapped and washed as with the OLI-
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MBs in particle traps. 500 µl of DiI squalane POPC LONDs were washed past the MBs 
at 10 µl/min, and then the chamber was washed with 500 µl of PBS at 10 µl/min. 
During this experiment the fluorescence was recorded as before on the confocal 
microscope (excitation 488 nm at 10 % power, and emission windows 500-520 nm and 
561-582 nm, 600 V gain) to assess if the MBs gained and then retained a fluorescent 
shell. This would indicate if the LONDs were capable of entering and spreading at a 
MB shell after the MB was already stable or if spreading only occurred in order to 
stabilise a MB. 
 
4.9.7. Förster/Fluorescence resonance energy transfer (FRET) 
enabled LONDs 
Fluorescence/Förster resonance energy transfer (FRET) was used to follow LOND 
destabilisation and LOND-LOND mixing at gas-aqueous interfaces, eventually leading 
to the positive conformation of oil layer formation at the MB surface. 
As shown in Figure 4.20, the general experimental concept used in these experiments 
was the following. Two LOND samples would be made, one encapsulating a FRET 
donor, and another encapsulating a FRET acceptor. After mixing of these two stable 
samples, if the LONDs remained stable then the FRET pair would not come into 
proximity to allow FRET to occur, on the other hand, if the LONDs destabilised and 
mixed their oil and loaded fluorophore then FRET proximity would be achieved. This 
method would firstly allow identification of the self-assembly/attachment of LONDs 
around a MB shell given by a fluorescent outside, with the further identification of if the 
LONDs had spread into an oil layer or remained stable by the presence or lack of FRET 
signal. 
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	Fig.	4.20.	 Schematic	of	 the	 concept	of	FRET	 loaded	LONDs	 for	OLI-MB	 formation.	 Showing	donor	(D)	excitation	leading	to	(ai	and	bii)	D	emission	if	the	nanodroplets	remain	stable,	and	(aii	and	bii)	acceptor	(A)	emission	if	the	nanodroplets	merge/spread.	Wavelength	given	are	for	DiO	and	DiI	 in	squalane	oil.	
 
DiO and DiI as hydrophobic FRET agents 
DiO and DiI have previously been used in literature as hydrophobic FRET agents both 
in oil phases and as the core of micelles.230–233 In both cases, it is well known that after 
excitation of DiO (donor) or DiI (acceptor) separately by a source within the donor 
excitation window, both fluorophores have emission signal in the donor and acceptor 
emission window without FRET occurring. However, when DiO and DiI are within 
proxity for FRET to occur, the DiO + DiI emission within the donor window is reduced 
and the DiO + DiI emission within the acceptor window is enhanced beyond that of the 
addition of the two separate DiO and DiI emissions. As shown in Equation 4.16, in 
order to identify any enhanced FRET fluorescence, it was therefore necessary to 
compare all samples containing donor + acceptor to the maximum intensity from 
control samples containing just donor and just acceptor.231,234 The concentrations of 
donor and acceptor had to be kept constant throughout all samples. 
 
  𝐹𝑅𝐸𝑇! = 𝐹𝑅𝐸𝑇! − 𝐼max!"#"$ + 𝐼max!""#$%&'    (4.16) 
Where FRETf is the final FRET image, FRETi is the initial FRET (donor + acceptor) 
image, and I is the intensity. 
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For all following experiments, without exception, stocks and samples were kept in light 
blocking containers or wrapped in foil when not in use, and handled in low-light 
environments when moving between the two. During imaging experiments, alignment 
and focusing were performed primarily in bright field, swapping to fluorescence 
imaging only when absolutely necessary for final adjustments and before imaging. This 
was done in order to minimise bleaching effects and keep all samples comparative for 
use in Equation 4.16. 
 
Calibration of DiO/DiI FRET in oil 
Excitation/absorbance and emission measurements were taken of DiO and DiI in 
squalane and triacetin oil, as in Chapter 2.1. Each fluorophore was solubilised at 30 
µg/ml, then diluted down to 0.015 or 2.1 µg/ml for samples containing one or both 
fluorophores. Absorbance measurements were performed with a 200-700 nm sweeping 
excitation laser light source, 480 nm/min, with a 1 nm slit width window, in reference to 
a control oil only sample. Emission measurements were performed with a 488, 549 or 
560 nm excitation laser for DiO in either oil, DiI in triacetin, and DiI in squalane 
respectively, based on peak absorbance measurements. The receiver performed a 500-
700 nm sweep, at 100 nm/min, with a 4 nm window. Control oil only samples were also 
measured as a reference for background correction of intrinsic oil fluorescence. 
Calibration and conformational measurements of DiO and DiI as a FRET pair were 
performed on the same inverted confocal microscope that would later be used for 
LOND FRET experiments. Here, three 50 µm deep chambers were filled with squalane 
oil loaded with 30 mg/ml DiO, DiI, or DiO + DiI, sealed, and turned over so that the 
glass coverslip was pointing toward to microscope lens. Each sample was excited by a 
488 nm source at 10 % power and observed through a x40 lens, with filters of 500-520 
and 561-582 nm, at a constant gain of 720 V, constant image dimension, without line 
averaging, and a pixel dwell time of 1.20 µs. Histograms of the white number of each 
image were then recorded, defining the image intensity that allowed for their use in 
Equation 4.16.  
 
Preparation of FRET LONDs 
Separate preparations of POPC squalane LONDs were made containing either DiO 
(donor) or DiI (acceptor) dye at 30 µg/ml or 1 mg/ml.  
Emission measurements were performed on the LOND solutions to examine if the 
fluorophore concentration was high enough to overcome scatter from the presence of 
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small particles (the LONDs) making the solution turbid. This was done using the 
fluorometer as explained above with a 488 nm excitation laser, over a range of LOND 
concentrations, 107 – 1012 LONDs/ml, diluted in PBS. As a control PBS alone was also 
tested. 
When considering the use of these FRET enabled LONDs in further experiments it was 
important to realise that by mixing the DiO and DiI LONDs at a 1:1 ratio, if their 
rupture and mixing occurred, then on average both the DiO and DiI would be diluted to 
half of their original concentration in the newly merged oil. Therefore, when performing 
all further comparative experiments of DiO only or DiI only LONDs, they were always 
mixed at a 1:1 ratio with a third batch of prepared POPC squalane LONDs which were 
non-fluorescent/empty. This meant that to reveal enhanced FRET fluorescence donor 
LOND + acceptor LOND samples were compared to control donor LOND + non-
fluorescent/empty LOND and empty LOND + acceptor LOND samples, changing 
Equation 4.16 to: 
 
  𝐹𝑅𝐸𝑇! = 𝐹𝑅𝐸𝑇! − 𝐼max!"#"$!!"#$% + 𝐼max!"#$%!!""#$%&'  (4.17) 
 
FRET at large bubble surfaces 
Separate donor, acceptor and non-fluorescent/empty LOND solution stocks were diluted 
1:10 in PBS to 1012 LONDs/ml then mixed 1:1 to make the sample and two control 
solutions as explained above of donor + acceptor, donor + empty, and empty + acceptor 
LOND solutions. Three 50 µm deep chambers were prepared where the spacers were 
arranged to prevent the solution from fully filling the chamber, leading to the active 
capturing of millimetre scale air pockets with near vertical water-air interfaces which 
fully filled the chamber from the top glass coverslip to the bottom glass slide. The air-
water interfaces of the gas pockets were then observed on the confocal microscope, as 
above in the bulk oil DiO/DiI calibration experiment, with the 488 nm laser at 10 % 
power, observing through both a x10 and x40 lens, at a constant gain of 800 V. The 
experimental images were compared as in Equation 4.17 to reveal any FRET signal, 
which would indicate LOND merging at millimetre-scale air-water interfaces that 
would appear flat relative to the nanoscale LONDs. 
 
FRET at OLI-MB surfaces 
In the following experiment, both squalane POPC and POPC + 5 mol% DSPE-PEG 
LONDs were tested. OLI-MBs were produced by both the microfluidic (just POPC lipid 
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shell) and mechanical agitation (both lipid shell types) method. OLI-MB samples were 
then loaded into BSA coated 50 µm deep glass-viewing chambers. Fluorescence was 
observed as before on the confocal system with a 40x objective, using the 488 nm 
excitation laser at 10 % power with a gain of 600 V. The experimental images were 
compared as in Equation 4.17 to reveal any FRET signal, which would indicate LOND 
merging at MB air-water interfaces. 
 
Washing OLI-MBs 
In order to confirm that the fluorescent regions of interest in the FRET experiments 
originated from the structure of the above OLI-MBs, rather than being due to something 
such as reflection, washing of mechanical agitation FRET OLI-MBs was repeated as in 
section 4.9.6 (p 92). 
 
4.10. Microfluidic FF formation of OLI-MBs from bulk phases 
The work in this section revolved around the concept of introducing bulk phases of 
aqueous lipid solution, oil and gas on-chip in FF regimes, with the intention of forming 
a gas-oil-lipid/aqueous interface around a gas bulb held at the microfluidic nozzle. This 
oil layer, with controllable oil layer thickness, would then pinch off with the gas 
through the nozzle to form OLI-MBs. 
All of the experimental work in this section used the inverted microscope described 
earlier (section 4.1, p 60). 
 
4.10.1. Evaluating oils for the control of the oil layer 
thickness during on-chip co-flow 
The large majority of the work described in this section of the project centred on using 
the ‘three-phase flow focus microchip’ geometry, described in Chapter 4.2.2 (p 65), 
where it was necessary for the oil and lipid solution phases to come into contact and co-
flow upstream from meeting the gas phase. As such, a number of the available oils that 
were used in the whole project were tested for their oil layer thickness and the 
thickness’s uniformity during this co-flow, over a range of flow rate and flow rate ratios 
between the oil and lipid solution. The aim here was to optimise the system for greater 
control over the oil layer thickness using a greater range of flow rates. 
Using a 3C1 microchip, C4F10 gas was held at a constant pressure of 3 psi (20.7 kPa). 
Squalane, isoamyl acetate, triacetin or dodecane oil was set to a specified flow rate at 
0.5, 0.1, 0.05, or 0.02 µl/min. The lipid solution flow rate was then varied from 6 to 40 
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µl/min (up to 100 µl/min for triacetin) with videos being recorded of the co-flow 
immediately after lipid solution and oil phase introduction. As shown in Figure 4.21, the 
oil layer thickness was measured over 390 µm for every other pixel column down the 
co-flow channel and at least three videos were taken for each flow rate ratio. 
 
	Fig.	 4.21.	 Method	 used	 to	 measure	 the	 thickness	 of	 oil	 during	 the	 co-flow	 channel.	 (a)	 The	fluorescence	video	is	scaled	into	micrometers	against	a	reference	graticule	measurement.	(b)	The	stack	 is	rotated	to	have	the	co-flow	channel	horizontal,	and	 is	made	binary	(black	and	white).	 (c)	Every	other	pixel	column,	for	each	image,	is	made	black.	The	stack	is	cropped	to	the	co-flow	channel	only,	 (d)	 and	 colour	 inverted.	 (e-f)	 Each	 black	 shape	 is	measured	 for	 the	 area	 and	 the	minimum	Feret	 diameter	 (the	 shortest	 edge,	 one	 pixel).	 During	 further	 analysis,	 each	 measured	 area	 is	divided	by	the	minimum	Feret	diameter	to	give	the	vertical	height,	equal	to	the	oil	layer	thickness.		
4.10.2. Evaluating on-chip pinch off mechanics of gas-in-oil 
and oil-in-aqueous 
The methods in this section of the project revolved around the idea of progressing to a 
system where pinch off of gas was achieved in oil with that oil being simultaneously 
pinched off in lipid solution, all at one FF nozzle. Therefore, it was necessary to 
understand the mechanisms under which pinch off occurred in two-phase FF systems 
(a)	 (b)	
(c)	 (d)	
(e)	
(f)	
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with an equivalent nozzle (to that of the three-phase FF design). Further mapping out 
the liquid flow rate and gas pressure ranges that achieved pinch off in a two-phase FF 
system would aid in estimating the velocity ranges for the three-phase FF system. 
Using the two-phase FF microfluidic design (described in section 4.2.2, p 63), the 
continuous phase, of lipid solution or oil, and the discontinuous phase, of oil or C4F10 
gas, were introduced on-chip. Aqueous flow rates tested ranged between 1 and 200 
µl/min. When the oil was being used as the discontinuous phase (with lipid solution) 
flow rates tested ranged between 0.01 and 30 µl/min. When the oil was being used as 
the continuous phase (with the gas) flow rates tested ranged between 2 and 160 µl/min. 
Gas pressures tested ranged between 1 and 15 psi. 1 vol% Triton solution and standard 
lipid solution was tested for use with an aqueous phase. For the oil and gas experiments, 
no surfactant and 1 vol% Span 80 in the oil phase were tested. Squalane, dodecane, 
isoamyl acetate, and triacetin oil were all tested. 
For both two-phase setups, the lipid solution flow rate or the gas pressure was set to a 
given value and then the oil phase was varied through a set of flow rates from the point 
that the discontinuous phase was held as a bulb at the nozzle to where the discontinuous 
phase flew through the nozzle without pinch off, remaining as a bulk phase. Pinch off 
was observed using the same apparatus as the three-phase experiments in the previous 
section.  
 
4.10.3. Three-phase FF trials 
This section of the work includes the experimental trials that were performed with the 
aim to produce OLI-MBs using three-phase FF microfluidics. 
The microfluidic designs that were used here were 5C1, 3C1, 3C2 and 3C3 as described 
in section 4.2.2 (p 65). Microchips in early experiments began with PMMA-SU8-
PMMA channel walls that were natively hydrophobic, however this was quickly 
changed to microchips that were treated to make the channel walls hydrophilic. 
Hydrophilic treatment was performed by Epigem before delivery and use. 
Primarily, 1 mg/ml standard lipid solution was flown through the aqueous inlet, which 
was changed to 1 vol% Triton in MilliQ, or 4 mg/ml BSA solution for a small number 
of experiments where specified. C4F10 gas was flown through the gas inlet. Triacetin, 
squalane, isoamyl acetate, dodecane or soybean oil was flown through the oil inlet. 
When specified, 1 mg/ml DPPC + 5 mol% DSPE-PEG lipid was added to the oil phase. 
Lipid was added to the oil as in the standard lipid solution, where it was dried in a glass 
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vial from a chloroform/methanol solution, then the oil was added and the vial was bath 
sonicated to redisperse the lipid. 
Pluronic F-68, with a stock of 10 vol% in deionised water, was added to both the lipid 
solution and oil phases at a variety of final concentrations; 0 and 0 vol%, 10 and 0 vol%, 
10 and 2 vol%, and 2 and 2 vol% respectively. For addition to aqueous phases, the 
required volume of pluronic simply replaced that volume of MilliQ, BB or PBS when it 
was added. For addition to oil phases, the pluronic was gently evaporated under 
nitrogen to remove all of the water, before it was redispersed in the oil. Pluronic 
polymers are triblock copolymers of [polyethylene oxide]a-[polypropylene oxide]b-
[polyethylene oxide]a, where a and b are commonly 2-130 and 15-67 units respectively. 
The naming describes the structure. For the pluronic naming, the initial letter defines the 
substance as liquid (L), paste (P) or solid/flake (F) at room temperature (not dissolved 
in water). The first number x300 gives the approximate molecular weight of the 
polypropylene oxide core block. The final number x10 gives the approximate 
percentage of the entire polymer that is polyethylene oxide. Pluronics have seen regular 
use in pharmaceuticals as emulsion stabilisers and for the solubilisation of hydrophobic 
drugs,235 and were used by Shih and Lee (2013) when they formed oil layer inclusive 
MBs through a FF system.95 
The full flow rate and pressure ranges recorded were 6 - 190 µl/min, 0.02 - 4 µl/min, 
and 0.8 - 25 psi for the lipid solution, oil and gas phases respectively. The lipid solution 
flow rates had three distinctive flow ranges, with the oil phase flow rate and gas 
pressure matching to allow the phases to be at a balance between not moving through 
the nozzle and flowing too greatly though it. Lower lipid solution flow rates around 6 
µl/min were tested to reduce flow velocities, which has previously been shown to 
inhibit coalescence of MBs during on-chip production.31 
Most of the experiments carried out in this section used fluorescence to distinguish the 
oil phase and lipid in the lipid solution. Nile red was added to the oil phase and imaged 
through either the FITC or TexRed filters dependent on the oil used. Oregon green was 
added to the lipid solution at 1 mol% of the entire lipid concentration and imaged 
through the FITC filter. 
Most data in this section of the work was collected using videos of the three phases 
flowing through the nozzle. Videos were captured under fluorescence and bright field, 
primarily using a x10 lens with an internal x1.5 modifier, and using high frame rate 
imaging in bright field only at 50 kfps, with the same magnification but without the 
internal modifier. 
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4.11. Activation of double emulsion liquid perfluorocarbon 
(PFC)-in-oil-in-aqueous droplets into OLI-MBs 
In this section of the work, the potential to form highly stable, long-lived liquid PFC 
droplets, both with and without oil shells, and further phase change them into gas PFC 
MBs was evaluated. If a PFC droplet with a surrounding oil shell was successfully 
activated into a stable MB, this would potentially produce the desired OLI-MB structure. 
 
4.11.1. Single emulsion PFC droplet production 
Single emulsion PFC droplet were stabilised in an aqueous continuous phase via the 
three methods described below. Surfactants tested were 0.5 mg/ml DPPC and 1 vol% 
Triton (or 10 vol% only when stated), both in PBS. Only when stated, isoamyl acetate, 
squalane, triacetin, or dodecane oil was used as the continuous phase with no surfactant, 
1 vol% Span 80, or 1 vol% Triton. All droplet solutions were measured for size or 
concentration as in section 4.7 (p 78-82). 
 
Two-phase microfluidics 
Microfluidic PFC droplet formation was used to give a microdroplet sample, with high 
monodispersity and repeatability. Here, two-phase FF microchips (described in section 
4.2.2, p 63) were used. Triton solution was pumped through the microchip at 1 – 40 
µl/min, with optimal production at 3 µl/min. C5F12, C6F14, or a 60:40 volume mix of 
both, was pumped through the microchip at 0.5 – 10 µl/min, with optimal production at 
1 µl/min. The droplet solution was collected in a 1.75 µl glass vial or eppendorf, and 
stored at 4 °C for up to one week. Concentration and size measurements were 
performed over a one-month period to assess stability.  
 
Tip sonication 
PFC droplet formation by tip sonication was used to give a nanodroplet sample, with 
high concentration and repeatability. In a falcon tube, a 4 ml solution was made up of 
2.5, 5 or 25 µl/ml C5F12 or C6F14 in Triton or DPPC solution. 5 µl/ml was the routine 
concentration. The solution was vortexed for 30 s, then transferred to a 4 °C cooled 
jacketed crucible, for tip sonication, making sure to retain all of the dense PFC with the 
solution. Tip sonication (Sonifier S-250A, Branson Ultrasonics, UK) then proceeded at 
200 W, 20% power, 100% duty cycle, for 5 min. The sample was collected and stored at 
4 °C for use during up to one month. If stated, this solution was further extruded 
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through a 400 nm filter. Concentration and size measurements were performed over 5 h 
and the following day to assess stability.  
 
Mechanical agitation 
PFC droplets were made by mechanical agitation to give a high concentration, high 
polydispersity, fast production sample. A 1.75 µl glass vial was filled with 99 vol% 
aqueous or oil and 1 vol% C5F12 or C6F14. If lipid were to be used, it was dried on to the 
glass vial before it was filled with solution. This method then followed that for 
mechanical agitation MB formation, as detailed in section 4.4 (p 71). After agitation, the 
vial was allowed to cool (often the vial, prepared at or below room temperature, was 
warm to the touch immediately after agitation) and then the lid was slowly removed for 
access to the droplets. This last step was done to inhibit droplets from prematurely 
activating into MBs due to the undesired apparent increase in temperature in 
combination with the pressure drop during the opening of the vial. The sample was used 
immediately. 
 
4.11.2. Double emulsion PFC droplet production 
Microfluidic, homogenisation, and mechanical agitation methods for the formation of 
PFC droplets, with surrounding oil layers, stabilised in aqueous (a.k.a. double emulsion 
PFC droplets) were trialled as detailed below. However, it was found that only the 
mechanical agitation method produced a double emulsion sample, and so for any further 
studies that was the method used. Nile red was added to the oil phase in all of the below 
experiments for fluorescent distinction from the outside aqueous and inside PFC phases. 
Droplet solutions were measured for size and concentration as in section 4.7 (p 78-82). 
Figure 4.22 shows how the ratio of PFC core to oil layer was measured for a double 
emulsion sample. For each droplet, the radius of the central PFC core and the radius of 
the total double emulsion droplet were measured and compared, resulting in a PFC core 
divided by total droplet radius ratio. For a sample with multiple droplets, an average 
was calculated from the ratios (rather than averaging the radiuses of the PFC cores and 
total droplets first). 
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 Fig.	 4.22.	 Method	 used	 to	 compare	 the	 PFC	 and	 oil	 contributions	 of	 a	 PFC-oil	 double	 emulsion	droplet.	 The	 area	 of	 the	 PFC	 core	 (blue)	 and	 total	 droplet	 (red)	 were	 measured.	 These	measurements	were	then	calculated	into	radii	and	compared	to	obtain	a	core	to	total	droplet	radius	ratio	
 
Microfluidic method 
Two solutions were prepared for use in two-phase FF microfluidics (described in 
Chapter 4.2.2.). The continuous phase was 1 vol% Triton in PBS, and was pumped in at 
0.05 - 0.5 µl/min. The discontinuous phase consisted of PFC droplets stabilised in oil, 
made using the mechanical agitation single emulsion PFC droplet method described in 
the previous section. Here, the oil used was dodecane and the surfactants tested were 1 
vol% Triton and 1 vol% Span 80 in the oil phase. The discontinuous phase was pumped 
in at 0.7 – 10 µl/min. Nile red in the oil phase allowed for imaging of on-chip pinch off 
as well as analysis of PFC core pinch-off efficiency. 
 
Homogenisation 
Tip sonication was performed on a three phase PFC, oil, aqueous solution under the 
same method as that for tip sonication of single emulsion PFC droplets as described in 
the previous section. The solution was 0.5 vol% C5F12 and 0.5 vol% soybean oil in 6 
mg/ml BSA in PBS solution. Control samples without the oil and without the BSA 
solution, increasing the oil to 99.5 vol%, were also tested. 
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Coarse homogenisation of 0.5 vol% C5F12 and 0.5 vol% triacetin in 6 mg/ml BSA in 
PBS solution was performed on the Polytron system used for LOND production 
(section 4.9.1, p 84-85), for 30 s – 5 min. 
 
Mechanical agitation 
A 1.75 µl glass vial was filled with 1 ml of 0.5 vol% C5F12, 0.5 vol% oil, in 6 mg/ml 
BSA in PBS. Soybean, isoamyl acetate, triacetin, dodecane, and squalane oil were all 
tested, with the oil being soybean if not specified in the remainder of this thesis. This 
method then followed that for mechanical agitation MB formation, as detailed in section 
4.4 (p 71). After agitation, the vial was allowed to cool (often the vial, prepared at or 
below room temperature, was warm to the touch immediately after agitation) and then 
the lid was slowly removed for access to the droplets. This last step was done to inhibit 
droplets from prematurely activating into MBs due to the undesired apparent increase in 
temperature in combination with the pressure drop during the opening of the vial. The 
sample was used immediately. 
 
In order to assess control over the diameter, concentration and oil layer thickness of the 
double emulsion droplets, the volume of oil and concentration of BSA were tested at 0, 
0.5, 1 and 2 vol% and 0, 2, 4 and 8 mg/ml respectively, whilst keeping the PFC volume 
constant at 1 vol%. This was also compared to initial experiments that used 10 vol% 
PFC, 10 vol% soybean oil, and 6 mg/ml BSA. 
 
4.11.3. Activation of single and double emulsion liquid PFC 
droplets 
 
 Thermal activation methods 4.11.3.1.
Thermal activation of both single and double emulsion liquid PFC droplets was tested 
both on macroscale, observing the entire solution by eye for volume change or an 
increase in turbidity, indicative of larger particles (MBs) appearing in the solution, and 
on microscale, observing single or a small number (≤ 30) of droplets for direct 
activation into gas. The general method here aimed to raise the PFC solution 
temperature to the point that the droplets’ were in a hotter environment than their 
boiling point. 
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Heating plate 
1 ml of PFC microdroplet solution in a 1.75 ml glass vial was placed on a heater plate. 
The temperature at the centre of the solution was monitored. The temperature was 
increased from 25 °C to 68 °C, and then allowed to cool back down. The solution was 
observed by eye, with camera photographs being taken, for a change in turbidity or a 
clear sign of boiling of the PFC droplets, which had quickly sank to the bottom of the 
vial before the thermal ramp began. 
This method was only used on 60 vol% C5F12 + 40 vol% C6F14 Triton PFC 
microdroplets that had been produced microfluidically. As such, bulk C6F14 and Triton 
were separately tested for their boiling points in 5 ml volumetric flasks using the above 
method with a stirring flea. Bulk C5F12 could not be tested in this manner since, even 
though the boiling point is 29 °C, the liquid begins to vapourise at room temperature, 
and due to material use. 
 
Peltier heating in a chamber  
As shown in Figure 4.23, observations were made of single PFC droplets under thermal 
ramping by injection of either a nano- or microdroplet PFC solution into a 50 µm deep 
viewing chamber, a PMMA-SU8-PMMA microfluidic chip or a PDMS flow cell, and 
the use of a Peltier heater. The chamber or chip was mounted onto the inverted 
microscope described in previous sections, but with the microscope stage changed to an 
in-house built plastic stage, for thermal insulation from the microscope, with a thin top 
copper plate, for thermal conduction, with a lens viewing port. The Peltier and the 
chamber or chip were then placed in close proximity on the copper plate, using thermal 
coupling gel (340, Dow Corning, USA), with the latter being placed over the viewing 
port. The temperature of the top surface of the chamber or chip was monitored with a 
thermocouple, using more thermal coupling gel, which led back to the Peltier controller. 
The static droplet solution temperature was ramped from 25 °C to 80 °C whilst droplet 
observations were made. 
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 Fig.	 4.23.	 Set-up	 for	 thermal	 control	 of	 microchip/chamber	 during	 imaging	 by	 the	 upright	microscope.	Chamber	is	the	device	from	Figure	4.8.	
 
DLS temperature ramp 
PFC nanodroplets were measured for diameter change by DLS during heating of the 
solution. Here, if droplets activated into MBs, any nanoscale particle measurements 
were expected to become less significant due to a rising microscale particle 
measurement or the sample gaining turbidity. The method used for DLS measurement 
was as described in section 4.7 (p 78-79), however instead of measuring at a constant 
25 °C, the temperature was ramped from 20 – 70 °C, with three measurements 
occurring every 10 °C. In order to prevent sample evaporation, a lid, provided with the 
DLS specifically for heating use, was loosely fitted onto the cuvette. 
 
 Hypobaric activation and on-chip pressure drop 4.11.3.2.
Pressure drop activation of both single and double emulsion liquid PFC droplets was 
tested with a hypobaric activation method and an on-chip pressure drop. Generally 
observations were made before and after activation for the first method and during the 
second method.  
 
Hypobaric activation 
A hypobaric activation method for transitioning PFC droplets into MBs was first 
discussed by Forsberg et al. (1998).236 A syringe was filled to ~10 % of its full volume 
with PFC solution. The plunger was then fully retracted, creating a pressure drop inside 
Thermocouple	
Pel-er	Copper	ﬁnger	 Brass	collar	
Viewing	port	Chamber/microchip	
Plas-c	insula-on	stage	
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the syringe, held for a few seconds, then released. It was understood that the pressure 
drop activates the PFC droplets into MBs, then a shock wave, produced from the release 
of the plunger, propagates through the liquid breaking apart any larger MBs, leaving 
only MBs of diagnostic relevance (< 10 µm). The shock wave is heard as an audible 
‘pop’. 
 
	Fig.	 4.24.	 Schematic	 of	 hypobaric	 activation	 apparatus.	 Capped	 syringe	 containing	 solution	 to	 be	activated	at	~10	%	of	the	full	syringe	volume.		
As shown in Figure 4.24, a 5 ml syringe was filled with 500 µl of PFC solution. The 
end of the syringe was then capped whilst preventing any gas pockets. The plunger was 
drawn back to its full extent with one smooth, rapid motion, held for ~1 s, then 
immediately released. The audible ‘pop’ was heard during every experiment otherwise 
the method was repeated with new PFC solution. The activated solution was then 
transferred to a vial for samples to be taken for imaging. Immediately after gentle 
agitation, samples were taken from the bottom and middle of the vial and placed in 50 
µm chambers, imaging for remaining PFC droplets and MBs respectively (as described 
in section 4.7, p 82). For direct comparison, samples were taken from the solution and 
imaged in the same manner before activation. Experiments were performed at ambient 
temperature. 
Single emulsion 1 vol% Triton droplets were activated using this technique. Triton 
solution has the ability to stabilise gasses previously solubilised in the aqueous 
continuous phase until being put under the stress of low pressure, in a similar way to 
cavitation. Control hypobaric activation experiments were performed on MilliQ and 
dilutions of 1 vol% Triton. It was found no MBs were stabilised in either MilliQ or 
Triton solution at 0.001 vol%. Therefore, before activation of any Triton PFC droplets, 
the droplets were evenly disperse in a falcon tube and then allowed to settle (≤ 1 min), 
the supernatant was removed, then the tube was refilled with MilliQ. This was repeated 
until the continuous phase was diluted 1000x. 
sa
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Hypobaric activation on C5F12 nanodroplets was also tested at elevated temperature to 
examine if having the PFC fluid above its bulk boiling point (29 °C) would increase 
activation efficiency. Here, 1 ml of C5F12 Triton nanodroplets, diluted of excess Triton, 
were heated to 32 °C in a heating block and allowed to remain there for 10 min. 
Meanwhile, the syringe for hypobaric activation was filled with 32 °C MilliQ in order 
to prevent cooling of the PFC solution on contact. The PFC solution was then 
transferred to the syringe and the method continued as described above. 
 
In order to observe single droplets during hypobaric activation, a PMMA-SU8-PMMA 
microfluidic chip was mounted onto the inverted microscope with the manifold in place, 
as described in section 4.2.3, p 69-70. The chip was filled with PFC solution before all 
of the channels were sealed, with a 5 ml syringe connected to one entrance. Hypobaric 
activation then occurred as above with the droplets being observed by high frame rate 
microscopy, at 5 – 50 kfps. 
 
On-chip pressure drop under flow 
Correas et al. (1997) discussed a technique for activation of C5F12 nanodroplets (~300 
nm diameter), by passing them through a 1.2 µm filter, inducing a pressure drop. 236,237 
In an attempt to observe this mechanism and assess it under a more controlled regime, 
C5F12 Triton nanodroplet and microdroplet solutions were passed through the 
discontinuous phase inlet of a two-phase FF microchip and a spray MB microchip, both 
with nozzles of ~7 µm. Further 1 vol% Triton solution was passed through the 
continuous phase inlet. The droplet solution was observed before, at and immediately 
after the nozzle. Flow rates tested were 5 – 200 µl/min for the PFC solution, and 0 – 200 
µl/min for the Triton solution. These experiments were performed at ambient 
temperature. C5F12 Triton nanodroplet solution was also tested at 29 °C, using the 
Peltier set up in the previous section. In a more direct comparison to Correas’s work, 
C5F12 Triton nanodroplet solution was flown through a 0.4 µm filter by hand via a 1 ml 
syringe. All of the C5F12 Triton nanodroplet solution work presented in this section was 
compared by measuring the diameter and concentration of nanodroplets in solution prior 
to the experiment, and directly after flow stopped, using the qNano described in section 
4.7 (p 80). 
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 US activation methods 4.11.3.3.
US activation of both single and double emulsion liquid PFC droplets was tested in the 
kHz and MHz regions for non-localised and localised activation respectively. 
Observations were made before and after activation for the first method and during the 
second method. The general method here aimed to lower the PFC solution pressure to 
the point that the droplets’ were in a lower pressure environment than their vapour 
pressure. During ultrasonification of a fluid the forward half of a wave compresses the 
fluid, causing an increase in pressure, which would pass through any incompressible 
PFC droplets, however the tail half of a wave expands the fluid, leading to the desired 
pressure drop, causing the droplets to activate into MBs. 
 
45 kHz US 
Following the work by Rapoport et al. (2009), where low frequency (90 kHz) US was 
used for PFC droplet activation,143 45 kHz US was supplied to a PFC solution by an 
ultrasonication bath (USC200T, VWR, USA). Here, 1 ml of PFC solution was diluted 
to 10 ml, with its continuous phase, in a ~1.5 cm diameter falcon tube. After gentle 
agitation, a sample was taken from the middle of the solution and imaged in a 50 µm 
chamber for size and concentration (section 4.7, p 82). If PFC microdroplets were being 
used, they were imaged at the bottom of the chamber and allowed to settle in the tube (≤ 
5 min) before continuing. The lower ~2 cm of the tube was then submerged into an US 
bath, emitting a 45 kHz, continuous wave, for 10 s. Again after gentle agitation, a 
sample was taken and imaged as before, looking at the top of the chamber for MBs. 
Samples were measured at ambient temperature and at 37 °C by placing the falcon tube 
in a heating block before use. PFC Triton nanodroplets were additionally observed over 
60 s of US exposure, removing samples at 5 s exposure and then, starting from 10 s, at 
10 s intervals. As a control for both single emulsion PFC Triton droplets and double 
emulsion PFC-oil-BSA droplets, a 1 vol% triton, 6 mg/ml BSA mixed solution was 
sonified and imaged with the same method. Only one MB was observed, suggesting that 
cavitation of the continuous phases alone did not lead to MB stabilisation from the 
gases solubilised in the solution. 
 
1.1 and 3.5 MHz US 
US in the MHz region was supplied locally to a region of PFC droplets. 
For 1.1 MHz US; a high intensity focused US transducer with a centre frequency of 1.1 
MHz was submerged in a degassed distilled water bath, at 34 °C, and directed vertically 
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down. Attached to the base of the water bath, and at the transducer’s focal length, was a 
flow cell with a 0.17 mm plastic lid and base (Ibidi) where inlet and outlet lines 
travelled up and out of the water bath. Below the flow cell was a 60x lens, focused at 
the flow cell. PFC solution was then injected into the flow cell, after which flow 
stopped. Images were taken of the PFC droplets prior to US exposure. The droplets 
were then exposed to ≤1 s of US at 1.1 MHz, 12 ms peak repetition frequency (prf), at 
1%, 20%, and 100% duty cycle (DC), where the peak negative pressure at the focal 
point was set to 0.5 or 3.5 MPa. Images were again taken after US exposure. Triton 
solution without PFC droplets was tested up to 20% DC, with no MBs observed. 
(Figure 4.25) For 3.5 MHz US; a transducer (V380 NDT, Olympus Panametrics, Japan) 
with a centre frequency of 3.5 MHz was attached to a fitted plastic collar, which was 2 
mm short of the acoustic focal depth (6.35 cm), and filled with degassed distilled water. 
The collar base was covered with acoustically transparent material (12.5 µm thick cling 
film), and the transducer directed downwards. A 50 µm chamber, spray microchip, 
PMMA-SU8-PMMA flow cell, or glass-PDMS-glass flow cell were filled with PFC 
solution, then placed on the inverted microscope detailed in previous sections. The 
collar base was brought into contact with the PFC filled device, using acoustic gel 
(Polaris II, GE medical systems, UK) for transparency. Acoustic gel was spun down in 
a centrifuge (Megafuge 16R, Thermo Scientific, USA) before use to remove any MBs. 
The droplets were then exposed to ~1 s of US at 3.5 MHz, 12 ms prf at 0.02% DC, 1 ms 
prf at 1 or 10% DC, or continuous wave. Drive voltages were 400-550 mVpp, which 
related to a focal point negative pressure of 0.92-1.04 MPa. High frame rate imaging 
was used at 5 – 50 kfps to capture videos of droplets during US exposure. The Peltier 
set up was used, as described in section 4.11.3.1 (p 104-105), to keep the PFC droplet 
chamber at ~40 °C. 
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	Fig.	4.25.	Set-up	used	for	US	exposure	to	a	MB/droplet	sample	using	the	heating	stage	from	Figure	4.23.	
 
Acoustic cluster therapy (ACT), first presented by Sontum et al. (2015), where a MB 
and a PFC droplet of opposite charge are allowed to form a two part cluster, has 
previously been shown to dramatically lower the negative US pressure required to 
activate the PFC droplets into MBs. 238 As such, a similar method was used with the 3.5 
MHz US as described above. Here, mechanical agitation DPPC + 10 mol% DPPA MBs, 
and mechanical agitation DPPC + 10 mol% DOTAP C5F12 microdroplets were made, 
both in a MilliQ-lipid suspension. The MBs were diluted 100 times, then the two 
solutions were mixed 1:1. The mixed solution was gently agitated before being injected 
into the desired chamber for US exposure. Zeta potentials were taken of both solutions 
on the DLS described in section 4.7 (p 78-79). 
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4.12. MB echogenicity 
 	Fig.	4.26.	Schematic	of	setup	for	measuring	US	scatter	signal	from	a	MB	population.	The	attenuated	signal	(parallel	to	the	transmitted	signal)	is	also	shown,	but	is	not	recorded	in	this	setup.		
US scatter measurements were used to determine the resonant frequency of MB samples. 
Figure 4.26 shows a schematic of the setup that was used for this. An in-house water 
tank was prepared with an open topped 30 mm diameter, cylindrical acrylic chamber 
placed in the middle (~100 or 10 ml). The tank was filled with degassed, 20 °C de-
ionised water, while the chamber was filled with non-degassed de-ionised water and a 
magnetic stirrer. The chamber included three 20 mm diameter, circular, acoustically 
transparent (12.5 µm thick cling film) windows, each 90° apart, half way up the 
chamber wall. An unfocused, 3.5 MHz central frequency US transducer was placed 
millimetres from the chamber wall, facing through one of the windows. A 1.0 mm 
needle hydrophone (Precision Acoustics, UK) was placed 90° to this, again facing 
through one of the windows. 
The MB sample was added to the chamber from the top, to give a concentration of 105 
MBs/ml in the chamber. 20 seconds passed to allow the bubbles to disperse themselves. 
A custom-built US array research platform was then used with US excitation 
waveforms designed in MatLab (Mathwork, USA), and the setup as described in section 
4.8 (p 83), to drive the transducer. The transducer was driven across a range of 0.5 – 5 
MHz frequencies, at a peak negative pressure of ~ 0.5 MPa. The signal scattered by the 
MB sample was then measured by the hydrophone. These results were processed and 
averaged using MatLab, outputting US scatter intensity across transducer frequency. 
Typically during these experiment, a MB sample with a stock concentration of at least 
108 MBs/ml was desired. This would allow small volumes of the stock MB solution to 
Wave	
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be added to the 100 ml chamber, and a single measurement to be acquired at one 
defined frequency. The chamber would then be emptied, refilled, and MBs added again 
for measurement at the next frequency. This allowed for at least 10 separate 
measurements, including repeats. During this thesis project, OLI-MB samples were 
only ever collected at low concentrations and volumes (106 OLI-MBs/ml, 1 ml total). 
Therefore during OLI-MB measurements, the 10 ml chamber was used, and 
immediately the entire stock OLI-MB solution was added and then measured over a 
frequency sweep with a larger number of frequency steps. 
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5. Results: Surface Energy of an OLI-MB 
 
The three results chapters that follow this one cover three separate approaches that were 
explored with the primary aim of producing OLI-MBs to a medically relevant size and 
concentration, with a high degree of control and repeatability. However, the possibility 
for each route to even begin to produce OLI-MBs that were stable enough to be useful 
hinged on one very crucial question; ‘Is an OLI-MB structure energetically favourable?’ 
This chapter addresses that question first by presenting surface pressure data collected 
at the air-water interface of the lipids used for the formation of OLI-MB shells. This 
included using the Langmuir method to determine the surface collapse pressure, and 
techniques to obtain the surface pressure and surface concentration at the characteristic 
“Equilibrium Spreading Pressure” (ESP). Contact angle experiments were also 
performed of several oils at air-lipid/MilliQ surfaces, with the lipid concentration 
informed by the experiments described above. Results from both of these experiments 
made it possible to calculate the total surface energy of an OLI-MB structure, and 
compare it to other possible conformations of the gas, oil, lipid and aqueous phases. 
This permitted for an estimation of whether the OLI-MB structure was theoretically 
thermodynamically stable or whether it should phase separate over time to result in 
other structures. 
 
5.1. Pressure-area Isotherms and the Equilibrium Spreading 
Pressure of lipids at the air-water interface 
The studies in this section were concerned with characterising the lipid monolayers that 
were used during this thesis, towards the formation of OLI-MBs, for the surface 
pressures they provided at an air-water surface when fully compressed and when 
allowed to spread to equilibrium, ESP. 
Pressure-area isotherms of DPPC, DPPC-PEG, and POPC lipid were performed on a 
Langmuir trough system (as discussed in the Experimental Chapter 4.5.1, p 74). Lipid 
was spread from a 1 mg/ml chloroform solution and three compression/expansion 
cycles were performed at 5-10 mm/min. The first cycle was ignored (due to the lipid 
interactions needing to equilibrate before a reliable measurement can be obtained), with 
the second and third being used for analysis providing their surface pressure 
relationships were equivalent. Figure 5.1 presents compression cycles for a DPPC 
monolayer over a range of speeds. ≤ 20 mm/min the differences in results were 
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negligible. Figure 5.2a presents the pressure-area isotherms for monolayers of stearic 
acid, DPPC, DPPC-PEG, and POPC. The compression cycle of stearic acid is well 
known with well defined characteristics, so was used as a reference to confirm that the 
protocols for set-up, cleaning, and use were being sufficiently carried out. The area per 
molecule was measured by tracking a straight line down to 0 mN/m from the ‘solid’ 
phase expansion of the lipid, and was found to be 21, 53, 67 and 66 Å2/molecule for 
stearic acid, DPPC, DPPC-PEG, and POPC respectively. Literature values for stearic 
acid, DPPC and POPC were found to be 22 ± 2 (SD 3),239–241 52 ± 2 (SD 3),242–245 and 
87 ± 8 (SD 17)242,246–250 Å2/molecule respectively. Apart from POPC, which was 
experimentally found to repeatedly have the same area per molecule, and in literature 
was found to have a wide spread of values, as given by the standard deviation of the 
values recorded, the experimental results were in good agreement with literature. 
	Fig.	 5.1.	 Pressure-area	 isotherms	 of	 DPPC	 measured	 over	 a	 variety	 of	 barrier	 compression	 and	expansion	 speeds,	 showing	 the	 average	 result	 between	 the	 second	 and	 third	 compression-expansion	cycle.		
	Fig.	5.2.	Pressure-area	isotherms	for	(ai)	stearic	acid	and	phospholipids	(aii)	DPPC,	DPPC-PEG,	and	POPC,	with	measured	area	per	molecule	(dotted	lines).	(b)	Pressure-area	isotherm	of	POPC	where	the	lipid	monolayer	was	compressed	until	the	barrier	reached	collapse,	barrier	speed	5	mm/min.	
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Figure 5.2b shows the pressure-area relationship of a POPC monolayer where barrier 
compression continued past the point of the monolayer collapse. It was observed that 
the sharp decrease in surface pressure, which indicated monolayer collapse, was 
accompanied by a collapse of the air-MilliQ meniscus, in the Langmuir trough’s Teflon 
dish, over the Teflon walls. Performing this type of compression allowed the 
determination of the maximum surface pressure that the lipid monolayer could 
withstand. This was important in the wider context of this thesis when MBs shrink due 
to gas diffusion, leading to a loss of surface area and subsequently concentrating their 
lipid monolayer shell. Early experimental work (as shown in Figure 5.2b) found the 
onset of collapse to occur at 18 ± 2 (SD 3) mN/m, with the highest achievable surface 
pressure before collapse to be 22 ± 1 (SD 2) mN/m. However, later work (at higher 
compression rates of 10 mN/m) found that surface pressures of 38 mN/m could be 
achieved before the onset of collapse. Literature values for the collapse pressure of 
POPC lipid have been recorded on average as 46.5 ± 0.5 mN/m.246,249–251 The lower 
collapse pressures seen in these results, compared to literature, could have been due to 
differences in the compression speed and any additives to the subphase. Since the 
values recorded experimentally for the POPC monolayer collapse were so varied, the 
literature value was used going forward with this project. The maximum surface 
pressure attained before collapse for both DPPC and DPPC-PEG was repeatedly 
recorded around 40 mN/m, with a spread of ~5 mN/m. Literature values for the collapse 
pressure of DPPC have been recorded as 55 ± 1 mN/m.242,245 However, since the 
experimental value was repeatable, it was used in further calculations. 
 
After the pressure-area traces and the collapse pressures had been acquired, the next 
step was to measure the ESP of the same lipid monolayers. Whereas the collapse 
pressure defines the maximum surface pressure that a lipid monolayer can withstand 
before collapse, the ESP defines the surface pressure attained when lipid monolayer 
molecules have equilibrated at a surface, only being driven by the surface tension, 
which will drive the further accumulation of lipid molecules, and their interaction with 
each other, which will inhibit further accumulation after a certain concentration. 
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	Fig.	5.3.	Equilibrium	spreading	pressure	experiments	where	lipid	was	added	drop-wise	to	the	air-MilliQ	surface.	Surface	pressure	over	time	as	droplets	of	(ai-iii)	DPPC	or	(aiv)	DPPC-PEG	in	(i	and	iv)	chloroform,	(ii)	hexane	or	(iii)	hexadecane	were	added	to	a	air-MilliQ	surface,	allowing	time	for	the	 surface	 pressure	 to	 plateau.	 Defined	 volumes	 of	 lipid	 solution	were	 added	 at	 time	 points	 as	shown.	Solution	concentration	was	1	mg/ml	 lipid.	 (bi-iv)	The	calculated	 (red	dots)	area	per	 lipid	molecule	at	 each	plateau	 regions	 is	 shown	on	 the	 surface	pressure-area	 isotherms	performed	on	the	same	lipid.		
 
ESP experiments were undertaken by setting the Langmuir trough area to be constant, 
then adding lipid to the surface drop-wise from a chloroform, hexane, or hexadecane 
solution, and recording the surface pressure as the number of lipid molecules on the 
surface increased (Experimental Chapter 4.5.2, p 74-75). After each droplet was 
deposited, the solvent was allowed to evaporate. As the lipid approached the ESP it 
should have reached equilibrium between spreading on the air-MilliQ interface and 
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remaining solubilised in the droplet solution, leaving a solid lipid crystal after solvent 
evaporation. Solvents with different spreading behaviours were tested. Hexane has a 
low spreading coeffienct and higher boiling point (longer evaporation time) relative to 
chloroform. Whilst Hexadecane has a negative spreading coefficient, meaning that any 
spreading would be purely from the lipid escaping the droplet (lens) formed at the air-
water interface. Figure 5.3a shows how the surface pressure changed with additions of 
lipid solution droplets and Figure 5.3b shows the relationship between the average area 
per lipid molecule and the surface pressure during these experiments compared to 
typical pressure-area isotherms of the same lipid formed during compression-expansion 
cycles. The results indicated that the relationship between the surface pressure and the 
molecular area of the lipid monolayers followed the general shape of pressure-area 
isotherms all the way to collapse. This showed that the lipids spread beyond the ESP 
and instead of forming a lipid deposit, they simply continued spreading up to the 
collapse pressure as the solvent evaporated. These observation did confirm that the 
previous measurements of molecular area were carried out correctly. 
A further ESP technique was introduced by Bois and Albon (1985) (Experimental 
Chapter 4.5.3, p 75).218 Here, they suggested that it is not possible to measure the ESP 
of DPPC from lipid crystals placed on the air-MilliQ surface below its lipid phase 
transition. They also found that the surface pressure recorded would be different 
dependant on whether the lipid monolayer had been taken through its ordered to fluid 
phase-transition temperature prior to the measurement.218 However, they introduced a 
new technique of depositing a highly concentrated lipid-chloroform solution onto a 
clean platinum plate, waiting for for solvent to evaporate, and then passing this plate 
with lipid deposit through a clean air-water surface. As the plate was slowly passed 
through the interface the surface pressure was found to steadily increase over time, 
followed by a decrease in this rate until, after ~50 min, a plateau of ~9 mN/m was 
reached.218 At this point an equilibrium had been reached between lipid molecules 
transferring onto the air-water interface and back onto the plate, with excess lipid 
passing into the water subphase or staying as a deposit on the plate. In these 
experiments, a similar technique was used, where a cleaned glass plate with lipid 
deposits was introduced to the aqueous phase (term as being ‘dipped’) and was retracted. 
This was repeated for multiple plates as shown in Figure 5.4 which shows how the 
surface pressure changed during dipping of the lipid deposits, with each dip being 
shown as a spike and following stabilisation in surface pressure. It was concluded that 
ESP had been reached when the surface pressure before and after multiple dips centred 
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around a single surface pressure value. After the surface pressure at ESP had been found, 
a typical pressure-area isotherm was performed on the ESP monolayer in respect to the 
total trough area. This was done to acquire the lipid per surface area concentration at 
ESP by comparing the trough area when the monolayer was in its ‘solid’ phase, to the 
known area per molecule from previous pressure-area isotherms. The surface pressure 
and lipid concentration at ESP were expected to intersect with previous pressure-area 
isotherms of the same lipid. This would aid in understanding the morphology of the 
monolayer at ESP. Intersections like this were found to occur for stearic acid and one of 
the two repeats for both DPPC and DPPC-PEG monolayers. Table 5.1 presents the 
results found including the surface pressure, lipid concentration, and monolayer 
morphology at ESP. For DPPC the surface pressure at ESP was found to be negligibly 
different over two separate runs, however the concentration at ESP was significantly 
different (57.2 and 71.1 Å), whereas for DPPC-PEG the lipid concentration at ESP was 
found to be negligibly different over two separate runs with the surface pressure being 
recorded as significantly different (7.0 and 10.1 mN/m). The more reliable value, 
recorded in Table 5.1, was determined by noting the alignment of the ESP surface 
pressure and concentration intersection with the pressure-area isotherms for the same 
lipid. A combination of the data from the DPPC and DPPC-PEG monolayers (which 
only differed by 5 mol% of lipid) suggests that the ESP for DPPC and DPPC-PEG 
occurred at the transition from the liquid expanded to liquid condensed phases, but that, 
due to the inconsistencies between recordings, the technique used might not always lead 
to a uniform monolayer.  
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	Fig.	5.4.	EPS	experiments	where	lipid	was	added	to	air-MilliQ	surfaces	from	concentrated	deposits	on	glass.	(a)	Surface	pressure	over	time	as	glass	plates	coated	with	(i)	stearic	acid,	(ii)	DPPC,	or	(iii)	DPPC-PEG	were	‘dipped’	through	air-MilliQ	interfaces	and	then	removed,	observed	as	spikes	in	the	surface	pressure.	(Blue	dotted	line)	The	ESP	found	is	shown.	(bi-iii)	The	(red	line)	surface	pressure	at	ESP	and	(blue	line)	lipid	concentration	at	ESP	overlaid	onto	pressure-area	isotherms	of	each	lipid.	
 Tab.	5.1.	Results	 from	 the	EPS	experiments	where	 lipid	was	added	 to	 the	air-MilliQ	 surface	 from	concentrated	deposits	on	glass.	
		
A mg/m2 concentration is noted at ESP in Table 5.1. This determines the lipid content 
that would be expected on a gas-water MB surface on formation – before concentration 
due to shrinkage. 	
5.2. Surface Energy of oil, air, MilliQ/lipid structures 
This section outlines studies of the contact angle of oil droplets to air-lipid/water 
surfaces, at the collapse and ESP pressures as determined by the results of the previous 
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Lipid ESP	[mN/m]
ESP	concentration	
[mg/m2]
ESP	area	per	
molecule	[Å2]
Monolayer	morphology
Stearic	acid 2.5 1.8 26.2 Gaseous-Liquid	transition
DPPC 8.0	±	0.1 1.7 71.1 Liquid	expanded-compressed	transition
DPPC+PEG 10.1 1.5	±	0.02 92.3	±	1 Liquid	expanded-compressed	transition
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section, in order to measure the oil-lipid/water surface tension and further calculate and 
compare the surface energies of gas, oil, and lipid/water constructs (Experimental 
Chapter 4.6, p 76-78). A lipid monolayer was formed on an air-MilliQ meniscus, in a 
Teflon dish, at either the ESP or close to the collapse pressure. The former could be 
achieved by the ESP concentrations as determined in the previous section, and the latter 
by adding enough lipid until just before the meniscus collapsed onto the Teflon dish 
walls. Using a contact angle system, oil (of the types that in Chapter 6.1 were used for 
LOND formation) was delivered on to the monolayer, from the air side, to simulate an 
air-oil-lipid/MilliQ interface without the need to consider the oil’s entering coefficient, 
ER (see Theory 3.3.1, p 50-51). Contact angle measurements were performed on the oil, 
thereby allowing calculations of the oil-lipid/MilliQ interfacial tension. 
 Fig.	 5.5.	 Contact	 angle	 images	 of	 (ai-vi)	 squalane	 and	 (bi-iv)	 tripropionin	 oil	 on	 air-lipid/MilliQ	interfaces,	 introduced	 from	 the	 air	 side.	 The	 lipid	 monolayer	 type	 and	 surface	 pressure	conformations	(collapse	or	ESP)	are	given.	(c)	A	schematic	is	given	(this	is	a	repeat	of	Figure	4.14),	which	should	be	compared	to	image	avi,	to	show	how	contact	angles	were	measured.		Tab.	5.2.	Average	contact	angles	recorded	from	the	experiments	depicted	in	Figure	4.13	of	squalane	and	tripropionin	oils	on	air-lipid/MilliQ	interfaces,	introduced	from	the	air	side.	
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POPC	(collapse)	
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Air	
Lipid	
Oil	 θo*w	
γoa	
γo*w	
γw*a	θoa	
(c)	
No	monolayer 25.0 ± 0.4
POPC	(collapse) 5.9 ± 0.3 14.5 ± 0.3
DPPC	(ESP) 16.9 ± 0.9
DPPC	(collapse) 13.8 ± 0.7 20.6 ± 0.4
DPPC+PEG	(ESP) 20.8 ± 1.4
DPPC+PEG	(collapse) 28.4 ± 0.6
0.0
Monolayer	type	
(surface	pressure)
Contact	angle	[°]
Squalane Tripropionin
0.0
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Figure 4.13 shows example images for squalane and tripropionin oils at the air-
lipid/MilliQ interfaces, and Table 5.2 shows the resulting average contact angles. For all 
oil/lipid conditions, the average difference between contact angle measurement of the 
left and right side of the droplets was 1.1°, which was considered negligible. Assuming 
that all of the lipids remained in contact with the MilliQ interface (the only hydrophilic 
phase for the hydrophilic side of the lipid amphiphiles to contact to), it was expected 
that as the concentration of lipid in the monolayer was increased, more hydrophobic 
tails would be presented to the air and oil phases, causing the oil to spread further, 
decreasing the contact angle. While this was true for squalane oil on DPPC and POPC 
monolayers, DPPC-PEG monolayers gave a lower contact angle at ESP, but followed it 
with an even greater contact angle at collapse. The hydrophilic PEG chain will have 
protruded directly into the MilliQ phase, so not contact the oil. Therefore this result was 
surprising since the only difference between the DPPC and DPPC-PEG monolayers in 
the monolayer portion itself was 5 mol% of DSPE. DPPC and DSPE lipid tail only 
differ by the addition of two C-C bonds to each of the two tails. Tripropionin on the 
other hand appeared to form a lens when the monolayers were highly concentrated at 
collapse and spread when the monolayers were at ESP or on the clean MilliQ surface. 
Tripropionin is a polar oil and is soluble in water at 3.07 mg/ml, at 37 °C.96 What might 
have been observed here is that the ER for tripropionin across the monolayer and into 
the MilliQ being achieved. A more accurate way to have performed this experiment 
would have been to pre-saturate the MilliQ with tripropionin oil. 
Table 5.3 gives the acquired surface tensions for the air-lipid/MilliQ and air-oil 
interfaces as well as the calculated interfacial tension for the oil-lipid/MilliQ interfaces 
for both squalane and tripropionin oils. It also gives the calculated spreading 
coefficients, S, of the oil between the air and lipid/MilliQ phases. The surface and 
interfacial tensions are also presented in Figure 5.6. 
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Tab.	 5.3.	 Surface	 and	 interfacial	 tensions	 for	 air,	 squalane	 and	 tripropionin	 oils,	 and	 lipid/MilliQ	phases	 in	 different	 combination,	 calculated	 using	 the	 contact	 angles	 shown	 in	 Table	 5.2,	 and	 the	spreading	coefficient	for	the	oils	between	the	air	and	lipid/MilliQ	phases	(SWOA).	Surface	tensions	of	air-lipid/water	surfaces	calculated	from	surface	pressure	values	given	in	section	5.1,	Table	5.1	and	references	(246,249–251).	
		
	Fig.	 5.6.	 Surface	 and	 interfacial	 tensions	 for	 the	 different	 interfaces,	 and	 (a)	 squalane	 or	 (b)	tripropionin	oil,	using	defined	lipid	monolayers.		
The spreading coefficient for squalane oil between the air and water phases (SAOW) was 
less than zero for all air, oil, water systems. This indicated that squalane oil (O) was 
expected to either partially spread or not spread at all between the air (A) and MilliQ 
(W) phases. However, SAWO and SWAO (not shown) were calculated to be even more 
negative. This indicated that it would be even less energetically favourable for MilliQ to 
spread between oil and air and for air to spread between oil and MilliQ. This all 
suggests that whilst it would be unlikely for an OLI-MB to form spontaneously, after 
formation a squalane OLI-MB would be expected to remain stable. However, it should 
be noted that this also means that any other surface stabilised between two of the three 
phases would also be expected to remain stable, for example separate non-oil-MBs and 
oil droplets. 
Surface	
tension	
(air-oil)	
[mN/m]
Interfacial	
tension	(oil-
lipid/water)	
[mN/m]
Spreading	
coefficient	
[mN/m]
Surface	
tension	
(air-oil)	
[mN/m]
Interfacial	
tension	(oil-
lipid/water)	
[mN/m]
Spreading	
coefficient	
[mN/m]
No	monolayer 72.8 28.0	±	3.0 52.3	±	5.7 -7.5 35.9	±	3.0 36.9	±	3.0 ≥	0.0
POPC	(collapse) 26.3	±	0.5 28.0	±	3.0 	-1.6	±	3.1	 -0.1 35.9	±	3.0 	-8.7	±	2.9	 -0.9
DPPC	(ESP) 64.8	±	0.2 28.0	±	3.0 39.7	±	8.2 -2.9 35.9	±	3.0 28.9	±	3.0 ≥	0.0
DPPC	(collapse) 32.8 28.0	±	3.0 5.8	±	5.4 -1.0 35.9	±	3.0 	-0.85	±	2.8	 -2.2
DPPC+PEG	(ESP) 64.2	±	2.1 28.0	±	3.0 40.7	±	14.5 -4.5
DPPC+PEG	(collapse) 32.8 28.0	±	3.0 9.3	±	8.2 -4.5
Squalane Tripropionin
Monolayer	type	
(surface	pressure)
Surface	
tension	(air-
lipid/water)	
[mN/m]
(a)	 (b)	
Air-water	
Air-lipid/water	
Air-oil	
Oil-lipid/water	
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Tripropionin oil on the other hand showed that SWOA ≥ 0 at low monolayer concentration 
and that SOWA > 0 at high monolayer concentration. The other S possibilities were found 
to be negative. This suggested that the oil was expected to spread between the air and 
MilliQ, allowing for the formation of an OLI-MB. 
For both squalane and tripropionin, negative interfacial tensions were calculated at high 
monolayer concentrations. This may suggest that a portion of both oils were solubilising 
into the MilliQ phase. As expected, for both oils, the more concentrated the lipid the 
lower the surface tension of all interfaces except for the oil-air interface which was 
assumed to be free of lipids and therefore constant. 
 
Using the interfacial tensions presented in Table 5.3, it was possible to calculate the 
total surface energy for an OLI-MB, over a range of oil layer thicknesses, based on the 
surface area present from each interface. The OLI-MB total surface energy was 
compared to that of other possible configurations of the oil, lipid, air, and water, at 
equal volumes of each fluid phase between the different conformations. This was done 
in order to calculate the most energetically favourable stucture for given volumes of 
each phase and with a given lipid monolayer type. Figure 5.7 shows how the total 
surface energies compared for a 2 µm OLI-MB, over a range of oil layer thicknesses 
(presented as an oil volume% of the constant total OLI-MB volume), a separate oil 
droplet and non-oil-MB, and an inverted OLI-MB of oil-in-air-in-water, with 
schematics of each configuration. The configurations are compared for squalane and 
tripropionin oils, over all of the monolayer types tested, and at equal oil and gas 
volumes between the configurations. Figure 5.8 shows how these values compared for 
each conformation equivalent to an OLI-MB with a 50 nm thick oil layer. Formation of 
OLI-MBs with this range of diameter and oil layer thickness was one of the goals of this 
thesis project. 
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	Fig.	5.7.	Total	surface	energy	(red)	of	a	2	μm	OLI-MB	over	a	range	of	oil	layer	thickness	(defined	as	oil	vol%	of	the	total	OLI-MB	volume),	using	(ai-vi)	squalane	or	(bi-iv)	tripropionin	oil,	(i)	without	a	shell	or	with	a	lipid	monolayer	of	(ii)	POPC,	(iii	and	iv)	DPPC,	or	(v	and	vi)	DPPC-PEG,	at	(ii,	iv,	and	vi)	 the	 collapse	 pressure	 or	 (iii	 and	 v)	 ESP.	 Comparative	 total	 surface	 energies	 of	 other	 possible	configurations	of	air,	oil,	lipid,	and	water	are	given	as	(black)	a	separate	non-oil-MB	and	oil	droplet,	and	(blue)	an	oil-in-air-in-water	structure,	for	equal	volumes	of	the	oil	and	gas	phases.	Schematics	are	 given	 of	 the	 (ci)	 non-oil-MB	 and	 oil	 droplet,	 (cii)	 OLI-MB,	 and	 (ciii)	 oil-in-air-in-water	configurations.	
	Fig.	 5.8.	 Total	 surface	 energy	 of	 (red)	 a	 2	 μm	OLI-MB	with	 a	 (a)	 squalane	 or	 (b)	 tripropionin	 oil	layer	thickness	of	50	nm,	for	a	range	of	lipid	monolayer	types.	Comparative	total	surface	energies	of	other	possible	conformation	of	air,	oil,	 lipid,	and	water	are	given	as	(black)	a	separate	non-oil-MB	and	droplet,	and	(blue)	an	oil-in-air-in-water	structure.	
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In general, Figure 5.7 shows that an oil-in-air-in-water structure (Figures 5.7ciii) is not 
energetically favourable for any of the monolayer types considered, with the energy 
difference compared to the other conformations being greater at higher oil content. 
Figure 5.8 shows that this energy difference becomes far smaller when considering the 
small oil content that would be present in an OLI-MB with a 50 nm thick oil layer. 
Whilst even at this low oil content, the oil-in-air-in-water conformation was still the 
least energetically favourable state, this could suggest that structures resembling MBs 
with small core oil droplets could be formed and remain stable, potentially even 
changing over time to MBs with a small oil lense. Meanwhile, the OLI-MB (Figures 
5.7cii) and separate non-oil-MB and oil droplet (Figures 5.7ci) conformations have very 
similar energies, with the OLI-MB being more favourable without lipid or when the 
monolayer is at ESP, and the separate non-oil-MB and droplet being more favourable at 
when the lipid monolayer is compressed up to the collapse pressure. At low oil content 
(<15 vol%) the energy of all three conformations converge, and at very low oil content 
(<5 vol%) Figure 5.7 would suggest that the OLI-MB can become the least 
energetically favourable structure. However the equations used here (see Experimental 
4.6, Equation 4.11) defines two interfaces for both the OLI-MB and air-in-oil-in-water 
structures even at the extremes of 0 or 100 vol% oil, where the oil or gas component 
respectively should be considered infinitely small. In the oil vol% extremes, this gives 
these two structures an equivalent surface area twice, and since γA-L/W ≠ γA-O + γO-L/W 
and ≠ γO-A + γA-L/W the total surface energies calculated will be incorrect at these vol% 
extremes. In reality, if the oil content was 0 vol%, all three configurations would result 
in a single non-oil-MB, so would have identical total surface energy. The same can be 
said at 100 vol% oil, with all configurations resulting in a single oil droplet. 
During introduction of the gas, oil, and water/lipid phases, the gas-oil and gas-water 
interfaces would be expected to either be bare of lipids, due to the lipids requiring time 
to self-assemble at the interfaces from the water phase, or contain a monolayer of lipids 
up to the ESP concentration. Over this monolayer range, the OLI-MB configuration was 
seen to be the most energetically favourable structure. As such, on introduction of the 
phases, the OLI-MB configuration would be the most likely and stable structure to be 
formed. However, as the recorded energies for the three configurations were all within 
the same range, and in most cases within error of one another, the results also suggests 
that the other two configurations could be formed along with OLI-MBs if production 
was not controlled. 
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Over time, lipid monolayer non-oil-MBs are observed to shrink, due to gas diffusion, 
until a point at which the rate of shrinking suddenly slows. It is thought that this is due 
to the lipid shell compressing up to the collapse pressure.180 Any OLI-MBs successfully 
formed were expected to go through a similar process. Figure 5.9 shows a schematic of 
an OLI-MB immediately after formation, followed by this shrinkage and monolayer 
concentration. It also shows a potential scenario under which the gas core and oil 
portion could phase separate. As an OLI-MB shrinks and the monolayer is compressed, 
the above results suggest that the structure could either remain stable or phase separate 
into a separate oil droplet and non-oil-MB. 
	Fig.	5.9.	Schematic	of	an	OLI-MB	immediately	after	formation	with	an	oil-lipid/water	monolayer	at	ESP,	 followed	 by	 (a)	 gas	 core	 shrinkage	 and	 concentration	 of	 the	 monolayer	 to	 the	 collapse	pressure.	 This	 is	 then	 followed	 by	 a	 potential	 scenario	 for	 separation	 of	 the	 (grey)	 gas	 core	 and	(orange)	oil	portion,	whereby	(b)	the	gas	core	rearranges	to	the	OLI-MB	wall,	then	(c)	ejects	itself	from	 the	 oil	 droplet,	 acquiring	 part	 of	 the	 (red)	 lipid	monolayer.	 The	 gas	 would	 be	 required	 to	shrink	further	to	accommodate	for	the	increase	in	total	surface	area	per	lipid	molecule.	
 
5.3. Mechanical agitation of gas, oil and lipid solution  
In respect to the findings in this chapter, it was expected that if gas, oil, and lipid 
solution phases were mixed chaotically, without control over how the phases were 
introduced to one another, separate non-oil-MBs, oil droplets, and OLI-MBs would all 
be formed. This hypothesis was tested using mechanically agitation in a similar 
technique to that used to typically form mechanically agitated non-oil-MBs (see 
Experimental Chapter 4.4, p 75). These are typically 1-5 µm, with a small portion >8 
µm.43,211–216 1 ml of 1 mg/ml DPPC-PEG lipid solution was prepared in a 1.75 ml glass 
vial, either 5 or 50 µl of squalane oil, loaded with Nile red for fluorescent identification, 
was added to this. C4F10 gas was bubbled through the solution and allowed to fill the 
vial headspace. The vial was then mechanically agitated for 45 s. A ~50 µl sample of 
the resulting solution was pipetted, from the middle of the solution, onto a clean glass 
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slide. Since water was the densest phase in the solution, the sample’s curved meniscus 
allowed for concentration of any structures that had been formed into the centre and top 
of the sample. Figure 5.10 shows examples of the resulting structures seen in the sample. 
	Fig.	5.10.	Observations	of	the	structures	formed	from	the	mechanical	agitation	of	C4F10	gas	and	(a)	5	μl	or	(b	and	c	-	different	samples)	50	μl	squalane	oil,	 in	1	ml	of	1	mg/ml	DPPC-PEG	lipid	solution.	Sample	pipetted	onto	glass	to	concentrate	buoyant	particle	via	sample	meniscus.	(i)	Brightfield	and	(ii)	fluorescence	of	Nile	red	solubilised	in	the	squalane	is	shown,	imaged	from	the	same	focal	area.	Example	 significant	 structures	 are	 labeled;	 (yellow	arrow)	non-fluorescent	 gas	 cores	 surrounded	by	 fluorescent	 oil	 rings,	 believed	 to	 be	 larger	 (>	 8	 μm)	 versions	 of	 the	OLI-MB	 structure,	 (green	arrow)	fully	fluorescecnt	oil	droplets,	and	(blue	arrow)	non-fluorescent	non-oil-MBs,	often	showing	reflection	of	fluorescence	from	neighbouring	structures.	
(ai)	 (aii)	
(bi)	 (bii)	
(ci)	 (cii)	
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The images in Figure 5.10 were taken of selective areas where OLI-MB like structures 
were found, after concentrating the sample by use of the sample’s meniscus. As such 
any OLI-MBs would be at a higher concentration than representative of the bulk sample. 
Even so, from a qualitative perspective, for the 50 µl squalane samples (Figures 5.10b-
c), OLI-MBs were very sparse, and were vastly outnumbered by non-oil-MBs and oil 
droplets. The OLI-MBs that were formed were all larger than medically useful (> 8 µm), 
at 30-70 µm, with high polydispersity and no uniformity in oil layer thickness between 
OLI-MBs. Dropping the oil content to the 5 µl squalane samples (Figure 5.10a) showed 
no OLI-MB structures, leaving only non-oil-MBs and oil droplets of 10-20 µm. All 
samples included a high concentration of 1-5 µm structures, however observation with a 
x60 lens showed that these were either fully fluorescent or held no fluorescence, 
indicating pure oil droplets or pure non-oil-MBs respectively. 
These results agreed with the calculated total surface energy results, which suggested 
that any self-assembly of the phases from an uncontrolled mixing, like with mechanical 
agitation, would result in a very mixed sample of OLI-MBs, non-oil-MBs and oil 
droplets. Though OLI-MBs were observed at even lower concentration than was 
expected. 
 
5.4. Conclusion 
This chapter dealt with the issue of whether the formation of the OLI-MB structure 
would be energetically favourable. It addressed OLI-MB formation and stability. 
Spreading coefficient calculations suggested that the probability for the spontaneous 
formation of squalane OLI-MBs would be low, but emphasised further that no matter 
the lipid monolayer concentration, after formation, OLI-MBs would be very stable. On 
the other hand spreading coefficient calculations for tripropionin oil suggested that OLI-
MBs would spontaneously form when the lipid monolayer was at a low coverage. 
However, upon lipid concentration increasing, for example from the MB core shrinking 
due to diffusion, the oil and gas components could spontaneously separate. Surface 
energy calculations for both oils showed that the energetic favourability of OLI-MBs 
was similar to that of separate oil droplets and non-oil-MBs, meaning that both 
configurations would be expected to form spontaneously. At low lipid coverage, the 
OLI-MB structure showed more energetic favourability, whilst at high lipid coverage, 
the separate oil droplet and non-oil-MBs showed more energetic favourability. This led 
to the expectation for the formation of OLI-MBs, but with the potential for phase 
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separation after surface stabilisation. Due to being less energetically favourable than the 
other configurations, oil-in-gas-in-MilliQ structures were not expected to be produced 
spontaneously or be stable. 
Chaotic mechanical agitation of the gas, oil, and lipid/water phases confirmed what the 
energetic calculations had suggested. Many oil droplets and non-oil-MBs were observed, 
whilst few OLI-MBs had been stabilised. Further, little control was shown over size or 
oil layer thickness between OLI-MBs. 
Together, the spreading coefficient and surface energy calculations, and mechanical 
agitation results all appear to direct to one particular conclusion. That the formation of 
OLI-MBs would be possible, and that they could be stable after formation, but that only 
with direct control over how the phases were allowed to meet could a sample be 
produced at a high concentration, with control over the average OLI-MB size, 
uniformity of the oil layer thickness between OLI-MBs, and a lack of pure oil droplets 
and non-oil-MBs. 
The three results chapters that follow all looked at this issue of gaining control over 
OLI-MB formation in different ways: (Chapter 6, p 130-179) Compartmentalising the 
oil phase into lipid stabilised oil nanodroplets in order to control the amount of oil 
meeting the gas surface and the position of the lipids. (Chapters 6 and 7, p 130-204) 
Microfluidics to reduce chaotic turbulence and push the system into controlled laminar 
flow between each phase as they were introduced to one another. (Chapter 8, p 205-
244) Forming defined double emulsion OLI-MB precursors that could be activated from 
liquid PFC-in-oil structures, in to gas PFC-in-oil structures.  
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6. Results: Lipid Oil Nanodroplet (LOND) 
adsorption and spreading to form a thin oil 
film 
 
In chapter 5 it was established that, due to energetic favourability, the ability to form the 
OLI-MB structure would be expected, but that its production would require high levels 
of control over how the phases were introduced (see Chapter 5.4). This chapter 
addresses that finding first by compartmentalising the oil phase into nanodroplets 
stabilised with a lipid monolayer shell, giving lipid oil nanodroplets (LONDs). 
Assembly of LONDs brought defined volumes of oil to the gas surfaces thereby 
limiting the oil layer thickness of OLI-MBs. For the formation of the thin oil film, the 
LONDs were required to rupture and spread from the stable nanodroplet emulsion. Due 
to the LOND’s stability against self-coalescence without the presence of a gas surface, 
this prevented the eventual OLI-MB samples from the inclusion of large oil droplets.  
Results in this chapter relate to LOND characterisation (size, concentration, and 
lifetime), their interaction with functionalised glass surfaces. Using a Langmuir-
Blodgett trough (LB) system and Quartz Crystal Microbalance with Dissipation 
monitoring (QCM-D), interactions between model MB surfaces and LONDs were 
monitored through changes to the surface pressure and changes to the crystal’s 
oscillations respectively. The thickness of the oil layer that would be provided by 
LONDs rupturing at the water-gas interface was then estimated from the QCM-D 
results. MBs were then formed from LOND solutions, both off- and on-chip, and 
fluorescence and Fluorescence Resonance Energy Transfer (FRET) assessments were 
made on the presence of oil portions at the MB surface, if the LONDs had remained 
stable at the surface or formed an oil shell, and the stability of the formed OLI-MBs. 
OLI-MB formation via microfluidics provided further control over how the phases were 
introduced to each other, allowing the formation of OLI-MBs to occur within clinically 
relevant sizes and size distributions. Finally, the OLI-MBs were put through initial tests 
of their ultrasound (US) properties. 
 
6.1. Size, concentration and lifetime of LONDs 
The protocol used for LOND formation by high-pressure homogenisation had 
previously been optimised by Mico et al. (2017).6 LOND solution formation by tip 
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sonication was used more readily during this project due to the 10x lower material 
volume and ability for parallel production of multiple formations allowing for more 
rapid testing of fluorescence loading, and use of the entire LOND solution with less 
concern of fluorescent or oil molecule degradation. This was especially true for the later 
FRET work and any work with squalene oil, which is prone to oxidation. LOND 
preparation time by tip sonication was optimised by measuring sample size and 
concentration after different sonication times using DLS and qNano. 
 
	Fig.	 6.1.	 Recordings	 of	 LOND	 diameter	 and	 concentration	 for	 a	 single	 batch	 of	 tip	 sonicated	squalane,	 POPC-PEG+Atto488	 LONDs,	 where	 samples	 were	 taken	 after	 different	 tip	 sonication	times	as	noted.	DLS	recordings	of	(a)	intensity	counts	over	particle	diameter	and	(b)	Z-average	over	tip	 sonication	 time.	 (c)	 qNano	 recordings	 of	 particles/ml	 concentration	 over	 particle	 diameter	using	a	200	nm	pore.		
Figure 6.1 shows how the diameter and concentration of POPC-PEG+Atto488 squalane 
LONDs evolved during tip sonication. As the total tip sonication time increased, the 
monodispersity and concentration both increased up to a time point of ~3 min, after 
which further tip sonication lead to negligible changes in the LOND population. Sizing 
data obtained by qNano (Figure 6.1c) was recorded using the 200nm pore, meaning that 
only particles in this size range would be detected. As expected, the peak concentration 
of 200-300 nm LONDs was relatively low at early time points, and reached a maximum 
at 5 min after which it remained unchanged up to the 30 min tested. 15 min was decided 
on as a total tip sonication time valid for all LOND species (shells, oils, and 
encapsulated fluorophore), as at least for the LOND type tested in Figure 6.1 this was 
significantly into excess time to give the final LOND population size and concentration. 
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  Fig.	6.2.	Examples	of	size	and	concentration	data	 from	multiple	LOND	types	prepared	during	 this	project.	(a)	DLS	data	collected	from	multiple	squalane	LOND	solution	stocks,	 indicating	shell	 type	and	encapsulated	 species	 (if	 any).	 (b)	Comparative	 (orange)	DLS	peak	 size	 and	 (blue)	NanoSight	total	 concentration	 from	15	 squalane	 LOND	 samples.	Here,	 all	measurements	 collected	 from	any	LOND	 samples	 that	 included	 the	 defined	 LOND	 component	 were	 averaged	 to	 identify	 which	components	were	significant	to	the	formation	process.	Typical	results	from	(c)	DLS	intensity	count	and	NanoSight	concentration	(red	indicates	the	error),	both	as	a	function	of	LOND	diameter,	for	(ci)	squalane,	 (cii)	 squalene,	 and	 (ciii)	 tripropionin	 LONDs	with	 POPC	 shells,	 loaded	with	 DiI.	 Errors	calculated	from	multiple	measurements	over	multiple	batches.	
 
Figure 6.2 shows comparative recordings of LOND size and concentration for a range 
of different LOND components including, (a and b) lipid shell and encapsulated species 
for squalane LONDs, and (c) oil types for POPC LONDs encapsulating DiI. For the 
squalane LONDs, the degree of random spread from the encapsulated species 
component suggested that any correlations observed for the other components were not 
significant enough to be reliable as a defining factor of final LOND size. All squalane 
samples gave peak diameters spanning 140-190 nm and 1-6 x 1013 LONDs/ml. The size 
ranges recorded in the three different LOND oil core examples given were typical of all 
LONDs with those specified oil cores (Figure 6.2c), though the peak concentration 
often varied between 1-10 x 1011 LONDs/ml for the same LOND type. Squalane 
(Figure 6.2ci) and squalene (Figure 6.2cii) POPC LONDs showed equivalent size 
results, with peak LOND diameters of ~100 nm and ~170 nm for NanoSight and DLS 
respectively. Tripropionin (Figure 6.2ciii) POPC LONDs gave peak diameters of ~170 
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nm for both measurement methods. DLS results for tripropionin LONDs showed a 
broader size distribution with a greater variation between measurements compared to 
the other LOND oils, whilst NanoSight results showed a comparable size distribution 
with similar error. This could suggest that along with the primarily tripropionin LOND 
population, a high proportion of large non-emulsified oil droplets were present, which 
could easily be overlooked by the NanoSight. 	
	Fig.	6.3.	Lifetime	of	different	LOND	samples.	Changes	to	(a)	concentration	and	(b)	size	are	shown,	measured	by	qNano,	NanoSight,	or	DLS	as	 indicated	(green	text	and	dashed	 line).	All	stock	LOND	solutions	were	squalane	oil.	The	key	 label	defines	 the	shell	 type	(all	 shells	 included	POPC,	 if	 they	were	100	mol%	POPC	this	 is	defined	by	“-”,	B	 is	short	 for	Biotin,	590	is	short	 for	ATTO	590),	any	species	 loaded	 into	 the	 oil	 core	 (oil	 cores	 without	 a	 loaded	 species	 are	 defined	 by	 “-”),	 and	 the	method	of	formation,	either	Emulsiflex	(E)	or	tip	sonication	(TS).	Errors	shown	for	diameter	are	the	FWHM	 from	 the	DLS	peak	diameter	distributions	 (for	an	example	of	peak	diameter	distributions	see	Figure	6.2).		
Figure 6.3 shows lifetime measurements performed on multiple LOND types, in terms 
of their size and concentration over time. The concentration remained on the order of 
1012 and 1013 LONDs/ml, for at least 4 months as measured by qNano and NanoSight. 
qNano	
NanoSight	
NanoSight	
All	DLS	
(a)	
(b)	
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Most samples were measured for LOND diameter over 1 or 2 months, within which the 
size remained stable. The LOND type measured over the longest period of time for size 
had a 100 mol% POPC shell, which remained stable for at least 7 months. LONDs with 
added PEG were expected to be even more stable due to added steric stabilisation. Tip 
sonicated LONDs, which were used for most of the following work, were generally 
used and replaced within one month, so were expected to be well within stable lifetime. 
 
6.2. LOND interactions with functionalised glass surfaces 
Since the goal of this chapter was to introduce LONDs to hydrophobic-hydrophilic MB 
surfaces with the intent of forming a thin oil layer, it was important to understand 
LONDs interaction with surfaces of varying hydrophobicity-hydrophilicity from their 
hydrophilic aqueous phase. Six glass surfaces were prepared and tested for contact 
angle to assess their hydrophobicity-hydrophilicity (see Experimental Chapter; for glass 
preparation 4.9.2, p 89, for assessment 4.6, p 80). LOND solution was then added to 
them as a free droplet or to fill a 50 µm chamber, for observation by eye and 
microscope respectively. 	
	Fig.	6.4.	Contact	angle	measurement	of	treated	glass	surfaces.	(a)	Example	contact	angles	of	MilliQ	on	the	most	hydrophilic	(piranha	cleaned)	and	hydrophobic	(octadecanethiol	(ODT)	SAM)	treated	glass	surfaces	that	were	prepared	for	this	work.	Example	images	shown	for	advancing	and	receding	contact	angles	from	which,	using	Equation	4.7,	the	(b)	surfaces’	contact	angles	were	calculated.	An	array	of	areas	were	tested	for	each	glass	surface	of	n	≥	3.252–254		
Figure 6.4 shows examples of the contact angles for the most hydrophilic and 
hydrophobic surfaces that were assessed, and gives the contact angles determined for 
each surface. Importantly the glass-Au-ODT treated surface was confirmed to be 
hydrophobic. Additional to the results shown in Figure 6.4b, a roughened glass surface 
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was prepared by coarse sanding, resulting in 2-4 µm wide groves, and cleaned to the 
same standard as the ‘cleaned N2’ surface. Following the results of Figure 6.4 the 
‘cleaned N2’, BSA coated, and roughened glass surfaces all showed identical results to 
the ‘Piranha cleaned’ surface, so for clarity are not shown. 	
	Fig.	6.5.	POPC	squalane	LOND	soluion	on	functionalised	glass	surfaces	(oil	loaded	with	Nile	red).	(a)	Birdseye	 camera	 phone	 images	 of	 LOND	 solution	~1	min	 after	 addition	 directly	 to	 treated	 glass	surfaces.	 (bi)	 Brightfield	 and	 (bii)	 fluorescent	 imaging	 of	 LOND	 solution	 filling	 50	 μm	 deep	chambers.	 (c)	Histograms	of	 the	droplet	 sizes	 observed	 from	 in	 the	50	μm	 chambers.	 The	 LOND	solution	used	here	was	not	filtered	immediatley	before	use.	
 
Figure 6.5 shows free droplets of POPC squalane LOND solution placed onto the 
functionalised glass surfaces (Figure 6.5a). It also shows the LOND solution-glass 
interface in similarly functionalised 50 µm deep glass chambers (Figure 6.5b), and gives 
diameter distributions of the droplets observed (Figure 6.5c). The LOND solution 
droplets remained stationary when placed on all of the surfaces apart from the glass 
surface that was used untreated, ‘fresh’, from the manufacturers. Here, after ~5 s, the 
solution moved across the glass surface. This glass surface was recorded as being 
strongly and uniformly hydrophilic. For this displacement of the primarily aqueous 
solution to occur, the surface must have become hydrophobic. One possible explanation 
is that of auto-wetting (self spreading), however, it seems more likely that the LOND 
solution’s displacement was due to a surfactant placed on the glass surface during 
manufacturing. Figure 6.6 shows a schematic explaining how the LONDs were thought 
to form a hydrophobic surface, which caused the solution displacement, and 
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fluorescence imaging of the area that the LOND solution had been displaced from. For 
the case of the latter, a highly concentrated array of ~1 µm fluorescent circle. These 
interactions could be explained by the LONDs’ oil portion rupturing on the glass 
surface without sufficient time for the LOND lipids to re-organise and stabilise at the 
new bare oil-aqueous interfaces. No other glass surface showed the same mechanics, 
indicating that this hydrophilic to hydrophobic surface transition was not due to the 
hydrophobicity-hydrophilicity of the initial glass surface, but rather some substance 
applied by the manufacturers, which was removed on any of the following applied 
surface treatments. When the same methods were performed with POPC-PEG LONDs 
no mobility was seen for any of the glass surfaces. 
 
	Fig.	6.6.	POPC	squalane	LOND	solution	on	a	 ‘fresh’	glass	surface	(oil	 loaded	with	Nile	red).	 (a)	An	image	is	shown	of	the	LOND	solution	after	displacement	over	the	glass	surfce,	with	a	(b)	schematic	explaining	 the	 hypothesis	 that	 the	 LONDs	 ruptured	 at	 the	 glass	 suface,	 forming	 a	 hydrophobic	surface.	(c)	Fluorescence	imaging	of	the	area	where	the	LOND	solution	had	been	displaced	from.	
 
Observations of the POPC LOND solution in 50 µm chambers (Figure 6.5b-c) showed a 
high concentration of 1.2 ± 0.1 (FWHM 2.3) µm droplets for both of the Piranha 
cleaned and ‘fresh’ glass surfaces, and 4.6 ± 0.2 (FWHM 4.4) µm droplets for the ODT 
functionalised glass surface. Since the former two surfaces were measured in the contact 
angle studies as hydrophilic and the latter as hydrophobic, this suggests that there was a 
driving force for coalescence on the hydrophobic surface. This was an important result 
as the same effect would be expected to occur at a freshly formed MB surface, due to its 
strong hydrophobicity, for example during MB formation, indicating the potential for 
LOND spreading and merging at the MB surface. 
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After the above experiments, the LOND solution was passed through a 200 nm filter 
and re-examined for droplet size both in the solution and at the Piranha cleaned glass 
surface. DLS measurements of the filtered nanoemulsion were shifted from a peak at 
190 nm (FWHM 165 nm) down to 178 nm (FWHM 117 nm) and Darkfield imaging of 
the filtered LOND solution in a cleaned 50 µm chamber clearly showed that all droplets 
above 0.5 µm in diameter were no longer present. The tighter LOND size distribution in 
solution and absence of coalesced droplet at the glass surface indicates that the 
coalesced droplets seen at the glass surfaces in Figure 6.5b originated from a low 
concentration of larger droplets within the LOND nanoemulsion. However, the fact that 
the hydrophobic surface induced more significant coalescence would still be expected to 
hold true with the nanoscale oil droplets. Importantly, this result also meant that any 
particle later observed above 0.5 µm, when LOND solution was used for MB formation, 
could be confirmed as not being from LOND self-coalescence. After this observation, 
all LOND solutions were filtered from this point forward. 	
Whilst this work showed that there was a potential positive relationship between the 
hydrophobicity of a hydrophobic-hydrophilic interface and the amount of POPC 
squalane oil droplet coalescence at this interface, this could only be applied to the small 
proportion of larger oil droplets present in LOND solution after formation. However, 
this work showed that filtered POPC squalane LONDs would not rupture on a cleaned 
glass surface. This was important as it meant that on the future successful formation of 
OLI-MBs from LOND solution, these samples could be injected into cleaned chambers 
with less concern for the oil portion being displaced or reacting with the glass surface 
on contact. 
 
6.3. QCM-D studies of LOND interactions with 
hydrophobic/hydrophilic surfaces 
In this section the interaction of LONDs with solid hydrophobic/hydrophilic surfaces 
was studied using Quartz crystal microbalance with Dissipation monitoring (QCM-D) 
(see Experimental Chapter 4.9.4, p 91-93).  
QCM-D sensors were treated either to have a hydrophobic (the quartz-Au surface was 
treated with an ODT SAM) or hydrophilic surface (the cleaned quartz surface was 
exposed to UV ozone) (see Experimental Chapter 4.9.2, p 89), and their contact angle 
was determined to establish their hydrophilicity-hydrophobicity (see Experimental 
Chapter 4.6, p 80). Squalane POPC or POPC-PEG LOND solution was injected and 
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then flow stopped, allowing the LONDs time to interact and for any monitored changes 
to equilibrate. Following this, PBS and MilliQ washes were used to remove excess 
LONDs and to observe changes in the frequency signal, which would indicate whether 
the adhered mass remained unchanged or was removed, the latter of which would 
indicate that the LOND attachment was non-specific. 
 
Figure 6.7 shows contact angle results for the hydrophobic QCM-D crystal. Contact 
angle results gave an average of 101.2 ± 0.8° (SD 2.8°) for the hydrophobic (n=11) 
surfaces, and were consitently below 90° (at ~10°) for the hydrophilic QCM-D. 
 
	Fig.	6.7.	Contact	angle	images	of	a	QCM-D	sensor	treated	to	have	a	hydrophobic	surface	(quartz-Au	treated	with	ODT).			
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	Fig.	6.8.	Changes	in	frequency	(green)	and	dissipation	(purple)	of	a	resonating	quartz	crystal	upon	the	 addition	 of	 (ai,	 aiii)	 Squalane	 POPC	 or	 (ai,	 aiv)	 	 POPC-PEG	 LONDs.	 Two	 different	 cases	were	studied,	 comprising	 QCM-D	 sensors	 where	 the	 surfaces	 were	 treated	 to	 be	 (ai-ii)	 hydrophilic	(quartz	treated	with	UV	ozone)	or	(aiii-iv)	hydrophobic	(quartz-Au	treated	with	ODT).	The	graphs	show	changes	 in	 frequency	and	dissipation	as	measured	by	 the	7th	overtone.	Time	points	 for	 the	start	of	washes	with	PBS	and	MilliQ	are	indicated	(blue	dotted	lines).	For	the	POPC	LONDs	on	the	hydrophobic	QCM-D,	a	(b)	zoomed	in	section	is	shown	of	the	first	40	min	where	characteristic	time	points	are	 indicated	 (black	dotted	 lines)	with	 (c)	 schematics	of	what	 is	 thought	 to	be	occuring	at	each	 time	 point.	 The	 experimental	 data	 for	 this	 Figure	 was	 collected	 in	 collaberation	 with	 Dr.	Victoria	Mico.		
Figure 6.8 shows the change in frequency (Δf) and dissipation (ΔD) of resonating 
QCM-D crystals, treated to have a hydrophobic or hydrophilic surface, on the 
introduction of squalane POPC and POPC-PEG LONDs, and further wash steps. The 
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Figure also shows schematics to explain what is thought to be occuring at characteristic 
time points on the POPC LOND, hydrophobic QCM-D crystal sample. For both LOND 
types interacting with the hydrophilicaly treated crystals, there was an initial rapid 
increase in -Δf, accompanied by a rapid increase in ΔD, indicative of the absorption of 
LONDs and the formation of a heterogeneous, non-uniform surface layer, which 
coupled strongly to the aqueous phase. After this, no further changes were observed, 
with washing showing little change to -Δf or ΔD, indicating that the adhered mass 
remained stable at the sensor, interpreted as the stable attachment of LONDs. A small 
decrease in -Δf and ΔD was observed when swapping from a wash of PBS to MilliQ 
(and visa versa). This phenomenon has been observed previously, and it is known to 
occur from the presence and then absence of free ions in the aqueous phase.255 Both -Δf 
and ΔD for the POPC-PEG LONDs was roughly double that of the POPC LONDs. This 
indicated that roughly double the POPC-PEG LOND mass had adhered. The additional 
mass could also have been due to entanglement between PEG chains, causing multiple 
layers of PEG shelled LONDs to adhere. However, in that case, -Δf would be expected 
to continue increasing over time with the entanglement of further LONDs and addition 
of their mass. POPC-PEG LONDs interacting with the hydrophobic surface showed a 
similar mechanism. Here, -Δf and ΔD were roughly 1/6 that of the POPC-PEG LONDs 
on the hydrophilic surface, with the two measurements approaching this value over 4 h, 
again indicating intact adherence. In contrast, introduction of the POPC LONDs to the 
hydrophobic surface showed a significant and important difference to the other surface-
LOND combinations. The initial rapid increase in -Δf and ΔD was observed again, here 
with 3 times the -Δf of the POPC-PEG LONDs on the hydrophobic surface. But over 
the following ~10 min Δf decreased and reached a plateau. Simultaneously, the ΔD 
decreased to a stable value of ~15 x 10-6. This behaviour is similar to that of bilayer 
formation via vesicle adsorption and rupture on hydrophilic surfaces.256–258 A similar 
two-stage mechanism is proposed to explain these observations. The attachment of 
LONDs (possibly partial wetting of the surface) (Figure 6.8ci-ii) followed by the slower 
spreading of droplets on the surface (Figure 6.8ciii-iv), leading to the detachment of 
entrapped water and possibly some oil. At the onset of washing the chambers, LONDs 
remaining in the dead space were introduced to the surface, leading to a smaller increase 
of -Δf and ΔD, followed by the PBS wash, which resulted in the signal recovering to the 
“before wash” level and further remaining stable. Further washes showed small changes 
due to ioninc differences between solutions.  
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	Fig.	 6.9.	 (ai-ci)	 Effect	 on	 Δf	 and	 ΔD	 from	 three	 POPC	 squalane	 LOND	 samples	 being	 added	 to	hydrophobic	QCM-D	 crystals.	 The	 graphs	 show	 the	5th,	 7th,	 and	9th	 overtones	with	 overlaid	Voigt	viscoelastic	modelling	curves.	Modelling	parameters	were	set	to;	fluid	density	=	850	-	1100	kg/m3,	viscosity	 =	 0.9	 -	 1.5	 kg/ms,	 oil-lipid	 layer	 density	 =	 700	 -	 900	 kg/m3,	 viscosity	 =	 21	 -	 41	 kg/ms,	shear	=	100	–	1012	Pa,	thickness	=	10-10	–	10-5	m.	(aii-cii)	Oil-lipid	layer	thickness	calculated	by	the	Voigt	modelling	(black),	from	the	corresponding	graph	directly	above,	and	the	Sauerbrey	equation	(red),	showing	semi-transparent	boxes	to	indicate	the	thickness.	
 
Figure 6.9 shows QCM-D data fitting to both the Voigt viscoelastic modelling and the 
Sauerbrey equation to estimate the thickness of the resulting oil layer upon POPC 
LONDs interaction with ODT-coated sensors. Results using the Sauerbrey equation 
were consistent between all samples recorded, giving an oil-lipid layer thickness of 11.7 
± 0.2 nm (SD 0.3 nm). On the other hand the Voigt viscoelastic modelling gave far 
more varied results between samples, which often did not appear sensible in relation to 
the Δf they were calculated from (see Figures 6.9ai-ii). Here, the oil-lipid layer 
thickness was given as 20 ± 6 nm (SD 10 nm). Taking all measurements into 
consideration, the oil-lipid layer was estimated as 16 ± 3 nm (SD 8 nm). 
 
It is important to remember that the aim of these experiments was to infer what might 
occur between LONDs and the surface of a newly formed, uncoated MB, where a 
hydrophobic gas surface would be presented in place of the solid surface. Therefore, all 
of the results shown in this section served to show that lipid stabilised oil droplets 
would adsorb and rupture, and also provide an estimation of the oil layer thickness, 
which was of the order of 10 s of nm. 
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6.4. Surface pressure changes to model MB surfaces on the 
addition of LONDs 
This section investigated surface pressure changes to a model MB’s aqueous-gas 
interface upon interaction with LONDs. This was to help understand what conditions 
would allow LONDs to enter the aqueous-gas interface to aid the formation of a thin oil 
layer. The following work was performed on a LB system where LONDs were 
introduced from a PBS subphase. 
Initially LONDs were introduced to a fully compressed lipid monolayer surface. Then 
the surface pressure was monitored as the monolayer was expanded and re-compressed. 
The aim here was to observe at what surface pressure (and thereby what surfactant 
concentration) the LONDs would enter the air-lipid/water interface. The second section 
of the work introduced LONDs to static semi-compressed lipid monolayer surfaces. The 
aim here was to observe the time dependence of LOND adsorption. 
 
6.4.1. LOND interactions at a water/lipid-air interface 
 Fig.	6.10.	Schematic	of	how	an	oil	droplet	can	enter	a	fully	compressed	monolayer	due	an	expansion	of	that	monolayer,	showing	(a)	an	oil	droplet	directly	underneath	a	compressed	monolayer,	(b)	the	monolayer	being	expanded,	 and	 (c)	 the	oil	droplet	 entering,	 resulting	 in	either	 (ci)	 an	oil	 lens	or	(cii)	oil	layer.		
Hotrum et al. (2002 and 2003) discussed how when fat or oil emulsion droplets come to 
an aqueous-gas interface, both stabilised by some surfactant, where their inclusion into 
the interface would be energetically favourable, they can be blocked from entering the 
interface by a kinetic energy barrier known as the entering coefficient, ER.115,259 As 
depicted in Figure 6.10, using a custom prepared LB system (with an indefinitely 
expandable surface), they were able to inject sunflower oil droplets stabilised by either 
whey protein isolate or sodium caseinate into their subphase, allowing the droplets time 
to rise, to obtain a system where the droplets were directly below an air-aqueous surface 
stabilised by the same protein. They then observed changes to the surface pressure on 
(a)	
γ	too	low	(π	too	high)	
for	oil	droplet	entry	
γ	increased	(π	decreased)	
to	allow	droplet	entry	
Oil	droplet	to	oil	lens	
forma9on	
Oil	droplet/lens	to	oil	
layer	forma9on	
water	
oil	
surfactant	
air	 (b)	 (ci)	 (cii)	
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constant expansion of the surface, defining the point of droplet entry as a ‘kink’ in the 
otherwise smooth surface pressure over time relationship. The point of droplet entry 
thereby identifying the surface pressure required from the droplet-free surface.259 
The Hotrum et al. method was followed during the follow work. In brief, on a LB 
system (see Experimental Chapter 4.9.5, p 93-95), a POPC monolayer was fully 
compressed, squalane POPC LONDs were then added to the subphase, and time was 
allowed for the LONDs to rise to the surface. The majority of the LONDs were 
observed to float to the surface in < 5 s. Therefore, it was assumed that for the LB 
trough that allowing 30 min was sufficient time for the LONDs to have reached the 
surface. The monolayer-LOND surface was then expanded until the surface pressure 
reduced to 0 mN/m, where any surface molecules were contributing a negligible surface 
tension decrease on the primarily bare air-aqueous interface. 	
	Fig.	 6.11.	 LB	 trough	 results	 showing	 a	 fully	 compressed	 POPC	monolayer,	with	 (red	 dotted	 line)	POPC	 squalane	 LONDs	 added	 underneath	 (enough	 to	 33%	 close	 pack	 under	 the	 surface),	where	time	 was	 allowed	 for	 their	 buoyancy,	 (grey)	 expanded	 at	 a	 constant	 rate	 of	 27	 mm/min,	 then	allowed	to	rest.	Inset	image	is	a	zoom	across	64-65	min,	where	two	kinks	(pink)	were	observed	in	the	otherwise	smooth	surface	pressure	over	time	relationship.	
 
Figure 6.11 shows how the surface pressure of the POPC monolayer – POPC squalane 
LOND surface changed over time during the LONDs’ addition, the surface’s expansion, 
and allowing the resultant surface to rest. The compressed monolayer was initially 
allowed to relax, reducing in surface pressure by ~7 mN/m over 30 min. No changes 
Kink	1	
Kink	2	
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were observed upon the addition of LOND solution or over the following 30 min, 
indicating that they remained below the surface monolayer and did not incorporate 
within it. On constant expansion of the surface, two kinks in the surface pressure over 
time relationship were observed. The first kink decreased the gradient whilst the second 
increased it back to before the first kink. These occurred at ~8 mN/m, covering ~1 
mN/m, with the first kink at 8.5 mN/m. It is thought that on the first kink the LONDs 
began to enter the surface, increasing the surface pressure at a rate slower than the 
decrease caused by the surface expansion, then on the second kink either there were no 
more LONDs left to enter the surface or something else was preventing them from 
further entry. These studies informed that for POPC squalane LONDs to enter the 
model MB’s POPC monolayer, the surface pressure had to be reduced enough to give a 
surface tension ≥ 64.3 mN/m. This differs from the current literature on the ER. Using 
Equation 3.27 (p 48), even if the LONDs were assume stable as possible, with their 
lipids at the oil-aqueous collapse pressure, they would still be expected to enter a POPC 
monolayer with a surface tension ≥ 29.6 mN/m (surface pressure ≤ 43.2 mN/m, 3.3 
mN/m less than the collapse pressure), with this upper limit decreasing if the LONDs 
were stabilised less by their lipid monolayer. 
 
From the results shown in Figure 6.11, a new method was used to more accurately 
assess the entry point of LONDs into the monolayer. The method entailed periodic 
expansions of the monolayer after LOND introduction, with the intention that once 
LONDs had entered the monolayer (dotted line), the monolayer could be compressed to 
the same area as before the expansions, allowing for the change in surface pressure by 
the oil and LOND lipids to be identified.  	
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	Fig.	6.12.	Changes	 to	 the	surface	pressure	of	a	PBS-air	surface	with	a	POPC	monolayer;	 (1,	black)	during	a	typical	pressure-area	isotherm,	ending	in	a	compression	close	to	collapse	of	the	monolayer,	(2,	red)	on	the	introduction	of	POPC	squalane	LONDs	directly	underneath	the	monolayer	(enough	to	 close	 pack	 at	 the	 surface)	 and	 subsequent	 periodic	 expansions	 of	 the	 surface	 at	 27	mm/min	beyond	0	mN/m,	(3,	blue)	compression-expansion	cycles	on	the	new	surface,	and	(4,	pink)	a	final	compression	 down	 to	 the	 same	 surface	 area	 as	 prior	 to	 LOND	 addition.	 The	 surface	 pressure	 is	shown	in	respect	to	(a)	time,	(b)	area	per	molecule	of	the	original	POPC	monolayer,	with	arrows	to	show	 if	 the	 area	was	 being	 compressed	 or	 expanded,	 and	 (c,	 dotted	 pink)	 area	 per	molecule	 re-calculated	to	account	for	additional	POPC	molecules	from	the	LONDs,	assuming	that	all	LOND	lipids	have	migrated	to	the	surface.	
	Fig.	 6.13.	 Sketch	 of	 the	 expected	 result	 for	 an	 experiment	 in	 which	 a	 POPC	 lipid	 monolayer	 is	compressed	(first	green	box),	then	squalane	LONDs	are	added	beneath	the	monolayer	(blue	dashed	line).	The	surface	pressure	is	then	monitored	as	a	function	of	the	monolayer’s	periodic	expansion	(red	boxes)	and	final	compression.	This	was	the	expected	result	from	the	Figure	6.12	experiment,	due	to	the	results	observed	in	Figure	6.11.	
Collapse	
(b)	 (c)	
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Figure 6.12 shows how the surface pressure of a POPC monolayer – POPC squalane 
LOND surface changed during a pressure-area isotherm experiment prior to LOND 
addition, during the addition of LONDs, for periodic expansions of the surface, 
following compression-expansion cycles of the new surface, and a final compression 
down to the same total surface area as before LOND addition. Figure 6.13 shows a 
sketch of the results that were expected from the experiment of Figure 6.12, based off of 
the results observed in Figure 6.11. During this experiment, a kink was not observed as 
in Figure 6.11. Rather, expanding the surface resulted in a greater surface pressure for 
the same area per molecule, compared to the POPC monolayer alone, starting at ~15 
mN/m (surface tension of 57.8 mN/m). (Figure 6.12b, blue dotted lines) On following 
compression-expansion cycles further increases to the surface pressure were observed 
for the same area per molecule. This suggested that during each expansion of the 
surface more LOND material was entering the surface monolayer. (Figure 6.12c) 
Comparing the final compression and the initial monolayer isotherm, both with respect 
to the total possible POPC molecules at the monolayer, showed the contribution of the 
oil to the surface pressure. It can be seen that at full compression, just before monolayer 
collapse (~55 Å2/molecule), there was negligible contribution from the oil. However, at 
higher areas (per POPC molecule) the surface pressure had an increased value, meaning 
that the surface tension, and therefore surface energy, was reduced. Figure 6.12c 
indicates that at the native area per POPC molecule (~80 Å2/molecule), the monolayer 
had a surface pressure of 8.7 mN/m, which was increased by 7.3 mN/m when the 
monolayer included the oil portion. This means that in cases where the air-water 
interface would have a low lipid coverage, for instance during the initial stages of MB 
formation, the Laplace pressure would be reduced, improving stability. If the oil portion 
was a full oil layer, it was expected that at a large surface expansion the surface would 
effectively be a non-lipid water-oil-air interface. This would lead to a non-zero plateau 
of the surface pressure over increasing expansion. However, the surface pressure 
continued towards 0 mN/m instead. This result suggested the presence of oil lenses, 
where at larger surface expansion the ratio of water-air interface to water-oil-air 
interface was increased. 
 
All of these results, including those from Figure 6.11 and Equation 2.27, strongly 
suggested that the transition of squalane POPC LONDs from below a POPC monolayer 
to entering it can occur at any surface pressure possible (apart from when the POPC 
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monolayer is fully close packed at the collapse pressure), but that the transition is a slow 
LOND by LOND process, rather than many to all of the LONDs entering on mass.  
 
6.4.2. Time dependence of LOND model MB interactions 
	Fig.	 6.14.	 Changes	 to	 the	 surface	 pressure	 of	 static	 DPPC	 monolayers,	 compressed	 to	 defined	surface	pressures,	after	the	addition	of	squalane	(a)	POPC-PEG	or	(b)	POPC	LONDs	underneath	the	monolayer	surface,	as	measured	by	a	LB	trough.	Time	=	0	min	was	the	moment	when	an	increase	in	surface	pressure	was	observed	(in	order	to	neglect	LOND	rise	time	and	inconsistent	LOND	addition	between	samples).		
The previous section suggested that the entering and potential spreading of LONDs into 
a POPC lipid monolayer was a stochastic process rather than all of the LONDs entering 
on mass. This section presents the results of experiments aimed at understanding the 
timescale of LOND adsorption, since this would be important for the stabilisation of 
MBs from LOND solution. Just after MB formation, the lipid monolayer would be 
expected to be at the equilibrium spreading pressure (ESP). The air-water interface was 
either left bare, or had a DPPC monolayer compressed to give a surface pressure of 0 
mN/m (at the highest compression possible to give 0 mN/m), 4 mN/m, or 8 mN/m 
(~ESP, see Results Chapter 5.1, p 119). These surfaces were considered representative 
of a MB surface during stabilisation. These surface pressures could also be related to an 
expansion of the monolayer to ∞, 1.3, 1.1 and 1 times the area per molecule at ESP 
respectively. This equates to lipid stabilised 2.0 µm MB expanding to ∞ µm, 2.3 µm, 
and 2.1 µm or not expanded respectively. Figure 6.14 shows how the surface pressure of 
these surfaces changed upon the introduction of POPC-PEG (Figure 6.14a) or POPC 
(Figure 6.14b) squalane LONDs from underneath the surface monolayer. Figure 6.15 
presents a schematic of a possible explanation for what was observed. 
For POPC-PEG LOND addition, without a starting monolayer, the LONDs were seen to 
rapidly enter the surface within 5 min, increase the surface pressure, and then remain 
POPC	LONDs	POPC+PEG	LONDs	
(a)	 (b)	
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unchanged. With higher initial DPPC monolayer compressions the timescale for LOND 
entry and surface pressure increase was significantly increased. After 80 min the 
initially bare air-water surface, and the DPPC monolayers at compressions of 0 and 4 
mN/m had all reached surface pressures of 18-19.5 mN/m. However, the 8 mN/m 
surface had only been increased by 5.5 mN/m and appeared to have a gradient that 
would never approach the 18-19.5 mN/m range even on much greater time scales. Since 
the monolayer at 8 mN/m was already highly compressed, this results could suggest that 
for the 8 mN/m surface, only a small fraction of LONDs were able to enter the 
monolayer until it was ‘full’ (Figure 6.15ai), contributing little surface pressure increase. 
Meanwhile, the less initially compressed monolayers could be filled by more LONDs 
(Figure 6.15aii), contributing greater surface pressure increases, which would occur 
more rapidly for LONDs that were not impeded from reaching the air phase by the 
presence of a semi-compressed monolayer. 
For POPC LOND addition, all of the DPPC monolayers showed an exponential increase 
to the surface pressure. After 80 min, all of the DPPC monolayers had surface pressures 
at 18-19.5 mN/m with no apparent dependence on the original monolayer compression. 
The only factor that the starting monolayer compression affected was the exponential 
rate in which the surface pressures increased to its final value. For an air-water interface 
with no monolayer, and starting DPPC monolayer compressions of 0, 4, and 8 mN/m, it 
took 26, 21, 14, and 10 min for each monolayer to reach 75% of its final surface 
pressure respectively. These results suggested that at a higher initial monolayer 
compression, the maximum change to that monolayer (caused by the progressive 
addition of LONDs) occurred over a shorter time frame, but that after 80 min the 
surfaces were effectively the same, regardless of the starting monolayer. One possible 
explanation for these observations was the result of the LONDs spreading (Figure 6.15i-
iii). In that way, regardless of the number of LONDs that had entered to the surface, an 
equivalent surface pressure would be found due to the two interfaces of water/lipid-oil 
and oil-air. The oil layer in-between these interfaces would then either have a small 
thickness (Figure 6.15ii), from the entry of a small number of LONDs due to a high 
initial monolayer compression (hence the more rapid increase to the final surface 
pressure value seen in Figure 6.14b) or a large thickness (Figure 6.15iii), from the entry 
of a high number of LONDs due to a low initial monolayer compression (hence the 
longer time to increase to the final surface pressure value as seen in Figure 6.14b). 
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 Fig.	6.15.	Schematic	of	the	suggested	differences	between	the	entering	of	(a)	POPC-PEG	LONDs	and	(b)	POPC	LONDs	on	a	DPPC	monolayer,	where	the	monolayer	is	defined	as	being	highly	compressed	(high	surface	pressure)	or	of	low	compression	(low	surface	pressure)	before	LOND	introduction.	As	shown,	for	POPC	LONDs,	the	air-oil	and	oil-lipid/water	interfaces	remain	the	same	(resulting	in	the	same	surface	pressure)	since	the	spreading	of	more	LONDs,	until	the	monolayer	is	‘full’,	only	results	in	 a	 larger	 volume	 of	 oil.	 Meanwhile,	 the	 intact	 POPC-PEG	 LONDs	 fill	 the	 surface	 less	 when	 the	initial	monolayer	is	highly	compressed	due	to	the	surface	becoming	‘full’.	
 
In conclusion: These results suggested that squalane POPC LONDs were able to enter 
and spread at a gas-aqueous surface, forming either oil lenses or an oil layer, whilst 
being relatively unaffected by the possible stabilisation of that surface by non-oil lipid 
structures. However, this spreading was a long process that occurred over 10-40 min. 
Meanwhile the results suggested that POPC-PEG LONDs entered but did not spread, 
forming a LOND covered surface, with the efficiency of entering being strongly 
dependant on the stabilisation rate of the surface by any non-LOND lipids. 
 
6.5. Formation of OLI-MBs from LOND solution 
During this chapter OLI-MBs were typically formed from LOND solution either 
through a variation on the lipid solution mechanical agitation method or monodisperse 
MB production method and using a LOND solution in place of the standard lipid 
solution (see Experimental Chapter, 4.4 and 4.9.6, p 75 and p 95). When reference is 
made on the use of OLI-MBs later in this thesis they are referring to OLI-MBs formed 
from by one of these two methods. This section addresses the methods that were 
undertaken to form OLI-MBs from LOND solution, and analysis of those MBs. All of 
(bi)	 POPC	LONDs	at	DPPC	monolayer	
Highly	compressed	
ini4al	monolayer	
Low	compression	ini4al	monolayer	
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(ai)	POPC+PEG	LONDs	
at	DPPC	monolayer	
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the preliminary work in developing and then confirm the success of the formation 
technique was completed with the use of squalane POPC and POPC-PEG LONDs. 
Once the formation technique was confirmed, the work moved on to the use of squalene 
and tripropionin POPC LONDs. 
Due to the results of POPC and POPC-PEG LONDs on model MB surfaces (see 
sections, 6.3 and 6.4) it was predicted that POPC LONDs would form oil lenses/an oil 
layer at the MB shell (the desired OLI-MB structure) and that POPC-PEG LONDs 
would form MBs that were shell stabilised by intact LONDs respectively. This 
prediction was later confirmed by the use of FRET enabled LONDs in section 6.7.3 
(Figure 6.39, p 171). As such, from here these two structures will be referred to in this 
section as OLI-MBs and LOND shelled MBs respectively. 
 
6.5.1. Mechanical agitation formation and MB lifetime 
	Fig.	6.16.	Example	MBs	formed	from	squalane	(a)	POPC	and	(b)	POPC-PEG	shelled	LONDs	through	the	mecahanical	agitation	method.	(c)	Size	histograms	of	the	POPC	LOND	MBs	(blue)	and	POPC-PEG	LOND	MBs	(red).		
Figure 6.16 shows the size distribution of MBs formed by mechanical agitation of 
POPC squalane LONDs (giving OLI-MBs) or POPC-PEG squalane LONDs (giving 
LOND shelled MBs). Mechanically agitated MBs, formed from squalane POPC and 
POPC-PEG LONDs, had peak diameters of 21.2 ± 0.7 µm (SD 26.2 µm) and 21.7 ± 0.7 
POPC	
(OLI-MBs)	
POPC+PEG	
(LOND	stabilised	MBs)	
(a)	
(b)	
(c)	
 156 
µm (SD 26.0 µm) respectively, and concentrations of 1.7 ± 0.5 x 106 OLI-MBs/ml and 
2.4 ± 1.0 x 106 MBs/ml respectively. Figure 6.17 shows changes in size and 
concentration over time of the mechanically agitated OLI-MBs formed from POPC 
squalane LOND (Figure 6.17ai-ii). By extrapolating the concentration profile to t = 0 
min - the time that the production stopped, it was found that the OLI-MBs averaging 
~15 µm took ~35 min to halve in concentration. After ~100 minutes, the OLI-MB 
concentration remained constant, whilst the size was observed to slowly increase. This 
could be due to Ostwald ripening from sub-micron MBs in the solution that were not 
observed.90 	
	Fig.	6.17.	Lifetime	results	from	mechanically	agitated	OLI-MBs	formed	from	POPC	squalane	LONDs.	(a)	 Two	 example	 Figures	 are	 shown	 from	 12	 and	 213	 min	 time	 points.	 (b)	 Diameter	 and	 (c)	concentration	changes	are	shown	over	time.	Each	time	point	is	measured	from	three	samples,	with	each	sample	being	measured	at	ten	locations	(n	=	30	images	per	time	point).	
	Fig.	 6.18.	 Mechanically	 agitated	 OLI-MBs,	 formed	 from	 squalane	 POPC	 LONDs,	 loaded	 with	 DiI,	microfluidically	 trapped.	 Showing	 (a)	 trapping	 of	 OLI-MBs	 in	 excess	 LOND	 solution,	 and	 (b)	 a	 z-stack	of	the	fluorescence	of	the	remaining	DiI	in	oil	after	washing	away	excess	material.	
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Figure 6.18 shows a population of mechanically agitated POPC squalane OLI-MBs 
microfluidically trapped, and a z-stack of the DiI fluorescence from a single OLI-MB 
after washing of excess LONDs (for trapping details see Experimental Chapter 4.2, p 
66-68). As seen, the OLI-MB retained its fluorescence, indicating that the oil portion 
was still present. The angle of the z-stack image shows that the MB’s fluorescence was 
a-symmetrical (the right side of the MB is more curved than the left). This was due to 
an imaging artefact whereby flourescence from the side of the MB facing away from the 
confocal lens could not be imaged. This artefact was confirmed by comparativley 
imaging known spherical, fluorescent, polystyrene beads, which also appeared a-
symmetrical in an identical manner (result not shown). Figure 6.19 compares the 
fluorescence intensity from the MB shell and the surrounding solution before and after 
washing. As seen by the white light image, the excess LONDs in solution were 
observable as ‘noise’ before washing, which was not present after the flow of PBS. 
Whilst the solution fluorescence dropped to ~0.7x that before washing, the OLI-MB 
shell fluorescence change was negligible. This indicated that the oil portion, which 
contained the fluorescence molecules, was stable against the increased concentratin 
gradient given by removal of the excess oil and lipid from the surroundings, as well as 
the shear forces produced by the flow during washing. 
 
	 	Fig.	6.19.	Washing	of	mechanical	agition	OLI-MBs	formed	from	a	mix	of	two	squalane	POPC	LOND	solutions,	 loaded	with	either	DiO	or	DiI.	The	fluorescence	signals	are	shown	from	the	(a)	DiO	and	(b)	DiI	emisson	windows,	and	the	(c)	white	light	signal,	from	(i)	before	and	(ii)	after	washing.	(d)	Bar	 chart	 comparing	 the	 fluorescence	 intensity	 from	 the	 DiI	 emission	 window	 before	 and	 after	washing	 (normalised	 to	 before	washing)	 at	 the	 (green)	 OLI-MB	 shell	 and	 in	 the	 (grey)	 solution,	measured	from	the	area	indicated	by	the	white	dotted	square.	All	fluorescent	images	were	contrast	enhanced	equally.	
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Figure 6.20 shows images from before and after washing of mechanical agition MBs 
formed from a mix of two squalane POPC-PEG LONDs solutions, loaded with either 
DiO or DiI. Here again it can be seen that the MB retained its fluorescence after 
washing, indicating that the oil portion was stable. A bright flourescent circle can also 
be seen directly above the trapped MB after washing. This was thought to be a large oil 
droplet that also became trapped around the stagnant MB, hence fully fluorescent. 	
	Fig.	 6.20.	Washing	 of	mechanical	 agition	 LOND	 shelled	MBs	 formed	 from	 a	mix	 of	 two	 squalane	POPC-PEG	 LOND	 solutions,	 loaded	with	 either	 DiO	 or	 DiI,	 presented	 as	 in	 the	 POPC	 OLI-MBs	 in	Figure	6.19.	
 
6.5.2. Microfluidic OLI-MB formation 
This section presents the results concerning the formation of MBs from LOND solution 
through FF microfluidics in a monodisperse regime. LOND core oils used her were 
squalane, squalene, and tripropionin. 
 
 Squalane OLI-MBs 6.5.2.1.
The microfluidic LOND assembly and spreading route for the formation of OLI-MBs 
was most extensively developed using POPC squalane LONDs. This was due to 
squalane being a strongly hydrophobic oil and so being good as a model for the 
mechanism (as well as a potential agent as a drug carrier). 
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	Fig.	6.21.	Two-phase	FF	MB	production	using	POPC	squalane	LOND	solution	diluted	1	in	10	in	BB	flown	at	(a)	20,	(b)	23,	and	(c)	50	μl/min.	Gas	pressure	of	3	psi	used.			
Figure 6.21 shows images of attempts to form OLI-MBs from POPC squalane LOND 
solution diluted to 1012 LONDs/ml in BB. A MB stream (which is typically observed 
for controlled FF non-oil-MB production) was able to be formed over a small range of 
flow rates (~5 µl/min) with optimal conditions at 23 µl/min LOND solution and 3 si gas. 
However the MB formation stream was highly unstable and difficult to control. 
Additionally, coalescence was often observed leading to large gas pockets coated in an 
oil layer (Figure 6.21a). Post-production imaging showed no evidence of MBs 
remaining after any sample production.   
Previous work has reported that, during the FF formation of lipid stabilised MBs, using 
higher concentrations of glycerol in the lipid solution phase (10-30 vol%) allows for the 
stabilistion of a higher concentration of MBs.260 As such, the POPC squalane LOND 
solution was diluted in BB containing 10 vol% glycerol in order to assess if this 
improved control over the production and MB stability for off-chip imaging. 
 
Coalescence		
Oil	layer	 MB	stream	
20	μl/min	 23	μl/min	 50	μl/min	
(a)	 (b)	 (c)	
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	Fig.	6.22.	(a)	Two-phase	FF	MB	production	using	POPC	squalane	LOND	solution	diluted	1	in	10	in	10	vol%	glycerol	BB,	with	(b)	high	frame	rate	imaging.	C4F10	gas	4	psi,	LOND	solution	27	μl/min.	(c)	A	schematic	is	shown	for	the	proposed	mechanism	of	LOND	self-assembly,	spreading,	and	merging,	into	an	oil	layer	in	order	to	stabilise	the	bare	aqueous-gas	interface.		
Figure 6.22 shows OLI-MB formation from POPC squalane LONDs diluted to 1012 
LONDs/ml in 10 vol% glycerol BB. It was observed that gas pressures as low as 3 psi 
could be used to form MBs, however MB formation rate was low at ~400 MBs/s. At 5 
psi, a large propotion of the MBs coalesced just past the nozzle. These large MBs then 
became trapped in the 25 µm deep outlet, leading to further coalescing. This could be 
due to the MBs being formed at a high rate with insufficient time for the LONDs to 
adsorb and rupture at the gas-aqueous interface in order to stabilise the MBs. Optimal 
production occurred when using 4 psi and 26-28 µl/min LOND solution, giving MB 
streams in a highly repeatable manner, with production rates of ~5 x 103 MBs/s, and on-
chip MB size of 9 ± 2 µm (SD 3 µm). 
Figure 6.23 shows OLI-MBs in microfluidic traps after washing steps, and their 
fluorescence from DiI loaded into the oil phase. These three MBs are from different 
formation repeats. The persistent fluorescent halo shows that, like the mechanical 
agitation OLI-MBs, the oil component was stable against shear forces and the removal 
of excess oil and lipid from the surrounding solution. Some of the OLI-MBs showed a 
fluorescent outside only (Figure 6.23cii), however more commonly OLI-MBs showed 
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more complex structuring at the shell consiting of a fluorescent outside plus a smaller 
fluorescent cirlcular structure at a point on the MB shell (Figure 6.23aii-bii). These 
circles were thought to be oil lenses. The appearance of both the fluorescent outside and 
the lens suggests that the during OLI-MB formation, the LONDs spread into pseudo-
partial wetting films.261,262 	
	Fig.	6.23.	Microfluidic,	DiI	encapsulted,	POPC	squalane	OLI-MBs	after	 trapping	and	washing	steps	form	three	different	samples.	(ai-ci)	White	light	and	(aii-cii)	DiI	fluorescence	shown.		
	Fig.	6.24.	Sizing	images	and	results	from	microfluidic,	POPC	squalane	OLI-MBs,	formed	using	4	psi	gas	and	24	μl/min	LOND	solution,	showing	(a)	dark-field	images	taken	after	production,	(b)	with	a	zoomed	in	section,	and	(c)	a	histogram	of	OLI-MB	sizes.		
Figure 6.24 shows off-chip imaging of microfluidic POPC squalane OLI-MB solution, 
for size distriubtion and concentration analysis. These MBs had diameters of 2.4 ± 0.3 
µm (SD 1.6 µm) with a concentration of 6.2 ± 0.8 x 106 MBs/ml. This was a reduction 
in size to ~0.27 times the on-chip size. This size change was most probably due to gas 
leakage from the interior of the MBs after production. A MB's diameter effectively 
stabilises when the lipid shell concentrates from an equilibrium state to being close 
(ai)	 (bi)	 (ci)	
(aii)	 (bii)	 (cii)	
(c)	(a)	 (b)	
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packed at the collapse pressure. This effect has been shown previously on 
DPPC:DPPA:DPPE-PEG5000 MBs formed using FF devices, where MBs shrank to 
0.39 times their initial size.180 The same effect would be expected to be observed from 
OLI-MBs due to the outer lipid shell. 
 
	Fig.	6.25.	(a)	Concentration	and	(b)	diameter	of	microfluidic	squalane	OLI-MBs	as	a	function	of	time,	at	 ~25	 °C.	 The	 data	 presented	 represents	 the	 average	 of	 two	 MB	 production	 runs.	 Each	 run	averaged	from	three	sample	aliquots.		
Figure 6.25 shows the changes in diameter and concentration of microfluidic squalane 
OLI-MB over time. The concentration over time showed an exponential decrease, with 
a sharp initial decrease in concentration over the first 90 minutes, after which the MB 
concentration appeared stable for the duration of the measurement. During this period 
the MB population showed a modest increase in size, presumably due to Ostwald 
ripening.90 Figure 6.26 shows a comparison of both the concentration of the mechanical 
agitation and microfluidic squalane OLI-MBs, both normalised to 100% when t = 0 min. 
Even though the average MB size was significantly different, both OLI-MB production 
routes showed very similar concentration decay mechanics, especially over the first 60 
min. Eventually the two routes stabilised at 26% and 33% of their original concentration 
for mechanical agitation and microfluidic samples respectively, though as can be seen, 
the differences were generally within error between the two routes. The high similarity 
in concentration decay between the two routes suggested that the LONDs had stabilised 
both MB samples in the same way. This is because MBs stabilised with different shells 
would be expected to have significantly different lifetime characteristics (dependant on: 
shell surface tension, gas diffusion rate across the shell, etc., see Theory Chapter 3.2.3, 
p 41-44). 
(b)	(a)	
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	Fig.	 6.26.	Concentration	over	 time	 for	both	 the	mechanical	 agitation	 (red	 circle)	 and	microfluidic	(blue	triangle)	POPC	squalane	OLI-MB	samples.	For	both	data	sets,	 the	exponential	 fits	have	been	normalised	to	100%	at	t	=	0	min.		
 Squalene OLI-MBs 6.5.2.2.
After the successful production of monodisperse squalane OLI-MBs, squalene OLI-
MBs were formed to be used in later intrinsic oil fluorescence work (see section 6.7). 
Here, the optimal production was again found, followed by wash steps. 	
	Fig.	6.27.	(a)	Two-phase	FF	OLI-MB	formation	using	POPC	squalene	LOND	solution	diluted	1	in	10	in	10	vol%	glycerol	BB.	C4F10	gas	4	psi,	LOND	solution	23	μl/min.	(b-c)	A	POPC	squalene	OLI-MB	is	then	shown	after	microfluidic	 trapping	and	washing.	 (i)	Brightfield	and	(ii)	 fluorescence	 from	DiI	loaded	 into	 the	 oil	 is	 shown,	 where	 the	 focal	 plane	 is	 (b)	 through	 the	 center	 and	 (c)	 at	 the	 top	surface	of	the	OLI-MB.			
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Figure 6.27a shows the optimal FF production found for forming OLI-MBs from POPC 
squalene LONDs diluted to 1012 LONDs/ml in 10 vol% glycerol BB. Optimal 
production occurred at 4 psi C4F10 and 23-25 µl/min LOND solution. Formation of MBs 
from squalene LOND solution was found to be less stable than that using squalane 
LONDs. This may have been due to the high proportion of unsaturated double bonds in 
squalene compared to squalane (which is fully saturated), presenting a weaker 
hydrophobic driving for LOND assembly and spreading at the gas-aqueous interface. 
As such the concentration and monodispersity of squalene OLI-MBs were expected to 
be lower than squalane OLI-MBs. Since the intended use of these MBs was for single 
MB analysis (Raman section 6.7), that was not a factor for this project, however it 
should be noted that due to this squalene OLI-MBs would not be of practical use for 
drug delivery. Figure 6.27b-c shows one of these squalene OLI-MBs after trapping and 
washing steps, where the imaging focal plane was placed either through the OLI-MB 
centre or at the top of the OLI-MB. Here it can be seen that the OLI-MB had a ‘patchy’ 
surface of high fluorescence, surrounded by a full MB shell of lower fluorescence. This 
was another suggestion of a pseudo-partial wetting oil layer around the MB (where the 
higher fluorescence would indicate a higher proportion of fluorophore and so a thicker 
oil structure at those locations), however, unlike the squalane OLI-MBs which appeared 
to have one concentrated oil lens, here there are many smaller lenses across the MB 
shell. 
 
 Tripropionin OLI-MBs 6.5.2.3.
Extending the successful formation technique of the microfluidic OLI-MB production 
to tripropionin oil would allow for the encapsulation of less hydrophobic, but still 
poorly water soluble drugs. Therefore, formation was also trialled with POPC 
tripropionin LONDs. 
   
 Fig.	6.28.	Two-phase	FF	MB	production	using	tripropionin	POPC	LOND	solution	diluted	1	in	10	in	tripropionin	staturated	10	vol%	glycerol	BB,	with	(a)	standard	and	(b)	high	frame	rate	imaging.	Gas	(a)	4	and	(b)	6	psi,	LOND	solution	23	μl/min.	
(a)	 (b)	
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Figure 6.28 shows OLI-MB formation from POPC tripropionin LONDs diluted to 1012 
LONDs/ml in 10 vol% glycerol BB that had been pre-saturated with tripropionin. In 
general, microfluidic OLI-MB formation using POPC tripropionin LONDs was vastly 
superior to that using squalane or squalene POPC LONDs. MB formation from any 
other LOND solution or non-oil-lipid solution used throughout this project was only 
ever observed to form MBs with enough control to give a single MB stream. Using 
tripropionin POPC LONDs, MBs were formed and stabilised rapidly enough to allow 
MBs to close pack without coalescing as they were flowing through the outlet. This 
gave the appearance of multilayered MB steams, some of which were close packed 
enough to fill the entire outlet channel (seen in Figures 6.28a and 6.28b). The 
implication of these results suggested two important features to the tripropionin OLI-
MBs; 
1) The stabilisation of the OLI-MBs by the accumulation and spreading of the 
tripropionin LONDs occurred at a far faster rate than either squalane LONDs or 
non-oil-lipid structures found in standard lipid solution (monomers, micelles, etc) 
2) The addition of the tripropionin oil led to the OLI-MBs’ effective gas-oil-lipid-
water interface shell having a dramatically reduced surface tension compared to 
OLI-MBs formed from squalane LONDs and MBs formed from lipid alone. 
Both of these features would be required from the MB shell to prevent coalescence and 
allow formation to occur at this high rate. 
 
When using 3 psi gas, the on-set of rapid coalescence was found to occur when using 
LOND solution flow rates above 35 µl/min. This indicated that as the flow rate 
increased, the LONDs were not having sufficent time to stabilise the OLI-MBs 
inbetween pinching-off from the main gas bulb and contact with another OLI-MB. Due 
to this, lower flow rates were preferred until coalescence was not observed in the outlet. 
Optimal production was found at 4-5 psi C4F10 and ~25 µl/min LOND solution, giving 
MB formation rates of 35 ± 10 x 103 MBs/s, seven times higher than that using POPC 
squalane LOND solution.  
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	Fig.	 6.29.	 Microfluidic	 tripropionin	 OLI-MBs,	 formed	 as	 in	 Figure	 6.28	 using	 optimal	 production	rates.	 (a-b)	OLI-MB	solution	placed	 inside	a	50	μm	chamber	and	(c-d)	after	microfluidic	 trapping	and	washing	steps.	Imaging	by	confocal	microscope	under	(i)	white	light	and	(ii)	fluorescence	from	nile	red	that	had	been	solubilised	into	the	tripropionin	before	LOND	formation.		
Figure 6.29 shows examples of the microfluidic POPC tripropionin OLI-MBs imaged in 
50 µm chambers (Figure 6.29a-b), and microfluidic traps after wash steps (Figure 6.29c-
d). In the 50 µm chambers, the OLI-MBs were found to have a thick fluorescent layer, 
suggesting the prescence of an oil shell (Figure 6.29a-b). The oil shell thickness was 
potentially exagurated due to the OLI-MBs sitting and being deformed against the glass 
suface, with the gas core being more buoyant than the oil layer. The 50 µm chamber 
OLI-MBs were found to have an average size of 4.8 ± 0.3 (SD 0.7) µm, with an 
apparent oil layer thickness of 1.1 ± 0.1 (SD 0.2) µm. For the OLI-MBs washed in 
microfluidic traps, the fluorescent oil portion was observed to remain around the OLI-
MBs’ shell (Figure 6.29c-d). Again evidence was given of pseudo-partial wetting in the 
form of fluorescent circles (with white light contrast) at the OLI-MBs’ shell in addition 
to the OLI-MBs’ fluorescent shell. 
 
(di)	(ci)	
(dii)	(cii)	
(bi)	(ai)	
(bii)	(aii)	
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	Fig.	6.30.	(a)	Sizing	image	and	(b)	resulting	sizing	histrogram	from	microfluidic	POPC	tripropionin	OLI-MBs,	 formed	using	gas	4	psi	and	LOND	solution	25	μl/min.	For	 imaging,	 the	OLI-MB	solution	was	placed	in	a	‘non-microfluidic	flow	cell’	(Experimental	Chapter	4.3,	p	71).		
Figure 6.30 shows an image of the tripropionin OLI-MBs off-chip and the resulting size 
distribution measured. Even though the tripropionin OLI-MBs were formed at a high 
rate on-chip, off-chip the OLI-MBs concentration was found to be very low. Therefore, 
the MB sample was imaged in one of the large volume ~500 µm deep non-microfluidic 
flow cells and the MBs allowed to float to the surface. The MBs were found to have an 
average diameter of 2.1 ± 0.1 µm (SD 0.8 µm), at a concentration magnitude of 105 
OLI-MBs/ml. Suprisingly, even though the on-chip production rate was seven times 
faster than when using squalane LONDs, the off-chip concentration was found to be an 
order of magnitde less. This means that the tripropionin OLI-MBs were less stable to 
the changes in shear forces when transfering from on-chip, to the OLI-MBs collection 
point, or simply less stable over time. Figure 6.31 shows size and concentration changes 
over time for two samples. At least over the first two hours of measurment the size of 
the OLI-MBs was stable. However, the concentration over time did not show an 
exponential decay as expected. Over the first ~90 min both samples increased in 
concentration, after which the concentration of first sample began to decrease, as 
expected, whilst the second sample continued to increase. This indicated that the rise 
time of the MBs was longer than expected, taking at least 90 min. Tripropionin is more 
(a)	(b)	
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dense than water whilst C4F10 gas is less dense. This meant that all of the structures 
floating to the top surface must have been at least part gas due to boyancy. For a 2 µm 
MB with a tripropionin shell to take on average 90 min to rise the chamber depth, the 
gas core diameter would need to be 0.86 µm with a 0.57 µm thick oil shell (tripropionin 
oil would make up 92% of the total OLI-MB volume). This total OLI-MB diameter to 
oil layer thickness ratio roughly agrees with that found for the OLI-MBs seen in Figure 
6.29 (where tripropionin oil would make up 84% of the total OLI-MB volume). 
However, for a MB to have zero boyancy in water the gas core diameter would need to 
be 0.81 µm with a 0.59 µm thick oil shell (93 vol% tripropionin). Clearly a very small 
change in oil layer thickness would have a dramatic impact on the boyancy of the 
tripropionin OLI-MBs. This might explain why samples 1 and 2 seen in Figure 6.31 
showed different concentration profiles. 
 
	Fig.	6.31.	(a)	Concentration	and	(b)	diameter	of	microfluidic	tripropionin	OLI-MBs	as	a	function	of	time,	at	~25	°C.	Two	sample	runs	are	shown,	where	each	sample	was	averaged	from	three	aliquots.		
6.5.3. Microfluidic spray production 
The production of OLI-MB samples by the microfluidic monodisperse regime gave 
concentrations of 106 and 105 OLI-MBs/ml when using squalane or tripropionin POPC 
LOND solutions respectively. 106 MBs/ml was the minimum concentration required for 
our set-up to determine US characteristics (see section 6.8). In order to have any repeats 
and more reliable measurements at individual frequencies, concentrations of 107 - 108 
OLI-MBs/ml were required. Gaining this higher concentration was also deemed 
necessary for their clinical application. The microfluidic formation of lipid shelled MBs 
via FF designs in the monodisperse regime has previously been shown to form MBs at a 
(a)	 (b)	
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concentration that is too low for clinical application.43 In Leeds, this problem was 
solved by using the ‘microspray’ regime. Here, MBs were readily formed at 108 to 109 
MBs/ml. Though the polydispersity index was higher, the average diameter was ~2 µm 
and with few MBs larger than 4 µm.43 Attempts to use that microspray regime for OLI-
MB formation unfortunately were not successful. 
  
The tripropionin sample did show successful formation of a population of MBs, 
averaging 2.9 ± 0.1 µm (SD 1.0 µm) at 3.4 ± 0.5 x 105 MBs/ml. However, the 
concentration was found to be only 14% higher than that of the monodisperse regime 
production. Futher, a bimodal distrubtion of MBs was found with the second 
distribution averaging 23 ± 1 µm (SD 5 µm) at 1.3 ± 0.1 x 105 MBs/ml. Table 6.1 
presents how the microspray formation compared to the monodisperse formation. 
 Tab.	6.1.	 Size	and	concentration	 results	 from	MB	 formation	 in	 the	monodisperse	and	microspray	regimes,	using	squalane	and	tripropionin	POPC	LONDs.	
		
These results showed that microspray production did not achieve the higher 
concentration samples that were desired. Moving forward, OLI-MBs were formed for 
further analysis from either the microfluidic monodisperse regime or mechanical 
agitation methods (since the mechanical agitation OLI-MBs were larger, they were used 
both as a preliminary tool to the analysis of the microfluidic OLI-MBs, and for greater 
resolution during fluorescence imaging of the OLI-MB shell). 	
6.6. LOND introduction to stable MBs 
In the previous sections OLI-MBs had been formed using POPC LOND solutions. The 
hypothesis was that LONDs adsorbed at the air-water interface and formed a lipid-oil 
lens or a continuous oil layer during formation. An important aspect of this hypothesis 
was that during formation the freshly formed MB surface would not yet be stabilised by 
lipid, so would have a high surface tension. 
Diameter	
[μm]
Error SD Concentration	
[MBs/ml]
Error
Squalane	monodisperse 2.4 0.3 1.6 6.2E+06 8E+05
Squalane	microspray
Tripropionin	monodisperse 2.1 0.1 0.8 3.0E+05 6E+04
2.9 0.1 1.0 3.4E+05 5E+04
22.8 1.1 5.3 1.3E+05 1E+04
MBs	were	not	found	to	be	stable	off-chip
Tripropionin	microspray
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Here, a study is presented of LOND interactions with stabilised lipid MBs. The LONDs 
were flown past the stabilised MBs and fluorescence observations were made to assess 
if the oil portion transferred into the MB shell. Lipid stabilised MBs were formed using 
a two-phase FF microchip, under a microfluidic monodisperse regime, from 4 psi C4F10 
gas and 20 µl/min DPPC-PEG lipid solubilised in 10 vol% glycerol BB. Off-chip sizing, 
showed that the MBs were formed at 12.3 ± 0.5 µm (SD 2.6 µm). These MBs were 
trapped in a microfluidic trap device and washed with PBS. DiI POPC squalane LONDs 
were flown past the MBs, after which the MBs were washed again with PBS until no 
background fluorescence was observed (indicating the removal of excess LONDs). 
	Fig.	6.32.	DPPC-PEG	MBs	trapped	and	washed,	followed	by	(a-c)	the	addition	of	DiI	POPC	squalane	LONDs	into	the	trapping	chamber,	and	then	(d)	washing	of	the	MBs	to	remove	the	excess	LONDs.	(i)	White	light	and	(b)	DiI	fluorescence	emission	window	are	shown.	All	flow	at	10	μl/min.	
 
Figure 6.32 shows the fluorescence signal from DiI encapsulated into POPC squalane 
LONDs as the LONDs were flown past multiple DPPC-PEG MBs (Figure 6.32a-c), and 
then after the excess LONDs have been removed by a washing step (Figure 6.32d). 
Most MBs remained non-fluorescent (as they were before LOND introduction). Figure 
6.32a shows that a small fraction of the MBs were seen to become fluorescent during 
the LOND introduction step, however after washing none of them remained fluorescent. 
These results showed that LONDs could adhere to the MB shell intact, but that the 
binding was non-specific, and that the LONDs could not have merged with the MB 
shell. These results agreed with those seen in the LB trough experiment and confirmed 
that LONDs cannot form OLI-MBs from MBs that are already fully stabilised by 
DPPC-PEG lipid shells. 
During	LONDs	on	 During	LONDs	on	 During	LONDs	on	 A.er	wash	oﬀ	
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6.7. Using FRET to assess LOND rupture at a MB surface 
In this section OLI-MBs were produced from LONDs that were formed with the 
specific intention of having FRET capabilities. This was done to assess whether POPC 
shelled LONDs led to the formation of OLI-MBs (with a complete oil layer or oil 
lenses) and whether POPC-PEG shelled LONDs led to the formation of MBs stabilised 
by intact LOND shells. The experimental concept was to form two sets of LOND 
solutions, one encapsulating a FRET donor, the other the FRET acceptor, and then mix 
them. If the LONDs ruptured at an aqueous-gas interface, this would lead to mixing of 
the oil cores loaded with the FRET fluorophores, and thus allow for the production of 
FRET signal. On the other hand if the LONDs remained intact, fluorescence would be 
observed but no FRET. 
 
6.7.1. Assessment of FRET fluorophores 
	Fig.	6.33.	DiO	and	DiI,	FRET	donor	and	acceptor	respectively,	dissolved	in	squalane	and	triacetin	at	15	μg/ml.	The	fluorophores	did	not	dissolve	in	MilliQ.		
Figure 6.33 shows DiO and DiI fluorophores at 15 µg/ml in ~1 ml of squalane oil, 
triacetin, and MilliQ. Successful solvation was indicated by colouration of the liquid 
phase. This was achieved for both squalane and triacetin. Solubilisation in MilliQ was 
unsuccessful, where aggregates of the fluorophores could be seen to have remained 
against the glass vial walls, which was expected due to the strong hydrophobic nature of 
the DiO and DiI. 
 
DiO	 DiO	 DiO	DiI	 DiI	DiI	
Triace+n	Squalane	 MilliQ	
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	Fig.	 6.34.	 Excitation	 and	 emission	 spectra	 of	 DiO	 and	 DiI	 in	 (a)	 squalane	 and	 (b)	 triacetin.	 The	graphs	were	corrected	for	oil’s	background,	and	their	maximum	value	was	normalised	to	1.	A	488	nm	laser	was	used	as	the	excitation	source	for	all	emission	recordings.		
Figure 6.34 shows the excitation and emission spectra of squalane and triacetin loaded 
with DiO or DiI. For both oils a significant spectral overlap was present between the 
donor (DiO) emission and acceptor (DiI) excitation spectra. This is one of the 
requirements for FRET to be able to occur (Theory Chapter 3.4, p 48-50). Tripropionin 
oil was used as a direct means of improving LOND solutions formed by triacetin oil due 
to its lower water solubility (results for triacetin LONDs are not shown). However, 
squalane oil had previously been shown to form more consistent LOND solutions, in 
regards to oil droplet size and concentration. Therefore, squalane oil was chosen as the 
primary oil carrier for the DiO and DiI fluorophores during the following FRET 
experiments.  	
 
 
   
(a)	Squalane	 (b)	Triace0n	
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	Fig.	6.35.	Confocal	images	of	squalane	oil	in	a	50	μm	chamber	loaded	with	DiO,	DiI	or	both,	where	the	 concentration	 of	 each	 fluorophore	was	 30	 μg/ml.	 All	 samples	 imaged	 in	 both	 the	 donor	 and	acceptor	emission	windows,	500-520	nm	and	561-582	nm	respectively.		
Figure 6.35 shows confocal images of the donor and acceptor emission window signals 
from squalane oil solutions loaded with DiO, DiO, or with a mix of both fluorophores. 
Figure 6.36 shows how the intensity varied across the pixels of these images. When 
both fluorophores were together the intensity of the donor emission window was found 
to be less than when DiO was without the DiI. This indicated that FRET was taking 
place as a portion of the energy from the DiO was being transferred to the DiI acceptor 
rather than being emitted. When both fluorophores were together the acceptor emission 
window intensity was found to be greater than the sum of the intensities from both the 
separate donor and acceptor images. The sum of the images was the intensity that was 
expected if the fluorophores emitted independent of each other without FRET occuring. 
Any intensity above this was therefore determined to be the FRET portion of the signal, 
which was seen in the signal from the donor + acceptor image. Since the intensity 
across each image was recorded as a distribution of pixel intensities, in reality this 
method may have discounted a portion of the FRET signal where there was overlap 
between the donor and acceptor sum distribution and the donor + acceptor distribution. 
However any pixels found to have intensities in this overlap region could not be defined 
as FRET occuring or not occuring, so could not be used as evidence of FRET, and 
therefore was disregarded. 
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	Fig.	6.36.	Histograms	of	the	intensity	(white	number)	from	the	images	in	Figure	6.35.	Showing	the	distribution	of	intensities	from	the	images	acquired	using	the	(a)	500-520	nm	donor	and	(b)	561-582	 nm	 acceptor	 emission	 windows.	 For	 the	 acceptor	 emission	 window	 distributions,	 a	 (black)	calculated	distribution	is	shown	of	the	addition	of	the	(DiO)	donor	and	(DiI)	acceptor	signals,	which	would	be	expected	if	FRET	did	not	occur,	and	(orange)	the	experimental	signal	from	the	(DiO	+	DiI)	donor	+	acceptor	sample,	where	(dotted	line)	the	higher	intensity	portion	of	the	signal	that	can	be	attributed	to	FRET	is	indicated.		
Figure 6.37 shows the emission spectra from POPC squalane LONDs loaded with either 
DiO or DiI flourophores and a spectra from a solution where both LOND types were 
mixed. The concentration for each LOND type was kept constant. Since the aim was to 
use the mixed LOND samples for forming MBs where they would rupture and mix, it 
was important that the LONDs did not spontaneously coalesce prior to MB formation. If 
spontaneous coalescence did occur, FRET would be enabled, and observed as an 
increase in the DiI peak emission intensity. The emission spectra for the mixed LONDs 
sample was compared to a calculation of the sum of emissions from the separate DiO 
and DiI LOND samples (Figure 6.37b, black trace). It can be seen that the experimental 
recording was equivelent to the calculated one, especially and importantly at the DiI 
emission peak wavelength. This result confirmed that the LONDs were not 
spontaneously rupturing, coalescing and mixing their oil cores as FRET had not 
occurred. 	
(a)	 (b)	
500-520	nm	
561-582	nm	
FRET	signal	
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	Fig.	6.37.	Emission	signal	from	separate	and	mixed	samples	of	DiO	and	DiI	POPC	squalane	LONDs.	Each	LOND	concentration	was	1011	LONDs/ml	the	signal	result	of	the	sum	of	the	DiO	and	DiI	signals	is	shown	in	black,		and	corresponds	to	what	would	be	expected	if	FRET	did	not	occur.	
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6.7.2. FRET at model MB air-water interfaces 
	Fig.	 6.38.	 Large	 air	 bubbles	 immobilised	 in	 50	 μm	 chambers	 by	 POPC	 squalane	 LOND	 solution	containing	mixes	of	donor	(D),	acceptor	(A),	and	non-fluorescent/empty	(E)	LONDs.	(i)	White	light	and	(ii)	acceptor	emission	window	fluorescence	(561-582	nm)	shown.	(d)	White	number	intensity	at	the	bubble	surfaces,	from	images	aii-cii,	is	shown	with	9th	order	polynomial	fits	to	each	data	set	(full	lines)	and	a	line	to	indicate	the	maximum	fluorescence	recorded	from	the	DiO	and	DiI	samples	(dotted	 black	 and	 green	 lines)	 (single	 point	 noise	was	 discounted)	 and	 a	 sum	 of	 two	maximum	fluorescence	values	(dotted	orange	line)	to	indicate	the	threshold	for	identification	as	FRET	signal	(as	 calculated	using	Equation	4.17,	 p	 96).	 (e)	The	DiO+DiI	 fluorescence	 image,	 cii,	 is	 then	 shown	with	the	FRET	threshold	value	removed.		
D	 E	 D	 A	A	E	
FRET	signal	
(ai)	 (bi)	 (ci)	
(aii)	 (bii)	 (cii)	
(e)	
(d)	
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Figure 6.38 shows the experimental acceptor emission following the trapping of large 
air bubbles by squalane POPC LONDs containing DiO donor, DiI acceptor, and no 
fluorophore. FRET was shown to occur at the fresh (not yet stabilised) gas-aqueous 
interface. This provides evidence that the LONDs adsorbed and ruptured at the interface, 
where the oil, and loaded fluorophores, from both LOND populations, mixed together 
allowing the FRET to occur. However the FRET signal was seen to be non-uniform 
along the surface, suggesting more oil at some locations compared to others. This 
implied the partial wetting of the air-water interface by the oil. The FRET image was 
calculated by taking the maximum fluorescence at the gas-aqueous interface from the 
donor + empty and empty + acceptor images (not including random point sources). This 
will likely have led to the FRET image to not include any of the thinner oil portions at 
the gas-aqueous interface, even though FRET may still have occurred there. Therefore, 
(Figure 6.38e) the FRET image seeming to show that FRET only occurred as lenses is 
likely an artefact of the image manipulation.  	
6.7.3. FRET to confirm OLI-MB formation 
	Fig.	 6.39.	 Mechanical	 agitation	 and	microfluidic	monodisperse	MBs	 formed	 from	 POPC	 squalane	LOND	solution	containing	mixes	of	donor	(D),	acceptor	(A),	and	non-fluorescent/empty	(E)	LONDs.	Acceptor	emission	window	(561-582	nm)	fluorescence	shown.	FRET	images	calculated	as	in	Figure	6.38.	
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Figure 6.39 shows the FRET experiment using MBs formed from the POPC squalane 
LOND solutions. Mechanical agitation and microfluidic monodisperse MBs (formed as 
in sections 6.5.1 and 6.5.2.1 respectively) are shown, with the former also being 
stabilised by POPC-PEG LONDs. FRET occurred at the MB surface for both formation 
techniques when using POPC LONDs. This confirmed that both formation techniques 
successfully formed OLI-MBs. Irregular fluorescence was seen around the shells, 
suggesting that the shell was not a simple uniform oil layer. For the microfluidic OLI-
MB FRET signal image, it can be seen that one of the MBs had this irregular but almost 
full shell FRET, whereas the other was lacking FRET across almost the entire shell. 
This suggested that the oil portion could vary from OLI-MB to OLI-MB. When 
repeating this experiment with POPC-PEG LONDs, FRET was not observed. Here, the 
fluorescence at the MB shells from the donor + acceptor sample was found to be 
slightly lower than the sum of the shell fluorescence from the donor + empty and empty 
+ acceptor samples. This agreed with the LOND fluorescence emission results found in 
Figure 6.37, where the mixed LOND samples had not yet merged. Since a high MB 
shell fluorescence was still observed the MBs must have been stabilised by the LONDs, 
but the lack of FRET showed that the LONDs remained intact, forming a shell of 
LONDs. 
 
6.8. Native oil fluorescence as an alternative to fluorescent oil-
loading 
Much of the work covered in the previous sections of this chapter used fluorescence as a 
marker for oil, to prove the formation of MBs with oil portions, including OLI-MBs. 
This was accepted as a method since the fluorophores used were known to be 
hydrophobic, solubilised well in to the oils used, and had previously been used in 
literature as drug mimics entrapped in micelle hydrophobic cores.230 However, since 
lipids have hydrophobic tails, even if very unlikely, it could be speculated that there 
would be the possibility for MBs to be stabilised by LONDs through a process of the 
LONDs supplying the MB surfaces with lipid and the loaded fluorophore, but no oil. 
Almost every section of this chapter holds evidence that disagrees with this as a 
possible mechanism of stabilisation. As a further conformation that oil had been loaded 
into the OLI-MBs, microfluidic and mechanical agitation POPC squalene OLI-MBs 
were formed and tested for fluorescence intrinsic to the oil without loading any 
fluorophore into any phase.  
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	Fig.	6.40.	Three	samples	of	MBs,	trapped	and	washed,	including	(a-b)	mechanical	agaitation	POPC	non-oil-MBs,	 (c-d)	 microfluidic	 monodisperse	 POPC	 squalene	 OLI-MBs,	 and	 (e-f)	 mechanical	agitation	POPC	squalene	OLI-MBs.	Two	MBs	are	shown	for	each	formation	type,	both	imaged	by	(i)	white	light	and	(ii)	500	-	794	nm	fluorescence,	using	a	488	nm	excitation	laser	source	(5%	power,	750	V	gain).	Fluorescence	 intensity	 in	the	background	trap	device	was	 indicative	of	 the	degree	of	washing,	 with	 (cii,	 eii)	 high	 background	 intensity	 images	 indicating	 LONDs	 remaining	 in	 the	surrounding	 solution,	 and	 (dii,	 fii)	 low	background	 intensity	 images	 indicating	a	 total	 removal	of	excess	LONDs.	Whilst	washing	(a,	c,	and	d)	many	of	the	MBs	rotated.	(Inset	in	d)	An	inset	is	shown	of	a	rapidly	acquired	snap	shot	from	one	of	the	spinning	MBs.		
Figure 6.40 shows the intrinsic fluorescence from POPC lipid stabilised non-oil-MBs 
and POPC squalene OLI-MBs, formed by both monodisperse regime microfluidics and 
mechanical agitation, during and after washing. Fluorescence was observed in both of 
the squalene OLI-MB types but not for the non-oil-MBs. Since all MB shells contained 
POPC, the fluorescence must have originated from the squalene oil. For both of the 
squalene OLI-MB types, the fluorescence was non-uniform over the MB area. Most 
OLI-MBs showed fluorescent rings around their perimeter with at least one fluorescent 
‘island’ closer to the middle. Presumably these islands were thicker oil patches, 
POPC	non-oil-MBs	
Microﬂuidic	OLI-MBs	 Mechanical	agita9on	OLI-MBs	
(ai)	 (bi)	
(ci)	 (di)	 (ei)	 (ﬁ)	
(aii)	 (bii)	
(cii)	
(dii)	
(eii)	 (ﬁi)	
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containing more fluorescent material. The fluorescent rings suggested the presence of 
complete oil layers, whilst the fluorescent islands presented evidence of oil lenses, 
together providing further evidence of pseudo-partial wetting. 		
6.9. Echogenicity of LOND formed OLI-MBs 
US scattering measurements were taken of the mechanical agitation and microfluidic 
monodisperse regime POPC squalane OLI-MBs. Since both sample concentrations were 
close to the concentration limit of our set-up for measuring US scatter response, these 
results are preliminary and the OLI-MB concentrations should be improved before more 
reliable US studies are performed. The experiments in this section were performed by 
Dr. James Mclaughlan. 
 
	Fig.	6.41.	Ultrasound	scatter	response	from	unwashed	POPC	squalane	OLI-MBs	formed	by	(a,	green)	mechanical	agitation	and	(b,	pink)	monodisperse	regime	microfluidics.	Responses	are	also	given	for	POPC	squalane	LOND	solution	(orange),	and	a	control	response	from	the	water	container	used	to	hold	a	sample	during	measurment	(blue).	All	measurments	shown	are	background	corrected	to	a	fiting	 of	 the	 raw	 water	 signal	 and	 removing	 that	 from	 all	 of	 the	 raw	 data.	 Fittings	 shown	 are	gaussians	(dark	green	and	red),	a	7th	order	polynomial	(black),	linear	(orange	line),	and	the	water	gaussian	after	background	correction	(blue	line).	
 
Figure 6.41 shows the US scattering from POPC squalane LONDs and OLI-MBs in the 
presence of excess LONDs. The OLI-MBs were formed through mechanical agitation 
and monodisperse regime microfluidics. During measurement, the mechanically 
agitated and microfluidic OLI-MBs were diluted to 104 and 105 OLI-MBs/ml 
respectively (due to the measurements taking place in a MilliQ filled 100 ml and 10 ml 
chamber respectively). As such, the intensity of the scatter should not be compared 
between the two samples. The resonant frequency should be unaffected by the OLI-MB 
dilution. The LOND solution did not show significant scattering above the signal from 
(a)	 (b)	 Microﬂuidic	OLI-MBs	
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the water chamber used for measurement. As such, any scatter from the OLI-MB 
samples can therefore be attributed fully to the MBs and not to the surrounding excess 
LONDs. The mechanical agitation and monodisperse OLI-MB samples had peak scatter 
responses at 3.0 and 1.8 MHz, with FWHMs of 1.9 and 1.2 MHz respectively. The 
broader width of the resonance from the mechanical agitation OLI-MBs is attributed to 
the broader size range in comparison to the microfluidic OLI-MBs, which had standard 
deviations of 11 and 1.6 µm respectively. From theory, assuming that each OLI-MB had 
one complete oil layer shell (between 20 and 500 nm thick), the mechanical agitation 
OLI-MBs (averaging 20 µm) and the microfluidic OLI-MBs (averaging 2.4 µm) were 
expected to have resonant frequencies centred on 0.3 and 4.1-4.3 MHz respectively 
(Chapter 3.2.2, page 40). The resonance expected from theory and the experimental 
results disagreed significantly. If the mechanical agitation OLI-MBs were resonating as 
lipid stabilised MBs (as though the oil layer were effectively invisible, or 0 nm thick, in 
regards to the effect on oscillations), the acquired peak resonance of 3.0 MHz would 
predict MB diameters averaging 3 µm. On the other hand, if the mechanical agitation 
OLI-MBs were resonating as MBs in a continuous oil phase (as though the oil layer 
were effectively of infinite thickness, with a single gas-oil shell, where χ = 0 N/m and 
γO-A = 28 mN/m), the acquired peak resonance of 3.0 MHz would predict MB diameters 
averaging 2 µm. In either of the above cases, which together cover MBs without any oil 
and OLI-MBs with thick oil shells, the mechanical agitation OLI-MBs were 
experimentally measured as significantly larger than this (averaging 20 µm). A similar 
result is seen for the microfluidic OLI-MBs. Here, the acquired peak resonance of 1.8 
MHz would predict lipid MBs and MBs in a continuous oil phase of 4.5 and 3.6 µm 
respectively, both predictions being larger than the measured microfluidic OLI-MBs 
(averaging 2.4 µm). There was the possibility of measuring subharmonic and harmonic 
resonance frequencies from the OLI-MBs during these experiments. However, no lower 
harmonics were apparent for the mechanical agitation OLI-MBs, and the microfluidic 
OLI-MBs were exposed to US of the predicted resonance frequency with no resonance 
being recorded other that region. Therefore, it can be assumed that the observations 
were not subharmonic and/or harmonic. Perhaps more importantly though, the smaller 
microfluidic OLI-MBs resonated at a lower resonant frequency compared to the larger 
mechanical agitation OLI-MBs that resonated at a higher resonant frequency. Since this 
disagrees with the well-known property that smaller MBs resonate at higher frequencies 
(see Theory Chapter 3.2.2, p 41-42), this result heavily suggested that the mechanical 
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agitation OLI-MBs and microfluidic OLI-MBs had fundamentally different acoustic 
responses to US. 
 
6.10. Conclusion 
In this chapter the experiments aimed to gain control over how the gas, oil, lipid and 
aqueous phases were introduced to each other through compartmentalising the oil phase 
into LONDs and by microfluidics. The former aided by controlling the amount of oil 
meeting the gas surface and the position of the lipid, while the latter reduced chaotic 
turbulence and pushed the system into a controlled laminar flow between each phase as 
they were introduced to one another. 
Squalane LONDs were found to have peak diameters of 140-190 nm and concentrations 
of 1-6 x 1013 LONDs/ml. LONDs were found to be stable in size for at least 25 days 
(potentially over 8 months), and remained at 1013 LONDs/ml at least for 4 months. No 
differences were found between squalane and squalene LONDs, whilst the size 
distribution of tripropionin LONDs was found to be larger. This is thought to be due to 
tripropionin’s far higher solubility in water, 3.07 mg/ml at 37 °C.96 
Introducing POPC squalane LONDs to glass saw the LOND solution spontaneously 
spread across ‘fresh’ glass surfaces. Observations of the glass surface from where the 
solution had been displaced showed that a randomly packed array of ~1 µm diameter oil 
patches had been deposited. This was the first indication that the LONDs could be 
induced to spread into either oil lenses or a complete oil layer. QCM-D experiments 
looked deeper at the mechanisms of LOND adsorption and spreading. When POPC 
squalane LONDs were introduced to hydrophobic QCM-D surfaces evidence was given 
that they adhered, followed by rupturing into an oil layer between 10 and 20 nm thick. 
Therefore, it was estimated that the POPC squalane LONDs would form OLI-MBs with 
oil layer thickness of 10s of nanometres. In comparison, POPC and POPC-PEG 
squalane LONDs were found to bind intact to hydrophilic QCM-D surfaces, and not be 
removed by washing. A weaker attachment was seen when the POPC-PEG LONDs 
were introduced to a hydrophobic QCM-D surface.  
The effect that LONDs have on the surface tension of air-lipid/water interfaces was 
studied using an LB trough. By fully compressing a POPC model MB monolayer, 
introducing POPC squalane LONDs directly underneath, then expanding the monolayer, 
the surface pressure was recorded as the LONDs were allowed to enter the monolayer. 
This study revealed that the LONDs did not enter the fully compressed monolayer, but 
as the surface pressure was reduced entered when the surface pressure was between 8 
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and 15 mN/m. These results indicated that once a model MB surface had a fully 
compressed monolayer, LOND entry to the air-water interface was not possible, but that 
at a lower monolayer concentration, for example when a MB is being formed, LONDs 
could enter and rupture. Studies where LONDs were allowed to interact with static 
DPPC model MB monolayers, compressed to different initial surface pressures, 
revealed the time scale for the LONDs to enter and change the surface pressure. The 
results showed that no matter the initial monolayer compression, all of the surfaces 
showed exponential increases to the surface pressure up to a similar end value. For the 
final surface pressures to all be the same, the same interfaces had to be present in every 
sample regardless of the initial monolayer compression. The only effect that the initial 
compression had was on the time-scale for surface pressure change up to this final value, 
with higher initial compressions requiring less time. For an air-water surface with no 
monolayer and a monolayer at ESP, 75% of the final surface pressure value was reached 
after 26 and 10 min respectively. This suggested a limit imposed on the monolayer that 
once it became ‘full’, from either lipids or a mixture of lipids and intact LONDs, 
interactions would stop. If the LONDs adhered to the air-water surface intact, this 
would require that a monolayer with a higher initial compression be filled with less 
LONDs when ‘full’. The only way for all of the interfaces to be equivalent and for the 
surface to have this limiting capacity was in the case that the LONDs spread. This 
would create two interfaces; water/lipid-oil and oil-air, where LONDs would continue 
to enter and spread until the combined lipids shells would fill the water/lipid-oil 
interface, while their oil cores would merge together, contributing thickness to an oil 
layer, where the amount of oil present would play no role in determining the effective 
surface pressure from the two interfaces. 
OLI-MBs were formed successfully from POPC LOND solutions by both mechanical 
agitation and monodisperse regime microfluidics using squalane, squalene, and 
tripropionin oils. Microspray microfluidics were unsuccessful at MB formation from 
POPC squalane LONDs but did work for tripropionin OLI-MBs, though without 
improving the yield as desired. Mechanical agitation POPC squalane OLI-MBs and 
POPC-PEG squalane LOND shelled MBs were formed at 20 ± 6 µm (SD 11) µm and 
1.7 ± 0.5 x 106 OLI-MBs/ml, and 26 ± 3 µm (SD 16) µm and 2 ± 1 x 106 MBs/ml 
respectively. Lifetime studies showed that these squalane OLI-MBs took 35 min to 
halve in concentration and had a stable size for the initial 60 min. Microfluidic 
monodisperse POPC squalane OLI-MBs and POPC tripropionin OLI-MBs were formed 
at 2.4 ± 0.3 µm (SD 1.6) µm and 6.2 ± 0.8 x 106 OLI-MBs/ml, at a rate of 5 x 103 MB/s, 
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and 2.1 ± 0.1 µm (SD 0.8) µm and 105 OLI-MBs/ml, at a rate of 35 x 103 MB/s, 
respectively. Lifetime studies showed that the squalane OLI-MBs took 35 min to halve 
in concentration with a very similar lifetime relationship to their mechanical agitation 
counterparts. After formation by either method, using POPC or POPC-PEG LONDs, all 
MBs showed fluorescent shells, indicating successful oil portion integration into the 
MB shell. The POPC LOND formed OLI-MBs often showing non-uniform 
fluorescence around the shell, either as a thicker or more intense fluorescent region. 
These regions could often been seen as surface morphology in corresponding white 
light images. These findings led to the conclusion that the OLI-MBs were stabilised by 
pseudo-partial wetting films. 
FRET work using squalane LONDs confirmed the conclusion made from the previous 
LB trough and QCM-D sections, showing that POPC LONDs merged as they stabilised 
MBs, resulting in the formation of OLI-MBs. On the other hand FRET was not 
observed for the fluorescent MBs stabilised by POPC-PEG LONDs, confirming that 
they remained intact as a LOND shell. Observations of OLI-MBs formed from squalene 
LONDs allowed observations to be made of fluorescence intrinsic to the oil, rather than 
needing to use a fluorophore loaded into the oil phase. It was confirmed that the oil 
portion had successfully been integrated into the OLI-MB shell. Irregular fluorescent 
structures were observed which translated to the white light images.  
US scatter measurements of the POPC squalane LONDs, monodisperse microfluidic 
OLI-MBs, and mechanical agitation OLI-MBs showed no scatter response above the 
noise, a peak resonant frequency at 1.8 MHz (FWHM 1.2 MHz) and a broader peak 
resonant frequency at 3.0 MHz (FWHM 1.9 MHz) respectively. The larger resonant 
frequency distribution was expected from the mechanical agitation OLI-MBs due to 
their larger size distribution compared to the monodisperse microfluidic OLI-MBs. 
However, the resonant frequency of the monodisperse microfluidic OLI-MBs was lower 
than that expected from theory for 2.4 µm OLI-MBs, resonating either as lipid MBs (4.1 
MHz), OLI-MBs with 20-500 nm thick oil layers (4.1-4.3 MHz), or MBs in a 
continuous oil phase (2.7 MHz). Similarly, the resonant frequency of the mechanical 
agitation OLI-MBs was far too high for that expected from theory for 20 µm OLI-MBs, 
resonating either as lipid MBs (0.3 MHz), OLI-MBs with 20-500 nm thick oil layers 
(0.3 MHz), or MBs in a continuous oil phase (0.3 MHz). These results suggested that 
neither OLI-MB was resonating as expected based on theory, but also that the two OLI-
MB populations were not resonating in the same manner, otherwise at least an inverse 
relationship between resonance and OLI-MB size should have been followed. 
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This chapter confirmed that OLI-MBs could be formed within clinical sizes from POPC 
LONDs of squalane, squalene and tripropionin. The former two oils would be possible 
carriers for highly hydrophobic drugs, whilst the latter would be a possible carrier for 
poorly water-soluble drugs. Many of the results showed that the OLI-MB oil portion 
would be an oil layer of 10s of nanometres, while indications were made that oil lenses 
were also present. This led to the conclusion that the OLI-MBs were stabilised by 
pseudo-partial wetting films. The surface tension of the OLI-MB shell was found to be 
the same as non-oil-MBs when at rest, but lower, and so more energetically favourable, 
when the MB shell was expanded, as it would be during clinical use if undergoing 
pressure drops from flow or US exposure. The OLI-MBs were found to take ~30 min to 
halve in concentration, meaning that for clinical use they would need to be formed on-
site and used immediately, or the lifetime needs to be improved by changing the gas 
core or lipid shell. However, changing the lipid shell to be more stable could inhibit the 
LONDs from spreading and forming the oil layer (see Conclusion Chapter 9, p 254, for 
a future experiment, using Diacetylene in the LOND shell that after OLI-MB formation 
could be activated into a cross-linked state, giving LONDs of a similar stability to the 
work in this chapter, but OLI-MBs with greater stabilising shells). US scatter responses 
revealed that the OLI-MBs did still have an acoustic response with the oil portion, 
however their response was not what was expected from theory. As such, more work 
needs to be done to characterise the OLI-MBs acoustic properties before work can be 
progressed to in vitro drug delivery analysis, and eventually in vivo work. 
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7. Results: Co-flow controlled, three-phase FF 
pinch-off 
 
Chapter 5 established that the formation of clinically relevant OLI-MB structures would 
require high levels of control over how the gas, oil, and aqueous phases were introduced 
to one another. This chapter evaluates the use of three-phase FF microfluidics to 
produce OLI-MB structures. Figure 7.1 shows a schematic of a gas bulb, held at a three-
phase FF nozzle, coated by a thin oil layer, surrounded by the aqueous phase. This was 
the idealised on-chip phase geometry that this project aimed to achieve. It was 
hypothesised that this would then enable the pinch-off of gas-in-oil simultaneously with 
oil-in-aqueous. In order to retain the fine control over the oil phase thickness at the 
nozzle, the oil and aqueous were introduced up-stream of gas phase in a co-flow regime 
where the oil layer could be finely controlled. The work performed in this chapter aimed 
to improve work presented by Hettiarachchi et al. (2009), Kendall et al. (2012), and 
Shih et al. (2013).31,94,95 The microfluidic systems used in this chapter were designed by, 
and later in collaboration with, Dr. S. A. Peyman. 
The results in this chapter cover: 
1) Observations of the oil layer thickness during oil-aqueous co-flow in the co-flow 
channel prior to pinch-off. The aim here was to determine which oils gave the 
greatest control over the oil layer thickness. 
2) Characterisation of two-phase FF pinch-off of gas-in-oil and oil-in-aqueous in order 
to determine if flow conditions exist that would enable both pinch-offs to occur 
simultaneously in a three-phase pinch-off system. 
3) Three-phase OLI-MBs pinch-off trials with aqueous surfactant solutions of lipid, 
pluronic, Triton, and BSA. 
 
All on- and off-chip imaging during this chapter used the upright microscope (Chapter 
4.1, p 60). 
All of the experiments in this chapter dealt with microfluidics. Four three-phase 
microfluidic designs were used throughout the work of this chapter; 5C1, 3C1, 3C2, and 
3C3. For more information on each design, refer to the Experimental Chapter 4.2.2 (p 
64-66). In brief; all of these designs brought the three input phases of gas, oil, and 
aqueous to one single FF nozzle region. Either all phases were introduced together, 
leading to a five channel system at the nozzle, ‘5C’, or the oil and aqueous phases were 
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introduced upstream of the gas phase in a co-flow channel, leading to a three channel 
system at the nozzle, ‘3C’. The last number (1-3) refers to the design number. 3C1 was 
the base design. For 3C2 the outlet was made thinner. For 3C3 the angle of incidence 
between the oil to aqueous phase inlets in the co-flow channel was reduced and the oil 
inlet was made thinner. 
 
	Fig.	7.1.	Schematic	of	OLI-MB	pinch-off	 in	the	3C1	microfluidic	device	with	the	regions	of	 interest	marked	by	black	dotted	lines	and	naming	terms	given	for	each	marked.	
 
7.1. Forming a thin oil layer under oil-aqueous co-flow 
In this section of work, during flow of standard lipid solution, oil, and gas phases 
through the 3C1 microfluidic device, the oil-aqueous co-flow channel was observed in 
order to assess the degree of control that could be obtained over the co-flow oil layer 
formed there. The main observations were of average oil layer thickness and the 
uniformity along the channel. This was important as a uniform, thin oil layer was 
desired to coat the gas bulb at the nozzle, and as such, a higher degree of control over 
the oil layer thickness upstream of the nozzle was thought to be important to facilitate 
Oil-aqueous	
co-ﬂow	channel	
Pinching	neck	
Gas	bulb	
OLI-MB	
Aqueous	
Surfactant/lipid	
Oil	
Gas	
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this. During this work oil and lipid solution flow rates were varied whilst gas pressure 
was kept constant at 3 psi (20.7 kPa). 	
	Fig.	7.2.	Fluorescence	images	used	to	measure	the	oil	layer	thickness	given	in	the	co-flow	channels	of	the	3C1	microfluidic	devices,	by	varying	the	oil	to	standard	lipid	solution	flow	rates.	(a)	Nile	red	in	 dodecane	 oil	 measurement	 image	 is	 shown.	 This	 indicates	 how	 the	 phases	 flowed,	 what	 was	measured,	and	where	the	device	bounderies	were.	This	 is	 followed	by	 images	using	(b)	squalane,	(c)	triacetin,	(d)	dodecane,	and	(e)	isoamyl	acetate,	where	all	images	were	at	3	psi	C3F8	gas	and	0.5	μl/min	oil,	with	(a)	28	or	(b-e)	16	μl/min	lipid	solution.			
Figure 7.2 shows example images of the oil-aqueous co-flow channel during flow of oil 
and standard lipid solution. For the same flow rates, squalane and triacetin both showed 
a much thicker oil layer compared to dodecane and isoamyl acetate. This was expected 
from their higher viscosity. However, squalane and dodecane both showed a far more 
unifom thickness along the co-flow channel compared to triacetin and isoamyl acetate. 
This was important as it identified that the latter two oils may be less likely to break-up 
before arrival at the nozzle. Figure 7.3 shows how the oil layer thickness changed over a 
range of oil to lipid solution flow rate ratios and how the gradients of these relationships 
related to the oil viscosity. All four oils showed a linear relationship between the oil 
layer thickness and the flow rate ratios, where the gradient of the relationship was 
strongly dependant on the oil viscosity, correlating well (R2 = 0.999) to an exponential 
relationship. For squalane and isoamyl acetate, the relationship fitted well to an 
intercept through 0, whereas for triacetin and dodecane did not. It is likely that this was 
due to some property of the oil or interaction of the oil with the lipid solution, however 
this could not be attributed to the oil viscosity, density, or surface tension. 
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	Fig.	 7.3.	 (a)	 Oil	 layer	 thickness	 given	 in	 the	 3C1	 co-flow	 channel,	 measured	 as	 in	 Figure	 7.2,	dependant	on	the	ratio	of	(Qo)	oil	to	(Ql)	lipid	solution	flow	rate.	Constant	gas	pressure	(3	psi)	and	oil	flow	rate	(Qo	=	0.5	μl/min).	Errors	shown	are	the	standard	deviation	of	the	oil	 layer	thickness	down	 the	 co-flow	 channel.	 Linear	 fits	 are	 shown	with	 (dotted)	 and	without	 (solid)	 the	 intercept	fixed	to	0.	(b)	The	gradients	of	these	fits	are	then	shown	verses	the	oil	viscosity.		
Figure 7.4 shows flow of a squalane oil layer after passing into the thinner portion of 
the 3C1 co-flow channel, just prior to the nozzle. A schematic is given to explain how 
the oil is thought to be flowing. This type of flow pattern was seen to occur with all of 
the oils trialled. The oil layer would partially dewet from the channel wall, sometimes 
passing into the middle of the channel or fully to another wall. This flow pattern 
occurred more often when the oil to lipid solution flow rate ratio and the oil flow rate 
itself were both low. It is expected that this occurred in the thinned co-flow due to the 
increase in fluid velocity, providing a higher degree of shear forces at the oil-aqueous 
interface. These flow patterns did not appear to affect the coating of the gas bulb, as the 
oil was often seen to pass back onto the gas bulb at the nozzle (as can be seen in the 
bottom right corner of Figure 7.4a). However, if the oil stream had remained against the 
original flow wall until contacting the gas phase, it can be assumed that no lipids would 
have stabilised the oil-wall interface, allowing the oil to easily wet the gas on contact. 
On the other hand, by passing from one wall to another, all sides of the oil stream may 
have become at least partially stabilised by lipid. This could prevent the oil layer from 
wetting the gas bulb, or at least make the wetting less efficient. This type of flow pattern 
was seen to be signicantly reduced when updating the microfluidic devices from the 
3C1 (and 3C2) design to the 3C3 design, where the angle of incidence for the 
introduction of the oil and aqueous phases was reduced, allowing for lower flow rates to 
be used more reliably. 
(a)	 (b)	
 		
 [.	]
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	Fig.	7.4.	(a)	Experimental	image	of	the	thinned	co-flow	region	of	the	3C1	device	during	three	phase	flow	of	3	psi	C3F8	gas,	0.1	μl/min	squalane	oil,	 and	15	μl/min	standard	 lipid	solution.	This	 image	presents	an	example	of	how	when	 the	oil	 stream	was	controlled	 to	become	thinner,	eventually	 it	would	stop	co-flowing	in	contact	with	the	entire	depth	of	the	microfluidic	channel,	and	often	flow	around	the	device	channel.	(b)	A	schematic	is	given	to	show	what	is	thought	to	have	been	occurring.		
From the results shown in Figures 7.2 and 7.3 squalane and dodecane were chosen as 
the main candidate oils going forward. This was because, at least in Figure 7.2, they 
both showed a higher degree of oil layer thickness uniformity along the co-flow channel, 
and because squalane and dodecane would allow for coarse and finer changes to the oil 
layer thickness during three-phase pinch-off trials. Importantly, this work informed on 
what should be expected during the three-phase trials in terms of how the oil layer 
would be presented at the nozzle and its dependance on changes to the flow rate and oil 
type. 
 
7.2. Mapping flow rate ratios to facilitate three-phase FF pinch-
off  
	Fig.	7.5.	Schematics	of	(a-b)	two-phase	and	(c)	three-phase	nozzles,	mid-pinch-off	of	gas	(white)	oil	(orange),	and	aqueous	(blue)	phases,	indicating	the	two	interfaces	where	enough	shear	force	needs	to	be	applied	for	pinch-off	 to	occur.	This	schematic	serves	as	an	 illustration	of	(a-b)	the	two	two-phase	 pinch-offs	 that	 were	 examined	 in	 order	 to	measure	 the	 oil	 velocities	 required	 at	 the	 two	interfaces	 and	 to	 estimate	 flow	 conditions	 that	 would	 allow	 the	 two-phase	 pinch-offs	 to	 occur	simultaneously	in	(c)	three-phase	pinch	off.		
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Two-phase pinch-off of oil-in-aqueous and gas-in-oil was studied to define the flow 
parameters that would allow the two-phase pinch-offs to occur. The volumetric flow 
rate of the oil phase was then converted into a flow velocity for the two experiments. 
This was done so that it could be assessed if there are oil velocity ranges that would 
facilitate both two-phase pinch-offs to occur simultaneously. This would then allow for 
an estimation of the conditions that would allow for three-phase pinch-off to occur. 
Figure 7.5 shows schematics of the two two-phase experiments and how they relate to 
three-phase pinch-off, including the interfaces where the oil velocity had to match the 
conditions to allow for two-phase pinch-off. This study worked under the assumptions 
that the two-phase gas and oil bulbs pinched with a similar geometry and that during 
three-phase pinch-off the oil layer would be negligibly thin relative to the rest of the 
phase geometry at the nozzle. Work was performed using two-phase FF microfluidics 
(detailed in Chapter 4.2.2, p 61), C4F10 gas, squalane, triacetin, dodecane, and isoamyl 
acetate oils, with standard lipid solution and 1 vol% Triton solution aqueous phases. 
 
7.2.1. Oil droplet pinch-off in water/surfactant 
	Fig.	 7.6.	 FF	 pinch-off	 trials	 of	 (a)	 triacetin-,	 (b)	 isoamyl	 acetate-,	 and	 (c)	 squalane	 oil-in-1	 vol%	Triton	solution.	Triton	solution	flow	rates	were	~0,	1,	and	3	μl/min,	with	oil	flow	rates	of	~0,	0.1,	and	 0.01	 μl/min	 respectivley.	 Triacetin	 pinch-off	 only	 occurred	 briefly	 under	 inertial	 flow,	 after	active	 flow	 had	 been	 stopped.	 Pinch-off	 regimes	 are	 also	 shown	 for	 (d)	 dodecane	 oil-in-Triton	solution,	showing	(di)	co-flow,	(dii)	jetting,	and	(diii)	dripping,	at	Triton	solution	flow	rates	of	5,	10,	and	1	μl/min,	with	oil	flow	rates	of	1.0,	0.5,	and	0.5	μl/min	respectivley.			
Figure 7.6 shows examples of attempted pinch-off of triacetin and isoamyl acetate, and 
successful pinch-off of squalane and dodecane in 1 vol% Triton solution. It also shows 
examples of co-flow and jetting for dodecane oil. Pinch-off of all four oils in standard 
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lipid solution was trialled, but no successful pinch-off was found for any flow ratio 
including flow that would have led to Ca << 0.1, where displacement of the oil bulb 
became so slow that the oil syringe pump led to a pulsatile flow that on average 
appeared stationary. Immediately this brought into question the capability of three-
phase pinch-off in lipid solution as the oil-aqueous interface of an oil droplet or a gas 
MB coated in oil is the same. For 1 vol% Triton solution, (Figure 7.6d) dodecane oil 
could easily be transitioned through co-flow, jetting, and dripping regimes, at 
progressively lower aqueous and oil flow rates. (Figure 7.6c) Squalane oil also achieved 
pinch-off at low flow rates, but only ever in a jetting-dripping cross-over type of regime, 
where the oil bulb elongated for a few tens of micrometres into the outlet, but on pinch-
off only left an oil bulb typical of a dripping regime. (Figure 7.6a) Triacetin was only 
seen to achieve pinch-off under limited inertial flow in the microfluidics, after the flow 
rates had been manually set to 0 µl/min. However, this pinch-off occurred as aqueous-
in-oil. (Figure 7.6b) At low flow rates, isoamyl acetate jetted into the outlet and part-
solubilise into the aqueous phase. 
 
	Fig.	7.7.	Mapping	of	the	pinch-off	regimes	for	dodecane	and	squalane	oil-in-1	vol%	Triton	solution.	For	 dodecane	 oil,	 (a)	 the	 different	 pinch-off	 regimes	 that	 were	 observed	 at	 specific	 oil	 against	Triton	solution	flow	rates	are	indicated,	with	semitransparent	shapes	indicating	the	regions	where	(orange)	 dripping,	 (green)	 jetting,	 and	 (black)	 co-flow	were	 observed.	 (b)	 The	 flow	 rates	where	dripping	was	observed	are	then	compared	for	both	oils.		
Figure 7.7 indicates which pinch-off regime (if any) was observed at specific volumetric 
flow rates for oil and Triton solution at a two-phase FF nozzle. It then compares the 
flow conditions that facilitated dripping pinch-off for squalane and dodecane. The semi-
(a)	 (b)	
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transparent coloured shapes give the rough limits of each pinch-off regime. Achieving 
the dripping pinch-off regime was less dependant on the flow rate ratio between the two 
phases than it was on the combined flow rate throughout the chip. In other words, the 
most effective way to transition the system into the dripping regime was to keep the 
flow rate ratio the same whilst lowering the combined flow rate. This agrees with Ca 
theory (see Theory Chapter 3.1.2, p 35-36). Dripping became the most prominent pinch-
off regime when the flow rates of both phases were reduced, which would have led to a 
reduction in both phases’ Ca. However, there was significant overlap between the flow 
conditions that would allow for either jetting or dripping pinch-off to occur. Both pinch-
off regimes were highly stable, meaning the once the system had achieved one of the 
flow regimes it remained in that regime until the flow rate of either or both of the phases 
was changed enough to transition the pinch-off into the other regime, at which point that 
regime would be highly stable in the overlap region. This agreed with Ca theory, with 
predicts a transition zone able to give both types of pinch-off regime for the same flow 
velocities. Squalane oil was only observed to give dripping pinch-off at flow rates far 
below that of dodecane. Squalane pinch-off in the dripping regime was only achieved 
up to ~0.02 times the oil flow rate and ~0.28 times the Triton solution flow rate. The 
necessary reduction to the oil flow rate was expected, due to Ca theory, in order to 
balance the ~23 times higher oil viscosity. The Triton solution was the same for both 
oils, meaning its viscosity was constant. Therefore, due to the remaining reduction to 
the oil flow rate and the reduction to the triton solution flow rate, it can be concluded 
that the interfacial tension for the Triton-squalane interface must have been lower than 
that of the Triton-dodecane interface during flow through the nozzle. These results 
estimate that the Triton-squalane interfacial tension must have been ~3 times lower than 
that of the Triton-dodecane interfacial tension at the nozzle. 
 
7.2.2. MB pinch-off in oil 
The flow rates needed for MB formation in oil in a FF microchip were mapped, with 
analysis of the MB sizes formed at given volumetric flow rate. Experimentally this 
work was undertaken with triacetin, squalane, and isoamyl acetate, however, since the 
previous section (7.2.1) showed that pinch-off of oil-in-aqueous was only effective with 
dodecane oil, a focus on dodecane oil is given here. 
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	Fig.	 7.8.	C4F10	 gas	 (light	 grey)	pinch-off	 in	dodecane	oil	 (orange).	 Schematics	 are	 shows	of	 (a)	oil	dominant	 flow	where	 the	gas	phase	 is	held	as	a	 static	bulb,	 (b)	 stable	MB	 formation,	 and	 (c)	 gas	dominant	 flow.	 (d)	 An	 experimental	 pinch-off	 image	 is	 given	 where	 the	 oil	 flow	 rate	 and	 gas	pressure	are	40	μl/min	and	2	psi	respectivley.	No	surfactant	was	present.		
	Fig.	 7.9.	 Schematic	 cross-section	of	 a	microfluidic	outlet	where	a	MB	with	a	diameter	>	25	μm	 is	squashed	 within	 the	 outlet’s	 depth	 of	 25	 μm,	 giving	 a	 MB	 slug.	 The	 diameter	 of	 the	 MB	 slug	 is	observed,	 giving	 an	 apparent	 MB	 diameter	 that	 would	 give	 an	 overestimation	 of	 the	 total	 MB	volume	 if	 the	on-chip	MB	was	assumed	spherical.	A	comparison	 is	given	 to	 the	real	MB	diameter	once	the	MB	moves	off-chip.		
Figure 7.8 shows schematics of the flow regimes when MB pinch-off is achieved 
(Figure 7.8b), and when either the oil (Figure 7.8a) or gas (Figure 7.8c) phases are 
dominant, preventing pinch-off. An example image for C4F10 MB formation in 
dodecane oil is also shown. In order to map the flow conditions that led to MB 
formation, the gas was set to a given pressure, then the oil flow rate was increased over 
a range of flow rates. Flow rates were noted where the gas phase transitioned from gas 
dominant, to MB formation with immediate coalescence, to stable MB formation, and 
then to a static gas bulb. MBs were seen to form on-chip with an apparent diameter of 
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30-61 µm. Figure 7.9 shows a schematic explaining how a MB that is observed in a 
channel that is thinner than its diameter off-chip will form a MB slug with an apparent 
diameter that is larger than the MB’s real diameter. Simplifying the MB slug to a 
cylindrical volume, the apparent diameter can be used to calculate the MB’s real 
diameter. Due to the MB slug’s edge curvature, this estimation becomes less accurate 
for MB slugs with apparent diameter closer to the channel depth. Hence, the recorded 
MB diameter was always the smallest out of the measured apparent diameter and the 
calculated real diameter. Therefore, the real MB diameter was estimated as ~30-52 µm. 
The large MB size was likely due to the lack of any surfactant in the oil phase. While 
the oil and gas were both hydrophobic, a surface tension will have still existed at the 
interface between them. An amphiphilic surfactant will not have decreased the surface 
tension as efficiently as for a hydrophilic-hydrophobic interface, but any surface active 
particles able to close pack at the surface (e.g. solid particles, hydrophobic-hydrophilic-
hydrophobic tri-block copolymers, etc.) could have stabilised the MBs to some degree, 
likely allowing for smaller MBs to be formed.  
 
	Fig.	7.10.	Apparent	MB	diameter	formed	at	given	flow	rate	ratios	between	the	discontinuous	C4F10	gas	phase	and	the	continuous	dodecane	oil	phase	(Qd/Qc).	MBs	measured	from	the	gas-in-oil	pinch-off	 images	presented	 in	Figure	7.8.	The	gas	volumetric	 flow	rate	was	calculated	 from	the	average	MB	volume	and	formation	rate,	knowing	the	chamber	height	was	25	μm.	The	lines	of	fit	(green)	are	
y	=	axn	power	relationships,	fit	to	all	of	the	data	with	an	equal	weighting	between	different	data	sets,	where	the	power	(n)	is	noted.		
Figure 7.10 shows the apparent MB diameters formed across a range of volumetric flow 
rate ratios between the gas and oil phases. Power relationships were fitted to the data, 
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with comparison to the literature scaling law for MB pinch-off (Equation 3.8). The 
device used in this study was a planar FF design with a short nozzle, which Garstecki et 
al. (2005) found to have a scaling law power of n = 0.4 (Figure 7.10d, dashed green 
line).159 However these studies followed a power of n = 0.2. Fitting a power relationship 
to each gas pressure data set showed a similar power value for each curve where the 
MB diameter was larger for higher gas pressures, even though the ratio of flow rates 
was the same. The larger MB size was likely due to the higher flow velocity delaying 
pinch-off relative to the amount of gas entered into the MB. Similar pinch-off in 
squalane, triacetin, and isoamyl acetate gave powers of 0.5, 0.1, and 0.3 respectively 
(data not shown). There was no apparent correlation between MB diameter and the 
viscosity, density, or surface tension of the relevant oils. 	
 	Fig.	 7.11.	 (a)	 Oil	 flow	 rates	 and	 C4F10	 gas	 pressures	 capable	 of	 forming	 gas-in-oil	 MBs	 without	surfactant	 (colour	 filled	 strips).	 The	maximum	 (down	 arrow)	 and	minimum	 (up	 arrow)	 oil	 flow	rates	are	indicated	at	set	gas	pressures.	Formation	regions	are	shown	for	squalane	(black),	triacetin	(red),	and	dodecane	(blue).	Isoamyl	acetate	(green)	only	showed	successful	pinch-off	at	2	psi	gas.	(b)	A	graph	is	given	comparing	the	oil	viscosities	to	the	associated	gradients	seen	in	graph	a,	with	both	a	power	(line)	and	linear	(dashed)	fit..		
Figure 7.11 shows the range of oil flow rates, at set gas pressures, that facilitated pinch-
off of C4F10 MBs in squalane, triacetin, dodecane, and isoamyl acetate. For all oils, the 
range of oil flow rates found to allow for stable MB pinch-off were found to be limited. 
For squalane, triacetin, dodecane, and isoamyl acetate the oil flow rate ranges were 4 ± 
1, 4 ± 1, 7 ± 1, and 8 µl/min respectively at each gas pressure. The lowest gas pressure 
given for each oil data set was the minimum gas pressure limit that allowed for MB 
(a)	 (b)	
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formation, under which only oil or gas dominant regime could be achieved. For 
squalane, triacetin, and dodecane the minimum gas pressures were 2.5, 2, and 1 psi 
respectively, whereas for isoamyl acetate MBs were only formed at 2 psi. The main oil 
property that determined what flow ratio facilitated MB formation was the oil viscosity, 
with a high oil viscosity requiring a lower oil flow rate or higher gas pressure (Figure 
7.11b), which was expected from Ca theory (Equation 3.6). 
 
7.2.3. Combining two-phase pinch-off regimes to estimate three-
phase pinch-off conditions 
	Fig.	 7.12.	Overlaying	 the	dodecane	oil	 flow	velocities	 that	 allowed	pinch-off	 to	occur	during	 two-phase	 pinch-off	 experiments.	 Assumptions	 were	 made	 (1)	 that	 the	 oil	 and	 gas	 bulbs	 of	 oil-in-aqueous	and	gas-in-oil	two-phase	pinch-off	were	of	equivilent	size	and	(2)	had	a	diameter	of	7	μm	(completely	filling	the	thinner	dimension	of	the	nozzle),	and	(3)	that	the	oil	 layer	thickness	in	the	three-phase	pinch-off	would	be	negligible.		
Figure 7.12 compares the range of dodecane oil velocities shown to give pinch-off at the 
gas-oil (grey) and oil-aqueous (blue) interfaces from the two-phase mapping 
experiments in the previous sections. Table 7.1 presents the minimum and maximum 
flow velocities recorded to achieve C4F10 gas-in-oil and oil-in-Triton solution pinch-off 
from the two-phase experiments in the previous sections for both squalane and 
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dodecane. The velocities given are only estimation for the velocities that would occur in 
a three-phase nozzle, since it has been assumed that the two-phase gas and oil bulbs 
were identical and that the three-phase oil layer would be negligibly thin. However it 
can be assumed that the two interfaces in the three-phase pinch-off would behave the 
same as in their individual two-phase pinch-off experiments since the phase volume 
plays no role on influencing the interface’s surface tension or Ca. 	Tab.	7.1.	Dodecane	and	squalane	oil	minimum	and	maximum	flow	velocities	that	allow	for	pinch-off	of	C4F10	gas-in-oil	and	oil-in-1	vol%	Triton	to	occur	in	a	two-phase	FF	device	respectively,	based	on	the	assumptions	defined	in	Figure	7.12.	
		
Figure 7.12 and Table 7.1 presented strong evidence to suggest that the pinch-off of 
OLI-MBs was not possible from a gas bulb coated with squalane or dodecane oil, using 
Triton solution, in the FF geometries used. However, if the act of thinning the oil to a 
negligible thickness meant that both the oil and gas phases’ pinch-off was dependant on 
the aqueous phase’s velocity, then theoretically pinch-off could still be possible based 
on estimated flow conditions. As an example, a dodecane oil flow velocity of 0.045 m/s 
would pinch-off in Triton solution up to 4 m/s. This aqueous phase velocity then 
pushing against the gas-oil interface would allow pinch-off to occur at gas pressures of 
1.8-2.2 psi. In this case, the full range of possible flow rates to allow OLI-MB pinch-off 
would be 1.0-2.8 psi C4F10 gas, 0.022-0.14 m/s dodecane oil, and 1.2-5.5 m/s Triton 
solution. The use of Triton shelled OLI-MBs is limited due Triton’s high toxicity 
towards bilayer membranes, such as the cell wall within the body.263,264 However, the 
results in the oil-in-aqueous pinch-off experiments showed that two-phase pinch-off 
was not possible in standard lipid solution. This was a strong reason to suspect that an 
oil-lipid/water interface would also not pinch-off in following three-phase experiments, 
and was a strong indication that the stable and reliable formation of OLI-MBs would 
not be possible using the microfluidic in this project. 
 
The work covered in this section of the chapter looked at estimating the flow conditions 
for successful three-phase pinch-off and so has been presented before the experimental 
three-phase pinch-off trials. However this work did strongly suggest that as an 
alternative to lipid stabilised OLI-MB, the formation of Triton stabilised dodecane OLI-
Oil Gas-oil	Vmin	[m/s] Oil-aqueous	Vmax	[m/s]
Dodecane 1.2 0.4
Squalae 0.3 0.009Squalane	
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MBs should be trialled as it would be more capable of pinch-off of the oil phase. This 
work is covered in Table 7.2 and section 7.3.3. 
 
7.3. Three-phase FF trials 
A large amount of work was spent on trials of three-phase pinch-off during this project. 
The ratio between the liquid flow rates and gas pressure were varied for each oil and 
microfluidic design detailed in the following section. This led to too many flow 
conditions to detail and explain the differences between in this discussion, when most 
did not lead to the formation of OLI-MB like structures. As such, presentation of these 
experiments has been simplified to describe one image of flow between the three phases 
that was representative of the optimal flow conditions observed for each experiment. 
Table 7.2 presents a list of the experiments trialled and a summary of what was 
observed. The results listed in Table 7.2 can be broken down into the four surfactant 
groups used to stabilise the OLI-MBs; (dark-light blue) lipid, (orange) lipid + pluronic, 
(orange) Triton, and (green) BSA protein. None of the three-phase FF trials were 
repeatedly successful at forming a solution of OLI-MBs of clinically relevant sizes at 
concentrations high enough for any further study.  
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Tab.	 7.2.	 A	 list	 of	 all	 three-phase	 OLI-MB	 formation	 trials,	 dependant	 on	 the	 microchip,	 oils,	surfactant,	noting	 the	optimum	flow	conditions	and	summary	details	of	 the	results.	Colour	bands	donate	a	change	in	experiment	‘type’.		
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7.3.1. Lipid shelled OLI-MBs 
Following the three-phase FF OLI-MB formation approach, the majority of this work 
was performed using DPPC-PEG standard lipid solution. Table 7.2 shows that the 3C1, 
3C2, 3C3, 5C1, and microspray microfluidic designs were tested here with, with 
squalane, dodecane, triacetin, and isoamyl acetate oils, all at a large range of flow rates. 
Figure 7.13 gives the optimal formation flow conditions and off-chip imaging that was 
observed during all of these trials. 
 
	Fig.	 7.13.	 3C3	microfluidic	 pinch-off	 trial	 of	 C4F10	 gas	 in	 squalane	 oil	 in	DPPC-PEG	 standard	 lipid	solution.	(a)	On-chip	formation	and	(b-d)	off-chip	imaging	is	shown,	with	(ii)	fluorescence.	Gas	3	psi,	oil	0.02	μl/min,	aqueous	40	μl/min.	 Images	b-c	were	 from	the	same	run	as	 image	a,	 image	d	was	from	a	different	run	on	a	different	day	with	similar	on-chip	formation.		
Figure 7.13 shows pinch-off of C4F10 gas in squalane oil in standard lipid solution 
through the FF 3C3 nozzle, with off-chip imaging of the sample. The MB streams 
shown here were very stable over time, which was a vast improvement from the earlier 
microfluidic 3C1 and 3C2 designs. Only the 3C3 device allowed the oil and aqueous to 
co-flow into a controlled, thin stream towards the nozzle, whilst forming a stable MB 
stream past the nozzle. For OLI-MB formation with this method, the most common 
structure seen off-chip were oil droplets of 1-10 µm, at 105-6 droplets/ml. However, as 
5	μm	
(ai)	 (aii)	
(bi)	 (ci)	 (di)	
(bii)	 (cii)	 (dii)	
5	μm	
5	μm	5	μm	
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shown by Figure 7.13b-d, for roughly half of the experiments runs, a low concentration 
(<105 MBs/ml) of 5-10 µm MBs also remained in the solution off-chip. These structures 
showed white light contrast indicative to that of non-oil-MBs (a thick black outline, as 
apposed to oil droplets which typically show a thin black outline), but also showed 
fluorescence across their shell indicating the presence of an oil layer and therefore 
suggesting the presence of OLI-MBs. These OLI-MB like structures were shown to 
have fluorescence in their cores, rather than just a fluorescent outside as expected. This 
may have been a combination of an imaging artefact, due to imaging these structures 
with fluorescence microscopy that had a long depth of field (rather than confocal 
imaging), and also due to the thickness of the fluorescent oil layer at the top and bottom 
of the structure. It is unlikely that this was due to an imaging artefact supplied by the 
lens resolution since objects down to 1 µm could still be resolved and if the subjects 
imaged were 5-10 µm oil droplets with central gas cores of ≤ 1 µm, the white light 
images would be expected to appear more like oil droplets than MBs. As described 
earlier, this approach lacked reproducibility even when using similar flow conditions. In 
cases where stable OLI-MBs were observed, non-fluorescent MBs were not. In cases 
where stable OLI-MBs were not observed, off-chip imaging showed samples consisting 
of fluorescent oil droplets and non-fluorescent MBs (result not shown), indicating that 
the MBs had been formed without an oil shell. The conclusion here was that a 
successful OLI-MB formation could be held stable on-chip. However, once formed the 
OLI-MBs were unstable, losing their gas core, either to dissolution or collapse, but not 
to separation and re-stabilisation as separate non-oil-MBs and oil droplets. On the other 
hand, the FF pinch-off could also be highly stable in its formation of non-oil-MBs and 
oil droplets, without OLI-MB formation. It is very likely that formation under these two 
different circumstances looked identical at the microfluidic nozzle. 
 
7.3.2. Pluronic shelled OLI-MBs 
Following the work of Shih et al. (2013) pluronic-F68 solution (a triblock copolymer, 
hydrophilic-hydrophobic-hydrophilic chain) was added to the lipid solution and triacetin 
oil phases.95 Shih et al. proposed that by adding pluronic to their liquid phases it 
inhibited coalescence in the outlet, allowing for a higher MB formation rate, and 
reduced the MB size. Table 7.2 shows that the 3C3 and 5C1 microfluidic designs were 
tested here, where pluronic was added to the triacetin and lipid solution phases at a 
concentration of 10 and 0.1 vol%, and 2 and 2vol% respectively. Glycerol concentration 
was also varied in the lipid solution from 1 to 30 vol%. Figure 7.14 gives the optimal 
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formation flow conditions and off-chip imaging that was observed during all of these 
trials. 
 
	Fig.	7.14.	5C1	microfludic	pinch-off	 trial	of	C4F10	gas	 in	 triacetin	+	10	vol%	pluronic	 in	DPPC-PEG	standard	lipid	solution	+	0.1	vol%	pluronic.	(a)	On-chip	formation,	with	double	layered	structures	(yellow	arows)	noted,	and	(b-g)	off-chip	imaging	is	shown,	with	(ai,	b,	d,	f,	g)	brightfield	and	(aii,	c,	e)	fluorescence.	Gas	3	psi,	oil	0.02	μl/min,	aqueous	40	μl/min.	Images	b	to	g	are	a	timeseries	where	the	time	between	each	image	was	5-10	s.		
Figure 7.14 shows pinch-off of C4F10 gas in 10 vol% pluronic triacetin oil in 0.1 vol% 
pluronic standard lipid solution, through the FF 5C1 nozzle, with an off-chip imaging 
time series (b to g, 5-10 s between frames) of the sample. Whilst the oil phase had a 
large volume during flow, it was found that any volumetric flow rate <1 µl/min caused 
the oil to be pushed back up the inlet by either the gas or lipid solution phases. During 
flow, the gas bulb was seen to rapidly displace between the end of its inlet and close to 
the nozzle. However, as can be seen in Figure 7.14aii, a number of 20-40 µm double-
layered structures were successfully formed on-chip. These were formed in the brief 
moments that the gas bulb was in the region of the nozzle. This indicated the potential 
for a more stable and repeatable formation regime if the bulb could be held at the nozzle, 
however a regime like this that successfully showed pinch-off was never achieved. 
(ai)	 (aii)	
(b)	 (c)	 (d)	
(f)	 (g)	(e)	
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Figure 7.14b-g shows the resultant solution off-chip. Immediately after sample 
preparation, ~100 µm MBs were observed. Since the double-layered MBs formed on-
chip were 20-40 µm, it is most likely that the off-chip MBs were a result of downstream 
coalescence. (Figure 7.14b-c) On initial observation, a partial oil ring was observed, 
with a similar radius of curvature to two neighbouring MBs. Parts of the oil were 
displaced into the ring and portions of the oil had jetted from the ring into the 
surrounding solution. (7.14d-e) On further observation of the same area, the two 
remaining MBs were seen to rapidly go through a gas core collapse, resulting in a 
similar structure to that of the first oil ring. (Figure 7.14f-g) The remaining oil was then 
shown to quickly coalesce into larger oil droplets. It is believed that; (1) large OLI-MBs 
had been successfully stabilised in the solution. After placing the solution, open-topped, 
on a glass slide, (2) the MBs quickly rose to the surface and began to concentrate at the 
interface. (3) The water film between the MB interface, of C4F10 gas-oil-lipid/pluronic-
water, and the sample meniscus interface, of water-lipid/pluronic-air, progressively 
became thinner. This continued until (4), akin to how a soap bubble bursts when the 
water layer between the two soap stabilised surfaces evaporates, the gas core of the 
MBs became exposed to the air, collapsing inwards due to Laplace pressure. (5) This 
caused a portion of the oil shell to be dragged inwards, and at the end of MB collapse 
caused an outward moving shock wave, forcing portions of the oil shell out into the 
surrounding solution. (6) The freshly formed, unstabilised oil surfaces then began to 
coalesce. Between OLI-MBs, these events may have occurred around the same time but 
independently. However, it is also possible that the shockwave generated by MB 
rupture led to aiding in the destabilisation of the neighbouring MBs. 
 
7.3.3. Triton shelled OLI-MBs 
During the studies detailed in section 7.2.3 it was seen that two-phase pinch-off of 
dodecane oil was possible using Triton solution as the aqueous phase, and estimations 
were given for flow conditions that could lead to three-phase pinch-off of C4F10 gas in 
dodecane in Triton solution. Therefore this section of the work looked at using 
dodecane and Triton solution for OLI-MB formation. Figure 7.15 gives the optimal 
formation flow conditions and off-chip imaging that was observed during all of these 
trials. 
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 Fig.	7.15.	3C3	microfludic	pinch-off	trial	of	C4F10	gas	in	dodecae	oil	+	10	vol%	Span80	in	MilliQ	+	1	vol%	Triton.	(a)	On-chip	formation	and	(b)	off-chip	imaging	is	shown,	with	(ii)	fluorescence.	Flow	of	 the	 aqueous	 phase	was	 set	 based	 on	 information	 from	 Figure	 7.12.	 Gas	 2	 psi,	 oil	 0.5	 μl/min,	aqueous	15	μl/min	respectivley.	For	off-chip	imaging,	the	MBs	and	oil	droplets	were	concentrated	by	adding	a	droplet	of	the	solution	to	a	glass	slide.	
 
Pinch-off of C4F10 gas in dodecane in Triton solution was found to be unsuccessful, 
leading to a high degree of coalescence on-chip. Therefore, 10 vol% Span80 was added 
to the oil phase in an attempt to aid stabilisation of the gas-oil interface. Span 80 was 
used here as it is a common surfactant of choice when forming water droplets where oil 
is the outer continuous phase.156,265–267 Figure 7.15 shows pinch-off of C4F10 gas in 
dodecane oil + Span80 in Triton solution through the FF 3C3 nozzle, with off-chip 
imaging of the sample. Flow conditions were set based on the information from Figure 
7.12. This led to the rapid formation of highly stable MB streams, allowing for close 
packing without coalescence. (Figure 7.15aii) Fluorescence was observed around the 
gas bulb and through the inner close-packed MB streams. This suggested that the oil 
had successfully coated the gas bulb, but that only a portion of the MBs formed 
contained oil. When the resultant solution was examined from this experiment, a high 
concentration of ~3 µm oil droplets were observed with a high concentration of MBs 
that showed inconsistent fluorescence around their shells, thought to be reflections from 
the oil droplets (in regions of view without droplets, the fluorescence was not observed). 
No evidence for the formation of stable OLI-MBs was observed. Either OLI-MBs were 
(ai)	 (aii)	
(bi)	 (bii)	
non-oil-MB	
oil	droplets	
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formed on-chip but the gas and oil components spontaneously came apart later 
downstream, or separate MBs and oil droplets were formed on-chip that could not be 
identified without high frame rate imaging. 
 
7.3.4. BSA shelled OLI-MBs 
	Fig.	 7.16.	 3C3	microfludic	 pinch-off	 trial	 of	 C4F10	 gas	 in	 soybean	 oil	 in	 BSA	 solution.	 (a)	 On-chip	formation	and	(b)	off-chip	imaging	is	shown,	with	(ai,	aii,	bii,	biii)	 fluorescence.	Gas	3	psi,	oil	0.05	μl/min,	 aqueous	 5	 μl/min.	 Focussed	 regions	 are	 shown	 from	 (aii)	 the	 nozzle	 during	 OLI-MB	formation,	and	(biii)	a	large	OLI-MB	that	was	observed	off-chip.	
 
Figure 7.16 shows pinch-off of C4F10 gas in soybean oil in BSA solution through the FF 
3C3 nozzle, with off-chip imaging of the sample. The on-chip formation of 43 ± 1 µm 
(SD 6 µm) OLI-MBs with oil layer thicknesses of 5 ± 1 µm (SD 3 µm) was regularly 
observed. Figure 7.16aii, shows a close up of the OLI-MB during pinch-off. The 
mechanism of formation was as follows: (1) Oil from the gas bulb jetted into the outlet. 
(2) This was followed by pinch-off of a gas MB, still inside of the oil jet. (3) The whole 
OLI-MB then pinched off of the bulb completely, allowing the formation of further 
OLI-MBs to formation to occur. It is most probable that the oil jet pinched off after the 
formation of the MB due to the momentum of the MB pushing against the oil-BSA 
interface, with it being more energetically favourable for the gas core to remain inside 
the oil phase than pass into the aqueous phase and be stabilised by the BSA alone. Off-
chip imaging showed a higher number of non-fluorescent MBs and a lower number of 
fluorescent oil droplets, indicating that stable OLI-MBs had not been formed. The MBs 
present were observed to reflect the droplet fluorescence. However, one 24.8 µm OLI-
(ai)	
(bi)	 (bii)	
(aii)	
(biii)	
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MB was observed with a single fluorescent oil lens, 3.6 µm at its thickest point, 
covering roughly half the of the gas core perimeter. There is a possibility that what 
occurred here was repeatable BSA shelled OLI-MB formation on-chip, followed by a 
subsequent de-wetting of the oil layer into separate non-oil-MBs and oil droplets. This 
effect has been shown in work by Deshpande et al (20016).268 They formed ~20 µm 
double emulsion droplets of water-(1-octanol)-water, using a FF microchip similar to 
the 5C1 design used in this project, with DOPC, DOPG, and Liss Rhod PE lipid 
dissolved in the 1-octanol oil phase. In timescales of seconds up to 10 min, they found 
that the oil portion concentrated to one side of the double emulsion droplet (cf. Figure 
7.16biii), whilst leaving behind lipid in the form of a bilayer between the inner and 
outer water phases. The oil portion then entirely phase separated from the remaining 
water-(bilayer)-water droplet, a vesicle. 
 
7.4. Conclusion 
During this part of the study, the aim was to gain control over how bulk phases of gas, 
oil, and aqueous interacted with each other in the presence of surfactant (primarily 
lipids), through the use of microfluidic devices. Flow of the liquid phases was 
controlled in a co-flow channel, and then the controlled liquid stream was introduced to 
the gas phase at a FF nozzle. Whilst this control was gained prior to the nozzle, results 
in this chapter showed that this was not enough to facilitate controlled, repeatable OLI-
MB pinch-off formation. 
 
Squalane and dodecane oil were found to give a higher degree of oil layer uniformity 
when flowing oil and water down a co-flow channel when compared to triacetin and 
isoamyl acetate. This study found that more viscous oils led to a thicker oil layer for the 
same oil to lipid solution flow rate ratio. This was expected, but important to verify, as a 
thin oil layer was desired at the gas bulb of a three-phase FF nozzle between gas, oil, 
and aqueous phases. Therefore squalane and dodecane were more useful in providing 
reliable oil layers. Study of parts of the three-phase pinch-off process showed that two-
phase pinch-off of squalane, triacetin, dodecane, and isoamyl acetate in lipid solution 
was not found to occur at any flow rates. Since the oil-lipid/water interface did not 
pinch-off in these experiments, and this interface also needed to pinch-off in three-phase 
microfluidics towards the formation of an OLI-MB, this was the first indication that the 
successful, stable, and repeatable pinch-off of OLI-MBs in lipid solution would not be 
possible. Pinch-off of the oils in Triton solution was found to be successful for 
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dodecane and squalane. For dodecane, the pinch-off regime could easily be controlled 
between co-flow, jetting, and dripping, with dripping occurring up to a maximum of 1 
µl/min oil. For squalane, a regime between dripping and jetting pinch-off occurred up to 
a maximum of 0.02 µl/min oil. Pinch-off of C4F10 gas in dodecane formed MBs at a 
minimum of 30 µm with larger MB sizes following a power relationship scaling law 
over the ratio between the gas and oil flow rates. Across all MB formation gas pressures, 
the range of oil flow rates that gave pinch-off was very limited, at 4.2 ± 1, 4.3 ± 1, 7.0 ± 
1, and 8.0 µl/min for squalane, triacetin, dodecane, and isoamyl acetate respectively. It 
was found that an oil with a higher viscosity required a lower flow rate to achieve 
pinch-off, which agreed with Ca theory. When comparing these two experiments for 
three-phase pinch off, where the two individual two-phase pinch-offs would need to 
occur simultaneously, it was found that no overlap existed for the oil velocities of the 
two two-phase pinch-off regimes. While assumptions were made to come to these 
findings, they did heavily suggest that stable pinch-off of OLI-MBs from a FF design 
was not possible. On the other hand, if both the oil and gas phases pinched-off due to 
shear forces contributed from the aqueous phase, then at least for dodecane oil pinch-off 
would be possible. For this case, the estimated formation ranges were 1.0-2.8 psi gas, 
0.02-0.14 m/s oil, and 1.2-5.5 m/s Triton solution. This lead to an estimated Triton 
solution flow rate of 10-45 µl/min. Later however, OLI-MB formation trials of C4F10 
gas in dodecane in Triton solution based on these estimated flow conditions did not 
provide OLI-MB pinch off, instead leading to a high degree of gas coalescence 
immediately after pinch-off. Adding Span80 to the dodecane oil prevented coalescence 
but resulted off-chip in separate oil droplets and non-oil-MBs. At this point the work 
progressed to trialling three-phase pinch-off of C4F10 gas in the four oils used in this 
study, in four types of aqueous solution, in a large number of microfluidic FF devices. 
For more detail on which combinations of oil, aqueous, and microfluidic design were 
tests and notes on what observed, see Table 7.2. Almost all OLI-MB formation trials 
using standard lipid solution did not result in OLI-MB formation on-chip. Squalane 
samples did show off-chip evidence of stable 5-10 µm OLI-MBs. However, only a low 
concentration of OLI-MBs (< 10) were observed per 70 µl of solution imaged, and only 
half of the repeats of the flow conditions resulted in OLI-MBs being observed off-chip. 
After this, the work transitioned to look at forming OLI-MBs without a pure lipid shell. 
Adding pluronic solution to both the lipid solution and oil phases had some limited 
success at OLI-MB formation. Using the 5C1 device, 20-40 µm double layered MBs, 
thought to be OLI-MBs, were formed on-chip. Off-chip imaging showed ~100 µm OLI-
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MBs that were observed to go through gas collapse. Pinch-off of C4F10 gas-in-soybean-
in-BSA was trialled. Formation in the 3C3 device showed the most promising on-chip 
OLI-MB formation throughout this chapter. Here, 43 ± 1 µm (SD 6 µm) OLI-MBs with 
oil layer thicknesses of 5 ± 1 µm (SD 3 µm), were formed through a combination of oil 
jetting, MB pinch-off in the oil jet, and the whole OLI-MB ejecting into the outlet. 
However, off-chip results showed that the majority of the sample stabilised as 5-10 µm 
non-oil-MBs and ~10 µm oil droplets. One 24.8 µm OLI-MB was observed off-chip, 
with an oil lens, 3.6 µm at its thickest, covering half of its perimeter. 
 
During this chapter some evidence for the successful formation of OLI-MBs was given. 
However, almost always, the introduction of the oil phase to the nozzle was found to 
destabilise any pinch-off occurring from just the gas and aqueous phases, and if any 
OLI-MBs were formed on-chip they were not stable to the point of off-chip imaging. 
This rapid destabilisation, for both scenarios, could indicate that the oil phase was 
presenting anti- or de-foaming effects (for a description of de-foaming, see Chapter 2.1, 
p 18). During the experiments in this chapter, only single MBs were created, not foams, 
but the associated local decreases to the surface tension of the MB shell may have still 
occurred, which would result in less stable gas-aqueous interfaces with lower MB 
lifetimes. Those OLI-MBs that were rarely observed off-chip ranged from 20-100 µm, 
with the squalane DPPC-PEG OLI-MBs being 5-10 µm but at an unusable 
concentration. The purpose of forming OLI-MBs during this project was to use them as 
drug delivery agents in the blood stream. This requires that their size be at maximum 8 
µm and their concentration be at least 106 MBs/ml for any further studies. As such all of 
the OLI-MBs formed through the methods used in this chapter would be unsuitable for 
further use. The most promising on-chip formation observed was that of the last study 
shown of C4F10 gas-in-soybean-in-BSA solution. This study was only brief and as such 
could benefit from further work. A potential improvement to this study would be to use 
both lipid and BSA in the aqueous phase to allow for the formation of OLI-MBs with a 
hybrid shell, capable of on-chip pinch-off due to the use of the BSA, but also capable of 
functionalisation with PEG lipid chains, for use of the OLI-MBs in the body without 
being removed by the immune system, and targeting molecules, for targeting to specific 
problem sites. It was also suggested that the apparent high rate of OLI-MB formation 
on-chip followed by lack of OLI-MBs off chip could be due to phase-separation post-
formation, as seen by Deshpande et al. (2016) for similarly formed water-(1-octanol)-
water double emulsion droplets.268 They claim that a crucial step to the success of their 
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formation was controlling the on-chip channel hydrophobicity/hydrophilicity, where the 
post-nozzle outlet was treated to be hydrophilic with PVA in order to prevent the 
adsorption of their droplets immediately after formation.  
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8. Results: Activation of perfluorocarbon-in-oil-
in-aqueous double emulsion droplets into OLI-
MBs 
 
Chapter 5 established that the formation of clinically relevant OLI-MB structures 
requires high levels of control over how the gas, oil, and aqueous phases are introduced. 
Instead of attempting to form an oil coated MB directly, this chapter studied the 
formation of oil coated liquid perfluorocarbon (PFC) double emulsion droplets and the 
potential to activate the liquid PFC into gas, forming an OLI-MB, as a second step. A 
benefit to this approach was that the dissolution time of liquid PFC is far lower than that 
of gas PFC, giving these a greater lifetime. This was appealing as it gave the prospect of 
forming long-life double emulsion droplets, with the ability for storage, and activation 
into OLI-MBs at the moment they were needed. However, a drawback to this approach 
was the volume expansion that occurs when a liquid converts into a gas. For a sphere of 
C5F12, the liquid to gas diameter expansion is ~5 times (see Chapter 3.5.1). In respect to 
the maximum size limit allowed for drug delivery systems in the blood stream (8 µm), 
this placed a condition on the double emulsion that the PFC liquid cores could be at 
maximum ~1.6 µm, preferably averaging ~600 nm, with oil loading requiring even 
smaller liquid PFC core diameters. The work in this chapter is split into two distinct 
sections. First, formation of single and double emulsion liquid PFC droplets is shown, 
where the aim was to form droplets that were theoretically within clinical size ranges 
after activation. Second, different methods of activating the liquid PFC droplets are 
shown where either the samples’ temperature was increased, or a global or local 
pressure drop was applied within the sample. 
 
8.1. Formation of single emulsion perfluorocarbon droplets 
This section of work looked at forming single emulsion PFC droplets without an oil 
coating. Surfactant shells tested were Triton and DPPC lipid. Formation techniques 
used consisted of microfluidic and tip sonication formation, which produced microscale 
and nanoscale PFC emulsions respectively. The nanoscale PFC droplets were formed 
with the intent of producing clinically relevant sized MBs after activation. However, as 
discussed in the relevant section of this thesis’s theory (Chapter 3.5.2-3), due primarily 
to Laplace pressure, the smaller the PFC droplet, the more energy that must be supplied 
 212 
in order to activate it into a gas (given by either an increase in the droplets temperature 
or decrease in pressure). As such, microscale PFC droplets were formed and used 
during preliminary testing to see if a particular method could be used for PFC droplet 
activation. PFC droplets were formed with cores of either C5F12, C6F14, or from a 
mixture of the two PFCs at 40 vol% and 60 vol% respectively (C5:C6). 
 
	Fig.	 8.1.	Microfluidic	 formation	of	C5F12	droplets	 in	1	vol%	Triton	 solution,	using	a	 two-phase	FF	device.	C5F12	and	Triton	solutions	at	1	and	3	μl/min	respectively.	Estimated	pressures	 (P)	 in	and	out	of	the	device	and	pressure	drops	at	specified	locations	are	indicated.		
Figure 8.1 shows microfluidic (flow focus) FF formation of C5F12 droplets in 1 vol% 
Triton solution. Formation of C6F14 and C5:C6 droplets showed equivalent pinch-off 
mechanics at the same flow rates, and formation with all PFC solutions was very 
repeatable. Formation was stable enough for the ~20 µm droplets to close pack in the 
outlet without any observation of coalescence. Optimal formation was found to occur at 
1 µl/min PFC solution and 2-3 µl/min Triton solution. In order to facilitate pinch-off all 
flow rates had to be kept low to reduce Ca. It should be noted that as a 1 ml sample was 
typically desired, formation required 5 h. As such a stable formation that did not require 
constant attention was highly desirable. Figure 8.2 shows a transition from the PFC 
phase being in a liquid state to gas state during FF pinch-off. This transition was both 
occasional (it was not repeatable so no rate could be identified) and short-lived (relative 
to the whole formation time), though it was observed across all PFC solutions. The 
transition always originated upstream from the nozzle region. Thorough checks were 
made to ensure that no gas bubbles had been added to the PFC inlet during experiments, 
so it can be concluded that this was the PFC liquid phase changing into gas. At the 
nozzle, in order to phase convert bulk C5F12, an estimated combined liquid flow rate of 
30 µl/min would be needed to provide the required pressure drop of 17 kPa from 
atmospheric pressure. The flow rate would need to be increased in the wider parts of the 
30	μm	
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microfluidics, for PFC at higher molecular weight, and for PFC droplets of smaller size. 
As such, the phase conversion was occurring without reaching the estimated pressure 
threshold. Observation of the solution collected immediately after this phase change 
was observed on-chip showed no MBs off-chip. Either the MBs reverted back to liquid 
droplets, or the concentration of stable MBs formed was low enough to be negligible to 
the sample. Importantly the observation of phase transition did show that bulk PFC 
liquid could be activated into PFC gas with very low flow rates, in the inlet tubing or 
the larger channels of the microfluidic device, and so at velocities < 2 cm/s. 	
	Fig.	 8.2.	 Transition	 of	 C5:C6	 liquid	 to	 gas	 during	 pinch-off	 in	 1	 vol%	 Triton	 solution.	 C5:C6	 and	Triton	solutions	set	to	liquid	flow	rates	of	1	and	2	μl/min	respectively.	High	frame	rate	imaging	at	49	kfps.		
10	μm	t	=	0.0	ms	 t	=	3.7	ms	 t	=	15.5	ms	
(a)	 (b)	 (c)	
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	Fig.	 8.3.	 (a)	 Off-chip	 sizing	 of	 C5F12	 (black),	 C5:C6	 (red),	 and	 C6F14	 (blue)	 Triton	 microfluidic	droplets,	with	(b)	example	images	that	the	sizing	information	was	measured	from.	n	≈	50.		
Figure 8.3 shows sizing histogram data from C5F12, C5:C6, and C6F14 droplets, which 
were formed microfluidically in Triton solution, as in Figure 8.1. C5F12 and C6F14 
droplets showed Gaussian distributions that agreed with the diameter averages, giving 
peak diameters of 25.0 ± 0.9 (FWHM 3.2) µm and 22.8 ± 0.1 (FWHM 1.9) µm 
respectively. However, the C5:C6 droplets showed a wide distribution of diameters, 
with a range from 12.3 µm up to 29.9 µm. The average C5:C6 droplet diameter was 
22.1 ± 1.9 (SD 3.3) µm. Even though C5F12 and C6F14 liquids are miscible, each droplet 
may have been formed with a slightly different volume ratio of C5:C6, partly due to the 
small droplet volume of ~6 pl on-chip. Since C5F12 is more volatile than C6F14 this 
could have led to imbalances between PFC droplets. C5F12, C5:C6, and C6F14 droplets 
were formed at concentrations of 1.5 ± 0.5 x 106 droplet/ml, 2.4 ± 0.4 x 107 droplet/ml, 
and 9.3 ± 1.1 x 106 droplet/ml respectively. 
 
(a)	 (bi)	
(bii)	
(biii)	
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	Fig.	 8.4.	 Diameter	 and	 concentration	measurments	 of	 C5F12	 Triton	microfluidic	 droplets	 over	 42	days.		
Figure 8.4 shows diameter and concentration lifetime measurements from C5F12 
microfluidic droplets over a period of 42 days from their formation. Average diameter 
started at 22.2 µm gradually rising to 23.5 µm, a 6% increase. This 1.3 µm increase was 
within the range of the average error of 1.1 µm, so can be assumed to be negligible. The 
concentration poorly correlated over the 42 days, but remained at 107 droplets/ml. PFC 
droplets of this size were observed to form a pellet out of solution in under 10 s. 
Therefore, the large variation in the concentration may have been due to the rapid 
falling out of the droplets immediately after the gentle agitation of the solution in order 
to extract a sample for sizing and concentration measurement. As the intent was to 
activate these droplets into MBs, of which typical second generation MBs (consisting of 
an inert gas core such as PFC) have been suggested to have maximum lifetime of 
several hours,186 these results provided the first indication, in this project, that the 
prospect of forming a long shelf life MB precursor could be achieved using liquid PFC 
droplets. 
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	Fig.	 8.5.	 (a)	 Histrogram	 of	 5	 min	 tip	 sonicated	 C5F12-Triton	 nanoemulsion	 droplet	 diameters	 in	respect	 to	concentration	and	(b-d)	 lifetime	measurments,	measured	 from	the	same	solution,	over	5.3	h	 from	the	end	of	nanoemulsion	 formation.	 (b)	Histrogram	of	droplet	diameters	 in	respect	 to	concentration,	for	each	time	measurment,	with	a	prediction	of	the	size	distribution	at	0	h	calculated	from	Figures	c-d.	(c)	Total	sample	concentration	recorded,	with	a	linear	fit	to	all	of	the	data	and	an	expoential	fit	to	all	data	past	the	first	measurment	(the	concentration	of	the	first	measurment	was	considered	 inacurate	–	 the	reason	 is	given	 in	main	text).	 (d)	Mode	and	peak	diameters	measured	from	the	total	sample	and	the	fittings	of	Figure	b,	with	errors	as	the	FWHM	of	Figure	b.	
 
Figure 8.5 shows diameter and concentration lifetime measurements from 5 min tip 
sonicated Triton-C5F12 droplets over a period of 5.3 h from their initial formation. 
Unlike the PFC microemulsion of Figure 8.4, tip sonicated PFC nanodroplets were 
found to lose concentration and increase in size over the time scale of hours. This was 
most likely due to the nanoemulsions’ higher surface area to volume ratio causing a 
more rapid Ostwald ripening effect (see Theory Chapter 3.2.3, p 47-48). Calculating the 
total C5F12 volume at each time point, from the data of Figure 8.5b, revealed that the 
first recorded time point (t = 0.33 h) had only accounted for 1/3 of the total C5F12 
(c)	 (d)	
(a)	 (b)	
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volume in the whole solution (concentration of 5 µl/ml). On the other hand each time 
point following this did account for the entire C5F12 volume, with a following decrease 
in total volume likely due to dissolution (data not shown). Due to this, the concentration 
of the first data point was considered to have been measured inaccurately, allowing an 
exponential to be fit to the data of Figure 8.5c. By the exponential fit, the C5F12 droplets 
had an initial concentration of 3.4 ± 0.7 x 1011 droplets/ml with a half-life of 1.1 h. For 
every half-life, the peak diameter of the droplets increased by 35 ± 7 nm (11 ± 3% for 
the initial half-life) and their FWHM distribution increased by 70 nm (69% for the 
initial half-life). From the concentration, peak size, and distribution data, a predicted 0 h 
plot was added to Figure 8.5b. During activation of PFC droplets into MBs a large 
problem that has appeared to plague much of the literature is low activation rates.269 
Shpak (2014) claimed that activation of PFC droplets at just 10% would be a relatively 
high activation, but that due to re-condensation stable MBs could be expected to be 
around or below 1%.270 As such, it is imperative that a high concentration of precursor 
droplets are present on activation, and that they are as monodisperse as possible to 
activate via the same energy provided by a single activation step. As such, the hourly 
half-life and rapid accumulation of polydispersity found for tip sonicated C5F12 droplets 
means that they do not have a desired shelf life, and that any use of samples during this 
project occurred immediately after production, with a fresh formulation for each 
experiment. 
2-3 µm MBs were desired to keep in line with current clinical applications of 
MBs.186,271–275 As such, PFC droplets of 400-600 nm were optimal. A number of 
nanoemulsions were tested for size based on; PFC core type, lipid or Triton shell, tip 
sonication times or extrusion formation. 5 min tip sonicated Triton-C5F12 droplets gave 
the optimal formation of droplets with peak size closest to 400-600 nm, without droplets 
above 1 µm. However due to the rapid change of sample concentration and size shown 
in Figure 8.5, any comparison was unreliable without factoring in the time after 
nanoemulsion formation, and so the data has not been shown. 
 
In this section it was discovered that microfluidically formed PFC microemulsion 
droplets had the potential for monthly if not yearly shelf life. However, these droplets 
were too large for clinical use, especially with further liquid to gas expansion. On the 
other hand, tip sonicated PFC nanoemulsion droplets could be formed at clinically 
relevant sizes, but their hourly half-life meant that they did not have a desirable shelf 
life and should be used immediately after formation. 
 218 
 
8.2. Formation of double emulsion perfluorocarbon-in-oil 
droplets 
This section of the work looked at forming double emulsion droplets of C5F12 
encapsulated in an oil layer, encapsulated in an aqueous solution with some surfactant 
layer. Oils tested were soybean, isoamyl acetate, triacetin, dodecane, and squalane. 
Surfactants studied were Span 80, Triton, BSA protein. The first set of experiments 
detail the success of a two-step method of forming a stable emulsion of C5F12 droplets in 
oil, then passing this through FF microfluidics to encapsulate the emulsion. The second 
set of experiments cover a simultaneous encapsulation of C5F12 in oil and oil in BSA 
solution by mechanical agitation, the findings of this method with different oils in terms 
of the droplet sizes and oil layer to total size ratio, and optimising control over these 
aspects of the droplets by varying the concentration of each phase. 
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	Fig.	8.6.	Mechanical	agitation	formation	and	sizing	of	C5F12	droplets	in	(a)	MilliQ,	(b)	dodecane,	and	(c)	 triacetin,	 using	 no	 surfactant,	 1	 vol%	 Span80,	 and	 1	 vol%	Triton.	 (i)	 Vials	 filled	with	 1	 vol%	C5F12	 in	 the	 continuous	 aqueous	 or	 oil	 phases	 are	 shown	 before	 and	 after	 45	 s	 of	 mechanical	agitation,	 with	 (ii)	 example	 images	 shown	 of	 post-formation	 droplets,	 and	 (d)	 sizing	 histograms	measured	from	those	images.		
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Figure 8.6 shows vials filled with C5F12 in MilliQ, dodecane, or triacetin, where no 
surfactant, Span 80, or Triton X-100 was solubilised into the continuous phase, before 
and after mechanical agitation (45 s agitation as in MB formation, Experimental 
Chapter 4.4, p 71). It then shows post-agitation example images of the droplet 
emulsions stabilised by Triton solution, followed by comparative histograms of the 
droplet diameters measured from all of the samples that showed a stable droplet 
emulsion. Squalane and isoamyl acetate samples were tested alongside the other oils, 
but neither showed any stable emulsion. Peak sizes were recorded as 1.5 ± 0.1 (FWHM 
1.4) µm, 8.8 ± 0.9 (FWHM 10.1) µm, and 0.6 ± 0.1 (FWHM 0.7) µm for C5F12 in 
triacetin + Triton, triacetin + Span80, and dodecane + Triton emulsions. C5F12 droplets 
in MilliQ Triton showed a bimodal distribution with peaks at 64 ± 2 (FWHM 25) µm 
and 20 ± 5 (FWHM 22) µm. Since for clinical use, droplets with a desired average and 
maximum allowed size were 200-600 nm and 1.6 µm respectively, only the C5F12 in 
dodecane + 1 vol% Triton emulsion had an acceptable size distribution for further 
encapsulation (this sample’s size distribution still had droplets > 1.6 µm, which might 
have meant that this emulsion would be clinically unviable, but they were of a low 
concentration). Figure 8.7 shows on-chip FF pinch-off of the C5F12-dodecane + Triton 
emulsion in MilliQ + 1 vol% Triton solution. Example images are shown from 
observations of the resultant emulsion off-chip. Histogram size distributions are 
presented of the droplet diameters recorded on- and off-chip. Droplets were recorded 
on- and off-chip at 25.5 ± 0.1 (FWHM 1.2) µm and 2.5 ± 0.7 (FWHM 13.6) µm 
respectively. (Figure 8.7bii) Fluorescence showed that a small number of droplets 
contained cores with decreased fluorescence, indicating a double emulsion structure. 
However, the large majority of droplets were fully fluorescent. The reduction in droplet 
diameter, increase in size distribution, and only a fraction of the droplets retaining C5F12 
cores, together suggested that a high proportion of the double emulsion droplets had 
been activated but left no stable MBs. The activation would have expanded the C5F12 
portions, potentially forcing the oil shells to break apart into smaller droplets, as is 
suggested by the off-chip images. One solution to the problem of premature activation 
would be to use a C6F14 core emulsion. However, the on-chip droplet size, which would 
be retained in the off-chip droplet size if premature activation did not occur, was more 
than 3 times the allowed maximum drug carrier diameter for clinical use. As such, this 
double emulsion formation technique stopped here. 	
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	Fig.	8.7.	(ai)	Experimental	 image	and	(aii)	schematic	of	pinch-off	of	C5F12	(white)	 in	dodecane	+	1	vol%	 Triton	 (orange)	 emulsion	 in	 MilliQ	 +	 1	 vol%	 Triton	 solution	 (blue),	 at	 1	 and	 2	 μl/min	respectivley.	 (b)	 Off-chip	 imaging	 of	 resulting	 droplet	 solution.	 (c)	 Sizing	 histograms	 of	 droplets	formed	on-chip	and	resultant	droplet	solution	off-chip.		
(bi)	 (bii)	
20	
μm	
(ai)	 (c)	(aii)	
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	Fig.	8.8.	Mechanical	agitation	 formation	of	C5F12-oil-BSA	double	emulsion	droplets.	 (ai-ei)	Vials	of	10	 vol%	C5F12	 +	 10	 vol%	 oil	 in	 4	mg/ml	 BSA	 solution	 before	 and	 after	 agitation.	 Imaging	 of	 the	resultant	droplet	solution	by	(aii-eii,	 fi)	white	 light	and	(aiii-eiii,	 fii)	 fluorescence	from	Nile	red	 in	the	oil	phase.	
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Figure 8.8 shows vials of 10 vol% C5F12 + 10 vol% oil in BSA solution before and after 
mechanical agitation, and gives example images of the remaining post-agitation solution. 
Dodecane, squalane, triacetin, isoamyl acetate, and soybean were tested. An example is 
also shown for soybean and C5F12 at 1 vol%. Apart from the triacetin sample, all 
samples formed large foams with ~100-500 µl of remaining solution. The triacetin 
sample did also form MBs that floated to the top of the vial, however it retained almost 
all of its solution. It is most probable that the majority of these foams were due to high 
shear stress activation of the non-emulsified C5F12 liquid, since similar mechanical 
agitation of BSA solution in the presence of PFC gas regularly forms a cloudy solution 
of MBs without this degree of foaming. Dodecane and squalane samples showed a 
small proportion of double emulsion droplets, but most droplets were either single 
emulsion C5F12 or oil droplets, as defined by either no fluorescence (potentially 
reflecting fluorescence) or fully fluorescent cores. Triacetin, isoamyl acetate, and 
soybean all showed successful double emulsion formation with few to no droplets 
observed as single emulsions. Determining which oils showed successful double 
emulsion formation could not be attributed to the oil viscosity, solubility, or oil-water 
surface tension. The density of both squalane and dodecane is lower than the other three 
oils, but given the relative densities of the successful oils to water, this did not seem to 
play any role in the success or fail of double emulsion formation. Figure 8.9 shows 
histograms of the double emulsion droplet sizes measured from the Figure 8.8 and how 
the total droplet radius related to the C5F12 core radius. Only data from the four 
successful formation samples (as defined above) are shown. All samples showed a 
clustering of the ratio between the core and total radius over the total droplet diameter, 
with no apparent relationship between the two aspects. Table 8.1 shows how the peak 
droplet diameter and the average ratio of core to total droplet radius compared for each 
sample. Triacetin double emulsion droplets were found to be larger than the other oil 
samples, at 34.5 µm. This may have been due to triacetin’s higher solubility than 
dodecane or soybean, at 70 g/l.96 During break-up of the bulk oil, the surface to volume 
ratio will have greatly and rapidly increased. This will have allowed for rapid 
solubilisation of the new triacetin surfaces, likely leading to a slower stabilisation of 
surfaces, and so a greater potential for coalescence of the C5F12 and oil emulsions. Both 
the isoamyl acetate and 10 vol% soybean samples showed smaller droplet peak sizes at 
7.7 and 5.3 µm respectively, though both samples had droplets above the clinical size 
limit before activation. As such, the 1 vol% soybean sample was also studied to see if 
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the total droplet diameter could be decreased whilst keeping the core to total droplet 
radius ratio constant. The 1 vol% soybean sample did decrease the peak droplet size to 
3.3 µm, and gave a more monodisperse peak size sample, but the spread of the core to 
total droplet radius ratio was increased. Attempts to control the droplet size and radius 
ratio are continued in Figure 8.10. 
 Tab.	8.1.	C5F12-oil-BSA,	mechanical	agitation,	double	emulsion	peak	droplet	diameter,	average	value	of	 the	 droplets’	 C5F12	 core	 radius	 divided	 by	 the	 radius	 of	 the	 whole	 droplet,	 and	 droplet	concentration.		
		
Oil	and	
C5	vol%
FWHM	
[μm]
Stdev Concentration	
[droplets/ml]
Triacetin 10 34.5 ± 3.3 47.4 0.68 ± 0.02 0.15 4.2E+06
Isoamyl	acetate 10 7.7 ± 0.4 5.8 0.69 ± 0.01 0.09 2.5E+08
10 5.3 ± 0.6 5.7 0.68 ± 0.01 0.10 1.2E+08
1 3.3 ± 0.1 1.8 0.59 ± 0.02 0.11 1.8E+07
Diameter	[μm] Radius	of	C5	core	/	
total	droplet
Soybean
 225 
	Fig.	 8.9.	 Sizing	 measurments	 of	 C5F12-oil-BSA	 double	 emulsion	 dropelts,	 using	 (a)	 triacetin,	 (b)	isoamyl	acetate,	and	(c)	soybean	oil.	C5F12	and	oil	phases	both	at	10	vol%	with	soybean	also	at	1	vol%.	(i)	Measurments	of	droplet	diameter	against	the	radius	of	the	C5F12	core	divided	by	the	radius	of	 the	 whole	 C5F12-oil	 double	 emulsion	 droplet	 (as	 a	 radius	 ratio).	 (ii)	 Sizing	 histograms	 of	 the	whole	droplet	diameters.			
(ai)	 (aii)	
(bi)	 (bii)	
(ci)	 (cii)	
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	Fig.	8.10.	Sizing	data	from	C5F12-soybean-BSA	double	emulsion	droplets	with	constant	1	vol%	C5F12	when	varying	oil	and	BSA	concentration.	Average	droplet	(a)	concentration,	(b)	diameter,	and	(c)	the	radius	of	the	C5F12	core	divided	by	the	radius	of	the	whole	C5F12-oil	double	emulsion	droplet	(as	a	radius	ratio).		
Figure 8.10 shows the average concentration, diameter, and ratio of core to total droplet 
radius measured for double emulsion C5F12-soybean-BSA droplets, due to varying the 
oil and BSA concentration whilst keeping the C5F12 concentration constant at 1 vol%. It 
was expected that increasing the oil concentration would decrease the core to total 
droplet radius ratio and increase the droplet size, or increase droplet concentration. 
However, overall no systematic control was gained over the droplets size, concentration, 
or ratio of core to total droplet radius over the oil and BSA concentration ranges tested. 
It should also be noted that the repeat results from Figures 8.9 and 8.10 did not agree 
with one another, showing large batch variability. This all suggests that the mechanical 
agitation method for forming C5F12-oil-BSA droplets does not have room for any 
Radius	ra)o	C5/O
il	
(a)	
(c)	
(b)	
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greater level of control. It is understood that this is most probably due to the chaotic 
nature of phase break-up by the mechanical agitation method. 
Tip sonication of C5F12, soybean oil, and BSA solution was studied as another 
technique for double emulsion formation since it had been shown to provide size 
control over single emulsion PFC droplet by sonication times in section 8.1. However, 
the results were inconclusive (results not shown) showing a bimodal distribution, with 
peak diameter at 0.6 and 2.2 µm, and little indication that C5F12 had been encapsulated 
into the oil phase. 
 
In this section the formation of double emulsion PFC-oil-aqueous droplets were studied. 
Encapsulating a PFC-oil precursor emulsion in aqueous was found to be successful on-
chip using dodecane oil. However the total droplet diameter formed on-chip was too 
large for clinical application, and at some point after on-chip formation to off-chip 
observation, the droplets were found to activate, leaving a highly polydisperse sample 
of oil droplets with a negligible concentration of double emulsion droplets remaining. 
Mechanical agitation of PFC, oil, and BSA solution was found to form the double 
emulsion for a number of the oils tested. Initially, the total droplet size was reduced by 
reducing the concentration of PFC and oil from 10 vol% to 1 vol%. However, deeper 
studies of the approach gave little control over the total droplet or PFC core size. During 
the activation trials detailed in the following sections, all experiments using the PFC-oil 
double emulsion droplets used the 10 vol% emulsion due to the larger size requiring a 
lower energy for activation. 
 
8.3. Activation of single and double emulsion droplets 
In this section, the single and double emulsion PFC droplets that had been formed in 
sections 8.1-8.2 were put through phase-change activation trials. These included 
increases to the temperature, to approach and pass the droplets’ boiling point, and 
decreases to the pressure, to approach and pass the droplets’ vapour pressure and 
nucleate phase-change. 
 
8.3.1. Thermal activation 
This section deals with the thermal activation trials. The temperature of PFC droplet 
micro- and nanoemulsions was gradually increased. Observations were made of the 
microemulsion solution by eye, focusing on solution turbidity, of the microscale 
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droplets by direct observation, and of the nanoscale droplets through DLS size 
measurements over time. 
 
	Fig.	8.11.	C5F12-Triton	microemulsion,	in	a	(a)	vial	and	(b)	50	μm	chamber,	during	heating	to	68	°C,	either	from	a	hot	plate	or	Peltier	heater	respectivley.		
Figure 8.11 shows microfluidically formed C5F12-Triton droplet solution, both at the 
bottom of a vial on a hot place and in a 50 µm deep chamber contacting a Peltier heater, 
on thermal ramp up to 70 °C. Due to the droplets’ size, as recorded in Figure 8.3, and an 
estimation of the C5F12-Triton-MilliQ interfacial tension being between 10 to 50 mN/m 
(this value was unknown partly due to the change in temperature), these droplets were 
expected to cross the boiling point and phase change between 30 to 32 °C. If the 
droplets in the vial activated into MBs, they were expected to float to the surface and 
increase solution turbidity due to the presence of larger particles and higher refractive 
index difference between water-C5F12 gas compared to water-C5F12 liquid. As can be 
seen for both experiments, none of the droplets were seen to activate. Approaching 
64 °C, the solution in the vial began to become turbid. In the chamber, this was 
accompanied by droplets nucleating in the solution at 60 °C with a different contrast to 
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the C5F12 droplets. However, this was not due to the C5F12. Instead it was the Triton 
cloud point, which has been well covered in literature and quoted to occur around 64 to 
67 °C, where the Triton molecules become insoluble in the aqueous phase and fall out 
of solution.276,277 Allowing the solution to cool back to below 60 °C reversed clouding. 
Figure 8.12 shows the results of a similar experiment where the size of tip sonicated 
nanoemulsion C5F12 DPPC and Triton droplets was recorded by DLS as the emulsion 
temperature was controlled. Due to the droplets’ initial peak and Z-average size (at 
25 °C), and estimation interfacial tension (10-50 mN/m), the DPPC and Triton droplets 
were expected to cross the boiling point and phase change between 42 to 117 °C and 39 
to 108 °C, with peak activation at ~68 and ~65 °C respectively. If activation had 
occurred, ~1.4-3.6 µm MBs would have been formed, which would have heavily 
contributed to solution polydispersity and turbidity. Since DLS is incapable of 
measuring turbid solutions, the recorded size after activation would have been large 
with high error. This was observed after 65 and 60 °C for the C5F12 Triton droplets and 
control Triton solution respectively, most probably due to the Triton cloud point. C5F12 
DPPC droplets did not show any evidence of activation. Even though this study was 
only performed up to just past the expected peak activation for both samples (and kept 
there for 15-30 min), it was expected that even a small fraction of activated droplets 
would cause a dramatic shift in the diameter recorded due to how DLS in more sensitive 
to larger particles.   
 
	Fig.	8.12.	Z-averages	and	diameter	distribution	peaks	from	C5F12	nanoemulsion	droplets	stabilised	by	Triton	(red)	and	DPPC	lipid	(blue)	during	heating	to	70	°C.	A	control	of	1	vol%	Triton	solution	(black)	is	also	shown.	
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The findings in this section showed that if PFC droplets were placed in an environment 
above their boiling point, this did not necessarily mean they would phase change into 
gas. Therefore, these results suggest that there must be an additional energy barrier that 
had to be overcome to cause gas nucleation, suggested as over 40 °C of thermal energy 
for the ~25 µm microemulsion droplets. Once one droplet nucleated, the rapid volume 
increase could have supplied enough kinetic energy to the surrounding droplets to push 
them over their energy barrier, allowing for a chain reaction of droplet nucleations. An 
energy barrier such as this has been discussed in literature before, however the theory 
and experimental results surrounding it are in disagreement. Evans et al. (2006) 
described that in order to phase-change a liquid droplet, enough energy must be 
supplied to take the liquid over the phase boundary (at an elevated temperature due to 
droplet confinement), but also to account for the increase in surface area due to the 
liquid expanding into a gas.197 However, they also stated that in an open, thermally 
heated system (such as that used in the above experiments), the energy required for the 
surface area increase would be accounted for, and therefore would not increase the 
droplet’s boiling point. Rapoport et al. (2007) showed that when PEG-PCL, C5F12 
droplets, averaging 428 nm, were heated to 37 °C, they phase converted into MBs.145 
Apposed to this, Schad et al. (2010) showed that when larger cholesterol (35 mol%), 
lecithin (65 mol%), C5F12 droplets, averaging 1.8-8.3 µm were placed at 37 °C, they 
remained as droplets and did not activate.142 For interfacial tensions from 10 to 50 
mN/m, the lowest theoretical boiling point for the 428 nm droplets is ~50 °C, and the 
highest theoretical boiling point for the 8.3 µm droplets is ~35 °C. This means that the 
former and latter droplets would be expected to remain as droplets and phase convert 
respectively at 37 °C, which disagrees with the above literature results. During the 
Figures 8.11 and 8.12 experiments, adding any additional thermal energy over what was 
already used in this work would have led to boiling of the continuous aqueous phase 
before droplet activation. As such, activation trials moved onto pressure drop methods. 
It was expected that this energy barrier would effect droplet activation by pressure drop 
to vapour pressure in a similar manner. 
 
8.3.2. Activation by pressure drop 
This section of work studied activation of the PFC micro and nanodroplets into MBs by 
decreasing the pressure surrounding the droplets, pushing the liquid phase beyond its 
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vapour pressure. Many of these experiments included heating the samples to lower the 
energy requirement needed for pressure decrease. 
 
  On-chip flow induced pressure drop 8.3.2.1.
Kripfgans et al. (2004) discussed how phase change can be induced by pulling a droplet 
away from a surface or when under flow of 14-23 m/s in a small tunnel.129 It is 
understood that the flow velocity puts the droplet in a pressure drop environment, and 
the shear forces induce a nucleation point for phase conversion from liquid PFC into gas, 
causing activation of the whole droplet into a MB. This method is promising for clinical 
use as a PFC droplet solution could be injected through a custom syringe filter outfitted 
with wide pores for the purpose of flow pressure drop and shear force activation, 
allowing one-step activation and injection with less concern for MB lifetime. This 
method was studied here, where 200 µl/min through a microfluidic two-phase FF nozzle 
achieved a flow velocity of 19 m/s at the thinnest point. Figure 8.13 shows C5F12-Triton 
microemulsion droplets being passed through the nozzle region of a two-phase FF 
device and a microspray device. If activation occurred, the ~25 µm droplets were 
expected to form ~125 µm MBs. In the two-phase FF device ~60 µm MBs were 
observed around the nozzle region, however these types of MBs are often seen to form 
when water alone is flowed at that rate as gases dissolved in the water phase cavitate out 
of the solution. Additional to this, PFC droplets were observed past the nozzle, as is 
shown in Figure 8.13a, with a droplet circulating around an eddy. The microspray 
device had an extra depth step in the outlet that should have led to a greater pressure 
drop and shear force across the nozzle region, however PFC droplets were still seen to 
pass through the nozzle without any indication of activation (Figure 8.13b). 	
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	Fig.	8.13.	Microfluidic	C5F12	Triton	droplets	passing	through	microfluidic	nozzles	of	a	(a)	two-phase	FF	and	(b)	microspray	design.	Outer	phase	is	1	vol%	Triton	solution.	All	flow	is	at	(a)	100	and	(b)	200	μl/min	respectivley.	
 
25 µm C5F12 droplets require a pressure drop of ~19 kPa to cross their vapour pressure 
into the gaseous phase (see Theory Chapter 3.5.3, p 58-59). Since the FF nozzle was so 
thin (7 µm x 25 µm), the minimum volumetric flow rate required to give this pressure 
drop was only ~33 µl/min. A flow rate of 200 µl/min would have supplied a pressure 
drop of ~115 kPa. Therefore, the high flow rates used in this study were far in excess to 
place the droplets in a pressure drop environment to facilitate phase change activation. 
However, the droplets will have only experienced this pressure drop for ~0.8 µs, 
through the nozzle. After this, the remaining outlet channel pressure drop was only ~34 
kPa. Still above the C5F12 droplet pressure drop threshold, but far less in excess. Whilst 
the shear forces in the outlet channel will have been reduced relative to the nozzle 
region, shear was expected to remain high due to the 25 µm channel depth being 
roughly equal to the droplet diameters. However, droplet activation was still never 
observed during these studies, even though all of the theory heavily suggested that it 
should have. 
 
(a)	
(b)	
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 Hypobaric activation 8.3.2.2.
Hypobaric activation was presented for activation of PFC droplets by Forsberg et al. 
(1998), involves rapidly forcing the expansion of a container (a syringe in the literature 
and during these experiments) filled with a PFC emulsion roughly 7.5 times its initial 
volume, holding the expanded volume for a few seconds, and then allowing elasticity to 
collapse the volume back down.236 The expansion places the PFC droplets under a 
pressure drop for a few seconds, presumably activating a proportion of the droplets into 
MBs. The following rapid decrease of the volume then sends a shockwave through the 
solution. This shockwave breaks apart many of the MBs into smaller fragments. If any 
droplets are still within the energy region for activation, the shockwave may also induce 
further nucleation, allowing further droplet activation, either from the force of the on-
coming half of the wave, or the pressure drop due to the tail half of the wave. During 
these experiments single microemulsion C5F12, C6F14, and C5:C6 Triton droplets, and 
double emulsion C5F12-soybean-BSA droplets were put through tests of hypobaric 
activation.  
Figure 8.14 shows example images of C5F12, C6F14, and C5:C6-Triton microdroplets 
before and after activation, and the MBs that were formed. Before activation, the 
droplets were allowed to settle in their vial, 90% of the Triton solution was aspirated off 
and replaced with fresh MilliQ, and the resultant solution was thoroughly mixed. This 
dilution was performed twice, which was found to prevent the formation of MBs from 
control Triton solution that lacked PFC. Table 8.2 presents the average measurements of 
the solutions’ droplet and MB diameter and concentration before and after activation. 
After activation all samples saw a reduction in droplet diameter, for C5F12 and C5:C6 
samples, to ~10 % of the initial droplet diameter, and an order of magnitude increase to 
concentration. This was the result of the shock wave fragmenting the emulsion either as 
droplets or MBs (in the case of the latter, with MB condensation back to droplets). 
Respectively, the C5F12, C5:C6, C6F14 samples resulted in MBs with 58, 112, and 154% 
of the initial droplet diameters, and 221, 61, and 14% the initial droplet concentrations. 
The higher content C5F12 MBs may have been smaller due to a faster dissolution rate 
than the larger C6F14 gas molecules, and will have had a higher concentration due to the 
lower energy requirement for phase conversion. All of the C6F14 MBs were coated in a 
layer of non-activated liquid C6F14, which did not appear to change for at least 10 min. 
The stable existence of contacting PFC gas and liquid simultaneously was important as 
it showed that PFC phase changes from liquid to gas and from gas to liquid must have 
energy landscapes that are different from one another. Otherwise, all discrete C6F14 
 234 
volumes would only have been able to be in one phase or another at one time. These 
findings are expected to be true for all PFC molecules. After activation, PFC MBs are 
expected to remain as gas due to the increase in their particle diameter and subsequent 
change to Laplace pressure, however this new finding (of coexistence and contacting 
liquid PFC and gas PFC) adds to the stability against PFC MBs from returning to their 
original phase once the source of activation returns to ambient conditions. 
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 	Fig.	8.14.	Hypobaric	action	of	microfluidic	PFC	Triton	droplets.	(a)	C5F12,	(b)	C5:C6,	and	(c)	C6F14	(i-ii)	droplets	and	the	resultant	(iii)	MBs	formed	are	shown	from	(i)	before	and	(ii-iii)	after	activation.	(civ)	Futher	C6F14	MBs	are	shown.	
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Tab.	8.2.	Average	droplet	and	MB	sizes	and	concentrations	measured	from	the	images	presented	in	Figure	8.14	during	hypobaric	activation	studies.		
		
Figure 8.15 shows C5F12-soybean-BSA droplets in a chamber upon heating to 50 °C, 
then undergoing the hypobaric activation method with the shockwave passing through 
the chamber from the inlet. Hypobaric activation trials of double emulsion droplets off-
chip (results not shown) in a ~25 °C syringe had not resulted in MB formation, instead 
giving an apparent slight reduction in the C5F12 core volume per droplet, with no overall 
change to solution concentration or morphology. The Figure 8.15 experiment aimed to 
observe the double emulsion droplets though the activation process by high frame rate 
imaging. The hypobaric image shown (Figure 8.15d) was during the shockwave portion 
of the process, after the initial volume increase, hence the displacement of droplets from 
the previous images (Figures 8.15a-c). The temperature increase during the experiment 
should have lowered the energy requirement for activation. However, even though the 
test fluid was displaced, no change to the morphology of any of the double emulsion 
droplets was observed.  	
	Fig.	8.15.	On-chip	heating	and	subsequent	hypobaric	activation	trial	of	C5F12-soybean-BSA	droplets.	
Sample StDev	
[μm]
Concentration	
[particles/ml]
StDev	
[μm]
Concentration	
[particles/ml]
StDev	
[μm]
Concentration	
[particles/ml]
Droplets	pre-
activation
23.3 ± 0.4 3.4 9.9E+06 22.7 ± 1.3 6.2 2.8E+06 22.1 ± 0.4 2.9 5.9E+06
	Droplets	post-
activation
2.2 ± 0.03 1.2 1.6E+08 2.7 ± 0.1 1.8 5.1E+07 9.1 ± 0.4 6.0 2.6E+07
Bubbles	post-
activation
13.6 ± 0.7 9.3 2.2E+07 25.5 ± 2.3 8.1 1.7E+06 34.1 ± 4.6 11.5 8.4E+05
C5F12	+	C6F14 C6F14C5F12
Diameter	
[μm]
Diameter	
[μm]
Diameter	
[μm]
(c)	(a)	 (b)	 (d)	25	°C	 25	°C	 50	°C	
Hypobaric	
ac3va3on	
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Hypobaric activation of single emulsion droplets was highly efficient, leading to twice 
as many C5F12 MBs as precursor droplets. However, translating this to the double 
emulsion C5F12-soybean droplets did not provide any activation. The pressure drop that 
both droplet types experienced were roughly the same (the method was user controlled, 
so would not be identical), however the oil layer may have acted to attenuate the shock 
wave before interaction with the PFC core. Added to this, the oil layers’ higher 
viscosity, 40.5 mPa.s,205 compared to water, and stiffness differences between a BSA 
protein-oil and Triton shell may have contributed to a damping effect against increases 
to the droplet volume, providing a higher energy requirement for activation. 
 
 Ultrasound activation 8.3.2.3.
In this section of work, activation of PFC single and double emulsion droplets by US 
was addressed through methods of ADV that were introduced in the Context and 
Background chapter (Chapter 2.3, p 24-27). Activation of bulk samples is first 
presented by low frequency US (45 kHz), followed by more clinically relevant 
frequencies (1.1 MHz), then activation of single droplets of PFC-oil was examined with 
the use of high frame rate imaging. 
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	Fig.	 8.16.	Exposure	of	dilute	microemulsion	C5F12	Triton	droplets	 to	~5	 s	 of	 continuous	wave	45	kHz	ultrasound.		
Figure 8.16 shows a falcon tube filled with a dilute solution of ~25 µm C5F12 Triton 
microfluidic droplets, where the droplets were allowed to settle to the bottom of the tube 
as a pellet, before, during, and after immersion of the droplet portion in a 45 kHz US 
bath. This was a preliminary experiment of PFC droplet activation. The low US 
frequency was used due to PFC activation work presented by Rapoport et al (2009) (see 
Context and Background Chapter 2.3, p 28).143 After exposure of ~2 s, a large (relative 
to the initial droplet pellet) white volume was seen to rapidly rise to the top of the tube 
and then, after ~5 s of the turbulent movement, led to the entire solution becoming 
turbid. This was an indication of droplet to bubble activation, likely of MBs at least 125 
µm in diameter, since the droplets and bubbles would be more and less dense than the 
Triton solution respectively. Exposure of Triton solution, without PFC, to 45 kHz US 
showed no bubble formation (both by eye and microscopic observation). This method 
was repeated and more thoroughly examined using tip sonicated C5F12 Triton 
nanoemulsions. Figure 8.17 shows light microscopy example images of the 
nanoemulsion before and after ~20 s of 45 kHz sonication, and the MBs that were 
formed. ‘Before sonication’ images involved gentle agitation of 1 ml of the PFC 
Before	ultrasound	 A/er	ultrasound	During	ultrasound	
Bubble	
‘cloud’	
(a)	 (b)	 (c)	
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nanoemulsion solution and extraction of a 70 µl sample for imaging. Activation then 
took place, after which the sample was agitated and 70 µl extracted again for ‘after 
images’. Histogram size distributions are given and Table 8.3 lists the size and 
concentration averages (measured from the microscope images) of the droplets (as point 
sources since their size was below optical limits) and MBs before and after activation 
respectively. Activation of C5F12 droplets into MBs was successful, however the MBs 
that were observed were 9.6 times larger (peak size) than expected from theory (see 
Chapter 3.5.1, p 54-56). Previous literature on PFC activation size increase would 
suggest this was due to a three-step system of (1) activation, (2) coalescence, and (3) 
diffusion of gasses from the solution into the newly formed MBs (this theory was 
introduced in Context and Background Chapter 2.3, p 24).123 However, due to the 
monodispersity of the MB sample (PDI ~0.2) it is most likely that coalescence played a 
small role, if any, in size expansion, otherwise a more polydisperse sample would be 
expected. Looking at the concentrations, the droplet point sources appeared to decrease 
by an order of magnitude, further suggesting that the MBs had been formed due to the 
droplets and not from gases dissolved in the solution. Knowing that the nanoemulsion 
was on the order of 5 x 1010 droplets/ml before activation (from qNano measurement, 
Figure 8.5b), if coalescence is disregarded as a reason for over-sized expansion, only ~1 
in 104 droplets activated. The end result was a monodisperse, 106 MBs/ml solution, 
potentially high enough for further US echogenicity studies, but where activation 
efficiency was extremely poor and the MBs were too large for clinical application. 	
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	Fig.	8.17.	Images	of	C5F12-Triton	nanoemulsion	(a-b)	droplets	and	(c)	MBs	(a)	before	and	(b-c)	after	exposure	 to	~5	 s	 of	 continuous	wave	 45	 kHz	 ultrasound,	with	 (d)	 sizing	 histograms	 from	 these	samples.		Tab.	 8.3.	 Average	 droplet	 and	MB	 sizes	 and	 concentrations	 from	 the	 C5F12	 Triton	 nanoemulsion	samples	of	Figure	8.17,	before	and	after	exposure	to	~5	s	of	continuous	wave	45	kHz	ultrasound.	
		
Since the activation efficiency of Figure 8.17 was so poor, a further study was done 
where the droplet solution was first diluted 1 in 100 in Triton solution. It was thought 
that there could be a maximum concentration of MBs allowed before the activation 
energy of the US wave was absorbed and shielded from the droplets. Figure 8.18 
presents this further study and shows measurements of the droplet and MB size and 
concentration over total sonication times, where samples were removed at the time 
Before	sonica,on	
Droplets	
a1er	
sonica,on	
Bubbles	
a1er	
sonica,on	
(a)	
(b)	 (c)	
(d)	
StDev	[μm]
Droplets	pre-activation 1.2 ± 0.02 0.7 1.0E+10 ± 7E+06
Droplets	post-activation 1.1 ± 0.03 0.8
Bubbles	post-activation 18.0 ± 0.2 4.2 7.9E+06 ± 8E+05
Diameter	[μm]
Concentration	
[particles/ml]
1.67E+09
 241 
points given (this solution was not allowed to settle before US exposure). The droplet 
size (microscope measurement) did not change. The droplet concentration was found to 
decrease over 20 s, after which it remained constant, indicating that all droplets that 
would activate had after the first 20 s. The MB size appeared to increase up to 30 s, and 
then began to decrease. The MB concentration had a high error up to 30 s, with some 
samples showing MBs and some not at all (zero MBs at 20 s, single MBs at 30 s). From 
40 s the MB concentration was consistent at ~2 x 105 MBs/ml. The concentration results 
suggest that activation by this method was unreliable. The appearance, disappearance, 
and then re-appearance of MBs could have suggested that activation was occurring on 
large groups of droplets at once, which were then removed from the solution by the 
continued US or floatation, followed by the next set of droplets. The sizing results 
suggest that post-activation, the continued US caused the MBs to rapidly loose their 
volume. This was most likely due to US driven oscillations decreasing shell stability, 
increasing gas dissolution. The initial droplet dilution increased activation efficiency to 
~1 in 103 droplets, though this was still a very poor activation efficiency, and the MB 
size was increased from 18 µm to 30-55 µm, likely due to the higher concentration ratio 
of gases dissolved in solution to MBs. 
 
	Fig.	 8.18.	 C5F12-Triton	 (a)	 nanoemulsion	 droplet	 and	 (b)	 MB	 sizes	 and	 concentrations	 after	exposure	to	continuous	wave	45	kHz	ultrasound	over	times	given.		
Figure 8.19 shows soybean and triacetin C5F12-oil double emulsion droplets before and 
after exposure to the 45 kHz US. No successful MB formation was observed. Instead, 
for the both samples, the C5F12 volumes were removed from almost all droplets and 
reduced in any droplets still loaded with C5F12. This suggested that activation of the 
C5F12 did occur, but that the newly formed MBs were not stabilised, leading to rapid 
dissolution or coalescence and removal by floatation, importantly without the oil 
(a)	 (b)	
Droplets	 Microbubbles	
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portions. Since larger oil droplets were not observed after activation compared to before, 
this did confirm that coalescence of the oil portions did not occur. 
 
	Fig.	8.19.	 Images	of	C5F12-oil-BSA	droplets	 (i)	before	and	(i)	after	exposure	 to	~5	s	of	continuous	wave	45	kHz	ultrasound.	(a)	Soybean	and	(b-c)	triacetin	samples	are	shown,	with	(c)	fluorescence	for	the	latter.	
 
The previous experiments looked at applying 45 kHz US to the PFC droplets at room 
temperature. The work below looked at applying more clinically applicable US of 1.1 
MHz to PFC droplets around body temperature. 
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	Fig.	8.20.	(a)	Microemulsion	C5F12-Triton	and	(b)	C5F12-soybean-BSA	(i-ii)	droplets	and	(iii)	MBs,	in	an	Ibidi	chip	at	34	°C,	(i)	before	and	(ii-iii)	after	exposure	to	≤	1	s,	DC	20%,	1.1	MHz,	12	ms	prf,	3.5	MPa	US.	No	MBs	were	observed	before	US	exposure.		
Figure 8.20 shows C5F12-Triton single emulsion microfluidic droplets, C5F12-soybean-
BSA double emulsion droplets, and the MBs formed before and after exposure to 1.1 
MHz US. Table 8.4 gives the average diameters and concentrations measured from the 
Figure 8.20 images. The double emulsion was compared to the C5F12-Triton 
microemulsion, rather than the nanoemulsion, due to the size differences giving less 
difference to the energy requirement for activation between the two samples. For both 
samples, the droplets reduced by ~9% diameter during US, suggesting more rapid 
dissolution. However, whilst the concentration of the C5F12-Triton microemulsion 
remained the same, indicating poor activation efficiency, the C5F12-soybean-BSA 
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concentration was reduced by ~5 times, suggesting far more efficient activation. The 
concentration of MBs post-activation (ignoring if coalescence occurred) agreed with 
this with only 6% of the C5F12-Triton droplets activating, up to 64% of the C5F12-
soybean-BSA droplets. This indicated that the oil layer aided droplet activation, likely 
by lowering the energy requirement. The major difference between the two samples was 
the polydispersity of MBs formed from activation. The C5F12-Triton droplets formed 
MBs 16.6 times larger than their initial size with a PDI of 0.2, whereas, whilst the 
C5F12-soybean-BSA MBs were on average 3.1 times larger than their initial droplet 
diameter, their PDI was 4.8, with MBs 100s of micrometres large and one bubble 
appearing to be on the millimetre scale. A 3.0 times expansion was expected for the 
C5F12-soybean-BSA droplets (on the basis that their oil volume would remain constant). 
These results suggest that gas diffusion into the C5F12-soybean-BSA MBs did not occur 
but played a large role in C5F12-Triton MB expansion, whereas, coalescence played a 
small role in C5F12-Triton MB expansion but played an important role in the resulting 
large C5F12-soybean-BSA MBs and led to a highly polydisperse sample. The inclusion 
of the thick BSA-oil layer may have prevented gas diffusion across the MB shell far 
greater than the thin Triton shell, but the oil layer may also have allowed for far greater 
coalescence due to requiring more time for stabilisation of the oil-BSA/water interface 
on expansion of the C5F12 core. 	Tab.	8.4.	Average	droplet	and	MB	sizes	and	concentrations	from	the	microfluidic	C5F12-Triton	and	C5F12-soybean-BSA	samples	of	Figure	8.20,	before	and	after	exposure	to		≤	1	s,	DC	20%,	1.1	MHz,	12	ms	prf,	3.5	MPa	US.	
	
 
The last part of this section studied focused US activation of single C5F12-soybean-BSA 
double emulsion droplets under observation with high frame rate microscopy. The aim 
here was to observe how the C5F12 core expanded, including uniformity in all directions, 
how the oil was displaced during activation, including if the C5F12 and oil components 
remained together or spontaneously came apart, and if coalescence occurred. 
 
StDev	
[μm]
Concentration	
[particles/ml]
StDev	
[μm]
Concentration	
[particles/ml]
Droplets	before	US 14.4 ± 0.6 11.4 1.2E+05 15.6 ± 0.4 13.9 3.3E+05
Droplets	after	US 12.9 ± 0.6 10.8 1.8E+05 14.3 ± 1 16.2 6.8E+04
Bubbles	after	US 238.7 ± 11 58.4 7.7E+03 48.7 ± 2 53.1 2.1E+05
Diameter	[μm]
C5-Triton,	Microfluidic	formation
Diameter	[μm]
C5-Soybean-BSA
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	Fig.	8.21.	High	frame	rate	imaging	of	activation	of	a	single	C5F12-soybean-BSA	droplet	by	focused	3.5	MHz,	 continuous	 wave	 (DC	 100%),	 ~1	 MPa	 US,	 at	 ~37	 °C.	 Arrows	 indicate	 the	 droplet	 that	activated	(blue),	one	frame	before	activation,	and	oil	droplets	that	on	the	next	image	have	coalesced	with	the	activated	gas	bubble	(orange).		
Figure 8.21 shows activation of one C5F12-soybean-BSA double emulsion droplet by 
continuous wave, 3.5 MHz US. Activation to full MB size was seen to occur over less 
than 80 µs. During expansion, the oil that had encapsulated the C5F12 core was not seen 
to separate from the C5F12 portion. Instead it rapidly thinned out, and over the next 2 ms, 
surrounding oil droplets were acquired and then merged with the shell of the newly 
formed MB. Since no surrounding oil droplets, which lacked C5F12 cores, were seen to 
coalesce with each other, it can be concluded that the merging was only due to the 
unstable, newly formed MB surface. This surface was formed so rapidly through 
expansion that the initial droplet’s pre-existing oil layer likely did not coat the entire 
MB surface. If a bulk sample was activated in a similar way, and two newly activated 
MBs both merged with one oil structure (or the oil layer from another oil coated MB), 
bridging the MBs together, this would be expected to allow for the MB gas cores to 
contact without stabilising surfactant, and so cause coalescence of the gas cores.  
Figure 8.22 looked at this potential further by observing activation of a more 
concentrated area of C5F12-soybean-BSA droplets. The DC here was reduced from 
100% to 10% in an effort to bring the US towards clinical viability (DC ≤1% is used 
with tissue to prevent heating)131,136. The US focal point was of the order of 1 mm2, 
meaning that the entire area observed (0.4 mm2) was expected to have been exposed to 
the US wave. Droplets were seen to activate in a stochastic manner, which agrees with 
claims in literature on single emulsion PFC droplets,278 at an estimated rate of 4 
0.00	ms	(a)	 0.08	ms	(b)	
1.20	ms	(c)	 1.42	ms	(d)	
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droplets/ms, rather than all at once, over the area observed. After activation of a C5F12 
double emulsion droplet, surrounding droplets were seen to be displaced by the 
expanding gas volume, rather than coalesce immediately on contact. When merging did 
occur (after ~1 ms), if the displaced droplet contained a liquid C5F12 core, immediately 
on contact of the liquid and gas C5F12 portions, the liquid core activated into further gas, 
causing another rapid expansion and the potential for further coalescence with 
surrounding droplets. After 9.9 ms it can be seen that almost all of the activated droplets 
had merged into one large gas pocket, and that the rapid displacement of the gas 
surfaces had led portions of the merged oil to break up into a polydisperse distribution 
of oil droplets. Towards 35.6 ms the main gas pocket merged with further C5F12 
droplets outside of the area of focus, with the main volume being displaced towards 
them. This allowed observations of the high degree of oil droplet break up that had 
occurred. 
 247 
	Fig.	8.22.	High	frame	rate	imaging	of	activation	of	C5F12-soybean-BSA	droplets	by	focused	3.5	MHz,	DC	10%,	~1	MPa	US,	at	~37	°C.	Arrows	indicat	droplets	that	by	the	next	image	had	activated	(blue).	
0.0	ms	(a)	 1.1	ms	(b)	
1.6	ms	(c)	 2.5	ms	(d)	
9.9	ms	(e)	 35.6	ms	(f)	
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The main features that were observed during these high frame rate activation 
experiments were that droplets activated in a stochastic manner, that on activation the 
expansion was rapid, and that surface stability was low, leading to the high potential for 
coalescence. All of these features would be problematic for activating a solution on 
mass for clinical use. Due to the stochastic activation, a high US exposure time would 
be required in order to activate enough droplets effectively, which clinically would 
mean a higher potential for damage to the patient from the US exposure. The rapid 
expansion on activation followed by the continued gas surface displacement from US 
(whilst activating more droplets) could lead to damaging shear stresses and mechanical 
forces on surrounding vasculature. The dramatic decrease to surface stability on 
activation and subsequent coalescence could easily lead to the formation of gas pockets 
and droplets of oil big enough to cause damaging vasculature occlusion.  
 
8.4. Conclusion 
During this chapter, the aims were to form liquid PFC-in-oil double emulsion 
precursors and assess their ability to be activated into OLI-MBs. There was a significant 
focus during this chapter on forming the emulsion so that after activation it would 
theoretically be of a sufficient size and concentration for clinical use, and on observing 
the conditions during activation to evaluate their suitability towards clinical application. 
The sections of work firstly look at forming single emulsion PFC droplets as a micro- 
and nanoemulsion, followed by the formation of double emulsion PFC-oil droplets. The 
work then progressed to study a few different methods for activation that could be 
suitable for activation either outside (heat, on-chip pressure drop, and hypobaric 
activation) or inside (US) the body.  
 
Single emulsion PFC droplets were formed with cores of C5F12, C6F14, and a mix of 
both PFCs (C5:C6). These were formed on the micro- and nanoscale, by microfluidic 
FF pinch-off and tip sonication respectively. Microscale C5F12 and C6F14 droplets were 
formed with Triton shells at 25.0 ± 0.9 and 22.1 ± 1.9 µm respectively. Kept at 4 °C, the 
C5F12 droplets showed a 6% diameter increase and negligible concentration change over 
42 days. As such, these PFC droplets showed a long shell life, very suitable for clinical 
application, though their size was far too large (> 8 µm) for injection into the blood 
stream. Nanoscale C5F12 droplets were formed with Triton shells at 327 ± 2 nm with 
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droplets up to 600 nm. At 4 °C, this nanoemulsion had a short half-life of 1.1 h. Over 
the first half life the droplets had an 11 ± 3% increase in their diameter, up to 50 ± 10% 
over 5 h. This meant that any further study performed with the PFC nanoemulsions 
would have to be performed as soon as possible on the day of formation, and that these 
nanoemulsions are not suitable for storage before any intended clinical use. At this point 
the experiments studied the formation of double emulsion PFC-oil droplets. Mechanical 
agitation formation of single emulsion C5F12 droplets in surfactant/oil solutions was 
studied with the aim to use FF microfluidic to pinch-off the PFC-oil emulsion into 
droplets in an aqueous phase. Dodecane and triacetin both showed successful 
encapsulation of C5F12 when mechanically agitated with 1 vol% Triton in the oil phase 
and triacetin was also successful when using 1 vol% Span80 in place of Triton. The 
dodecane emulsion had droplets of 638 ± 9 (FWHM 583) nm. Attempted encapsulation 
of the C5F12-(dodecane+Triton) emulsion into droplets on-chip using Triton aqueous 
solution gave monodisperse PFC-oil droplets on-chip of 26 µm. Off-chip the size 
dropped to 2.5 µm with a wide size distribution (FWHM 13.6 um). It is believed that 
during the transition from on-chip to off-chip imaging a high proportion of the PFC 
cores phase converted into gas, expanding and breaking the thick oil shells apart into 
smaller oil droplets. As such, this formation route was unusable for further activation 
studies during this project, but would be worth revisiting in the future for further study. 
Formation of double emulsion PFC-oil droplets was possible through mechanical 
agitation of 10 vol% C5F12, 10 vol% oil, and BSA solution using triacetin, isoamyl 
acetate, and soybean oil, where droplets were given at 35 ± 3 (FWHM 47), 7.7 ± 0.4 
(FWHM 5.8), and 5.3 ± 0.6 (FWHM 5.6) µm respectively. For soybean, dropping the 
C5F12 and oil to 1 vol% showed a reduction in droplet size to 3.3 ± 0.1 (FWHM 1.8) µm, 
however further variation of the oil and BSA concentrations were not found to give any 
further control over the droplet size, concentration, or oil fraction for each droplet. For 
all 10 vol% (oil and C5F12) samples, on average the droplets were found to have a C5F12 
core that was 0.68 times (SD 0.11) the total droplet diameter. This dropped to 0.59 
times (SD 0.11) for the 1 vol% soybean sample. This disagreed with literature on the 
same C5F12-soybean-BSA mechanically agitated droplet formation technique presented 
by Fabiilli et al. (2010), where they found that 12 vol% droplets had C5F12 cores ~0.4 
times the total droplet diameter.138  
Activation studies showed that none of the PFC droplet samples showed any activation 
into MBs on heating up to 50 °C. Pressure drop supplied by high flow rates through an 
on-chip nozzle was not found to activate any droplet emulsions either. Hypobaric 
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activation did show success at activating the C5F12, C6F14, and C5:C6 microemulsions. 
All samples showed a dramatic decrease in droplet size after activation, caused by the 
activation method’s shock wave breaking apart the droplets. The C5F12 microemulsion 
gave MBs that were the smallest, at 13.6 ± 0.7 (SD 9.3) µm, and the highest 
concentration, at 2.2 x 107 MBs/ml, 220% of the initial droplet concentration. However, 
C5F12-soybean-BSA double emulsion droplets were not seen to activate by hypobaric 
activation, even after heating to 50 °C on-chip. Continuous wave, 45 kHz US was 
observed to activate the C5F12 microemulsion in under 5 s. 45 kHz US applied to the 
C5F12 nanoemulsion showed MB formation at 18 ± 0.2 (SD 4.2) µm and 7.9 x 106 
MBs/ml. However, the efficiency of activation was low at around 1 in 104 droplets. 
Diluting the bulk nanoemulsion 1 in 100 showed an increase in activation efficiency to 
1 in 103 droplets, but increased MB size to 30-55 µm. Attempting to activate the C5F12-
soybean-BSA double emulsion using 45 kHz US gave a post-US sample where the PFC 
core was significantly reduced if not removed from all droplets, with no OLI-MBs. 
Activation of single and double emulsion C5F12-Triton and C5F12-soybean-BSA droplets 
by 1.1 MHz US in a 37 °C Ibidi chip showed a drop in droplet diameter for both 
samples by ~9%. However, where as the concentration of the C5F12-Triton droplets 
remained roughly the same, the concentration of the C5F12-soybean-BSA droplets 
showed a 5 times reduction, suggesting a greater activation efficiency. This means that 
while the oil layer had retarded activation in the hypobaric studies, the oil layer had 
aided activation in the 1.1 MHz US studies. The C5F12-Triton and C5F12-soybean-BSA 
1.1 MHz US activated MBs were formed at 240 ± 10 (SD 60) µm and 49 ± 2 (SD 53) 
µm respectively, equating to an average diameter increase of 16.6 times and 3.1 times 
the initial average diameter respectively, and at 103 and 105 MBs/ml respectively. From 
theory, the C5F12-Triton and C5F12-soybean-BSA droplets were expected to expand in 
diameter by 5 times and 3.0 times respectively during activation into MBs. This led to 
the conclusion that on activation, the larger expansion of the monodisperse C5F12-Triton 
MBs was driven by the diffusion of gases in from the surrounding solution, while the 
high polydispersity of the C5F12-soybean-BSA MBs, which expanded as theory dictated 
without regarding diffusion, was driven by coalescence. The higher degree of 
coalescence was likely caused by the surfactants being less efficient at stabilising the 
water-oil interface than they would be at stabilising a water-gas interface. This problem 
of the oil layer causing a far greater coalescence of the PFC MBs was later confirmed 
when observing activation of single C5F12-soybean-BSA droplets by high frame rate 
microscopy using 3.5 MHz US. Observing a single droplet undergo activation showed 
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that the full MB diameter was achieved in less than 80 µs. Observing multiple droplets 
showed significant coalescence over the area of activation, eventually forming a large 
gas pocket, surrounded by a thick oil layer, covering most of the 0.4 mm2 observed area. 
For the US used, activation occurred at a rate of ~4 droplets/ms over the 9 x 10-3 mm3 
volume observed rather than all of the droplet activating at once. Similarly, Fabiilli et al. 
(2010) have previously shown that they could only achieve ~5% activation for C5F12-
soybean-BSA droplets of 2 µm through US activation.138 
These last two US studies brought serious concerns to the future prospects of double 
emulsion PFC-in-oil droplets for clinical use. The rapid expansion during activation 
could cause damage to tissue surrounding the droplet/MB through the shear forces and 
mechanical pressure it could impart on vasculature walls. The low rate of activation 
would require a long US exposure to be used in order to active enough droplets. This 
would prolong exposure to the patient and could result in damage to healthy tissue. 
Alternatively, a higher concentration of drug-loaded droplets could be delivered to the 
patient to alleviate the need for a higher proportion of droplets activated into MBs. 
However, this would greatly increase the required total dosage of drug delivered into 
the patient and the remaining drug left over after activation, reducing bioavailability. 
Lastly, the far greater degree of coalescence observed with oil coated PFC droplets 
increases the danger that large pockets of gas or droplets of oil could be formed in the 
blood stream during activation, leading to blood flow problems that could have serious 
impact on patient health. 
  
 252 
9. Conclusions 
 
The primary, overarching goal of this thesis project was to develop a reliable and simple 
method for the formation of MBs with a thin oil layer coating (OLI-MBs) of clinically 
relevant size and concentration. With that aim in mind, the energetic favourability of 
different conformations of gas, oil, and lipid/aqueous phases was studied with a view to 
see if the OLI-MB structure would be expected to be able to be formed, and then after 
formation if the structure would be stable. It was concluded that the formation of OLI-
MBs would be possible, and that they could be stable after formation, but that only with 
direct control over how the phases were allowed to meet could a sample be produced at 
a high concentration, with control over the average OLI-MB size, uniformity of the oil 
layer thickness between OLI-MBs, and a lack of pure oil droplets and non-oil-MBs. 
This thesis then presented three possible routes for the formation of OLI-MBs under 
controlled conditions; three-phase pinch-off through a single FF microfluidic nozzle, 
formation of double emulsion liquid PFC-oil droplets to be used as precursors for 
activation into gas filled OLI-MBs, and oil nanodroplet self-assembly and spreading 
into a thin oil layer at newly formed MB surfaces. The three-phase pinch-off route had 
previous been shown to be possible by Hettiarachchi et al. (2009), Kendall et al. (2012), 
and Shih et al. (2013),31,82,94,95 though in the last publication they had admitted that 
collection of a sufficient OLI-MB sample off-chip was not possible. During the studies 
of this thesis we were never able to replicate the on-chip MB formation results. This 
may have been due to limitations in the apparatus used. For example using 
microfluidics formed from different materials as the above publications, leading to 
changes to the wall rigidity and interfacial tension with the gas, oil, and aqueous phases, 
or the pump systems not supplying sufficient control over the interaction of these 
phases. The liquid PFC-oil precursor route was first presented by Fabiilli et al. 
(2010).138 Since the method of formation was mechanical agitation, a chaotic route, 
work in this thesis looked to optimise the formation process, in order to form a more 
monodisperse sample, by varying the concentrations of the droplet components. 
However, batch variation both in and between samples remained high. Activation by 
US then shed new light on the clinical potential for these structures. Compared to non-
oil-PFC droplets, the oil-PFC droplets showed a far greater potential for coalescence. 
Whilst on average OLI-MBs were formed only 3 times larger than the precursor 
microdroplets, the sample polydispersity was large, forming many MBs 100s of µm in 
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diameter, even up to millimetres in scale. Stable particles of this size could easily 
occlude the vasculature, leading blood flow to stop, potentially causing serious damage 
to a patient. Observing activation at high frame rate showed that the full MB volume 
was achieved in under 80 µs, which has the potential for damaging shear forces and 
mechanical stresses if activation were to occur in vivo. The last study also confirmed 
that, like non-oil-PFC droplets,278 activation of the PFC-oil droplets was stochastic, 
which would require long US exposure times for adequate droplet activation efficiency. 
These findings bring serious questions to the clinical viability of liquid PFC-oil double 
emulsion droplets as precursors for in vivo activation. Use of oil nanodroplets for 
microfluidic FF formation of OLI-MBs was a route novel to this thesis. OLI-MBs were 
successfully formed from squalane, squalene, and tripropionin oil, with POPC shells. 
Extending formation to these three oils has resulted in extending the capabilities of the 
OLI-MB structure. Highly hydrophobic payloads can be loaded into the squalane and 
squalene, whilst low water solubility payloads can be loaded into the tripropionin. 
Squalane and tripropionin OLI-MBs were formed at 2.4 ± 0.3 (SD 1.6) µm and 2.1 ± 
0.1 (SD 0.8) µm respectively, meaning that they have been formed at size for further 
clinical interest. Off-chip, OLI-MB samples only reached concentrations of 106 and 105 
OLI-MBs/ml respectively and samples halved in concentration after ~35 min. This 
concentration and lifetime must be improved upon if the OLI-MB structures are to be 
considered for further clinical application. While OLI-MBs showed US response, 
indicating the presence of a gas core, the frequency at resonance was unexpected. Large 
~20 µm OLI-MBs showed a wide resonance, with a centre at 3 MHz, where as the 
smaller microfluidic 2.4 µm OLI-MBs showed a lower resonance at 1.8 MHz. 
According to theory, smaller MBs should show higher resonance frequencies. As such, 
further US work needs to be done to address how the OLI-MBs were oscillating under 
the US exposure, and the effect the oil layer gave to damping oscillations. 
 
In terms of future work, the three-phase FF studies could be improved by looking at 
surface treatment of the microfluidic walls and use of more reliable fluid inlet pumps. 
Work by Deshpande et al. (2016) looked at forming water-oil-water emulsions in a 
similar three-phase microfluidic nozzle design to that used during this project.268 They 
claimed that without surface treatment of microfluidic device to be hydrophobic before 
the nozzle and hydrophilic after the nozzle, and the use of fluid pumps more reliable 
than syringe drivers, pinch-off of water-oil-water droplets was not possible. The same 
pinch-off limitations are likely to also apply to the formation of gas-oil-water emulsions 
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(OLI-MBs). For the LOND formed OLI-MBs, the most important future steps are to 
study the US response further, look into OLI-MB drug loading capacity and drug 
release, and to try to improve OLI-MB concentration and lifetime. Traditionally, MB 
concentration and lifetime can be improved by increasing the stability of the MB shell. 
A problem with using this method for OLI-MB stability is that the shell comes from the 
precursor LONDs, which if too stable, will not spread. Therefore, a method needs to be 
used in which the OLI-MB shell can be further stabilised after formation of the thin oil 
layer. One candidate material for this would be diacetylene molecules. MBs have 
previously been formed with lipid-diacetylene shells. After exposure to ultraviolet light, 
these MBs were shown to have significantly increased lifetime due to the diacetylene 
molecules cross-linking with one another within the lipid shell.214 Using this method, 
LONDs could be formed with POPC-diacetylene shells, remain non-cross-linked, and 
be used for the formation of OLI-MBs. After formation, these OLI-MBs could then be 
exposed to ultraviolet light, cross-linking the shell, extending their lifetime. Figure 9.1 
shows a schematic of a more efficient system, where a serpentine could be added to the 
microfluidic outlet with the ultraviolet light being shone through it. This would allow 
the OLI-MBs time to form, stabilise, and be exposed to the ultraviolet light all on-chip. 
This method could potentially have the very desirable effect of increasing the off-chip 
OLI-MB concentration towards the far higher concentration of OLI-MBs predicted 
from on-chip observations. 
 Fig.	9.1.	Schematic	of	the	microfluidic	formation	of	OLI-MBs	from	lipid-diacetylene	LONDs	(orange),	followed	by	an	on-chip	serpentine	to	allow	OLI-MB	stabilisation	time	and	a	further	ultraviolet	light	exposure	step	to	cross-link	the	diacetylene	molecules	 in	the	shell	(purple).	MB	outline	represents	the	 entire	 lipid-diacetylene	 and	 oil	 shell,	 even	 though	 only	 the	 outer	 lipid-diacetylene	 portion	becomes	cross-linked.		 	
UV	exposure	
Non-cross-linked	 Cross-linked	
LOND	solu7on	
OLI-MBs	
Gas	
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